Document:

Exhibit

Exhibit 10.2

AMENDED AND RESTATED

PURCHASE AGREEMENT

by and among

ALERE INC.,

QUIDEL CARDIOVASCULAR, INC.,

for purposes of Section 11.15,

QUIDEL CORPORATION

and

for the limited purposes herein set forth,

ABBOTT LABORATORIES

Dated as of September 15, 2017

TABLE OF CONTENTS
	
			
	ARTICLE I DEFINITIONS
	1
	

	SECTION 1.01. Certain Defined Terms.
	1
	

	SECTION 1.02. Definitions.
	12
	

	SECTION 1.03. Interpretation.
	13
	

	ARTICLE II PURCHASE AND SALE
	14
	

	SECTION 2.01. Purchase and Sale of Assets.
	14
	

	SECTION 2.02. Assumption and Exclusion of Liabilities.
	16
	

	SECTION 2.03. Foreign Acquisition Agreements.
	18
	

	SECTION 2.04. Non-Assignment; Consents.
	18
	

	SECTION 2.05. Purchase Price.
	20
	

	SECTION 2.06. Purchase Price Allocation.
	20
	

	SECTION 2.07. Closing.
	22
	

	SECTION 2.08. Deferred Asset Transfers.
	23
	

	SECTION 2.09. Closing Deliveries by Seller.
	24
	

	SECTION 2.10. Closing Deliveries by Purchaser.
	24
	

	SECTION 2.11. Transferred Inventory Determination and Adjustment.
	24
	

	ARTICLE III REPRESENTATIONS AND WARRANTIES OF ABBOTT
	26
	

	SECTION 3.01. Organization; Standing.
	26
	

	SECTION 3.02. Corporate Authorization; Noncontravention.
	26
	

	SECTION 3.03. Litigation.
	27
	

	SECTION 3.04. Brokers and Other Advisors.
	27
	

	SECTION 3.05. No Other Representations or Warranties.
	27
	

	ARTICLE IV REPRESENTATIONS AND WARRANTIES OF SELLER
	28
	

	SECTION 4.01. Organization; Standing.
	28
	

	SECTION 4.02. Corporate Authorization; Noncontravention.
	29
	

	SECTION 4.03. Governmental Approvals.
	30
	

	SECTION 4.04. Financial Statements; Undisclosed Liabilities.
	30
	

	SECTION 4.05. Absence of Certain Changes.
	31
	

	SECTION 4.06. Legal Proceedings.
	31
	

	SECTION 4.07. Compliance with Laws; Governmental Authorizations.
	32
	

	SECTION 4.08. Tax Matters.
	32
	

	SECTION 4.09. Intellectual Property.
	32
	

	SECTION 4.10. Assets.
	33
	

	SECTION 4.11. Material Contracts.
	33
	

	SECTION 4.12. Regulatory Compliance.
	34
	

	SECTION 4.13. Brokers and Other Advisors.
	35
	

	SECTION 4.14. No Other Representations or Warranties.
	35
	

	ARTICLE V REPRESENTATIONS AND WARRANTIES OF PURCHASER
	36
	

	SECTION 5.01. Organization; Standing.
	36
	

	SECTION 5.02. Corporate Authorization; Noncontravention.
	36
	

i

	
			
	SECTION 5.03. Governmental Approvals.
	37
	

	SECTION 5.04. Litigation.
	38
	

	SECTION 5.05. Financing.
	38
	

	SECTION 5.06. Solvency; Fraudulent Conveyance.
	38
	

	SECTION 5.07. Brokers and Other Advisors.
	38
	

	SECTION 5.08. Investigation.
	38
	

	ARTICLE VI COVENANTS AND AGREEMENTS
	40
	

	SECTION 6.01. Conduct of the Business.
	40
	

	SECTION 6.02. Efforts; Regulatory and Other Authorizations.
	41
	

	SECTION 6.03. Public Announcements.
	44
	

	SECTION 6.04. Access to Information; Confidentiality.
	45
	

	SECTION 6.05. Notification of Certain Matters.
	47
	

	SECTION 6.06. Credit and Performance Support Obligations.
	47
	

	SECTION 6.07. Seller Names and Marks.
	47
	

	SECTION 6.08. Records Access and Transfer.
	49
	

	SECTION 6.09. Further Assurances; Post-Closing Cooperation.
	50
	

	SECTION 6.10. Audited Financial Statements.
	51
	

	SECTION 6.11. Specified Business Contracts.
	52
	

	ARTICLE VII TAXES
	52
	

	SECTION 7.01. Periodic Taxes.
	52
	

	SECTION 7.02. Refunds and Credits.
	52
	

	SECTION 7.03. Resolution of Tax Controversies.
	53
	

	SECTION 7.04. Tax Cooperation.
	53
	

	SECTION 7.05. Conveyance Taxes.
	53
	

	SECTION 7.06. VAT.
	53
	

	SECTION 7.07. Survival of Obligations.
	54
	

	ARTICLE VIII CONDITIONS TO CLOSING
	54
	

	SECTION 8.01. Conditions to Obligation of Purchaser.
	54
	

	SECTION 8.02. Conditions to Obligation of Seller.
	55
	

	ARTICLE IX TERMINATION
	56
	

	SECTION 9.01. Termination.
	56
	

	SECTION 9.02. Effect of Termination.
	57
	

	ARTICLE X INDEMNIFICATION
	58
	

	SECTION 10.01. Survival of Representations and Warranties.
	58
	

	SECTION 10.02. Indemnification by Seller.
	58
	

	SECTION 10.03. Indemnification by Purchaser.
	59
	

	SECTION 10.04. Limitations on Indemnifiable Losses.
	59
	

	SECTION 10.05. Indemnity Procedures.
	60
	

	SECTION 10.06. Tax Treatment of Indemnity Payments.
	62
	

	SECTION 10.07. Exclusivity.
	62
	

	ARTICLE XI GENERAL PROVISIONS
	62
	

	SECTION 11.01. Amendment.
	62
	

	SECTION 11.02. Extension of Time; Waiver, Etc.
	62
	

ii

	
			
	SECTION 11.03. Assignment.
	63
	

	SECTION 11.04. Counterparts.
	63
	

	SECTION 11.05. Entire Agreement; No Third Party Beneficiaries.
	63
	

	SECTION 11.06. Governing Law; Jurisdiction.
	63
	

	SECTION 11.07. Specific Enforcement.
	64
	

	SECTION 11.08. WAIVER OF JURY TRIAL.
	64
	

	SECTION 11.09. Notices.
	65
	

	SECTION 11.10. Bulk Sales Laws.
	66
	

	SECTION 11.11. Severability.
	66
	

	SECTION 11.12. Fees and Expenses.
	67
	

	SECTION 11.13. No Recourse.
	67
	

	SECTION 11.14. Rescission.
	67
	

	SECTION 11.15. Guarantee.
	67
	

	SECTION 11.16. Supremacy.
	68
	

EXHIBITS
Exhibit A    -    Accounting Methodologies
Exhibit B    -    Assignment, Assumption and Bill of Sale
Exhibit C    -    [Intentionally Deleted]
Exhibit D    -    Scios Assignment and Assumption Agreement
Exhibit E    -    Transition Services Agreement
Exhibit F    -    FIRPTA Affidavit

iii

AMENDED AND RESTATED PURCHASE AGREEMENT
THIS AMENDED AND RESTATED PURCHASE AGREEMENT is dated as of September 15, 2017, by and among Alere Inc., a Delaware corporation (“Seller”), Quidel Cardiovascular Inc. (f/k/a QTB Acquisition Corp.), a Delaware corporation (“Purchaser”), for purposes of Section 11.15, Quidel Corporation, a Delaware corporation (“Purchaser Parent”) and, for the limited purposes herein set forth, Abbott Laboratories, an Illinois corporation (“Abbott”). Seller and Purchaser are referred to herein collectively as the “Parties” and individually as a “Party”.  
WHEREAS, the Parties, Abbott and Purchaser Parent entered into that certain Purchase Agreement, dated as of July 15, 2017 (the “Original Purchase Agreement”), and the Parties and Abbott now desire to amend and restate the Original Purchase Agreement (it being understood that all references herein to this Agreement refer to the Original Purchase Agreement as amended and restated hereby and that all references herein to the “date hereof” or the “date of this Agreement” refer to July 15, 2017);
WHEREAS, Seller and Abbott have entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated as of January 30, 2016, as amended on April 13, 2017, pursuant to which, subject to the conditions set forth in the Merger Agreement, Angel Sub, Inc., a Delaware corporation and a wholly owned Subsidiary (as hereinafter defined) of Abbott, will be merged with and into Seller (the “Merger”), with Seller surviving (the “Merger Transaction”); and
WHEREAS, Seller desires to effect the sale and divestiture of the Business and Purchaser desires to purchase the Business. 
NOW, THEREFORE, in consideration of the promises and the mutual agreements and covenants hereinafter set forth, and intending to be legally bound, the Parties, Purchaser Parent and Abbott hereby agree as follows:
ARTICLE I
DEFINITIONS
SECTION 1.01.    Certain Defined Terms. For purposes of this Agreement:
“Accounting Methodologies” means the accounting methodologies, conventions, policies, practices and procedures set forth on Exhibit A.
“Accounts Payables” means all trade accounts payables to the extent related to the Business as of the Closing arising out of the purchase or other acquisition of goods or services of the Business prior to the Closing.

1

“Accounts Receivable” means all trade accounts and notes receivable and other miscellaneous receivables to the extent related to the Business as of the Closing arising out of the sale or other disposition of goods or services of the Business prior to the Closing. 
“Affiliate” means, as to any Person, any other Person that, directly or indirectly, controls, or is controlled by, or is under common control with, such Person. For this purpose, “control” (including, with its correlative meanings, “controlled by” and “under common control with”) shall mean the possession, directly or indirectly, of the power to direct or cause the direction of management or policies of a Person, whether through the ownership of Securities or partnership or other ownership interests, by contract or otherwise. For purposes of this Agreement, (a) prior to the Effective Time (as defined in the Merger Agreement), none of Abbott or any of its Affiliates shall be deemed or considered Affiliates of Seller or any of its Affiliates and (b) from and after the Effective Time, Seller and its Affiliates shall be deemed Affiliates of Abbott and its Affiliates.
“Agreement” means this Purchase Agreement, including all Schedules and Exhibits hereto, as it may be amended from time to time in accordance with its terms. 
“Ancillary Agreements” means, collectively, Assignment, Assumption and Bill of Sale, Foreign Acquisition Agreements, Scios Assignment and Assumption Agreement, Transition Services Agreement and any other agreements that the Parties and Abbott may mutually agree.
“Archived Records Agreement” means the Archived Records Agreement to be entered into between Seller and Purchaser pursuant to the Triage Purchase Agreement.
“Asset Seller Entities” means, individually, or collectively, Seller and the Subsidiaries of Seller that are identified in Schedule 1.01(a).
“Assignment, Assumption and Bill of Sale” means the assignment, assumption and bill of sale, in the form attached as Exhibit B, to be entered into at the Closing between the applicable Asset Seller Entities and the applicable Designated Purchasers.
“BC” means Beckman Coulter, Inc.
“BC Agreements” means, collectively, the OEM Supply Agreement and the other Contracts related thereto or contemplated thereby, in each case that are between Seller or its Affiliates, on the one hand, and BC or its Affiliates, on the other hand, listed on Schedule 1.01(b).
“BNP” means the human protein known as B-type natriuretic peptide.
“BNP Antibodies” means the antibodies binding to BNP that are described more specifically in, and which as of the date of this Agreement are being supplied to BC by the Asset Seller Entities pursuant to, the OEM Supply Agreement, including Scios Antibody 106.3 and BNP .10 Antibody as supplied to BC pursuant thereto.

2

“Books, Records and Files” means any studies, reports, records (including shipping records), books of account, invoices, instruments, surveys, data (including financial, sales, purchasing and operating data), computer data, disks, tapes, marketing plans, customer lists, supplier lists, distributor lists, correspondence and other documents.
“Business” means (a) the OEM Supply Agreement, and (b) the distribution, marketing, promotion, selling or offering for sale of the Product, as and to the extent conducted by the Asset Seller Entities as of the date of this Agreement, but excluding in each case the discovery, generation, formulation, production or manufacture of the BNP Antibodies or any other any antibody or reagent.  
“Business Confidential Information” means any confidential or proprietary information known as of the Closing to Seller or Abbott or their respective Affiliates that relates to the Business or the Purchased Assets, including trade secrets, processes, price, customer and supplier lists, pricing and marketing plans, policies and strategies, details of client and consultant Contracts, operations methods or business acquisition plans, in each case other than any such information (a) to the extent that it also relates to the Excluded Assets, Excluded Liabilities, Excluded Businesses or Other Transactions or (b) as to which Seller or its Affiliates owns or retains an undivided interest following the Closing.
“Business Day” means any day that is not a Saturday, a Sunday or other day that (a) is a statutory holiday under the federal Laws of the United States or (b) is otherwise a day on which banks in New York, New York are authorized or obligated by Law or executive order to remain closed.
“Cash Equivalents” means, with respect to any Person at any date, without duplication, money orders, bank drafts, commercial paper, treasury bills, short-term United States federal government bonds, checks received but not yet deposited or money market funds, in each case on hand or credited to an open account in the name of such Person with a Third Party financial institution.
“Code” means the Internal Revenue Code of 1986.  
“Competition Laws” means the Sherman Antitrust Act, the Clayton Antitrust Act, the Hart-Scott-Rodino Antitrust Improvement Act of 1976, the Federal Trade Commission Act, all applicable foreign antitrust Laws and all other applicable Laws that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization, lessening of competition or restraint of trade through merger or acquisition.
“Consent” means any consent, approval, authorization, consultation, waiver, permit, grant, agreement, certificate, exemption, order, registration, declaration, filing, notice of, with or to any Person or under any Law, or the expiration or termination of a waiting period under any Competition Law.
“Contract” means any loan or credit agreement, indenture, debenture, note, bond, mortgage, deed of trust, lease, sublease, license, or contract.

3

“Datasite” means the virtual data room entitled “Temple-B” hosted by Merrill Corporation at https://global.merrillcorp.com.
“Designated Purchaser” means Purchaser or, if directed in writing by Purchaser, any direct or indirect wholly owned Subsidiaries of Purchaser Parent.
“Dollars” and “$” shall each mean lawful money of the United States.
“Encumbrance” means any mortgage, deed of trust, lease, license, condition, covenant, restriction, hypothecation, option to purchase or lease or otherwise acquire any interest, right of first refusal or offer, conditional sale or other title retention agreement, adverse claim of ownership or use, easement, encroachment, right of way or other title defect, Third Party right or encumbrance of any kind or nature.
“Exchange Rate” means, with respect to a given day, the exchange rate between the applicable Foreign Currency and Dollars as observed by Bloomberg (ask rate or, if the Foreign Currency is in Euros, bid rate) at 9:00 a.m. Eastern Time on such day.
“Excluded Businesses” means any and all businesses of Abbott, the Asset Seller Entities or their respective Affiliates other than the Business. 
“Foreign Currency” means any currency other than Dollars.
“Fraud” means common law liability of a Party or Abbott for willfully and knowingly committing fraud, with the specific intent to deceive and mislead, arising from a breach of, or inaccuracy in, a representation and warranty set forth in Article III, IV or V.
“Fundamental Representations” means the representations and warranties of Seller contained in Section 4.01 (Organization; Standing), Sections 4.02(a) and (b) (Corporate Authorization), Section 4.08 (Tax Matters) and Section 4.13 (Brokers and Other Advisors).
“GAAP” means generally accepted accounting principles in the United States, consistently applied.
“Governmental Authority” means any government, court, regulatory or administrative agency, commission or authority or other legislative, executive or judicial governmental entity (in each case including any self-regulatory organization), whether federal, state or local, domestic, foreign or multinational.
“Governmental Authorization” means, other than a Registration, any licenses, approvals, clearances, permits, certificates, waivers, amendments, consents, exemptions, variances, expirations and terminations of any waiting period requirements (including pursuant to Competition Laws), other actions by, and notices, filings, registrations, qualifications, declarations and designations with, and other authorizations and approvals issued by or obtained from, a Governmental Authority.

4

“Healthcare Regulatory Authority” means any federal, national, foreign or multinational governmental health regulatory agency or authority with jurisdiction over (a) the development, marketing, labeling, sale, use, handling and control, safety, efficacy, reliability, manufacturing, approval, or licensing of any drug, device or over-the-counter pharmaceutical product, (b) healthcare programs under which such products are purchased, or (c) the protection of personal health information, including Notified Bodies established by European Union member states to assess whether products comply with the EU Medical Devices Directive.
“Indebtedness” means, with respect to any Person at any date, without duplication, (a) all indebtedness or obligations of such Person for borrowed money, including any indebtedness evidenced by notes, bonds, debentures or similar Contracts, (b) all debt securities or warrants or other rights to acquire any debt securities of such Person, (c) all guarantee obligations of such Person of any of the foregoing indebtedness, obligations or debt securities of another Person, (d) all obligations under capitalized leases, determined in accordance with GAAP and (e) all “keep well” or other agreements entered into by such Person to maintain any of the foregoing.
“Intellectual Property” means all intellectual property and other similar proprietary rights in any jurisdiction, whether registered or unregistered, including such rights in and to: any patent (including all reissues, divisions, continuations, continuations-in-part and extensions thereof), patent application or invention discovery; any Trademark; any copyright, copyright registration, design, design registration or database rights; any Internet domain name, and registrations and applications therefor; any Know-How; and any computer software (including source and object codes, databases and related documentation).
“Know-How” means trade secrets, confidential know-how, confidential customer data, or other confidential information, whether tangible or intangible, including algorithms, ideas, designs, formulas, methods, processes, programs, prototypes, systems and techniques.
“knowing, material and intentional breach” means a breach by a Party or Abbott of the terms of this Agreement where (a) the action (or failure to act) that constituted the breach was deliberate and willful and not inadvertent, and (b) at the time, Abbott or the Party or its Representative taking or authorizing such action (or failure to act) (i) knew that such action (or failure to act) would constitute, or would reasonably be expected to result in, a material breach of this Agreement, and (ii) intends for such action (or failure to act) to breach this Agreement.
“Knowledge” means (a) with respect to Seller, the actual knowledge of the officers or directors of Seller or the Asset Seller Entities listed on Schedule 1.01(c)(i), (b) with respect to Abbott, the actual knowledge of the individual listed on Schedule 1.01(c)(ii), and (c) with respect to Purchaser, the actual knowledge of the officers or directors of Purchaser Parent listed on Schedule 1.01(c)(iii).
“Liabilities” means any and all debts, liabilities and obligations, whether accrued or fixed, known or unknown, absolute or contingent, matured or unmatured or determined or determinable, including those arising under any Law, Action or Judgment of a Governmental Authority and those arising under any Contract.

5

“Lien” means any pledge, lien, charge, Encumbrance or security interest of any kind or nature.
“Local Tax Purchase Price” means an amount of an Additional Payment,  modified as may be required by applicable local Tax Law.
“Losses” means any and all losses, damages, costs, deficiencies, assessments, fees and expenses, including interest, penalties, judgments, fines, reasonable fees of attorneys and other advisors and other reasonable expenses and costs of investigation or defense; provided, that “Losses” shall not include any consequential, exemplary, indirect, special or punitive damages, including loss of future revenue, income or profits, business interruption, diminution of value or loss of business reputation or opportunity, except for any such damages to the extent actually awarded and paid to a Third Party.
“Material Adverse Effect” means with respect to the Business, any effect, change, event or occurrence that, individually or in the aggregate (a) would prevent or materially delay, interfere with, impair or hinder the consummation of the Transactions or the compliance by Seller with its obligations under this Agreement or (b) has a material adverse effect on the business, results of operations, assets or condition (financial or otherwise) of the Business taken as a whole; provided, however, that none of the following, and no effect, change, event or occurrence arising out of, or resulting from, the following, shall constitute or be taken into account in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur with respect to this clause (b): any effect, change, event or occurrence (i) generally affecting (A) the industry in which the Business operates, including changes in the use, adoption or non-adoption of technologies or industry standards, or (B) the economy, credit or financial or capital markets, in the United States or elsewhere in the world, including changes in interest or exchange rates, or (ii) to the extent arising out of, resulting from or attributable to (A) changes or prospective changes in Law (including changes or prospective changes in generally applicable rules, regulations and administrative policies of the FDA) or in GAAP or in accounting standards, or any changes or prospective changes in the interpretation or enforcement of any of the foregoing, or any changes or prospective changes in general legal, regulatory or political conditions, (B) any change proximately caused by (1) the negotiation, execution or announcement of the Merger Agreement or this Agreement or the performance of the Merger Agreement or this Agreement in accordance with their respective terms or the consummation of the Merger or the Transactions (other than compliance with Section 6.01(a) or for purposes of any representations or warranties contained in Sections 4.02(c), 4.03, 4.11(a)(i) or (ii)) or (2) the announcement of the Other Transactions or the consummation thereof pursuant to Contracts that do not, by their respective terms, adversely affect in any material way the composition of the Business, Purchased Assets or Assumed Liabilities (other than with respect to co-owned Intellectual Property included within the Purchased Assets or the separation of Shared Contracts on terms and subject to conditions substantially similar to Section 2.04) or contravene the covenants of Seller or Abbott hereunder, including in the case of each of (1) and (2) the impact thereof on relationships, contractual or otherwise, with customers, suppliers, distributors, partners, employees or regulators, or any litigation arising from allegations of breach of fiduciary duty or violation of Law relating to the Merger Agreement, this Agreement or the consummation 

6

of the Merger or the Transactions, (C) acts of war (whether or not declared), sabotage or terrorism, or any escalation or worsening of any such acts of war (whether or not declared), sabotage or terrorism, (D) volcanoes, tsunamis, pandemics, earthquakes, hurricanes, tornados or other natural disasters, (E) any action taken by Seller or its Subsidiaries with Purchaser’s written consent or at Purchaser’s written request, (F) any change resulting or arising from the identity of, or any facts or circumstances relating to, Purchaser or any of its Affiliates, (G) any change or prospective change in Seller’s credit ratings, (H) any decline in the market price, or change in trading volume, of the capital stock of Seller or (I) any failure of the Business to meet any internal or public projections, forecasts, guidance, estimates, milestones, budgets or internal or published financial or operating predictions of revenue, earnings, cash flow or cash position (it being understood that the exceptions in clauses (G), (H) and (I) shall not prevent or otherwise affect a determination that the underlying cause of any such change, decline or failure referred to therein (to the extent not otherwise falling within any of the exceptions provided by clause (i) and clauses (ii)(A) through (I) hereof) is, may be, contributed to or may contribute to, a Material Adverse Effect); provided further, however, that any effect, change, event or occurrence referred to in clause (i) or clauses (ii)(A), (C) or (D) may be taken into account in determining whether there has been, or would reasonably be expected to be, a Material Adverse Effect to the extent such effect, change, event or occurrence has a disproportionate adverse effect on the Business, taken as a whole, as compared to other participants in the industry in which the Business operates (in which case the incremental disproportionate impact or impacts may be taken into account in determining whether there has been, or would reasonably be expected to be, a Material Adverse Effect).
“Merger Clearances” means the Consents of Governmental Authorities under applicable Competition Laws for (a) the Merger Transaction as described in the Merger Agreement and (b) the Other Transactions.
“OEM Supply Agreement” means that certain BNP Assay Development, Manufacture and Supply Agreement, dated effective as of June 24, 2003, by and between Biosite Incorporated and BC. 
“Other Transactions” means the sale, transfer or other conveyance of any assets, rights, properties or Liabilities of Seller and its Affiliates (other than the Purchased Assets) to one or more Third Parties in connection with the consummation of the Merger Transaction or receipt of the Merger Clearances.
“Permitted Liens” means (a) statutory Liens for Taxes, assessments or other charges by Governmental Authorities not yet due and payable or the amount or validity of which is being contested in good faith and by appropriate proceedings, (b) mechanics’, materialmen’s, carriers’, workmen’s, warehouseman’s, repairmen’s, landlords’ and similar Liens granted or which arise in the ordinary course of business consistent with past practice for amounts that are not delinquent and that are not, individually or in the aggregate, material to the Business, (c)(i)  pledges or deposits under workmen’s compensation Laws, unemployment insurance Laws or similar legislation, (ii) good faith deposits in connection with bids, tenders or Contracts with Governmental Authorities, customers or suppliers in the ordinary course consistent with past 

7

practice (other than for the payment of Indebtedness) or leases for tangible personal property, or (iii) deposits to secure public or statutory obligations or to secure surety or appeal bonds or deposits as security for contested Taxes, in each case incurred or made in the ordinary course of business consistent with past practice, (d) non-exclusive licenses of Intellectual Property granted in the ordinary course of business consistent with past practice and (e) such other Liens, Encumbrances or defects or imperfections of title that do not, individually or in the aggregate, materially detract from the value or the ownership, operation or existing use of the asset or property affected by such Lien, Encumbrance, defect or imperfection.
“Person” means an individual, corporation, limited liability company, partnership, joint venture, association, trust, unincorporated organization or any other entity, including a Governmental Authority.
“Post-Closing Tax Period” means any taxable period (or portion thereof) commencing after the Closing, including such portion of any Straddle Period commencing after the Closing.
“Pre-Closing Tax Period” means any taxable period (or portion thereof) ending on or prior to the Closing, including such portion of any Straddle Period up to and including the date of Closing.
“Product” means a diagnostic BNP assay for use in the diagnosis of cardiac diseases in humans that is used as of the date of this Agreement on the BC automated immunoassay (or combination chemistry/immunoassay) laboratory instruments capable of performing the measurement of analytes in human biological materials, and the BNP calibrator and controls for use with such BNP assay, together with all improvements and replacements thereto, all as marketed by or on behalf of Seller or its Affiliates. 
“Purchaser Disclosure Letter” means the Purchaser Disclosure Letter attached hereto, dated as of the date hereof, delivered by Purchaser in connection with this Agreement.
“Purchaser Occupied Real Property” means the San Diego Real Property other than (a) any portion thereof leased by Seller or one its Affiliates as tenant pursuant to any lease agreement with Purchaser or one of its Affiliates or (b) occupied solely by Seller or one of its Affiliates pursuant to the Triage Transition Services Agreement to be entered into pursuant to the Triage Purchase Agreement.
“Registered” means registered with or the subject of a pending application before any Governmental Authority or Internet domain name registrar.
“Registrations” means authorizations and/or approvals issued by any Healthcare Regulatory Authority (including premarket approval applications, premarket notifications, investigational device exemptions, manufacturing site approvals or authorizations, CE Marks, pricing and reimbursement approvals, labeling approvals or their foreign equivalent) held by the Asset Seller Entities as of the Closing that are required for the manufacture, distribution, marketing, storage, transportation, use or sale of the Product.

8

“Representatives” means, with respect to any Person, its officers, directors, employees, consultants, agents, financial advisors, investment bankers, attorneys, accountants, other advisors, Affiliates and other representatives.
“Restricted Contract” means any Contract which would be applicable to Purchaser or its Affiliates following Closing that: (a) contains any standstill or similar restriction on an Asset Seller Entity’s ability to acquire assets or Securities of another Person, (b) indemnifies or holds harmless any Person, or assumes the Tax, environmental or other Liability of any Person, which indemnity or assumption of Liability is material to the Business taken as a whole (other than indemnification provisions or assumptions of Liability in commercial Contracts entered into in the ordinary course of business consistent with past practice), or (c) contains terms that would limit or purport to limit the ability of Purchaser or its Affiliates to conduct the Business, including any Contract that would limit the ability of Purchaser or its Affiliates to compete in any line of business or with any Person or in any geographic area or during any period of time.
“San Diego Real Property” means the building, structures, facilities and real property described on Schedule 1.01(d). 
“Scios Agreement” means that certain Semi-Exclusive BNP Diagnostic License Agreement between Biosite Incorporated and Scios Inc., dated December 30, 1996.
“Scios Assignment and Assumption Agreement” means an assignment and assumption agreement for the assignment by the applicable Asset Seller Entity to the applicable Designated Purchaser of rights under the Scios Agreement and the assumption by the applicable Designated Purchaser of the obligations and other Liabilities related thereto, in the form attached as Exhibit D.
“SEC” means the Securities and Exchange Commission.
“Securities” means, with respect to any Person, any class or series of common stock, preferred stock, membership interest and any other equity securities or capital stock of such Person, however described and whether voting or non-voting.
“Seller Charter Documents” means Seller’s certificate of incorporation (including the Certificate of Designations) and by-laws, each as amended.
“Seller Disclosure Letter” means the Seller Disclosure Letter attached hereto, dated as of the date hereof, delivered by Seller to Purchaser in connection with this Agreement.
“Seller Transitional Marks” means the Trademarks set forth on Schedule 1.01(e).
“Specified Qualifications” means the following: (a) all instances of the word “material” in Section 4.04, (b) both instances of the phrase “Material Adverse Effect” (including the use of the word “Material” in the defined term and all instances of the word “material” in the definition thereof) in Section 4.05, (c) the instance of the word “material” in Section 4.11(b)(iii), 

9

and (d) use of the word “Material” when used as the first word of the defined term “Material Contract”.
“Specified Business Contracts” means the Contracts set forth on Schedule 1.01(f).
“Straddle Period” means any taxable period beginning on or before the date of the Closing and ending after the date of the Closing.
“Subsidiary”, when used with respect to any Person, means any corporation, limited liability company, partnership, association, trust or other entity of which Securities or other ownership interests representing more than 50% of the ordinary voting power (or, in the case of a partnership, more than 50% of the general partnership interests) are, as of such date, owned by (a) such Person or (b) one (1) or more Subsidiaries of such Person or (c) such Person and one (1) or more Subsidiaries of such Person.
“Tax” or “Taxes” means (a) any and all federal, state, provincial, local or foreign taxes, fees, levies, duties, tariffs, imposts, and other similar charges (together with any and all interest, penalties and additions to tax) imposed by any Governmental Authority, including taxes or other charges on or with respect to net income, gross income, franchises, windfall or other profits, gross receipts, property, sales, use, goods and services, service use, harmonized sales, capital stock, payroll, employment, social security, workers’ compensation, unemployment compensation, employment insurance premiums or net worth; taxes or other charges in the nature of excise, severance, occupation, withholding, ad valorem, stamp, transfer, value added, or gains taxes; license, lease, registration and documentation fees; and customs’ duties, tariffs, and similar charges, together with any interest or penalty, addition to tax or additional amount imposed by any Governmental Authority, (b) any Liability for payment of amounts described in clause (a) whether as a result of transferee Liability, of being a member of an affiliated, consolidated, combined or unitary group for any period or otherwise through operation of Law, and (c) any Liability for the payment of amounts described in clauses (a) or (b) as a result of any tax sharing, tax indemnity or tax allocation agreement or any other express or implied Contract to indemnify any other Person.
“Tax Returns” means returns, reports, claims for refund, declarations of estimated Taxes, elections, designations and information statements, including any schedule or attachment thereto or any amendment thereof, with respect to Taxes filed or required to be filed with any Governmental Authority, including consolidated, combined and unitary tax returns.
“Territories” means each country in which (a) the Business recognized revenue for sales of the Products in the period commencing on January 1, 2014 and terminating on the Closing Date, or (b) a Registration has been issued.  
“Third Party” means any Person other than Abbott, Seller, Purchaser, and their respective Affiliates.

10

“Trademark” means any trademark, trademark registration, trademark application, service mark, trade name, logo, business name or brand name, trade dress and similar rights (in each case whether or not Registered) and all goodwill associated with the foregoing.
“Transactions” means the sale and acquisition of the Purchased Assets and the assumption of the Assumed Liabilities pursuant to this Agreement and the other transactions contemplated by this Agreement and the Ancillary Agreements (but expressly excluding the Merger Transaction and the Other Transactions).
“Transaction Expenses” means the aggregate amount of any and all fees and expenses payable to (a) investment bankers, brokers, finders or similar agents or (b) counsel, accountants or other advisors, in each case in connection with the Transactions that are incurred by or on behalf of, or paid or to be paid directly by, any Asset Seller Entity or any Person that any Asset Seller Entity pays or reimburses or is otherwise legally obligated to pay or reimburse.
“Transition Services Agreement” means the transition services agreement in the form attached as Exhibit E.
“Treasury Regulations” means the United States Treasury Regulations promulgated under the Code. 
“Triage Purchase Agreement” means the Amended and Restated Triage Purchase Agreement dated as of September 15, 2017, by and among Seller, Purchaser, for purposes of Sections 6.13 and 12.15 thereof, Purchaser Parent and for the limited purposes set forth therein, Abbott.
“U.S. Tax Purchase Price” means an amount equal to the net present value of an Additional Payment determined using the discount rate that is the lower of: (a) the lowest applicable Federal rate published by the Secretary of Treasury in a revenue ruling in effect during the three (3) month period ending with the first month in which this Agreement is signed, or (b) the lowest applicable Federal rate published by the Secretary of Treasury in a revenue ruling in effect during the three (3) month period ending with the month of the Closing Date.

SECTION 1.02.    Definitions. The following terms have the meanings set forth in the Sections set forth below:
	
			
	 
	Term
	Section

	 
	2016 P&L Information
	4.04(a)

	 
	Abbott
	Preamble

	 
	Action
	4.06

	 
	Additional Payment
	Schedule 2.05

	 
	Allocation Dispute Notice
	2.06(a)

	 
	Allocation Firm
	2.06(a)

	 
	Archived Records
	6.08(a)

11

	
			
	 
	Term
	Section

	 
	Assumed Liabilities
	2.02(a)

	 
	Audited Financial Statements
	6.10(a)(i)

	 
	Auditor
	6.10(a)(i)

	 
	Bankruptcy and Equity Exception
	3.02(a)

	 
	Business Records
	2.01(a)(vii)

	 
	Cap
	10.04(a)(iii)

	 
	Closing
	2.07

	 
	Closing Date
	2.07

	 
	Confidentiality Agreement
	6.04(b)

	 
	Consultant
	2.11(b)

	 
	Conveyance Taxes
	7.05

	 
	Deductible
	10.04(a)(ii)

	 
	Deferred Asset Jurisdiction
	2.08(a)

	 
	Deferred Assets and Liabilities
	2.08(a)

	 
	Deferred Transfer Closing
	2.08(b)

	 
	Direct Claim
	10.05(b)

	 
	Direct Claim Notice
	10.05(b)

	 
	Dispute Notice
	2.11(b)

	 
	EC Decision
	11.16

	 
	End Date
	9.01(e)(ii)

	 
	Estimated Allocation of the Assumed Liabilities
	2.06(a)

	 
	Estimated Allocation of the Initial Payment
	2.06(a)

	 
	Estimated Allocation of the Initial Purchase Price
	2.06(a)

	 
	Estimated Allocation of the Local Tax Purchase Price
	2.06(b)

	 
	Estimated Allocation of the U.S. Tax Purchase Price
	2.06(b)

	 
	Estimated Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price
	2.06(b)

	 
	Exchange Act
	4.03

	 
	Excluded Assets
	2.01(b)

	 
	Excluded Liabilities
	2.02(b)

	 
	Excluded Seller Marks
	6.07(b)

	 
	Exclusive Contract
	2.01(a)(i)

	 
	FDA
	4.12(a)

	 
	Filed SEC Documents
	Article IV

	 
	Final Allocation
	2.06(a)

	 
	Final Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price
	2.06(b)

	 
	Final Transferred Inventory
	2.11(b)

	 
	Financial Statements
	4.04(a)

	 
	Food and Drug Laws
	4.12(a)

12

	
			
	 
	Term
	Section

	 
	Foreign Acquisition Agreements
	2.03

	 
	FTC
	6.02(b)

	 
	Guarantor
	11.15

	 
	Health Care Laws
	4.12(a)

	 
	Indemnified Party
	10.05(a)(i)

	 
	Indemnifying Party
	10.05(a)(i)

	 
	Initial Interim Financial Statements
	6.10(a)(i)

	 
	Initial Payment
	Schedule 2.05

	 
	Interim Balance Sheet
	4.04(a)

	 
	Interim Financial Statements
	6.10(a)(ii)

	 
	Judgment
	4.06

	 
	Laws
	4.07

	 
	Material Contract
	4.11(a)

	 
	Merger Agreement
	Recitals

	 
	Merger
	Recitals

	 
	Merger Transaction
	Recitals

	 
	Parties
	Preamble

	 
	Periodic Taxes
	7.01

	 
	Purchase Price
	2.05

	 
	Purchased Assets
	2.01(a)

	 
	Purchaser
	Preamble

	 
	Purchaser Indemnitees
	10.02

	 
	Purchaser Parent
	Preamble

	 
	Reference Balance Sheet
	4.04(a)

	 
	SEC Financial Statements
	4.04(b)

	 
	Securities Act
	4.03

	 
	Seller
	Preamble

	 
	Seller Guarantees
	6.06

	 
	Seller Indemnitees
	10.03

	 
	Shared Contract
	2.01(a)(i)

	 
	Subsequent Payment Date
	Schedule 2.05

	 
	Third Party Claim
	10.05(a)(i)

	 
	Third Party Claim Notice
	10.05(a)(i)

	 
	Transferred Inventory
	2.01(a)(v)

	 
	Transferred Inventory Calculation
	2.11(a)

SECTION 1.03.    Interpretation.  
(a)     When a reference is made in this Agreement to an Article, a Section, Exhibit or Schedule, such reference shall be to an Article of, a Section of, or an Exhibit or Schedule to, this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the 

13

meaning or interpretation of this Agreement. Whenever the words “include”, “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation”. The words “hereof”, “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The words “date hereof” when used in this Agreement shall refer to the date of this Agreement. The terms “or”, “any” and “either” are not exclusive. The word “extent” in the phrase “to the extent” shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply “if”. The word “will” shall be construed to have the same meaning and effect as the word “shall”. The words “made available to Purchaser” and words of similar import refer to documents (i) posted to the Datasite at least 24 hours prior to the date hereof or (ii) delivered in person or electronically to Purchaser or its Representatives at least 24 hours prior to the date hereof. All accounting terms used and not defined herein shall have the respective meanings given to them under GAAP. All terms defined in this Agreement shall have the defined meanings when used in any document made or delivered pursuant hereto unless otherwise defined therein. The occurrence of any effect, change, event or occurrence set forth in clause (ii)(B) of the definition of Material Adverse Effect shall not be deemed to constitute the operation of the Business outside the ordinary course.  The definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term. Any agreement, instrument or statute defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement, instrument or statute as from time to time amended, modified or supplemented, including (in the case of agreements or instruments) by waiver or consent and (in the case of statutes) by succession of comparable successor statutes or promulgation of regulations and rules thereunder and references to all attachments, schedules and exhibits thereto and instruments incorporated therein. References to a Person are also to its permitted assigns and successors. Any reference herein to the Purchased Assets as of the date hereof, or at any time prior to the Closing, including in Article IV and Section 6.01 shall mean the assets, rights and properties of the Asset Seller Entities at such referenced time, which if owned on the Closing Date would be Purchased Assets. 
(b)    The Parties, Purchaser Parent and Abbott have participated jointly in the negotiation and drafting of this Agreement and, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the Parties, Purchaser Parent and Abbott and no presumption or burden of proof shall arise favoring or disfavoring the Parties, Purchaser Parent or Abbott by virtue of the authorship of any provision of this Agreement.

ARTICLE II     
 
PURCHASE AND SALE 

SECTION 2.01.    Purchase and Sale of Assets.
(a)    Purchased Assets. Upon the terms and subject to the conditions of this Agreement, at the Closing, Seller shall sell, convey, assign and transfer, and Seller shall cause the other applicable Asset Seller Entities to sell, convey, assign and transfer to the applicable 

14

Designated Purchaser, and Purchaser shall, or shall cause the other applicable Designated Purchasers to, purchase from the applicable Asset Seller Entities, free and clear of any Liens, other than Permitted Liens, all of the right, title and interest of Seller and the other Asset Seller Entities, in and to the following assets, rights and properties (the “Purchased Assets”):
(i)    subject to Section 2.04, the rights under (A)(1) the BC Agreements as in effect on the date hereof or as modified or amended with the consent of Purchaser pursuant to Section 6.01(b) and (2) each other Contract to which any Asset Seller Entity is a party that relates exclusively to the sale of Product by such Asset Seller Entity to a Third Party distributor or customer (each of the BC Agreements, together with each other Contract included in the Purchased Assets pursuant to clause (A)(2) of this Section 2.01(a)(i), an “Exclusive Contract”), and (B) each Contract (other than any BC Agreement) to which any Asset Seller Entity is a party that relates, but not exclusively, to the sale of Product by such Asset Seller Entity to a Third Party distributor or customer, in each case to the extent used in or related to the Business (each such Contract, a “Shared Contract”); 
(ii)    subject to the Scios Assignment and Assumption Agreement, the applicable rights under the Scios Agreement as in effect on the date hereof or as modified or amended with the consent of Purchaser pursuant to Section 6.01(b);
(iii)    except as provided in Section 2.01(b)(vi), subject to Section 2.04 and to the extent transferable, the Registrations and Government Authorizations used exclusively in the distribution, marketing, promotion, selling or offering for sale of the Product; 
(iv)    subject to Section 6.07, all advertising, marketing and promotional materials and all other printed or written materials, including website content and the design of such websites protected by applicable Law, in each case that is used exclusively in, or related exclusively to, the Business;
(v)    except as provided in Section 2.01(b)(iii), all inventories of finished Product (the “Transferred Inventory”);
(vi)    except to the extent related to or arising out of or in connection with any Excluded Liabilities or Excluded Assets, all claims, counterclaims, causes of action, choses in action, rights of recovery, and rights of set-off of any kind to the extent related to, arising out of or in connection with the Business, the Purchased Assets or the Assumed Liabilities;
(vii)    subject to Section 6.08, to the extent permitted by applicable Law, (A) sole ownership of Books, Records and Files and Tax Returns relating exclusively to the Business, the Purchased Assets or the Assumed Liabilities, and (B) co-ownership of an undivided interest (with each Party retaining, subject to Section 6.04, the right to use, license, disclose, grant access to, transfer and convey the same without restriction except as expressly set forth in Sections 6.04(b), (c) and (d)) in any Books, Records and Files and Tax Returns to the extent relating to the Business, the Purchased Assets or the Assumed Liabilities and not 

15

included in clause (A) of this Section 2.01(a)(vii); provided that Seller may redact any information not related to the Business from any Books, Records and Files or Tax Returns (the documents and other tangible and electronic embodiments of the items described in clauses (A) and (B) of this Section 2.01(a)(vii), the “Business Records”); 
(viii)     the cell lines described more particularly on Schedule 2.01(a)(viii) to the extent not conveyed to Purchaser or an Affiliate of Purchaser pursuant to the Triage Purchase Agreement; and
(ix)     all goodwill of the Business as a going concern.  
(b)    Excluded Assets.  Notwithstanding anything in Section 2.01(a) to the contrary, no Designated Purchaser shall purchase or otherwise acquire any right, title and interest in or to any assets, rights or properties of Abbott, Seller or their respective Affiliates, regardless of kind, description or location or whether tangible or intangible, real, personal or mixed except for the Purchased Assets (the “Excluded Assets”), including the following:  
(i)    all cash and Cash Equivalents, including any cash or Cash Equivalents residing in any collateral account securing any obligation or contingent obligation;
(ii)    any and all Accounts Receivable;
(iii)    any BNP Antibodies or any inventories, including raw materials, works in process, semi-finished products, packaging and labelling materials, in each case to the extent used or intended for use in connection with the generation, production or manufacture of BNP Antibodies;
(iv)    all current and prior insurance Contracts and all rights of any nature with respect thereto, including all insurance proceeds received or receivable thereunder;
(v)    any assets, rights or properties used or held for use in connection with the discovery, generation, formulation, production or manufacture of any antibodies or reagents used in or for the Excluded Businesses or the Product (including the BNP Antibodies);
(vi)    the Registrations used in the discovery, generation, formulation, production or manufacture of BNP Antibodies; and
(vii)    all claims, counterclaims, causes of action, choses in action, rights of recovery, and rights of set-off of any kind to the extent related to the Excluded Businesses or any other Excluded Assets.

SECTION 2.02.    Assumption and Exclusion of Liabilities.
(a)    Assumed Liabilities. Upon the terms and subject to the conditions and exclusions set forth in this Agreement, at the Closing, Purchaser shall, or shall cause the applicable Designated Purchasers to, assume and satisfy, pay, perform and discharge when due the following Liabilities of the Asset Seller Entities, to the extent arising out of or relating to acts or omissions in the conduct of the Business or ownership of the Purchased Assets, whether accrued or fixed, known or unknown, absolute or contingent, matured or unmatured or 

16

determined or determinable as of the Closing Date, other than the Excluded Liabilities (all of the following Liabilities to be so assumed, satisfied or discharged being herein collectively called the “Assumed Liabilities”), and no Designated Purchaser or its Affiliates shall assume (by succession, transfer or assignment or otherwise) or have any responsibility for any other Liabilities of the Asset Seller Entities: 
(i)    all Liabilities to the extent arising out of or relating to acts or omissions after the Closing in the conduct of the Business or the ownership of the Purchased Assets from and after the Closing (except as expressly excluded pursuant to subclauses (1) and (2) of clause (ii) of this Section 2.02(a));
(ii)    to the extent related to the Business, all Liabilities arising after Closing to the extent arising out of or resulting from: (A) Exclusive Contracts included in the Purchased Assets under Section 2.01(a)(i)(B), (B) Shared Contracts included in the Purchased Assets under Section 2.01(a)(i)(A), and (C) the Scios Agreement to the extent included in the Purchased Assets under Section 2.01(a)(ii), except in each case to the extent (1) arising out of or relating to the performance or nonperformance by any Asset Seller Entity of any obligation that was required to be performed or fulfilled by such Asset Seller Entity prior to the Closing or (2) attributable to the acts or omissions of any Asset Seller Entity prior to the Closing; and
(iii)    all Liabilities for or with respect to which Purchaser bears responsibility pursuant to Article VII.
(b)    Excluded Liabilities. After the Closing, Seller and its Affiliates shall retain (or, if necessary, expressly assume), and shall be responsible for paying, performing and discharging when due, all Liabilities of the Asset Seller Entities other than the Assumed Liabilities, whether accrued or fixed, known or unknown, absolute or contingent, matured or unmatured or determined or determinable as of the Closing Date, including the following Liabilities (all of the foregoing, the “Excluded Liabilities”):
(i)    all Liabilities to the extent arising out of or relating to acts or omissions prior to the Closing in the conduct of the Business or the ownership of the Purchased Assets prior to the Closing;
(ii)    all Indebtedness of the Asset Seller Entities;
(iii)    all Transaction Expenses;
(iv)    all Accounts Payables;
(v)    all Liabilities to the extent arising out of or relating to the Excluded Assets or the Excluded Businesses; and
(vi)    all Liabilities for or with respect to which Seller bears responsibility pursuant to Article VII.

17

SECTION 2.03.    Foreign Acquisition Agreements.  The transfer of Purchased Assets or Assumed Liabilities in or to a jurisdiction in which local Laws require observance of specified formalities or procedures to legally effect a transfer of Purchased Assets or Assumed Liabilities will be effected pursuant to short-form acquisition agreements substantially in the form of the Assignment, Assumption and Bill of Sale, except for: (a) the deletion of provisions which are inapplicable to such Purchased Assets or Assumed Liabilities; (b) such changes as may be necessary to satisfy the requirements of applicable local Law; and (c) such changes as may be reasonably agreed upon in writing by Seller, Purchaser and Abbott (the “Foreign Acquisition Agreements”); provided, in each case that the Foreign Acquisition Agreements shall serve purely to effect and make enforceable vis-à-vis Third Parties the transfer of the legal and beneficial interest in and to the Purchased Assets and Assumed Liabilities and shall not have any significant effect on the value being received by any Designated Purchaser or any Asset Seller Entity, including the allocation of assets and Liabilities as between them, all of which shall be determined by this Agreement.

SECTION 2.04.    Non-Assignment; Consents.
(a)    Notwithstanding anything in this Agreement to the contrary, this Agreement shall not constitute an agreement to sell, assign, transfer, convey, deliver or assume a Purchased Asset or an Assumed Liability to the extent that a sale, assignment, transfer, conveyance, delivery or assumption thereof (i) would be prohibited by Law or (ii) would, without the Consent by any relevant Third Party, (A) constitute a breach or other contravention thereof or of any Contract related to the Business or (B) be ineffective, void or voidable, in the case of each of clauses (A) and (B) unless and until such Consent is obtained.
(b)    If the Closing occurs and (i) the circumstances described in Section 2.04(a) exist or (ii) any Consent of a Governmental Authority that is required to permit a Designated Purchaser to  place the Product on the market in a particular jurisdiction under a Registration included within the Purchased Assets has not then been obtained and such jurisdiction is not a Deferred Asset Jurisdiction (which are the subject of Section 2.08), until the earlier of such time as such Consent is obtained and the first anniversary of the Closing Date, (A) Seller and Purchaser shall use their respective commercially reasonable efforts to obtain, or cause to be obtained, any such Consent required to: (x) sell, assign, transfer, convey or deliver (directly or indirectly) any Purchased Asset to Purchaser or another Designated Purchaser, and (y) obtain the unconditional release of the Asset Seller Entities and their respective Affiliates so that Purchaser or another Designated Purchaser shall be solely responsible for the Assumed Liabilities; provided, that (1) nothing in this Agreement shall obligate or in any way require the Asset Seller Entities, Abbott or any of their respective Affiliates to expend money, commence any Action or offer or grant any material accommodation (financial or otherwise) to any Third Party in connection with obtaining any Consent to transfer any Purchased Asset and (2) costs to obtain subscriptions, software as a service or software or information technology licenses shall not be deemed a cost to obtain Consent, and Purchaser shall be solely responsible for the cost of any such subscriptions, software as a service or software or information technology licenses for the operation of the Business or ownership of the Purchased Assets following Closing, and (B) pending such Consent and continuing until the earlier of (1) the receipt of such Consent and (2) 

18

the first anniversary of the Closing Date, Seller and Purchaser will put in place any lawful arrangement, the content of which shall be reasonably acceptable to Purchaser and Abbott (with any appropriate “firewalls” or similar procedures required under applicable Competition Laws), intended to provide Purchaser, to the fullest extent practicable, the claims, rights and benefits of any such Purchased Asset and the burdens and costs of any such Assumed Liability (including by means of any agency, contract manufacturing, distribution, supply, subcontracting, sublicensing or subleasing arrangement).  Seller shall pay to Purchaser promptly upon receipt thereof, all income, proceeds and other monies received by Seller or its Affiliates with respect to any such Purchased Assets (net of any Assumed Liabilities, Taxes or any other reasonable out-of-pocket costs imposed upon or incurred by Seller or any of its Affiliates in connection with the arrangements contemplated by this Section 2.04(b)).  Once a required Consent for the sale, assignment, conveyance, assumption, transfer and delivery of a Purchased Asset is obtained, Seller will promptly transfer such Purchased Asset or Assumed Liability to Purchaser or another Designated Purchaser at no additional cost to Purchaser in accordance with the terms of this Agreement.  
(c)    Without limiting the provisions of Section 2.04(a) and 2.04(b), any Shared Contract to be assigned, transferred or conveyed in accordance with Section 2.01(a) shall, to the extent commercially reasonable, be separated as of the Closing, so that each of Purchaser and Seller or their respective Affiliates shall be entitled to the rights and benefits and shall assume the related portion of any Liabilities inuring to their respective businesses (with respect to Purchaser, from and after the Closing).  The Parties shall cooperate with each other to effect such separation.  The costs to effect such separation shall be borne equally by Seller and Purchaser; provided that (A) Purchaser shall be solely responsible for the costs of any subscriptions, software as a service or software or information technology licenses for the operation of the Business or ownership of the Purchased Assets following Closing, and (B) Seller shall be solely responsible for the costs of any subscriptions, software as a service or software or information technology licenses not related to the operation of the Business or ownership of the Purchased Assets following Closing.  If any Shared Contract cannot be so separated, Seller and Purchaser shall, and shall cause each of their respective Affiliates to, use their commercially reasonable efforts to cause, for the period after the Closing and for the duration of the then-current term after the Closing (i) the rights and benefits under each Shared Contract to the extent relating to the Business to be enjoyed by the applicable Designated Purchaser, (ii) the Liabilities under each Shared Contract to the extent constituting an Assumed Liability and relating to the Business to be borne by the applicable Designated Purchaser, (iii) the rights and benefits under each Shared Contract to the extent related to the Excluded Businesses to be enjoyed by the applicable Asset Seller Entity, and (iv) the Liabilities under each Shared Contract to the extent constituting an Excluded Liability or related to the Excluded Businesses to be borne by the applicable Asset Seller Entity. Seller shall use commercially reasonable efforts to enforce, at the request (and for the benefit and burden) of Purchaser, any rights of any Asset Seller Entity, as applicable, arising from the portion of any Shared Contract that is not assigned or transferred to the applicable Designated Purchaser to the extent such rights are related to the Business.

SECTION 2.05.    Purchase Price. Subject to the terms and conditions of this Agreement, Purchaser, on behalf of itself and the other Designated Purchasers, shall (a) 

19

pay to Seller, on behalf of the Asset Seller Entities, an aggregate purchase price for the Purchased Assets in an amount in cash described in, and pursuant to, Schedule 2.05 and (b) assume the Assumed Liabilities (together with the amounts payable pursuant to Schedule 2.05, the “Purchase Price”). The Initial Payment and each Additional Payment shall be paid in Dollars on the date specified on Schedule 2.05 by wire transfer in immediately available funds to a bank account or accounts designated in writing by Seller no later than three (3) Business Days prior to the date such payment is required to be made pursuant to this Agreement. Notwithstanding anything to the contrary herein, if any portion of the Purchase Price is required under applicable Law to be paid in a Foreign Currency or to a specific Asset Seller Entity, the applicable Dollar amount (as allocated pursuant to Section 2.06) shall be converted into the applicable Foreign Currency at the Exchange Rate in effect three (3) Business Days prior to the date such payment is required to be made pursuant to this Agreement and paid by Purchaser or another Designated Purchaser to the applicable Asset Seller Entity by wire transfer to one (1) or more bank accounts designated in writing by Seller at least three (3) Business Days prior to the date such payment is required to be made pursuant to this Agreement in lieu of the payment of such portion of the Purchase Price in Dollars pursuant to this Section 2.05.

SECTION 2.06.    Purchase Price Allocation.
(a)    As soon as practicable after the date of this Agreement, Seller shall prepare and deliver to Purchaser: (i) a proposed allocation of the Assumed Liabilities by country based on an estimate of the fair market values of the Purchased Assets and, if required by applicable Law, an allocation by asset category within a particular country (the “Estimated Allocation of the Assumed Liabilities”) and (ii) a proposed allocation of the Initial Payment by country based on an estimate of the fair market values of the Purchased Assets and, if required by applicable Law, an allocation by asset category within a particular country (the “Estimated Allocation of the Initial Payment”, and together with the “Estimated Allocation of the Assumed Liabilities”, the “Estimated Allocation of the Initial Purchase Price”).  Subject to Section 6.04(a), during the fifteen (15) day period following delivery of the Estimated Allocation of the Initial Purchase Price, Seller shall make its Representatives reasonably and timely available to Purchaser, Abbott and their respective Representatives to discuss the Estimated Allocation of the Initial Purchase Price.  The Estimated Allocation of the Initial Purchase Price shall be prepared in accordance with the principles of Section 1060 of the Code and the Treasury Regulations promulgated thereunder. If Purchaser does not deliver written notice of any dispute (an “Allocation Dispute Notice”) within fifteen (15) days after receipt of the Estimated Allocation of the Initial Purchase Price, the Estimated Allocation of the Initial Purchase Price shall be deemed the Final Allocation of the Initial Purchase Price for all purposes hereunder.  Prior to the end of such fifteen (15) day period, Purchaser may accept the Estimated Allocation of the Initial Purchase Price by delivering written notice to that effect to Seller and Abbott, in which case the Estimated Allocation of the Initial Purchase Price shall be deemed the Final Allocation for all purposes hereunder when such notice is given.  If Purchaser delivers an Allocation Dispute Notice within such fifteen (15) day period, the Parties and Abbott shall use reasonable best efforts to resolve such dispute during the thirty (30) day period following Seller’s receipt of the Allocation Dispute Notice from Purchaser.  If the Parties and Abbott do not agree upon a final resolution with respect to the Estimated Allocation of the Initial Purchase Price within such 

20

fifteen (15) day period, then the Estimated Allocation of the Initial Purchase Price shall be submitted immediately to an internationally recognized, independent accounting or valuation firm reasonably acceptable to the Parties and Abbott (the “Allocation Firm”).  The Allocation Firm shall be requested to render a determination of the applicable dispute within fifteen (15) days after referral of the matter to such Allocation Firm, which determination must be in writing and must set forth, in reasonable detail, the basis therefor.  The determination of the Allocation Firm shall be final and binding, absent manifest error.  Any fees payable to the Allocation Firm shall be borne equally by Seller and Purchaser.  The Estimated Allocation of the Initial Purchase Price accepted by the Parties and Abbott or determined by the Allocation Firm, as the case may be, shall be the “Final Allocation of the Initial Purchase Price”.  The Final Allocation of the Initial Purchase Price shall be done at arm’s length based upon a good faith determination of fair market value.
(b)    As soon as practicable after each Subsequent Payment Date, Seller shall determine the U.S. Tax Purchase Price and Local Tax Purchase Price and prepare and deliver to Purchaser a proposed allocation of each of the U.S. Tax Purchase Price and Local Tax Purchase Price by country based on an estimate of the fair market values of the Purchased Assets and, if required by applicable Law, an allocation by asset category within a particular country (the “Estimated Allocation of the U.S. Tax Purchase Price” and the “Estimated Allocation of the Local Tax Purchase Price”, respectively, and together the “Estimated Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price”).  Subject to Section 6.04, during the fifteen (15) day period following delivery of each Estimated Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price, Seller shall make its Representatives reasonably and timely available to Purchaser, Abbott and their respective Representatives to discuss such Estimated Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price. The Estimated Allocation of the U.S. Tax Purchase Price shall be prepared in accordance with the principles of Section 1060 and Section 483 of the Code and the Treasury Regulations promulgated thereunder. The Estimated Allocation of the Local Tax Purchase Price shall be prepared in accordance with the principles of applicable local Law. If Purchaser does not deliver an Allocation Dispute Notice within fifteen (15) days after receipt of the Estimated Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price, the Estimated Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price shall be deemed the Final Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price for all purposes hereunder.  Prior to the end of such fifteen (15) day period, Purchaser may accept the Estimated Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price by delivering written notice to that effect to Seller and Abbott, in which case the Estimated Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price shall be deemed the Final Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price for all purposes hereunder when such notice is given.  If Purchaser delivers an Allocation Dispute Notice within such fifteen (15) day period, the Parties and Abbott shall use reasonable best efforts to resolve such dispute during the thirty (30) day period following Seller’s receipt of the Allocation Dispute Notice from Purchaser.  If the Parties and Abbott do not agree upon a final resolution with respect to the Estimated Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price within such fifteen (15) day period, then the Estimated Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price shall be submitted immediately to an Allocation Firm.  The Allocation Firm shall be requested to render a determination of the applicable dispute 

21

within fifteen (15) days after referral of the matter to such Allocation Firm, which determination must be in writing and must set forth, in reasonable detail, the basis therefor.  The determination of the Allocation Firm shall be final and binding, absent manifest error.  Any fees payable to the Allocation Firm shall be borne equally by Seller and Purchaser.  The Estimated Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price accepted by the Parties and Abbott or determined by the Allocation Firm, as the case may be, shall be the “Final Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price”.  The Final Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price shall be done at arm’s length based upon a good faith determination of fair market value.
(c)    Except as otherwise provided in this Agreement, each of Seller and Purchaser and each of their respective Affiliates shall be bound by: (i) the Final Allocation of the Initial Purchase Price and the Final Allocation of the U.S. Tax Purchase Price for purposes of determining any U.S. Taxes related to the transfer of the Purchased Assets and (ii) the Final Allocation of the Initial Purchase Price and the Final Allocation of the Local Tax Purchase Price for purposes of determining any non-U.S. Taxes related to the transfer of the Purchased Assets.  Seller and Purchaser shall prepare and file, and cause their respective Affiliates to prepare and file: (A) their U.S. Tax Returns on a basis consistent with the Final Allocation of the Initial Purchase Price and the Final Allocation of the U.S. Tax Purchase Price and (B) their non-U.S. Tax Returns on a basis consistent with the Final Allocation of the Initial Purchase Price and the Final Allocation of the Local Tax Purchase Price.  Except as otherwise provided in this Agreement, none of Seller, Purchaser or their respective Affiliates shall take any position inconsistent with the Final Allocation of the Initial Purchase Price and the Final Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price in any Tax Return, in any Tax refund claim, in any Action or otherwise unless required by a final determination by an applicable Governmental Authority. If any Party, or any Affiliate of any Party, receives notice from any Governmental Authority that such Governmental Authority is disputing the Final Allocation of the Initial Purchase Price,  the Final Allocation of the U.S. Tax Purchase Price, or the Final Allocation of the Local Tax Purchase Price, such Party shall promptly notify the other Party, and Seller and Purchaser agree to use their reasonable best efforts to defend such Final Allocation of the Initial Purchase Price, the Final Allocation of the U.S. Tax Purchase Price, or the Final Allocation of the Local Tax Purchase Price, as applicable, in any Action.

SECTION 2.07.    Closing. Subject to the terms and conditions of this Agreement, the sale and purchase of the Purchased Assets and the assumption of the Assumed Liabilities contemplated by this Agreement shall take place at a closing (the “Closing”) to be held at the offices of Baker & McKenzie LLP, 300 East Randolph Street, Suite 5000, Chicago, Illinois 60601, at 9:00 a.m., Chicago time, on the third (3rd) Business Day following the satisfaction or waiver of the conditions to the obligations of the Parties and Abbott set forth in Article VIII (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the fulfillment or waiver of those conditions), or at such other place or at such other time or on such other date as the Parties and Abbott may mutually agree upon in writing (the “Closing Date”).  Subject to Section 2.08, for the purposes of this Agreement, the Closing shall be deemed to have occurred at 12:01 A.M. local time in each applicable jurisdiction on the Closing Date.

22

SECTION 2.08.    Deferred Asset Transfers.
(a)    If (i) any Consent of a Governmental Authority required to (A) consummate the sale of the Purchased Assets or assumption of the Assumed Liabilities in any applicable jurisdiction, or (B) permit a Designated Purchaser to place the Product on the market in a particular jurisdiction under a Registration included within the Purchased Assets has not been obtained at the time of the Closing, (ii) despite the exercise by Purchaser of its reasonable best efforts, the applicable Designated Purchaser (A) is not fully formed, organized or incorporated, or (B) in any applicable jurisdiction has not received the Governmental Authorizations or Registrations necessary for the conduct of the Business in such jurisdiction prior to the Closing Date or (iii) any Governmental Authority in an applicable jurisdiction shall have enacted, issued, promulgated, enforced or entered any Judgment (whether temporary, preliminary or permanent) that has the effect of making the portion of the Transactions contemplated in such jurisdiction illegal or otherwise prohibiting the consummation of such Transactions in such jurisdiction that is continuing as of the Closing Date (each such jurisdiction, a “Deferred Asset Jurisdiction”), then the Parties shall, in accordance with this Section 2.08(a) and Section 2.08(b), defer (to the extent permitted under applicable Law) the consummation of the portion of the Transactions contemplated in such Deferred Asset Jurisdiction solely with respect to the Purchased Assets and Assumed Liabilities in respect of such Deferred Asset Jurisdiction (such items for each Deferred Asset Jurisdiction, the “Deferred Assets and Liabilities”); provided, however, that the Parties shall have no obligation to consummate the Transactions if any of the conditions set forth in Section 8.01, in the case of Purchaser, or Section 8.02, in the case of Seller, shall not have been satisfied or waived by such Party.
(b)    From and after the Closing, and until such time as the applicable Deferred Assets and Liabilities have been transferred to Purchaser pursuant to Section 2.08(c) (each, a “Deferred Transfer Closing”), such Deferred Assets and Liabilities will be held for Purchaser’s benefit and account and will be managed and operated by the applicable Asset Seller Entity(ies) for the benefit and account of the applicable Designated Purchaser, with all gains, income, Losses, Taxes and Tax benefits or other items generated thereby to be for the account of the applicable Designated Purchaser.  Seller and Purchaser will use their respective reasonable best efforts to allow the applicable Designated Purchaser to receive the uninterrupted use and benefit of any Deferred Assets and Liabilities from the Closing Date to the date of its Deferred Transfer Closing. Except as otherwise contemplated by this Section 2.08 or the other provisions of this Agreement, to the extent permitted under applicable Law, until the applicable Deferred Transfer Closing occurs, Seller will conduct the Business in such Deferred Asset Jurisdiction in accordance with the reasonable and lawful instructions of Purchaser and its Affiliates and, except to the extent resulting from or arising out of the gross negligence or willful misconduct of or violation of Law by Seller or its Affiliates, Purchaser shall defend and indemnify the Seller Indemnitees and save and hold each of them harmless against any Losses incurred, sustained or suffered by them arising out of or as a result of the performance by Seller and its Affiliates of its and their respective obligations under this Section 2.08 in respect of any Deferred Assets and Liabilities from and after the Closing until the applicable Deferred Transfer Closing in accordance with the terms and provisions of this Section 2.08.

23

(c)    The Deferred Transfer Closing of any Deferred Assets and Liabilities shall occur as promptly as is reasonably practicable after receipt of all applicable required Consents, completion of the formation, organization or incorporation of the applicable Designated Purchaser (and the receipt of necessary Governmental Authorizations and Registrations), the resolution of all applicable Judgments and the expiration of all mandatory waiting periods, or at such time as the Parties may mutually agree upon in writing.  For purposes of Sections 2.01(a), 2.02, 2.04, 2.09(a), 2.10(a), 6.02, 6.04(a), and 6.09, the instance of “Closing” in the last sentence of Section 1.03(a), and the instance of “Closing” in the second sentence of Section 2.07, to the extent applicable in connection with any Deferred Asset Jurisdiction, all references to the Closing or the Closing Date shall be deemed to be references to the applicable Deferred Transfer Closing and the date thereof.

SECTION 2.09.    Closing Deliveries by Seller. At the Closing, Seller shall deliver, or cause to be delivered, to the applicable Designated Purchaser:
(a)    executed counterparts of each Ancillary Agreement to which any Asset Seller Entity is a party, the agreements expressly contemplated thereby, and such other instruments, in form and substance reasonably satisfactory to Purchaser, as may be reasonably requested by Purchaser or necessary under applicable Law to effect the transfer of the Purchased Assets to the Designated Purchasers, in each case duly executed by the Asset Seller Entities, as applicable; and
(b)    the certificate required by Section 8.01(a).

SECTION 2.10.    Closing Deliveries by Purchaser. At the Closing, Purchaser shall deliver, or cause to be delivered, to the applicable Asset Seller Entity:
(a)    executed counterparts of each Ancillary Agreement to which any Designated Purchaser is a party and such other instruments, in form and substance reasonably satisfactory to Seller or Abbott, as may be reasonably requested by Seller or Abbott or necessary under applicable Law to effect the assumption by the applicable Designated Purchasers of the Assumed Liabilities; and
(b)    the certificate required by Section 8.02(a).

SECTION 2.11.    Transferred Inventory Determination and Adjustment.
(a)    As soon as practicable, but no later than sixty (60) days after the Closing Date, Purchaser shall prepare and deliver to Seller a good faith calculation of the aggregate value 

24

of the Transferred Inventory, calculated as of immediately prior to the Closing in accordance with the Accounting Methodologies and in a manner consistent with the preparation of the “Inventory, net” item set forth in the Reference Balance Sheet (the “Transferred Inventory Calculation”).
(b)    After receipt of the Transferred Inventory Calculation, Seller shall have sixty (60) days to review the Transferred Inventory Calculation, together with the work papers used in the preparation thereof and the other written documentation supporting the basis of Purchaser’s determination of the Transferred Inventory Calculation. During such sixty (60) day period, Purchaser shall, and shall cause each of its Affiliates to, upon reasonable advance notice, provide Seller and its Affiliates and their respective Representatives with reasonable access during normal business hours and without unreasonable interference with Purchaser and its Affiliates’ operations to the books, records and employees engaged in financial accounting and related functions for the Business as may be reasonably necessary for Seller and its Affiliates and their respective Representatives to evaluate the Transferred Inventory Calculation and, if applicable, prepare written notice of any dispute regarding the Transferred Inventory Calculation (a “Dispute Notice”). If Seller does not deliver a Dispute Notice to Purchaser within sixty (60) days after receipt of the Transferred Inventory Calculation, the Transferred Inventory Calculation shall be deemed the Final Transferred Inventory for all purposes hereunder. Prior to the end of such sixty (60) day period, Seller may accept the Transferred Inventory Calculation by delivering written notice to that effect to Purchaser, in which case the Transferred Inventory Calculation shall be deemed the Final Transferred Inventory for all purposes hereunder when such notice is given. If Seller delivers a Dispute Notice to Purchaser within such sixty (60) day period, Seller and Purchaser shall use reasonable best efforts to resolve such dispute during the thirty (30) day period commencing on the date Purchaser receives the Dispute Notice from Seller. Any Dispute Notice delivered pursuant to this Section 2.11(b) shall specify in reasonable detail the nature and amount of any disagreements. If Seller and Purchaser do not agree upon a final resolution with respect to any items included in the Dispute Notice within such thirty (30) day period, then the remaining items in dispute shall be submitted immediately to an internationally or nationally recognized independent accounting firm reasonably acceptable to Seller and Purchaser (the “Consultant”). Within thirty (30) days after the Consultant’s selection, the Consultant shall make a final determination in accordance with the Accounting Methodologies and the terms and definitions of this Agreement and based solely on the written submissions of the Parties of the appropriate amount of each of the matters that remain in dispute, which determination shall be final and binding on the Parties, absent manifest error; provided that the Consultant shall under no circumstances be permitted to resolve any disputes (i) with respect to any matter other than the matters indicated in the Dispute Notice that remain in dispute or (ii) regarding the scope of the disputes to be resolved by the Consultant pursuant to this Section 2.11, which such disputes shall in all cases be resolved in accordance with, and subject to the limitations of, Section 11.06 and Section 11.08.  Purchaser and Seller shall make their respective financial records, to the extent related to the calculation of the aggregate value of the Transferred Inventory, reasonably available to the Consultant in connection with such determination.  With respect to each disputed matter, the determination by the Consultant pursuant to this Section 2.11, if not in accordance with the position of either Seller or Purchaser, shall not be in excess of the higher, or less than the lower, of the amounts advocated by Seller in the Dispute Notice or by Purchaser in the 

25

Transferred Inventory Calculation with respect to such disputed matter. The dispute resolution under this Section 2.11 shall constitute an expert determination under New York CPLR Article 76. Any fees payable to the Consultant shall be borne equally by Seller on the one hand, and Purchaser on the other hand. Except as provided in the immediately preceding sentence, all other costs and expenses incurred by the Parties in connection with resolving any dispute hereunder before the Consultant shall be borne by the Party incurring such cost or expense. Seller and Purchaser shall revise the Transferred Inventory Calculation to reflect the resolution of any disputes with respect thereto pursuant to this Section 2.11 and, as so revised, such Transferred Inventory Calculation shall be deemed to set forth the final aggregate value of the Transferred Inventory (the “Final Transferred Inventory”) for all purposes hereunder.
(c)    If the Final Transferred Inventory is less than $4,000,000, then Seller shall pay to Purchaser within ten (10) Business Days after the determination of the Final Transferred Inventory pursuant to Section 2.11(b) an amount equal to the absolute value of such deficit by wire transfer of immediately available funds in Dollars to an account designated in writing by Purchaser. If the Final Transferred Inventory is greater than $4,400,000, Purchaser shall pay to Seller within ten (10) Business Days after the determination of the Final Transferred Inventory pursuant to Section 2.11(b) the amount of such excess by wire transfer of immediately available funds in Dollars to an account designated in writing by Seller.

ARTICLE III     
 
REPRESENTATIONS AND WARRANTIES 
OF ABBOTT
Abbott represents and warrants to Purchaser that:

SECTION 3.01.    Organization; Standing.  Abbott is a corporation duly organized, validly existing and in good standing under the Laws of the State of Illinois. 

SECTION 3.02.    Corporate Authorization; Noncontravention.  
(a)    Abbott has all necessary corporate power and corporate authority to execute and deliver this Agreement and to perform its obligations hereunder and, subject to the Consents required for the Merger Transaction and the other transactions contemplated by the Merger Agreement, to consummate the Transactions to the extent applicable to Abbott. The execution, delivery and performance by Abbott of this Agreement, and the consummation by it of the Transactions to the extent applicable to Abbott, have been duly authorized by all necessary corporate action on the part of Abbott. This Agreement has been duly executed and delivered by Abbott and, assuming due authorization, execution and delivery hereof by the Parties, constitutes a legal, valid and binding obligation of Abbott, enforceable against Abbott in accordance with its terms, except that such enforceability (i) may be limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar Laws of general application affecting or relating to the enforcement of creditors’ rights generally and (ii) is subject to general principles of equity, whether considered in a proceeding at law or in equity (the “Bankruptcy and Equity Exception”).

26

(b)    Neither the execution and delivery of this Agreement by Abbott, nor the consummation by it of the Transactions to the extent applicable to Abbott, nor performance or compliance by Abbott with any of the terms or provisions hereof applicable to Abbott, will, subject to the receipt of the Consents required to consummate the Merger Transaction as set forth in the Merger Agreement, (i) conflict with or violate any provision of the organizational documents of Abbott, or (ii) assuming the Consents and other filings referred to in Section 4.03 are made or obtained (including the termination or expiration prior to the Closing of any applicable waiting periods), violate any Law or Judgment applicable to Abbott.

SECTION 3.03.    Litigation.  As of the date of this Agreement, there is no Action pending or, to the Knowledge of Abbott, threatened seeking to prevent, hinder, modify, delay or challenge the Transactions.

SECTION 3.04.    Brokers and Other Advisors. Except for Evercore Partners Inc., the fees and expenses of which will be paid by Abbott, no broker, investment banker, financial advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s or other similar fee or commission, or the reimbursement of expenses in connection therewith, in connection with the Transactions based upon arrangements made by or on behalf of Abbott or any of its Subsidiaries. 

SECTION 3.05.    No Other Representations or Warranties.  Except for the representations and warranties made by Abbott in this Article III, Abbott makes no other express or implied representation or warranty with respect to Abbott or its Affiliates.  None of Abbott, its Affiliates or its or their respective Representatives makes or has made any express or implied representation or warranty with respect to any Asset Seller Entity, the Purchased Assets or the Business (including operations, properties, assets, Liabilities, conditions (financial or otherwise) or prospects), or any estimates, projections, forecasts and other forward-looking information or business and strategic plan information regarding the Business, notwithstanding any delivery or disclosure to Purchaser or any of its Representatives of any documentation, forecasts or other information with respect to any one or more of the foregoing, and Purchaser acknowledges the foregoing. In particular, and without limiting the generality of the foregoing, none of Abbott, its Affiliates or its or their respective Representatives makes or has made any express or implied representation or warranty to Purchaser or any of its Representatives with respect to (a) any financial projection, forecast, estimate, budget or other information relating to the Business or (b) any oral or written information presented to Purchaser or any of its Representatives in the course of their due diligence investigation of the Business, the negotiation of this Agreement or the course of the Transactions.

27

ARTICLE IV     
 
REPRESENTATIONS AND WARRANTIES 
OF SELLER
Seller represents and warrants to Purchaser that, except as (A) set forth in the Seller Disclosure Letter (it being understood that any information, item or matter set forth on one section or subsection of the Seller Disclosure Letter shall be deemed disclosure with respect to, and shall be deemed to apply to and qualify, the section or subsection of this Article IV to which it corresponds in number and each other section or subsection of this Article IV to the extent that it is reasonably apparent on the face of such disclosure that such information, item or matter is relevant to such other section or subsection) or (B) disclosed in any report, schedule, form, statement or other document (including exhibits) filed with, or furnished to, the SEC by Seller after January 1, 2016 and publicly available prior to the date hereof (the “Filed SEC Documents”), to the extent that it is reasonably apparent on the face of such disclosure that it is relevant to the Business, and other than any risk factor disclosures (other than statements of historical fact) in any such Filed SEC Document contained in the “Risk Factors” section thereof or other similarly cautionary, forward-looking or predictive statements in such Filed SEC Documents:
SECTION 4.01.    Organization; Standing.  
(a)    Seller is a corporation duly organized, validly existing and in good standing under the Laws of the State of Delaware and has all requisite corporate power and authority to own, lease and operate the Purchased Assets owned by Seller and to carry on the Business as currently conducted by Seller.  Seller is duly qualified or licensed as a foreign corporation to do business, and is in good standing (where such concept is recognized under applicable Law), in each jurisdiction where the ownership of the Purchased Assets owned by Seller or the conduct of the Business as currently conducted by Seller makes such qualification or licensing necessary, except for any such failures to be so qualified or licensed and in good standing that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.
(b)    Each Asset Seller Entity (other than Seller) is an entity duly organized, validly existing and in good standing (where such concept is recognized under applicable Law) under the Laws of the jurisdiction of its organization, except to the extent that the failure to be in good standing, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.  Each Asset Seller Entity (other than Seller) has all requisite corporate or limited liability company power to own, lease and operate the Purchased Assets owned by such Asset Seller Entity and to carry on the Business as currently conducted by such Asset Seller Entity.  Each Asset Seller Entity (other than Seller) is duly qualified or licensed as a foreign entity to do business, and is in good standing (where such concept is recognized under applicable Law), in each jurisdiction where the ownership of the Purchased Assets owned by such Asset Seller Entity or the conduct of the Business as currently conducted by such Asset Seller Entity makes such qualification or licensing necessary, except for any such failures to be so qualified or 

28

licensed and in good standing that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.

SECTION 4.02.    Corporate Authorization; Noncontravention.
(a)    Seller has all necessary corporate power and corporate authority to execute and deliver this Agreement and to perform its obligations hereunder and, subject to the Consents required for the Merger Transaction and the other transactions contemplated by the Merger Agreement, to consummate the Transactions. The execution, delivery and performance by Seller of this Agreement, and the consummation by it of the Transactions, have been duly authorized by all necessary corporate action on the part of Seller. This Agreement has been duly executed and delivered by Seller and, assuming due authorization, execution and delivery hereof by Purchaser and Abbott, constitutes a legal, valid and binding obligation of Seller, enforceable against Seller in accordance with its terms, except that such enforceability may be limited by and is subject to the Bankruptcy and Equity Exception.
(b)    Each Asset Seller Entity has all necessary corporate or limited liability company power and authority to execute and deliver each of the Ancillary Agreements to which it will be a party and to perform its obligations thereunder and, subject to the Consents required for the Merger Transaction and the other transactions contemplated by the Merger Agreement, to consummate the transactions contemplated thereby. The execution, delivery and performance by each Asset Seller Entity of each Ancillary Agreement to which it will be a party, and the consummation by each such entity of the transactions contemplated thereby, have been duly authorized by all necessary corporate or limited liability company action on the part of each Asset Seller Entity. Each Ancillary Agreement, assuming due authorization, execution and delivery thereof by the other parties thereto (other than any other Asset Seller Entity), will constitute a legal, valid and binding obligation of each Asset Seller Entity (to the extent a party thereto) enforceable against each Asset Seller Entity (to the extent a party thereto) in accordance with its terms, except that such enforceability may be limited by and is subject to the Bankruptcy and Equity Exception. 
(c)    The execution and delivery of this Agreement by Seller, the execution and delivery of each of the Ancillary Agreements by each Asset Seller Entity that will be a party thereto, the consummation by the Asset Seller Entities of the Transactions, the performance and compliance by Seller with any of the terms or provisions hereof, and the performance and compliance by each Asset Seller Entity with any of the terms or provisions of each Ancillary Agreement to which it will be a party, will not, subject to the receipt of the Consents required to consummate the Merger Transaction as set forth in the Merger Agreement, (i) conflict with or violate any provision of (A) the Seller Charter Documents or (B) the equivalent organizational documents of any other Asset Seller Entity, (ii) assuming the Consents and other filings referred to in Section 4.03 are made or obtained (including the termination or expiration prior to the Closing of any applicable waiting periods), violate any Law or Judgment applicable to any Asset Seller Entity (to the extent related to the Business or the Transactions), the Business or any of the Purchased Assets, or by which any Asset Seller Entity (to the extent related to the Business or the Transactions), the Business or any of the Purchased Assets may be bound or affected, (iii) violate or constitute a breach of or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, modification, or cancelation of any obligation or to the loss of any benefit under any of the terms or provisions of, any Contract to which any Asset Seller 

29

Entity is a party to the extent related to the Business, the Transactions or any of the Purchased Assets, or accelerate any Asset Seller Entity’s obligations under any such Contract to the extent applicable to the Business or the Transactions or (iv) result in the creation of any Lien (other than Permitted Liens) on any of the Purchased Assets, except, in the case of clause (iii), as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, and, in the case of clauses (ii) or (iv), as would not, individually or in the aggregate, reasonably be expected to be material to the Business.

SECTION 4.03.    Governmental Approvals.  Except for (a) compliance with the applicable requirements of the Securities Act of 1933 (the “Securities Act”) and the Securities Exchange Act of 1934 (the “Exchange Act”), (b) compliance with the rules and regulations of the New York Stock Exchange, (c) the Consents and other filings required in connection with the Merger Transaction or the Other Transactions, (d) Consents and other filings required under, and compliance with other applicable requirements of Competition Laws, including the Merger Clearances, and (e) compliance with any applicable state securities or blue sky laws, no Consent of any Governmental Authority is necessary for the execution and delivery of this Agreement by Seller and the Ancillary Agreements by the Asset Seller Entities that will be parties thereto, the performance by Seller of its obligations hereunder and by the Asset Seller Entities of their obligations thereunder, and the consummation by the Asset Seller Entities of the Transactions, other than such other Consents and other filings that, if not obtained, made or given, would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

SECTION 4.04.    Financial Statements; Undisclosed Liabilities. 
(a)    Attached as Section 4.04(a) of the Seller Disclosure Letter are (i) the unaudited special purpose statement of net assets of the Business as of December 31, 2016 (the “Reference Balance Sheet”), (ii) the related special purpose statement of revenues and expenses of the Business for the fiscal year then ended, (iii) the unaudited special purpose statement of net assets of the Business as of March 31, 2016 and 2017 (the later of which is the “Interim Balance Sheet”), (iv) the related special purpose statement of revenues and expenses of the Business for the fiscal quarters then ended and (v) the unaudited net revenue, gross profit, R&D, SG&A, Operating Earnings, Depreciation and EBITDA for the Business for the fiscal year ended December 31, 2016 (the “2016 P&L Information”) (items (i) through (v), collectively, the “Financial Statements”).  The Financial Statements have been prepared from the books of account and other financial records of the Business in accordance with the Accounting Methodologies applied on a consistent basis.  The special purpose statements of revenues and expenses and the 2016 P&L Information included in the Financial Statements present fairly in all material respects the revenues and expenses, and profit and loss information, of the Business for the periods covered thereby, and the Reference Balance Sheet, the March 31, 2016 statement of net assets and the Interim Balance Sheet each present fairly in all material respects the accounts of the Business set forth thereon as of its date, in each case in accordance with the Accounting Methodologies applied on a consistent basis; provided, that the Financial Statements and the foregoing representations and warranties are qualified by the fact that the Business has not 

30

operated as a separate standalone entity and therefore the Financial Statements do not include all of the costs necessary for the Business to operate as a separate standalone entity. 
(b)    The financial statements to be delivered under Section 6.10 (the “SEC Financial Statements”), at the time of delivery, (i) will have been prepared from the books of account and other financial records of the Business in accordance with GAAP applied on a consistent basis, (ii) the statements of revenues and direct expenses included in the SEC Financial Statements will present fairly in all material respects the revenues and direct expenses of the Business for the period covered thereby, and the statement of assets acquired and Liabilities assumed contained therein shall each present fairly in all material respects the accounts of the Business set forth thereon as of its date, in each case in accordance with GAAP applied on a consistent basis.
(c)    The Business does not have any Liabilities of any nature (whether accrued, absolute, contingent or otherwise) that would be required to be reflected or reserved against in the Financial Statements prepared in accordance with the Accounting Methodologies except Liabilities (i) constituting, or that would constitute, Excluded Liabilities, (ii) reflected or reserved against in the Reference Balance Sheet (or the notes thereto) or Interim Balance Sheet, (iii) incurred after the date of the Reference Balance Sheet or Interim Balance Sheet in the ordinary course of business consistent with past practice that are not, individually or in the aggregate, material to the Business, (iv) as contemplated by this Agreement or otherwise incurred in connection with the Transactions or (v) as would not, individually or in the aggregate, reasonably be expected to be material to the Business.

SECTION 4.05.    Absence of Certain Changes.  Since the date of the Interim Balance Sheet, except for the performance of the Merger Agreement, execution and performance of this Agreement and the discussions, negotiations and transactions related thereto and to any transaction of the type contemplated by the Merger Agreement or this Agreement, (a) through the date of this Agreement, the Business has been carried on and conducted in all material respects in the ordinary course of business consistent with past practice, (b) there has not been any Material Adverse Effect or any event, change or occurrence that would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, and (c) there has not been any act or omission that, if such act or omission occurred following the execution of this Agreement, would have resulted in a breach of Section 6.01.

SECTION 4.06.    Legal Proceedings.  Except as would not, individually or in the aggregate, reasonably be expected to be material to the Business, as of the date of this Agreement there is, and since January 1, 2016 there has been, no (a) pending or, to the Knowledge of Seller, threatened legal or administrative proceeding, suit, claim, audit, investigation, arbitration, mediation or action (an “Action”) against Seller or any other Asset Seller Entity, in each case, with respect to or relating to the Business, or (b) outstanding or, to the Knowledge of Seller, threatened order, judgment, injunction, ruling, writ or decree of any Governmental Authority (a “Judgment”) imposed upon Seller or any Asset Seller Entity, in each case, with respect to or relating to the Business.  Except as would not, individually or in the aggregate, reasonably be expected to materially and adversely affect the ability of Seller to carry 

31

out its obligations under this Agreement and to consummate the Transactions, as of the date of this Agreement, there is no Action pending or, to the Knowledge of Seller, threatened seeking to prevent, hinder, modify, delay or challenge the Transactions.

SECTION 4.07.    Compliance with Laws; Governmental Authorizations.  Solely with respect to the Business, Seller and each other Asset Seller Entity are, and have been since January 1, 2015, in compliance with all state, federal, local, national, foreign or multinational laws, statutes, ordinances, codes, rules or regulations (“Laws”) or Judgments applicable to the Asset Seller Entities, except for such failures to comply as would not, individually or in the aggregate, reasonably be expected to be material to the Business.  Seller and each other Asset Seller Entity hold all Governmental Authorizations necessary for the lawful conduct of the Business as presently conducted, and Seller and each other Asset Seller Entity are, and have been since January 1, 2015, in compliance with all such Governmental Authorizations, except where the failure to hold the same or be in compliance would not, individually or in the aggregate, reasonably be expected to be material to the Business. Without limiting the generality of the foregoing, except as would not, individually or in the aggregate, reasonably be expected to be material to the Business, Seller, each other Asset Seller Entity and each of its and their directors, officers and employees and, to the Knowledge of Seller, each of its and their other agents acting on its or their behalf, is and has been since January 1, 2015 in compliance with (a) the Foreign Corrupt Practices Act of 1977 and (b) any rules and regulations promulgated thereunder with respect to the Business.  This Section 4.07 does not relate to compliance with Laws or Governmental Authorizations to the extent relating to Tax matters, which are the subject of Section 4.08, Intellectual Property matters, which are the subject of Section 4.09, or compliance with (i) the rules or regulations of the FDA or any comparable Healthcare Regulatory Authority having jurisdiction over the Asset Seller Entities or (ii) matters the subject of Food and Drug Laws and Health Care Laws, which are the subject of Section 4.12.

SECTION 4.08.    Tax Matters. 
(a)    All material Tax Returns required by applicable Law to have been filed with any Governmental Authority in connection with the Business, have been filed in a timely manner (taking into account any valid extension) in accordance with all applicable Laws, and all such Tax Returns are true and complete in all material respects.
(b)    All material Taxes in respect of the Business (whether or not shown to be due on any Tax Return) have been timely paid.
(c)    There are no Liens for Taxes on the Purchased Assets other than Permitted Liens.

SECTION 4.09.    Intellectual Property.  Except as would not, individually or in the aggregate, reasonably be expected to be material to the Business, no claims or other Actions are pending or, to the Knowledge of Seller, threatened in writing, and since January 1, 2015, no Asset Seller Entity has received any written notice or claim alleging that any Asset Seller Entity is infringing, misappropriating or otherwise violating the Intellectual Property of any Person in the operation of the Business.

32

SECTION 4.10.    Assets. 
(a)    The Asset Seller Entities own and have good and marketable title to, or  have a valid leasehold interest in, all of the tangible assets included within the Purchased Assets, free and clear of all Liens, except for Permitted Liens.
(b)    Assuming all required Consents of Third Parties have been obtained and except for (i) the Purchased Assets transferred to Purchaser under the Triage Purchase Agreement, (ii) cash and Cash Equivalents, and (iii) any services made available to Purchaser and its Affiliates pursuant to any Ancillary Agreement, the Purchased Assets constitute, in all material respects, the assets, properties and rights used in the conduct of the Business as presently conducted. 
(c)    Except as would not reasonably be expected to be material to the Business, all of the Transferred Inventory has been stored by the Asset Seller Entities in accordance with past practice of the Business.

SECTION 4.11.    Material Contracts. 
(a)    Section 4.11(a) of the Seller Disclosure Letter sets forth all Material Contracts as of the date of this Agreement. For purposes of this Agreement, “Material Contract” means (i) the OEM Supply Agreement, (ii) the Scios Agreement, and (iii) any other Contracts included within the Purchased Assets or under which there exists Assumed Liabilities with a customer of the Business, including distributors, which provided for aggregate payments to the Asset Seller Entities related to the Business of more than $500,000 during the fiscal year ended December 31, 2016.
(b)    Seller has made available to Purchaser a complete and accurate copy of each Material Contract, subject in each case to the redaction by Seller of any information not related to the Business. Subject to Section 2.04 and except as would not reasonably be expected to be material to the Business: (i) each Material Contract is valid and binding on the Asset Seller Entities to the extent such Person is a party thereto, as applicable, and, to the Knowledge of Seller, each other party thereto, (ii) each Material Contract is in full force and effect, (iii) each of the Asset Seller Entities, and, to the Knowledge of Seller, any other party thereto, has performed in all material respects all obligations required to be performed by it under each Material Contract, (iv) no Asset Seller Entity has received written notice of the existence of any material breach or default on the part of such Asset Seller Entity under any Material Contract, (v) there are no events or conditions which constitute, or, after notice or lapse of time or both, will constitute a material default on the part of any Asset Seller Entity, or to the Knowledge of Seller, any counterparty under such Material Contract, and (vi) Seller has not received any notice in writing from any Person that such Person intends to terminate, amend in a manner adverse to the Business, or not renew, any Material Contract.
(c)    Attached as Section 4.11(c) of the Seller Disclosure Letter is a true and complete list of the countries under which royalties were payable under the Scios Agreement, including on a country-by-country basis, (i) the date on which sales of Licensed Product (as 

33

defined in the Scios Agreement) commenced in such country and (ii) the royalty percentage and total royalties paid in calendar year 2016. 

SECTION 4.12.    Regulatory Compliance. 
(a)    Except as would not, individually or in the aggregate, reasonably be expected to be material to the Business, the Asset Seller Entities are and have been, since January 1, 2015, in compliance with the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 301 et seq.), Section 402(j) of the Public Health Service Act (42 U.S.C. § 282(j)), the rules and regulations enforced by the United States Food and Drug Administration (the “FDA”) or comparable Governmental Authorities of any other jurisdiction in which the Business is conducted, and any other similar Law that governs the development, testing, manufacture, marketing, sale or distribution of the Product in any jurisdiction in which the Business is or was conducted during such period (the “Food and Drug Laws”) and with the federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)), the Stark Law (42 U.S.C. § 1395nn), the False Claims Act (31 U.S.C. § 3729 et seq.), the Physician Payment Sunshine Act (42 U.S.C. § 1320a-7h) and the Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. § 1320d et seq.) as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, and any other similar Law that governs interactions with and among healthcare professionals, claims for payment by any Governmental Authority, applications for premarket approval of any product by the FDA or 510(k) premarket submissions to the FDA, transparency of payments made to healthcare professionals and privacy of patient and consumer personal and health information in any other jurisdiction in which the Business is or was conducted during such period (the “Health Care Laws”) to the extent they are, in each case, applicable to the Business.
(b)    No Asset Seller Entity is, with respect to the Business, subject to any obligation arising under any consent decree, warning letter or FDA Form 483 or any similar obligation issued or imposed by the FDA or any comparable Governmental Authority having jurisdiction over the Asset Seller Entities, except for any such obligation that would not, individually or in the aggregate, reasonably be expected to be material to the Business.
(c)    Except as would not, individually or in the aggregate, reasonably be expected to be material to the Business, each Product in current commercial distribution, or sold or distributed since January 1, 2015, that is subject to any Food and Drug Law and was or has been distributed or marketed by or on behalf of any Asset Seller Entity in connection with the Business, is currently being and since January 1, 2015 has been, promoted, distributed and sold in compliance with all Governmental Authorizations from the FDA, applicable state licensing authorities, or any comparable Governmental Authority having jurisdiction over such Product.
(d)    Notwithstanding any other provision of this Agreement, the representations and warranties contained in Section 4.12(a) through Section 4.12(c) constitute the sole and exclusive representations and warranties of Seller relating to (i) the rules or regulations of the FDA or any comparable Healthcare Regulatory Authority having jurisdiction over the Asset Seller Entities or (ii) matters the subject of Food and Drug Laws or Health Care Laws.

34

SECTION 4.13.    Brokers and Other Advisors. No broker, investment banker, financial advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s or other similar fee or commission, or the reimbursement of expenses in connection therewith, in connection with the Transactions based upon arrangements made by or on behalf of Seller or its Subsidiaries. 

SECTION 4.14.    No Other Representations or Warranties.  Except for the representations and warranties made by Seller in this Article IV or as may be set forth in any Ancillary Agreement, no Asset Seller Entity or any other Person makes any other express or implied representation or warranty with respect to the Asset Seller Entities, the Purchased Assets, or the Business (including operations, properties, assets, Liabilities, conditions (financial or otherwise) or prospects), or any estimates, projections, forecasts and other forward-looking information or business and strategic plan information regarding the Business, notwithstanding the delivery or disclosure to Purchaser or any of its Representatives of any documentation, forecasts or other information with respect to any one or more of the foregoing, and Purchaser acknowledges the foregoing. In particular, and without limiting the generality of the foregoing, none of Seller, any Asset Seller Entity or any other Person makes or has made any express or implied representation or warranty to Purchaser or any of its Representatives with respect to (a) any financial projection, forecast, estimate, budget or other information relating to the Business or (b) except for the representations and warranties made by Seller in this Article IV, any oral or written information presented to Purchaser or any of its Representatives in the course of their due diligence investigation of the Business, the negotiation of this Agreement or the course of the Transactions.   

35

ARTICLE V     
 
REPRESENTATIONS AND WARRANTIES 
OF PURCHASER
Purchaser hereby represents and warrants to Seller and Abbott as follows:
SECTION 5.01.    Organization; Standing.  
(a)     Purchaser is a corporation, duly organized, validly existing and in good standing under the Laws of the State of Delaware and has all requisite corporate power and authority to operate its business as now conducted.  Purchaser is duly qualified or licensed as a foreign corporation to do business, and is in good standing (where such concept is recognized under applicable Law), in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except to the extent that the failure to be so licensed or qualified and in good standing would not, individually or in the aggregate, reasonably be expected to materially and adversely affect the ability of Purchaser to carry out its obligations under this Agreement or the Ancillary Agreements and to consummate the Transactions.
(b)    Each Designated Purchaser (other than Purchaser) is an entity duly organized, validly existing and in good standing (where such concept is recognized under applicable Law) under the Laws of the jurisdiction of its organization, except to the extent that the failure to be in good standing individually or in the aggregate would not reasonably be expected to materially and adversely affect the ability of such Designated Purchaser to carry out its obligations under this Agreement or the Ancillary Agreements and to consummate the Transactions.  Each Designated Purchaser (other than Purchaser) has all requisite corporate or limited liability company power and corporate or limited liability company authority necessary to carry on its business as now conducted.  Each Designated Purchaser (other than Purchaser) is duly licensed or qualified as a foreign entity to do business, and is in good standing (where such concept is recognized under applicable Law), in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except to the extent that the failure to be so organized, existing, qualified or licensed and in good standing would not, individually or in the aggregate, reasonably be expected to materially and adversely affect the ability of any Designated Purchaser to carry out its obligations under this Agreement or the Ancillary Agreements and to consummate the Transactions.

SECTION 5.02.    Corporate Authorization; Noncontravention.
(a)    Each of Purchaser and Purchaser Parent has all necessary corporate power and corporate authority to execute and deliver this Agreement and to perform its obligations hereunder and, in the case of Purchaser, to consummate the Transactions. The execution, delivery and performance by each of Purchaser and Purchaser Parent of this Agreement, and, in the case of Purchaser, the consummation by Purchaser of the Transactions, have been duly authorized by all necessary corporate action on the part of Purchaser and Purchaser Parent. This Agreement has 

36

been duly executed and delivered by each of Purchaser and Purchaser Parent and, assuming due authorization, execution and delivery hereof by Seller and Abbott, constitutes a legal, valid and binding obligation of each of Purchaser and Purchaser Parent, enforceable against each of Purchaser and Purchaser Parent in accordance with its terms, except that such enforceability may be limited by and is subject to the Bankruptcy and Equity Exception.
(b)    Each of the Designated Purchasers has all necessary corporate or limited liability company power and authority to execute and deliver each of the Ancillary Agreements to which it will be a party and to perform its obligations thereunder and to consummate the transactions contemplated thereby. The execution, delivery and performance by each of the Designated Purchasers of each Ancillary Agreement to which it will be a party, and the consummation by each such Person of the transactions contemplated thereby, have been duly authorized by all necessary corporate or limited liability company action on the part of each of Designated Purchaser. Each Ancillary Agreement, assuming due authorization, execution and delivery thereof by the other parties thereto (other than any other Designated Purchaser), will constitute a legal, valid and binding obligation of each of the Designated Purchasers (to the extent a party thereto) enforceable against each of the Designated Purchasers (to the extent a party thereto) in accordance with its terms, except that such enforceability may be limited by and is subject to the Bankruptcy and Equity Exception.
(c)    The execution and delivery of this Agreement by each of Purchaser and Purchaser Parent, the execution and delivery of each of the Ancillary Agreements by each Designated Purchaser that will be a party thereto, the consummation by each Designated Purchaser of the Transactions, the performance and compliance by each of Purchaser and Purchaser Parent with any of the terms or provisions hereof, and the performance and compliance by each Designated Purchaser with any of the terms or provisions of each Ancillary Agreement to which it will be a party, will not, (i) conflict with or violate any provision of the corporate organizational documents of Purchaser or Purchaser Parent or similar organizational documents of any Designated Purchaser, (ii) violate any Law or Judgment applicable to any Designated Purchaser, or by which any Designated Purchaser may be bound or affected, (iii) violate or constitute a breach of or default (with or without notice or lapse of time, or both) under, require any Consent under, or give rise to a right of termination, modification, or cancelation of any obligation or to the loss of any benefit under any of the terms or provisions of any material Contract to which any Designated Purchaser is a party or accelerate any Designated Purchaser’s obligations under any such material Contract, or (iv) result in the creation of any Lien (other than Permitted Liens) on any asset of any Designated Purchaser, except, in the case of clauses (ii), (iii) or (iv), as would not, individually or in the aggregate, reasonably be expected to materially and adversely affect the ability of any Designated Purchaser to carry out its obligations under this Agreement or the Ancillary Agreements and to consummate the Transactions.

SECTION 5.03.    Governmental Approvals.  Except for (a) compliance with the applicable requirements of the Securities Act and the Exchange Act, (b) compliance with the rules and regulations of NASDAQ and (c) the Consents and other filings required under, and compliance with other applicable requirements of, the Competition Laws set 

37

forth in Section 5.03(c) of the Purchaser Disclosure Letter, no Consent of any Governmental Authority is necessary for the execution and delivery of this Agreement by Purchaser and the Ancillary Agreements by the Designated Purchasers that will be parties thereto, the performance by Purchaser of its obligations hereunder and by the Designated Purchasers of their obligations thereunder, and the consummation by each Designated Purchaser of the Transactions, other than such other Consents that, if not obtained, made or given, would not, individually or in the aggregate, reasonably be expected to prevent or materially delay the performance by any Designated Purchaser of its obligations under this Agreement or any Ancillary Agreement.  

SECTION 5.04.    Litigation. Except as would not, individually or in the aggregate, reasonably be expected to materially and adversely affect the ability of any Designated Purchaser to carry out its obligations under this Agreement or the Ancillary Agreements and to consummate the Transactions, there is no (a) pending or, to the Knowledge of Purchaser, threatened Action against any Designated Purchaser, or (b) outstanding Judgment imposed upon any Designated Purchaser. 

SECTION 5.05.    Financing.  Purchaser has, or will have, cash on hand in an amount sufficient to pay the Purchase Price in the amounts and at the times set forth herein.

SECTION 5.06.    Solvency; Fraudulent Conveyance. Assuming the accuracy of the representations and warranties of Seller set forth in Article IV, immediately after giving effect to the Transactions, Purchaser and each of its Subsidiaries (including each other Designated Purchaser) will be able to pay their respective debts as they become due and will own property that has a fair saleable value greater than the amounts required to pay their respective debts when due (including all contingent Liabilities). Immediately after giving effect to the Transactions, Purchaser and the other Designated Purchasers will have adequate capital to carry on their respective businesses. No transfer of property is being made and no obligation is being incurred in connection with the Transactions with the intent to hinder, delay or defraud either present or future creditors of Purchaser or its Subsidiaries (including any other Designated Purchaser).

SECTION 5.07.    Brokers and Other Advisors. Except for Perella Weinberg Partners, the fees and expenses of which will be paid by Purchaser Parent, no broker, investment banker, financial advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s or other similar fee or commission, or the reimbursement of expenses in connection therewith, in connection with the Transactions based upon arrangements made by or on behalf of any Designated Purchaser or any of their respective Subsidiaries.

SECTION 5.08.    Investigation.  Purchaser acknowledges and agrees that it (a) has made its own inquiry and investigation into, and, based thereon, has formed an independent judgment concerning the Purchased Assets, the Assumed Liabilities and the Business and (b) has been furnished with or given access to such information about the Purchased Assets, Assumed Liabilities and the Business as it has requested. Purchaser further acknowledges and agrees that (i) the only representations, warranties, covenants and agreements made by Abbott or any of its Affiliates or Representatives are the representations, warranties, 

38

covenants and agreements made in this Agreement and, except as set forth in Article III, none of Abbott or any of its Affiliates or Representatives makes any other representation or warranty of any kind or nature whatsoever, oral or written, express or implied, with respect to any Asset Seller Entities, the Purchased Assets, the Assumed Liabilities, the Business, this Agreement or the Ancillary Agreements (or the Transactions), including representations, warranties, covenants and agreements relating to the financial condition, results of operations, assets or Liabilities of any of the foregoing entities, (ii) the only representations, warranties, covenants and agreements made by Seller or any of its Affiliates or Representatives are the representations, warranties, covenants and agreements made in this Agreement or as may be set forth in the Ancillary Agreements and, except as set forth in Article IV or as may be set forth in the Ancillary Agreements, none of Seller or any of its Affiliates or Representatives makes any other representation or warranty of any kind or nature whatsoever, oral or written, express or implied, with respect to any Asset Seller Entities, the Purchased Assets, the Assumed Liabilities, the Business, this Agreement or the Ancillary Agreements (or the Transactions), including representations, warranties, covenants and agreements relating to the financial condition, results of operations, assets or Liabilities of any of the foregoing entities and (iii) none of the Asset Seller Entities, Abbott or any of their respective Affiliates or Representatives makes any representation or warranty as to (A) the operation of the Business by Purchaser after the Closing in any manner or (B) the probable success or profitability of the Business after the Closing.  Except for the representations and warranties of Abbott contained in Article III and the representations and warranties of Seller in Article IV or as may be set forth in the Ancillary Agreements, neither Purchaser nor any of its Affiliates have relied upon any other representations or warranties or any other information made or supplied by or on behalf of any Asset Seller Entity, Abbott or any of their respective Affiliates or Representatives, and Purchaser acknowledges and agrees that none of the Asset Seller Entities, Abbott or any of their respective Affiliates or Representatives has any Liability or responsibility for any other representation, warranty, opinion, projection, forecast, advice, statement or information made, communicated or furnished (orally or in writing) to Purchaser, its Affiliates or their respective Representatives (including any opinion, projection, forecast, advice, statement or information that may have been or may be provided to Purchaser by any Affiliate or Representative of Purchaser). Purchaser acknowledges that, should the Closing occur, Purchaser shall acquire the Purchased Assets and the Business without any representation or warranty as to merchantability or fitness thereof for any particular purpose, in an “as is” condition and on a “where is” basis, except as otherwise expressly set forth in this Agreement.  Purchaser hereby waives any and all rights under Section 1542 of the California Civil Code.

39

ARTICLE VI     
 
COVENANTS AND AGREEMENTS
SECTION 6.01.    Conduct of the Business.
(a)    Except as required by applicable Law, Judgment or a Governmental Authority, as expressly contemplated, required or permitted by this Agreement or the Merger Agreement or otherwise undertaken to implement this Agreement, any Ancillary Agreement or the Merger Agreement, or as set forth in Schedule 6.01, during the period from the date of this Agreement until the Closing (or such earlier date on which this Agreement is terminated pursuant to Section 9.01), unless Purchaser otherwise consents in writing (such consent not to be unreasonably withheld, delayed or conditioned), (i) Seller shall, and shall cause the other Asset Seller Entities to, use its and their commercially reasonable efforts to carry on the Business in all material respects in the ordinary course consistent with past practice, and (ii) to the extent consistent with the foregoing, Seller shall, and shall cause the other Asset Seller Entities to, use its and their commercially reasonable efforts to (A) preserve the business organizations of the Business substantially intact and (B) preserve existing relations with key customers and distributors of the Business and with other Persons with whom Seller and the other Asset Seller Entities have significant business relationships with respect to the Business, in each case, consistent with past practice.
(b)    Without limiting the generality of the foregoing, except as required by applicable Law, Judgment or a Governmental Authority, as expressly contemplated, required or permitted by this Agreement or the Merger Agreement or as set forth in Schedule 6.01, during the period from the date of this Agreement until the Closing (or such earlier date on which this Agreement is terminated pursuant to Section 9.01), unless Purchaser otherwise consents in writing (such consent not to be unreasonably withheld, delayed or conditioned), Seller shall not, and shall not permit any other Asset Seller Entity to, in each case solely to the extent relating to the Business:
(i)    incur any Indebtedness that creates or results in a Lien (other than a Permitted Lien) upon any of the Purchased Assets, except for Indebtedness incurred in the ordinary course of business consistent with past practice that (A) constitutes an Excluded Liability, (B) does not result in a Lien (other than a Permitted Lien) on the Purchased Assets that will survive the Closing, or (C) constitutes a letter of credit, bank guarantee, security or performance bond or similar credit support instrument, overdraft facility or cash management program;
(ii)    sell, lease, license or otherwise transfer, directly or indirectly, to any Person, in a single transaction or series of related transactions, any of the Purchased Assets, except (A) ordinary course dispositions of inventory to customers and distributors consistent with past practice, (B) dispositions consistent with past practice of (1) obsolete, surplus or worn out assets or (2) assets that are no longer used or useful in the Business, or (C) transfers among the Asset Seller Entities;

40

(iii)    make any acquisition of, or investment in, any properties, assets, Securities or business for the Business, except for the acquisitions of supplies, inventory, equipment, merchandise or products in the ordinary course of business consistent with past practice; 
(iv)    grant any Lien (other than a Permitted Lien) on any of the Purchased Assets other than (A) to secure Indebtedness and other obligations permitted under Section 6.01(b)(i), or (B) any such Lien that will not survive the Closing and will not (1) require any Consent to be obtained in connection with the Transactions or (2) delay in any material respect the consummation thereof;
(v)    (A) modify, amend or terminate, or waive, in each case in any material respect, any rights or claims under, any Material Contract or any Restricted Contract other than in the ordinary course of business consistent with past practice or (B) enter into any new Contract that (1) would, in the twelve (12)-month period immediately following the entry into such Contract, reasonably be expected to meet the threshold monetary requirement set forth for such type of a Contract in Section 4.11(a)(iii) for the fiscal year ended December 31, 2016, (2) is a Restricted Contract, or (3) contains a change in control or similar provision in favor of the other party or parties thereto that would require a material payment to or would give rise to any material rights of such other party or parties in connection with the consummation of the Transactions (including in combination with any other event or circumstance), other than pursuant to a tender offer process for Contracts with a Governmental Authority in the ordinary course consistent with past practice; or
(vi)    authorize any of, or commit or agree, in writing or otherwise, to take any of, the foregoing actions.
(c)    Nothing contained in this Agreement is intended to give Purchaser, directly or indirectly, the right to control or direct the operations of the Business prior to the Closing, and nothing contained in this Agreement is intended to give Purchaser at any time, directly or indirectly, the right to control or direct any Excluded Businesses. Prior to the Closing, each of Purchaser and Seller shall exercise, consistent with the terms and conditions of this Agreement and with applicable Competition Laws, complete control and supervision over its and its Subsidiaries’ respective operations.

SECTION 6.02.    Efforts; Regulatory and Other Authorizations.
(a)    Subject to Section 6.02(d), each of the Parties and Abbott shall cooperate with the other parties hereto and use (and shall cause their respective Subsidiaries to use) their reasonable best efforts (unless, with respect to any action, another standard of performance is expressly provided for herein) to promptly:
(i)    take, or cause to be taken, all actions and to do, or cause to be done, and assist and cooperate with the other parties in doing, all things necessary, proper or advisable to cause the conditions to Closing to be satisfied as promptly as reasonably practicable and to consummate and make effective, in the most expeditious manner reasonably 

41

practicable, the Transactions, including preparing and filing promptly and fully all documentation to effect all necessary filings, notices, petitions, statements, registrations, submissions of information and applications;
(ii)    obtain all Consents and other confirmations from any Governmental Authority or Third Party necessary, proper or advisable to consummate the Transactions;
(iii)    execute and deliver any additional instruments necessary to consummate the Transactions on the terms and subject to the conditions hereof; and
(iv)     defend or contest in good faith any Action brought by a Third Party that could otherwise prevent or impede, interfere with, hinder or delay in any material respect the consummation of the Transactions;
in the case of each of clauses (i) through (iv), other than with respect to Consents and other confirmations relating to Competition Laws, which are dealt with in Sections 6.02(b) through (d) below.  Without limiting the foregoing, the Parties shall use their reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable, for the Designated Purchasers to acquire in connection with the consummation of the Transactions the Registrations for the Product included within the Purchased Assets and to obtain the necessary Governmental Authorizations or other Registrations required to do so, including using reasonable best efforts in (A) preparing and filing as promptly as reasonably practicable with any Governmental Authority or other Third Party all documentation to effect all necessary, proper or advisable filings, notices, petitions, statements, registrations, submissions of information, applications and other documents, and (B) obtaining and maintaining such Consents and other confirmations required to be obtained by such Designated Purchasers from any Governmental Authority or other Third Party therefor.
(b)    The Parties and Abbott agree (i) to make or cause to be made the appropriate filings or notifications under applicable Competition Laws as promptly as reasonably practicable with respect to the Transactions or the approval by any applicable Governmental Authority of Purchaser as purchaser of the Purchased Assets or Assumed Liabilities, (ii) to supply as promptly as reasonably practicable any additional information and documentary material that may be requested pursuant to applicable Competition Laws in connection with the Transactions or the Merger Transaction (including, in the case of Purchaser, to promptly make available to the United States Federal Trade Commission (“FTC”) and any other applicable Governmental Authority information and appropriate personnel in response to any queries made by them that are raised in connection with the Merger Clearances or the Consents of Governmental Authorities under applicable Competition Laws in connection with the Transactions, which may include information regarding this Agreement, Purchaser’s capabilities as the potential purchaser of the Business, or other matters), and (iii) to promptly take any and all steps necessary to avoid or eliminate each and every impediment and obtain all Consents under any such Competition Laws that may be required by any foreign or U.S. federal, state or local Governmental Authority, in each case with competent jurisdiction, so as to enable the parties hereto to consummate the Transactions.  Without limiting the foregoing, Purchaser shall 

42

promptly take all actions necessary to secure the expiration or termination of any applicable waiting period under any applicable Competition Law and resolve any objections asserted with respect to the Transactions under the Federal Trade Commission Act or any other applicable Law raised by any Governmental Authority, in order to prevent the entry of, any restraint that would prevent, prohibit, restrict or delay the consummation of the Transactions.  Purchaser shall respond to and seek to resolve as promptly as reasonably practicable any objections asserted by any Governmental Authority with respect to the Transactions and none of the Parties or Abbott or any of their respective Affiliates shall take any action with the intention to, or that could reasonably be expected to, hinder or delay the expiration or termination of any waiting period or the obtaining of approval under any applicable Competition Laws.  Anything to contrary in this Section 6.02 notwithstanding, (A) neither Seller nor Abbott shall be required to expand in any way the nature or scope of the Business or Purchased Assets or to include within the Business any aspect of the Excluded Businesses or otherwise include within the Purchased Assets any Excluded Assets, and (B) none of Purchaser or its Affiliates shall be required (1) to commence or defend through litigation any claim asserted in court or other administrative tribunal by any Person (including any Governmental Authority) in order to avoid the entry of, or to have vacated or terminated any Judgment that would prohibit, enjoin, or make illegal the consummation of the Transactions, or (2) to enter into or agree to enter into any consent decree or hold separate order or other arrangement that would require the divestiture, exclusive license (including as to Purchaser and its Affiliates) or discontinuation, before or after the Closing Date, of any assets or current businesses of Purchaser or any of its Affiliates or any portion of the Business or the Purchased Assets.
(c)    Subject to the Confidentiality Agreement and applicable Law or Judgment, Purchaser shall promptly disclose to Seller and Abbott, and provide copies to Seller and Abbott of, all correspondence, filings or communications between Purchaser or any of its Representatives, on the one hand, and any Governmental Authority or members of its staff, on the other hand, relating to the matters that are the subject of this Agreement and the Transactions.  To the extent permitted by such Governmental Authority, Purchaser shall permit Seller and Abbott to review in advance any proposed correspondence, filings or communication by Purchaser to any Governmental Authority relating to the matters that are the subject of this Agreement; provided, however, that materials may be redacted (i) to remove references concerning the valuation, projections, strategy, business plans or prospects of Purchaser and its Affiliates, the Purchased Assets or the Business, (ii) as necessary to address reasonable attorney-client or other privilege concerns; provided, that Purchaser shall use its reasonable best efforts to enter into such joint defense agreements or other arrangements with Seller and Abbott, as appropriate, so as to allow for such disclosure in a manner that does not result in the loss of attorney-client or other privilege, and (iii) as necessary to otherwise comply with contractual arrangements or applicable Law; provided further, that, in the case of each of the foregoing clauses (i), (ii), and (iii), if Purchaser provides redacted materials to Seller or Abbott, it must also provide on an “outside counsel only” basis a copy of the same materials without any redactions applied.  Notwithstanding anything to the contrary herein and subject to the provisions in the Merger Agreement, Abbott shall, on behalf of the Parties, have control over and lead all communications and strategy relating to obtaining all Consents and other confirmations from any Governmental Authority or other Third Party necessary, proper or advisable to consummate the 

43

Transactions or to conduct any litigation arising therefrom.  Neither Seller nor Purchaser shall agree to participate in any meeting with any Governmental Authority in respect of any filings, investigation (including any settlement of the investigation), litigation or other inquiry related to the Transactions unless it, to the extent permitted by such Governmental Authority, gives Abbott the opportunity to attend and participate at such meeting. Seller and Purchaser shall consult with Abbott’s counsel with respect to, or give Abbott’s counsel the opportunity to attend, that portion of any meeting with any Governmental Authority in which the valuation, projections, business plans or prospects of Purchaser and its Affiliates, the Purchased Assets or the Business are discussed. Subject to the Confidentiality Agreement, Abbott and each Party shall coordinate and cooperate fully with each other in exchanging such information and providing such assistance as Abbott or such other Party may reasonably request in connection with the foregoing and in seeking Consents under the applicable Competition Laws.
(d)    Purchaser acknowledges that the entry by Seller and Abbott into this Agreement, the performance by Seller and Abbott of their respective obligations hereunder and, if applicable, the consummation of the Transactions are being undertaken by Seller and Abbott to obtain the Merger Clearances and to consummate the Merger Transaction.  Anything to the contrary in this Section 6.02 notwithstanding, (i) neither Seller nor Abbott shall be obligated to, and the use of reasonable best efforts by each of Seller and Abbott shall in no event require Seller, Abbott or any of their respective Affiliates to, take, or cause to be taken, any actions or do, or cause to be done, or assist and cooperate in the doing of, anything that Abbott, in its reasonable discretion, determines would (A) contravene any covenant or agreement set forth in the Merger Agreement or (B) result in the staff of the FTC, the European Commission, or any other antitrust or competition Governmental Authority not recommending to such applicable Governmental Authority the approval of, or such applicable Governmental Authority not approving (1) the Merger Agreement, the Merger Transaction or the Other Transactions or (2) this Agreement, the Transactions and Purchaser as the purchaser of the Business, the Purchased Assets and the Assumed Liabilities for all Merger Clearances conditioned upon the divestiture of the Business and (ii) Seller and Abbott may, and may cause their respective Affiliates to, take, or cause to be taken, any actions contemplated by or otherwise taken in furtherance of or in connection with (A) the Merger Transaction or (B) the entry into or performance under any Company Acquisition Agreement (as defined in the Merger Agreement).

SECTION 6.03.    Public Announcements. Each of Purchaser, on the one hand, and Seller and Abbott, on the other hand, shall consult with the other(s) before issuing, and give the other(s) the opportunity to review and comment upon, any press release or similar public statements with respect to the Transactions, and shall not issue any such press release or make any such similar public statement prior to such consultation, except as may be required by applicable Law, Judgment, court process or the rules and regulations of any national securities exchange or national securities quotation system.  Notwithstanding the forgoing, this Section 6.03 shall not apply to any press release or similar public statement made by Seller, Purchaser or Abbott (a) which is consistent with any press release or similar public statement mutually agreed by Purchaser, Seller and Abbott, and the terms of this Agreement and does not contain any information relating to Seller, Abbott, Purchaser Parent, Purchaser or the Transactions that has not been previously announced or made public in accordance with the 

44

terms of this Section 6.03 or (b) which is made in the ordinary course of business and does not relate to this Agreement or the Transactions.

SECTION 6.04.    Access to Information; Confidentiality.  
(a)    Subject to applicable Law, between the date of this Agreement and the earlier of the Closing and the termination of this Agreement pursuant to Section 9.01, upon reasonable notice, Seller shall afford to Purchaser and Purchaser’s Representatives reasonable access during normal business hours to each Asset Seller Entity’s officers, employees, agents, properties, books, Contracts and records (in each case to the extent related to the Business and other than any of the foregoing that relate to the negotiation and execution of this Agreement, the Merger Agreement, the Other Transactions or any other transactions potentially competing with or alternative to the Transactions or proposals from other parties relating to any competing or alternative transactions) and Seller shall furnish promptly to Purchaser and Purchaser’s Representatives such information to the extent concerning the Business and its personnel, assets, Liabilities and properties as Purchaser may reasonably request, including the information set forth on Schedule 6.04(a)(i); provided that (i) Purchaser and its Representatives shall conduct any such activities in such a manner as not to interfere unreasonably with the business or operations of Seller or its Affiliates and (ii) Abbott shall be provided copies of any information provided to Purchaser pursuant to this Section 6.04(a) and afforded reasonable prior notice of, and the opportunity to accompany Purchaser’s and Seller’s respective Representatives in connection with, any access by Purchaser or its Representatives provided pursuant to this Section 6.04(a); provided further, however, that Seller shall not be obligated to provide such access or information if Seller determines, in its reasonable judgment, that doing so is reasonably likely to (A) violate applicable Law or an applicable Judgment, (B) jeopardize the protection of an attorney-client privilege, attorney work product protection or other legal privilege or (C) expose Seller or its Affiliates to risk of Liability for disclosure of sensitive or personal information.  In any such event, Seller shall use its reasonable efforts to communicate, to the extent feasible, the applicable information in a way that would not violate the applicable Law, Contract or obligation or risk waiver of such privilege or protection or risk such Liability, including entering into a joint defense agreement, common interest agreement or other similar arrangement.  All requests for information made pursuant to this Section 6.04 shall be directed to the Person designated by Seller on Schedule 6.04(a)(ii) with a copy to the Person designated by Abbott thereon (or in each case, any replacement thereto, as to which Purchaser receives written notice).
(b)    The terms of the letter agreement related to confidentiality, dated as of November 15, 2016, among Seller, Purchaser Parent and Abbott, as amended on February 16, 2017 (as so amended, the “Confidentiality Agreement”), shall continue in full force and effect until the Closing, at which time such Confidentiality Agreement and the obligations of Purchaser under this Section 6.04(b) shall terminate; provided, however, that, from and after the Closing, except as would have been permitted under the terms of the Confidentiality Agreement, Purchaser shall, and shall cause its Affiliates and their respective Representatives to, treat and hold as confidential, and not disclose to any Person, (i) information related to the discussions and negotiations among the Parties and Abbott regarding this Agreement and the Transactions and (ii) all confidential information relating to Seller, Abbott or their respective Subsidiaries or 

45

Affiliates.  If this Agreement is, for any reason, terminated prior to the Closing, the Confidentiality Agreement shall continue in full force and effect in accordance with its terms.
(c)    Nothing provided to Purchaser pursuant to Section 6.04(a) shall in any way amend or diminish Purchaser’s obligations under the Confidentiality Agreement. Purchaser acknowledges and agrees that any information provided to Purchaser or its Affiliates or their respective Representatives pursuant to Section 6.04(a) or otherwise by or on behalf of Seller, Abbott or their respective Affiliates or any of their respective Representatives shall be subject to the terms and conditions of the Confidentiality Agreement.
(d)    From and after the Closing: 
(i)    (A) Each of Seller and Abbott agree to, and shall cause their respective Affiliates to, not use any Business Confidential Information for a period of five (5) years, and (B) each of Seller and Abbott agree to, and shall cause their Affiliates to, and shall use reasonable best efforts to cause their respective Representatives to, for a period of five (5) years, treat and hold as confidential (and not (except as expressly permitted by this Agreement or any Ancillary Agreement) disclose or provide access to any Person (other than the respective Affiliates of Seller and Abbott and their respective Representatives) to) any Business Confidential Information unless, in the case of each of sub-clause (A) and (B), such information: (w) is or becomes generally available to the public through no direct or indirect disclosure in violation hereof by Seller, Abbott or their respective Affiliates or any of their respective Representatives; (x) subject to subclause (ii) of this Section 6.04(d), is required to be publicly disclosed by Law or the rules or regulations of any U.S. or foreign securities exchange or similar organization; (y) is or has been (1) at any time before the consummation of the Merger, independently developed by Abbott or any of its Affiliates or (2) after the Closing, independently developed by Seller, Abbott or any of their respective Affiliates, in either case without the use of Business Confidential Information, as evidenced by its written records; or (z) becomes available to Seller, Abbott, their respective Affiliates or any of their respective Representatives from and after the Closing, from a Third Party source that is not known by Abbott to be under any contractual, legal or fiduciary obligation of confidentiality in respect of such information.
(ii)    In the event that any Asset Seller Entity, Abbott or any of their respective Representatives becomes legally compelled as advised by its outside counsel to disclose any Business Confidential Information (including by Law, by oral questions, interrogatories, requests for information or documents in legal proceedings, subpoena, court order, civil investigative demand or similar process, or by the rules or regulations of any stock exchange on which its Securities or those of an Affiliate are traded), such Person shall provide Purchaser (to the extent permitted by Law and reasonably practicable) with prompt written notice of such requirement so that Purchaser may seek, at Purchaser’s sole expense, a protective order or other remedy or waive compliance with this Section 6.04(d), and in the event that such protective order or other remedy is not obtained, or Purchaser waives compliance with this Section 6.04(d), furnish only that portion of such Business Confidential Information which is legally required to be provided. 

46

Nothing in clause (i) or (ii) of this Section 6.04(d) shall prohibit Seller, Abbott, their respective Affiliates or any of their respective Representatives from using the Business Confidential Information described in this Section 6.04(d) for the purpose of complying with the terms of this Agreement or any of the Ancillary Agreements, including any Contract that has not been assigned or transferred pursuant to Section 2.01. Furthermore, the provisions of this Section 6.04(d) will not prohibit any retention pursuant to Section 6.09 of Archived Records or any other retention of copies of records or any disclosure in connection with the preparation and filing of financial statements or Tax Returns of Seller, Abbott or any of their respective Affiliates or any disclosure made in connection with the enforcement of any right or remedy relating to this Agreement, the Ancillary Agreements or the Transactions.
(e)    Effective as of the Closing, Seller and Abbott hereby assign to Purchaser their respective rights under any confidentiality agreements entered into by Seller and Abbott (or their respective Affiliates or Representatives) in connection with any transaction involving the acquisition or purchase of all or any portion of the Business or the Purchased Assets, in each case to the extent relating to the Business Records or Business Confidential Information that would be required to be kept confidential by Abbott or the Asset Seller Entities pursuant to Section 6.04(d).  

SECTION 6.05.    Notification of Certain Matters. Each of Purchaser, Seller and Abbott shall promptly notify the other parties in writing of any effect, change, condition or occurrence or nonoccurrence of any event of which it is aware that will or would reasonably be expected to result in the failure of the conditions set forth in Section 8.01 or Section 8.02 to be satisfied; provided, however, that the delivery of any notice pursuant to this Section 6.05 shall not limit or otherwise affect the remedies available hereunder to the Person receiving such notice, including not having any effect for purposes of (a) determining the satisfaction or failure to satisfy any of the conditions set forth in Article VIII or (b) any rights to indemnification under Article X.

SECTION 6.06.    Credit and Performance Support Obligations. Purchaser shall use its reasonable best efforts to cause the Asset Seller Entities and their respective Affiliates to be absolutely and unconditionally relieved at the Closing of all Liabilities arising out of the letters of credit, performance bonds, corporate guarantees and other similar items issued and outstanding in connection with the Business that constitute Assumed Liabilities (together the “Seller Guarantees”), and Purchaser shall, to the extent in accordance with the procedures set forth in Article X, indemnify the Asset Seller Entities, Abbott and their respective Affiliates against any Losses arising with respect to such Liabilities. Purchaser agrees to continue to use its reasonable best efforts after the Closing to relieve the Asset Seller Entities, Abbott and their respective Affiliates of all such Seller Guarantees.

SECTION 6.07.    Seller Names and Marks.
(a)    Solely with respect to the limited and specific uses and time periods, and subject to the other terms and conditions, set forth in this Section 6.07:

47

(i)    for a period of two (2) years after the Closing Date, Seller, on its own behalf and on behalf of its Affiliates, grants to the Designated Purchasers a limited, non-exclusive, non-transferable, non-sublicenseable, royalty-free, right and license to continue to use the Seller Transitional Marks in the Territories (A) to manufacture, package and label the Product to the same extent as the Product was manufactured, packaged and labeled in the Business immediately prior to the Closing and (B) on any existing advertising, marketing and promotional materials of the Product (including on websites), in each case for the sole purpose of selling the Product in the Territories; and
(ii)    for a period of sixty (60) days after the Closing Date (or such later period set forth in the proviso hereto), Seller, on its own behalf and on behalf of its Subsidiaries, grants to the Designated Purchasers a limited, non-exclusive, non-transferable, non-sublicenseable, royalty-free, right and license to continue to use the Seller Transitional Marks in the Territories on any existing signs, billboards and telephone listings as used in the Business immediately prior to the Closing, for the sole purpose of selling the Product in the Territories; provided that if, during the period of two (2) years after the Closing Date, the management of Purchaser is not aware of any such use of the Seller Transitional Marks in the Territories on any signs, billboards or telephone listings, then the right and license set forth herein shall extend for such use for a period of sixty (60) days after Purchaser or its Affiliates becomes aware of such use; provided further that nothing in this Section 6.07(a)(ii) shall be deemed to permit Purchaser to use any of the Seller Transitional Marks in the Territories on any signs, billboards or telephone listings after the two (2)-year anniversary of the Closing Date.
(b)    Effective as of the Closing, Purchaser shall, and shall cause its Affiliates to, cease any and all uses of any (i) Trademarks of Seller and its Affiliates other than the Seller Transitional Marks, (ii) Trademarks that constitute, include or are derived from any of the Seller Transitional Marks and (iii) other Trademarks confusingly similar to or that dilute the distinctiveness of any Trademarks described in the foregoing items (i) – (ii) (such Trademarks described in items (i) – (iii) collectively, the “Excluded Seller Marks”). Purchaser acknowledges and agrees that it shall have no right to use and shall receive no interest in any Trademark of Abbott pursuant to this Agreement. Except as provided in Section 6.07(a)(i) and Section 6.07(a)(ii), effective as of the Closing, Purchaser shall, and shall cause its Affiliates to, as soon as reasonably practicable, cease any and all uses of the Seller Transitional Marks, including by no later than ninety (90) days after the Closing Date, deleting all the Seller Transitional Marks from all public or customer-facing materials, including, as applicable, all business cards, schedules, stationery, packaging materials, displays, promotional materials, forms, websites, email, computer software and systems and other materials, and deleting or stickering over the Seller Transitional Marks in all manuals, distributed in connection with the Business. 
(c)    Notwithstanding anything to the contrary herein, Purchaser and its Affiliates shall have no rights to use any Excluded Seller Marks or any of the Seller Transitional Marks other than as expressly provided in this Section 6.07, and all right, title, and interest of Seller, Abbott or their respective Affiliates in and to the Seller Transitional Marks and Excluded Seller Marks not expressly granted to the Designated Purchasers under this Agreement shall 

48

remain the exclusive property of Seller, Abbott and their respective Affiliates, as applicable.  Any use by the Designated Purchasers of any of the Seller Transitional Marks as permitted in this Section 6.07 is subject to (i) the use of such Seller Transitional Marks in a form and manner, and with standards of quality, consistent with any written usage requirements in effect for the Seller Transitional Marks as of the Closing Date and (ii) compliance by the Designated Purchasers with applicable Law. The Designated Purchasers shall not use the Seller Transitional Marks in a manner that could reasonably be expected to reflect negatively on such name and marks or on Seller, Abbott or any of their respective Affiliates. Purchaser shall not (and shall ensure its Affiliates do not) contest, dispute, or challenge the right, title, and interest of Seller, Abbott or their respective Affiliates in and to the Seller Transitional Marks or Excluded Seller Marks.  Purchaser shall not (and shall ensure its Affiliates do not) file applications to register any Trademarks or apply for any domain names, user names or hashtags in any jurisdiction worldwide that (A) are confusingly similar to any of the Seller Transitional Marks or Excluded Seller Marks, (B) consist of, in whole or part, any of the Seller Transitional Marks or Excluded Seller Marks, or (C) dilute the distinctiveness of any of the Seller Transitional Marks or Excluded Seller Marks.  Purchaser shall indemnify and hold harmless Seller, Abbott and any of their respective Affiliates for any Losses arising from any Third Party Claims relating to the use of any of the Seller Transitional Marks pursuant to this Section 6.07 or any violation hereof.  All use of the Seller Transitional Marks under this Section 6.07, including all goodwill arising from any Designated Purchaser’s use of the Seller Transitional Marks, shall inure to the benefit of Seller, Abbott and their respective Affiliates.
(d)    Purchaser acknowledges and agrees that the remedy at Law for any breach of the requirements of this Section 6.07 would be inadequate, and agrees and consents that without intending to limit any additional remedies that may be available, each of Seller and Abbott shall be entitled to a temporary or permanent injunction, without proof of actual damage or inadequacy of legal remedy, and without posting any bond or other undertaking, in any Action which may be brought to enforce any of the provisions of this Section 6.07.
(e)    NONE OF SELLER, ABBOTT, THEIR RESPECTIVE AFFILIATES OR ANY OF THEIR AND THEIR AFFILIATES’ RESPECTIVE REPRESENTATIVES MAKE OR HAVE MADE ANY REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, AT LAW OR IN EQUITY, IN RESPECT OF ANY OF THE SELLER TRANSITIONAL MARKS, AND ANY SUCH REPRESENTATION OR WARRANTY IS HEREBY EXPRESSLY DISCLAIMED, AND SELLER AND THEIR AFFILIATES, AS APPLICABLE, ARE LICENSING THE SELLER TRANSITIONAL MARKS TO THE DESIGNATED PURCHASERS UNDER THIS SECTION 6.07 ON AN “AS IS” BASIS.

SECTION 6.08.    Records Access and Transfer. 
(a)    Paper copies or tangible embodiments of the Business Records stored in any facilities of Seller or its Affiliates or any Third Party records storage facility (“Archived Records”) shall, subject to the Archived Records Agreement, remain in such facility, or a successor thereto, until the earlier of the transfer or destruction of such Archived Records in accordance with the processes and procedures set forth in the Archived Records Agreement.

49

(b)    Purchaser shall receive possession and control of paper copies or tangible embodiments of the Business Records stored as of the Closing at the Purchaser Occupied Real Property.  Purchaser agrees to retain and maintain any Books, Records and Files received by Purchaser or its Affiliates in connection with the Transactions and any other Books, Records and Files that relate to any Excluded Liability for a period of at least seven (7) years after Closing or such longer minimum period as is required by applicable Law (plus, in each case, any additional time during which Purchaser has been advised by Seller that (i) there is an ongoing Tax audit with respect to periods prior to the Closing or (ii) any such period is otherwise open to assessment). During any such period, Purchaser agrees to give Seller and its Affiliates and their respective Representatives reasonable cooperation, access (including copies, at Seller’s expense) and staff assistance (at Seller’s expense), as needed, during normal business hours and upon reasonable notice, with respect to such Books, Records and Files as may be necessary for general business purposes, including the defense of litigation, the preparation of Tax Returns and financial statements and the management and handling of Tax audits.

SECTION 6.09.    Further Assurances; Post-Closing Cooperation. 
(a)    Subject to the terms and conditions of this Agreement, at any time or from time to time after the Closing, each of the Parties shall, and shall cause their respective Affiliates to, execute and deliver such other documents and instruments, provide such materials and information and take such other actions as may reasonably be necessary, proper or advisable, to the extent permitted by Law, to fulfill its obligations under this Agreement and to cause the Transactions to occur.
(b)    Without limiting the obligations of the Parties and Abbott under Section 6.08(b) or Section 10.05(a), from and after the Closing, the Parties and Abbott shall reasonably cooperate with each other in the investigation, prosecution or defense of any Action (other than Actions with respect to Taxes, which are governed by Article VII or any Action in which the Parties or Abbott, as applicable, are adverse to each other) from or related to the conduct of the Business, the operation or use of the Purchased Assets, the Assumed Liabilities, the Excluded Assets or the Excluded Liabilities and, in each case, involving one or more Third Parties.  Such cooperation shall include, upon reasonable advance notice, (i) providing, and causing their respective Affiliates to provide, documentary or other evidence, (ii) implementing, and causing their respective Affiliates to implement, record retention, litigation hold or other documentary or evidence policies or (iii) making, and causing their respective Affiliates to make, available directors, officers and employees to give depositions or testimony, all as reasonably related to such Action and reasonably requested by the requesting Party or Abbott from time to time.  Except as otherwise provided in Article X, the Person requesting such cooperation shall pay the reasonable out-of-pocket expenses incurred in providing such cooperation (including reasonable legal fees and disbursements) by the Person party hereto (or Affiliate thereof, as the case may be) providing such cooperation and by its officers, directors, employees and agents, but not including reimbursing such Person (or Affiliate thereof, as the case may be) or its officers, directors, employees and agents for their time spent in such cooperation.
(c)    If, following the Closing:

50

(i)    any right, property or asset not forming part of the Purchased Assets or otherwise constituting an Excluded Asset is found to have been transferred to Purchaser in error, either directly or indirectly, or received by Purchaser, Purchaser shall transfer, or shall cause its Affiliates to transfer, at no cost to Seller, Abbott or their Affiliates, such right, property or asset (and any related Liability) as soon as reasonably practicable to Seller, Abbott or their Affiliate as directed in writing by Seller;
(ii)    any right, property or asset forming part of the Purchased Assets is found to have been retained by any Asset Seller Entity in error, either directly or indirectly, or received by any Asset Seller Entity, Seller shall, or shall cause the other applicable Asset Seller Entity to transfer, at no cost to Purchaser, such right, property or asset (and any related Liability, to the extent an Assumed Liability) as soon as reasonably practicable to the applicable Designated Purchaser; and
(iii)    any right, property or asset that, if held by an Asset Seller Entity would have formed part of the Purchased Assets pursuant to Section 2.01(a), is found to have been held as of the Closing by an Affiliate of Seller that is not an Asset Seller Entity, Seller shall cause such Affiliate to transfer, at no cost to Purchaser, such right, property or asset (and any related Liability, to the extent an Assumed Liability) as soon as reasonably practicable to the applicable Designated Purchaser.

SECTION 6.10.    Audited Financial Statements.
(a)    Seller and Abbott shall:  
(i)    use their reasonable best efforts to prepare and deliver to Purchaser no later than 45 days after the Closing Date abbreviated financial statements, which shall consist of: (A)(1) audited statements of assets acquired and Liabilities assumed for the Business as of December 31, 2015 and December 31, 2016 and (2) the audited combined statements of revenues and direct expenses for the Business for the years ended December 31, 2014, December 31, 2015 and December 31, 2016, in each case together with footnotes thereto, as audited by PricewaterhouseCoopers LLP (“Auditor”) and accompanied by the unqualified report thereon by Auditor to the effect that such statements fairly present in all material respects the financial position of the Business at each of the statement of assets acquired and Liabilities assumed dates and for each of the periods covered by the statement of revenues and direct expenses (the “Audited Financial Statements”), and (B) unaudited statement of assets acquired and Liabilities assumed of the Business as of June 30, 2017 and as of the corresponding quarter from the previous fiscal year, and the related statements of revenues and direct expenses for the six (6) month periods ended June 30, 2016 and June 30, 2017, together with footnotes thereto, as reviewed by Auditor (the “Initial Interim Financial Statements”); and
(ii)    with respect to any fiscal quarter beginning with the fiscal quarter ended June 30, 2017 and ending on or before the Closing Date, as soon as practicable, but in no event later than forty-five (45) days after the end of such fiscal quarter, prepare and deliver to Purchaser unaudited statements of assets acquired and Liabilities assumed of the Business as of the end of each such fiscal quarter and for the corresponding quarter from the previous fiscal year, and the related statements of revenues and direct expenses of the Business for the interim periods then ended and the corresponding interim period from the previous fiscal year together with footnotes thereto, as reviewed by Auditor (together with the Initial Interim Financial Statements, the “Interim Financial Statements”).

51

(b)    The Audited Financial Statements and the Interim Financial Statements shall be prepared in accordance with the SEC regulations for Regulation S-X, Rule 3-05 financial statements.

SECTION 6.11.    Specified Business Contracts. Purchaser shall assume and fulfill the Liabilities and other obligations of the applicable Asset Seller Entity under the Specified Business Contracts and shall execute and deliver, or cause to be executed and delivered, to Seller and the other Persons party to the Specified Business Contracts a written instrument in form and substance reasonably acceptable to such Persons evidencing Purchaser’s assumption of, and agreement to fulfill, the Liabilities and other obligations of the applicable Asset Seller Entity under the Specified Business Contracts.  Nothing in this Section 6.11 or any instrument delivered by Purchaser in respect of any Specified Business Contract to a Third Party, including BC or its Affiliates, shall limit or otherwise affect any remedies available to Purchaser hereunder, including any right to indemnification pursuant to Article X.

ARTICLE VII     
 
TAXES

SECTION 7.01.    Periodic Taxes.  All personal property Taxes and similar ad valorem obligations levied with respect to the Purchased Assets for a Straddle Period (“Periodic Taxes”) shall be apportioned to the Pre-Closing Tax Period of such Straddle Period by multiplying the amount of such Taxes for the entire Straddle Period by a fraction the numerator of which is the number of days in the portion of such Straddle Period ending on the Closing Date and the denominator of which is the number of days in the entire Straddle Period. The excess of such Periodic Taxes for such Straddle Period over the amount apportioned to the Pre-Closing Tax Period shall be apportioned to the Post-Closing Tax Period. Seller shall be liable for the amount of such Periodic Taxes attributable to the Pre-Closing Tax Period except to the extent payment therefor had been made prior to Closing. Purchaser shall be liable for the amount of such Periodic Taxes attributable to the Post-Closing Tax Period and shall reimburse Seller for any portion of the Periodic Taxes attributable to the Post-Closing Tax Period paid by Seller within ten (10) days of being notified by Seller of the amount so due. Purchaser shall be responsible for preparing and filing all Tax Returns for Periodic Taxes required to be filed after the Closing; provided, however, such Tax Returns shall be subject to the approval of Seller, which approval shall not be unreasonably withheld, conditioned or delayed.

SECTION 7.02.    Refunds and Credits. Seller and its Affiliates shall be entitled to retain or, to the extent actually received by or otherwise available to Purchaser or its Affiliates, receive immediate payment from Purchaser or its Affiliates of, any refund or credit with respect to Taxes (including without limitation refunds arising by reason of amended Tax Returns filed after the Closing Date or otherwise) with respect to any Pre-Closing Tax Period relating to the Business or the Purchased Assets. Purchaser shall be entitled to retain or, to the extent actually received by Seller or its Affiliates, receive immediate payment from Seller or its Affiliates of, any refund or credit with respect to Taxes (including without limitation refunds arising by reason of amended Tax Returns filed after the Closing or otherwise) with respect to any Post-Closing Tax Period relating to the Business or the Purchased Assets. Any refunds or 

52

credits of Taxes with respect to Straddle Periods shall be apportioned pursuant to the principles set forth in Section 7.01.

SECTION 7.03.    Resolution of Tax Controversies. If, following the Closing, a claim shall be made by any Governmental Authority that might result in an indemnity payment to a Purchaser Indemnitee pursuant to Section 10.02, Purchaser shall promptly notify Seller of such claim. If, following the Closing, a claim shall be made by any Governmental Authority that might result in an indemnity payment to a Seller Indemnitee pursuant to Section 10.03, Seller shall promptly notify Purchaser of such claim. In the event that a Governmental Authority determines a deficiency in any Tax, the Party ultimately, following the Closing, responsible for such Tax under this Agreement, whether by indemnity or otherwise, shall have authority to determine whether to dispute such deficiency determination and to control the prosecution or settlement of such dispute; provided that with respect to Straddle Periods, the Party with the greater potential Tax burden shall control the dispute. The Party that is not ultimately responsible for such Tax under this Agreement shall, following the Closing, have the right to participate at its own expense in the conduct of any such proceeding involving a Tax claim that would adversely affect such Party. 

SECTION 7.04.    Tax Cooperation.  From and after the Closing, each of Seller and Purchaser shall provide the other Party with such information and records and make such of its officers, directors, employees and agents available as may reasonably be requested by such other Party in connection with the preparation of any Tax Return or any audit or other proceeding that relates to the Business or the Purchased Assets.

SECTION 7.05.    Conveyance Taxes. Notwithstanding any other provisions of this Agreement to the contrary, all transfer, documentary, recording, registration, stamp and other similar Taxes (including all applicable real estate transfer Taxes, but excluding any Taxes based on or attributable to income or capital gains) together with any notarial and registry fees and recording costs imposed by any Governmental Authority in connection with the transfer of the Purchased Assets to the Designated Purchasers (“Conveyance Taxes”) will be shared equally by Purchaser and its Affiliates, on the one hand, and Seller and its Affiliates, on the other hand, regardless of which Person is obligated to pay such Conveyance Taxes under applicable Law; provided, however, that Purchaser and its Affiliates shall pay and be solely responsible for all value added, goods and services, sales or other similar Taxes. To the extent that one Party claims any exemptions from any Conveyance Taxes, such Party shall provide to the other Party the appropriate exemption certificates. Seller, Purchaser and their respective Affiliates will cooperate in timely making and filing all Tax Returns that may be required to comply with Law relating to Conveyance Taxes.

SECTION 7.06.    VAT. Any payment of the Purchase Price shall be exclusive of value added, goods and services and any other similar Taxes, and if such Taxes are properly charged or chargeable upon Seller or any of its Affiliates, Purchaser and its Affiliates shall pay Seller (in addition to the portion of the Purchase Price payable at such time) the amount of such Taxes within five (5) Business Days of receipt by Purchaser of notice thereof from Seller and a copy of a Tax invoice in compliance with local Laws.

53

SECTION 7.07.    Survival of Obligations. Notwithstanding anything herein to the contrary, the obligations contained in this Article VII shall survive the Closing until thirty (30) days after expiration of the applicable statute of limitations, as extended to the maximum extent permitted by Law.  In no event shall an Indemnified Party be indemnified for the same Taxes more than once (even if such Indemnified Party is entitled to indemnification for such Taxes pursuant to more than one provision contained in this Agreement).

ARTICLE VIII     
 
CONDITIONS TO CLOSING

SECTION 8.01.    Conditions to Obligation of Purchaser. The obligation of Purchaser to consummate the Transactions shall be subject to the fulfillment or written waiver by Purchaser, at or prior to the Closing, of each of the following conditions:
(a)    Each of the representations and warranties of Seller contained in this Agreement shall be true and correct (without regard to any qualification as to materiality or Material Adverse Effect (other than with respect to the representation contained in Section 4.05(b))) as of the Closing (other than such representations and warranties as are made as of another date, which shall be true and correct as of such date), except where the failure of such representations and warranties to be so true and correct would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.  The covenants and agreements contained in this Agreement to be complied with or performed by Seller on or before the Closing shall have been complied with or performed in all material respects.  Purchaser and Abbott shall have received a certificate signed on behalf of Seller by an officer of Seller to the effect that the conditions set forth in this Section 8.01(a) have been satisfied.
(b)    Each of the representations and warranties of Abbott contained in this Agreement shall be true and correct (without regard to any qualification as to materiality) as of the Closing (other than such representations and warranties as are made as of another date, which shall be true and correct as of such date), except where the failure of such representations and warranties to be so true and correct would not, individually or in the aggregate, reasonably be expected to materially delay or prevent the consummation of the Transactions contemplated hereby in accordance with the terms hereof.  The covenants and agreements contained in this Agreement to be complied with or performed by Abbott on or before the Closing shall have been complied with or performed in all material respects.  Purchaser and Seller shall have received a certificate signed on behalf of Abbott by an officer of Abbott to the effect that the conditions set forth in this Section 8.01(b) have been satisfied.
(c)    Any Consents of Governmental Authorities under applicable Competition Laws for the Transactions for the jurisdictions set forth on Schedule 8.01(c) shall have been received.
(d)    No Law or Judgment (whether temporary, preliminary or permanent) shall have been promulgated, entered, enforced, enacted or issued by any Governmental Authority that 

54

remains in effect and that prohibits, enjoins, or makes illegal the consummation of the Transactions.
(e)    Purchaser shall have received an executed copy of each of the documents required to be delivered to it pursuant to Section 2.09(a).
(f)    With respect to each Asset Seller Entity listed on Schedule 8.01(f), an affidavit that such Asset Seller Entity is not an “foreign person” within the meaning of the Foreign Investment in Real Property Tax Act of 1980, substantially in the form of Exhibit F hereto.
(g)    The transactions contemplated by the Triage Purchase Agreement shall be simultaneously consummated.

SECTION 8.02.    Conditions to Obligation of Seller. The obligation of Seller to consummate the Transactions shall be subject to the fulfillment or written waiver by both of Seller and Abbott, at or prior to the Closing, of each of the following conditions:
(a)    Each of the representations and warranties of Purchaser contained in this Agreement shall be true and correct (without regard to any qualification as to materiality) as of the Closing (other than such representations and warranties as are made as of another date, which shall be true and correct as of such date), except where the failure of such representations and warranties to be so true and correct would not, individually or in the aggregate, reasonably be expected to materially delay or prevent the consummation of the Transactions contemplated hereby in accordance with the terms hereof.  The covenants and agreements contained in this Agreement to be complied with or performed by Purchaser on or before the Closing shall have been complied with or performed in all material respects.  Seller and Abbott shall have received a certificate signed on behalf of Purchaser by an officer of Purchaser to the effect that the conditions set forth in this Section 8.02(a) have been satisfied.
(b)    To the extent required by the applicable Governmental Authority, (i) the FTC shall have accepted for public comment an Agreement Containing Consent Order that includes a proposed Decision and Order in connection with the Merger Transaction that, if issued as a final order, would require Seller and Abbott to divest the Business to Purchaser, as an FTC-approved acquirer; (ii) the European Commission shall have issued a decision approving the Merger Transaction pursuant to Article 6(1)(b) in conjunction with Article 6(2) of Council Regulation (EC) 139/2004 and Purchaser shall have been approved by the European Commission as the purchaser of the Purchased Assets and Assumed Liabilities in accordance therewith; (iii) all other Merger Clearances shall have been received; (iv) approval of this Agreement, the Transactions and Purchaser as the purchaser of the Purchased Assets and Assumed Liabilities shall have been received by Governmental Authorities for all Merger Clearances conditioned upon the divestiture of the Business; and (v) any Consents of Governmental Authorities under applicable Competition Laws for the Transactions for the jurisdictions set forth on Schedule 8.02(b) shall have been received.

55

(c)    No Law or Judgment (whether temporary, preliminary or permanent) shall have been promulgated, entered, enforced, enacted or issued by any Governmental Authority that remains in effect and that prohibits, enjoins, or makes illegal the consummation of the Transactions.
(d)    The Merger Transaction shall have been consummated in accordance with the Merger Agreement or shall be consummated simultaneously with the satisfaction (other than those conditions that, by their nature, cannot be satisfied until the Closing, but would be satisfied if the Closing were to occur) or waiver of the other conditions set forth in this Article VIII.
(e)    Seller shall have received an executed copy of each of the documents required to be delivered to it pursuant to Section 2.10(a).
(f)    The transactions contemplated by the Triage Purchase Agreement shall be simultaneously consummated.

ARTICLE IX     
 
TERMINATION

SECTION 9.01.    Termination. This Agreement may be terminated, or in the case of clause (d) below shall terminate, at any time prior to the Closing in the following circumstances:
(a)    by the mutual written consent of Purchaser and Abbott;
(b)    upon written notice, by Abbott to Purchaser (with a copy to Seller) in the event that Abbott determines, in its sole discretion to be exercised in good faith, that the staff of the FTC, the European Commission, or any other antitrust or competition Governmental Authority is not likely to recommend the approval of, or such applicable Governmental Authority is not likely to approve, this Agreement, the Transactions or Purchaser as the purchaser of the Business, the Purchased Assets or Assumed Liabilities for all Merger Clearances conditioned upon the divestiture of the Business;
(c)    by either Purchaser or Abbott, upon written notice to the non-terminating Person (with a copy to Seller), if any Governmental Authority of competent jurisdiction shall have issued a Judgment permanently restraining, enjoining or otherwise prohibiting the Transactions and such Judgment shall have become final and non-appealable, provided, however, that the right to terminate this Agreement under this Section 9.01(c) shall not be available to either Purchaser or Abbott if such Judgment was due to the failure of such Person (or in the case of termination by Abbott, Seller) to perform any of its obligations under this Agreement or due to the breach by such Person (or in the case of termination by Abbott, Seller) of its representations and warranties set forth in this Agreement; 
(d)    immediately, without any action by any Party or Abbott, if the Merger Agreement is terminated; 

56

(e)    by Purchaser, if Seller shall have materially breached or failed to perform any of its representations, warranties, covenants or agreements set forth in this Agreement, which breach or failure to perform (i) would give rise to the failure of a condition set forth in Section 8.01(a) and (ii) is incapable of being cured within ninety (90) calendar days after the consummation of the Merger Transaction (the “End Date”) or, if capable of being cured by the End Date, Seller shall not have commenced good-faith efforts to cure the breach or failure to perform within thirty (30) calendar days following (or the breach or failure to perform is not cured within sixty (60) calendar days following) receipt by Seller of written notice from Purchaser of the breach or failure to perform; provided, that Purchaser shall not have the right to terminate this Agreement pursuant to this Section 9.01(e) if Purchaser is then in material breach of any of its representations, warranties, covenants or agreements under this Agreement, which breach would give rise to the failure of a condition set forth in Section 8.02(a); 
(f)    by Abbott, if Purchaser shall have materially breached or failed to perform any of its representations, warranties, covenants or agreements set forth in this Agreement, which breach or failure to perform (i) would give rise to the failure of a condition set forth in Section 8.02(a) and (ii) is incapable of being cured by the End Date or, if capable of being cured by the End Date, Purchaser shall not have commenced good-faith efforts to cure the breach or failure to perform within thirty (30) calendar days following (or the breach or failure to perform is not cured within sixty (60) calendar days following) receipt by Purchaser of written notice from Abbott (with a copy to Seller) of the breach or failure to perform; provided, that Abbott shall not have the right to terminate this Agreement pursuant to this Section 9.01(f) if Abbott or Seller is then in material breach of any of its representations, warranties, covenants or agreements under this Agreement, which breach would give rise to the failure of a condition set forth in Section 8.01(a) or Section 8.01(b);
(g)    by Purchaser or Abbott, if the Closing shall not have occurred prior to the End Date, provided that the right to terminate this Agreement under this Section 9.01(g) shall not be available to (i) Abbott if the failure of the Closing to have occurred by the End Date was due to the failure of Seller or Abbott to perform any of their respective obligations under this Agreement or due to the breach of the representations and warranties of Seller or Abbott set forth in this Agreement or (ii) Purchaser if the failure of the Closing to have occurred by the End Date was due to the failure of Purchaser to perform any of its obligations under this Agreement or due to the breach of the representations and warranties of Purchaser set forth in this Agreement; or
(h)    by Abbott, if all Consents of the FTC required for the consummation of the Transactions have not been received within twenty-five (25) days after the consummation of the Merger Transaction.

SECTION 9.02.    Effect of Termination.  In the event of the termination of this Agreement in compliance with Section 9.01, this Agreement shall be terminated and this Agreement shall forthwith become void and have no effect, without any Liability or obligation on the part of any Party, Purchaser Parent or Abbott (or any shareholder or Representative of such Party, Purchaser Parent or Abbott), other than Section 1.03 (Interpretation), Section 6.03 (Public Announcements), this Section 9.02 and Article XI 

57

(including the definitions used in each such Section; but excluding Section 11.07), all of which shall survive such termination; provided, that nothing in this Section 9.02 shall relieve any Party or Abbott from Liability for any Fraud or knowing, material and intentional breach of this Agreement.

ARTICLE X     
 
INDEMNIFICATION

SECTION 10.01.    Survival of Representations and Warranties.The representations and warranties of Abbott, Seller and Purchaser contained in this Agreement shall survive the Closing for a period of twelve (12) months following the Closing Date; provided, however that (a) the representations and warranties of Abbott contained in Section 3.01 (Organization; Standing), Section 3.02 (Corporate Authorization) and Section 3.04 (Brokers and Other Advisors), (b) the Fundamental Representations, and (c) the representations and warranties of Purchaser contained in Section 5.01 (Organization; Standing), Sections 5.02(a) and (b) (Corporate Authorization) and Section 5.07 (Brokers and Other Advisors) shall survive the Closing until thirty (30) days after the expiration of the applicable statute of limitations (including any extensions thereof, whether automatic or permissive). All covenants contained in this Agreement which are to be performed prior to the Closing shall terminate on the Closing Date.  The covenants contained in this Agreement which are to be performed at or after the Closing shall terminate thirty (30) days after the expiration of the applicable statute of limitations (including any extensions thereof, whether automatic or permissive).  Notwithstanding the foregoing, each representation, warranty, covenant and agreement contained in this Agreement shall survive the time at which it would otherwise expire pursuant to this Section 10.01 if, prior to such time, a Third Party Claim Notice or Direct Claim Notice with respect to the breach shall have been timely delivered to the Party against whom such indemnity may be sought in accordance with Section 10.05.  Any claim not asserted in accordance with this Article X on or prior to the expiration of the applicable survival period set forth in this Section 10.01 will be irrevocably and unconditionally released and waived.

SECTION 10.02.    Indemnification by Seller.  Subject to the provisions of this Article X, from and after the Closing, Seller shall indemnify Purchaser and its Affiliates and its and their respective officers, directors, agents, successors and assigns (collectively, the “Purchaser Indemnitees”) from and against all Losses actually suffered or incurred by them to the extent arising out of or related to: (a) any breach of any representation or warranty of Seller in this Agreement, (b) nonfulfillment of or failure to perform any covenant or agreement on the part of Seller contained in this Agreement, or (c) any Excluded Liability.

58

SECTION 10.03.    Indemnification by Purchaser.  Subject to the provisions of this Article X, from and after the Closing, Purchaser shall indemnify Seller and its Affiliates and each such entity’s respective officers, directors, agents, successors and assigns (collectively, the “Seller Indemnitees”) from and against all Losses actually suffered or incurred by them to the extent arising out of or related to: (a) any breach of any representation or warranty of Purchaser in this Agreement, (b) nonfulfillment of or failure to perform any covenant or agreement on the part of Purchaser contained in this Agreement, or (c) any Assumed Liabilities.

SECTION 10.04.    Limitations on Indemnifiable Losses.
(a)    Notwithstanding anything to the contrary contained in this Agreement:
(i)    no indemnification payments will be made by or on behalf of Seller pursuant to Section 10.02(a) in respect of any individual claim or series of claims having the same nature or origin where the aggregate Losses relating to such claims or series of claims are less than $150,000, and such claims or series of claims with Losses relating thereto of less than $150,000 will not be aggregated or counted for purposes of calculating the Deductible in clause (ii) below;
(ii)    no indemnification payments will be made by or on behalf of Seller pursuant to Section 10.02(a) until the aggregate amount of Losses for which Seller would (but for this clause (ii)) be liable thereunder exceeds $2,800,000 (such amount being, the “Deductible”), and then only to the extent of such excess over the Deductible; provided, that the Deductible shall not apply to Losses arising out of or relating to the breach of any Fundamental Representation; 
(iii)    the aggregate total amount in respect of which Seller will be liable to indemnify and hold harmless the Purchaser Indemnitees pursuant to Section 10.02(a) will not exceed $22,400,000 (such amount being the “Cap”); provided, that the Cap shall not apply to Losses arising out of or relating to the breach of any Fundamental Representation; and
(iv)    subject to Section 10.04(a)(iii), the aggregate total amount in respect of which Seller will be liable to indemnify the Purchaser Indemnitees pursuant to Section 10.02(a) and (b) shall not exceed the aggregate amount payable pursuant to Schedule 2.05.
(b)    For all purposes of this Article X, “Losses” shall be net of any insurance proceeds, indemnification payments, contribution payments or reimbursements actually received by or paid to an Indemnified Party with respect to such Losses or any of the circumstances giving rise thereto.
(c)    In the event a Person seeks indemnification under this Article X for any Losses, Purchaser (if such Person is a Purchaser Indemnitee) or Seller (if such Person is a Seller Indemnitee) shall use its commercially reasonable efforts to take all actions as may be reasonably required or necessary to mitigate, to the extent practicable, such Losses (including, to the extent commercially reasonable, pursuing in good faith available insurance coverage, indemnification payments, contribution payments or reimbursements).
(d)    Any indemnity provided hereunder by Seller shall be so applied as to avoid any double counting and no Indemnified Party shall be entitled to obtain indemnification 

59

more than once for the same Losses pursuant to this Agreement, any Ancillary Agreement, the Triage Purchase Agreement or any other Contract entered between the Parties or their respective Affiliates in connection with the transactions contemplated by the Triage Purchase Agreement.
(e)    For purposes of this Article X, the representations and warranties of Seller shall not be deemed qualified by any reference to “materiality” or “Material Adverse Effect” (other than the Specified Qualifications).

SECTION 10.05.    Indemnity Procedures. Claims for indemnification under this Agreement shall be asserted and resolved as follows:
(a)    Third Party Claims.
(i)    Any Purchaser Indemnitee or Seller Indemnitee seeking indemnification under this Agreement (an “Indemnified Party”) with respect to any claim asserted or threatened against the Indemnified Party by a Third Party (a “Third Party Claim”) in respect of any matter that is subject to indemnification under Section 10.02 or Section 10.03, as applicable, shall promptly deliver to the other Party (the “Indemnifying Party”) a written notice (a “Third Party Claim Notice”) setting forth a description in reasonable detail of the nature of the Third Party Claim or, in the alternative, include a copy of all papers served with respect to such Third Party Claim (if any); provided, however, that the failure to so transmit a Third Party Claim Notice shall not affect the Indemnifying Party’s obligations under this Article X, except to the extent that the Indemnifying Party is materially prejudiced as a result of such failure.  
(ii)    If a Third Party Claim is asserted against an Indemnified Party, the Indemnifying Party shall be entitled to participate in the defense thereof and, if the Indemnifying Party delivers a written notice to the Indemnified Party within thirty (30) days after receipt of a Third Party Claim Notice (or sooner, if the nature of the Third Party Claim so requires) stating that the Indemnifying Party shall assume and control the defense of such Third Party Claim and specifying any reservations to its defense (except that the failure to so specify any reservation to its defense in a timely delivered written notice shall not affect the validity of such written notice unless the Indemnified Party is materially prejudiced as a result of such failure), the Indemnifying Party may assume and control the defense thereof with counsel selected by the Indemnifying Party and reasonably satisfactory to the Indemnified Party and settle such Third Party Claim at the discretion of the Indemnifying Party; provided, that the Indemnifying Party shall not, except with the written consent of the Indemnified Party (such consent not to be unreasonably withheld, conditioned or delayed), enter into any settlement or consent to entry of any Judgment that (A) does not include the provision by the Person(s) asserting such claim to all Indemnified Parties of a full, unconditional and irrevocable release from all Liability with respect to such Third Party Claim, (B) includes an admission of fault, culpability or failure to act by or on behalf of any Indemnified Party, (C) includes injunctive or other nonmonetary relief affecting any Indemnified Party other than nonmonetary relief incidental to the monetary damages that does not restrict the operation of  the business of the Indemnified Party, or (D) if the Indemnifying Party is Seller, includes monetary amounts in respect of, or that would be, Assumed Liabilities.  If the Indemnifying Party elects to assume 

60

the defense of a Third Party Claim, the Indemnifying Party shall not be liable to the Indemnified Party for legal fees or expenses subsequently incurred by the Indemnified Party in connection with the defense thereof; provided, that the Indemnified Party shall have the right to participate in the defense thereof and to employ counsel, at its own expense, separate from the counsel employed by the Indemnifying Party (it being understood that the Indemnifying Party shall control such defense); provided further, that if, based on the reasonable opinion of legal counsel to the Indemnified Party reasonably acceptable to the Indemnifying Party, a conflict or potential conflict of interest exists between the Indemnifying Party and the Indemnified Party which makes representation of both parties inappropriate under applicable standards of professional conduct, the reasonable fees and expenses of such separate counsel shall constitute indemnifiable Losses pursuant to this Article X; provided further that the Indemnifying Party shall not be required to pay for more than one such counsel (plus any appropriate local counsel) for all Indemnified Parties in connection with any Third Party Claim.  The Indemnified Party may retain or take over the control of the defense or settlement of any Third Party Claim the defense of which the Indemnifying Party has elected to control if the Indemnified Party irrevocably waives its right to indemnity under this Article X and fully releases the Indemnifying Party with respect to such Third Party Claim.  If an Indemnifying Party elects not to assume and control the defense of any Third Party Claim or fails to notify the Indemnified Party of its election within thirty (30) days after receipt of a Third Party Claim Notice, then such Indemnified Party shall be entitled to continue to conduct and control the defense of such Third Party Claim and the reasonable fees and expenses of counsel for the Indemnified Party in connection with the defense of such Third Party Claim shall constitute indemnifiable Losses pursuant to this Article X.  
(iii)    The Parties shall reasonably cooperate with each other in the investigation, prosecution or defense of any Third Party Claim.  Such cooperation shall, upon reasonable notice to the Party providing such cooperation, include (A) providing, and causing their respective Affiliates to provide, documentary or other evidence in its possession or control that is reasonably related to the Third Party Claim, (B) implementing, and causing their respective Affiliates to implement, reasonable record retention or litigation hold policies and (C) making available, and causing their respective Affiliates to make available, directors, officers and employees to give depositions or testimony.  Except as otherwise provided in Section 10.05(a)(ii), the Party requesting such cooperation shall pay the reasonable out-of-pocket expenses incurred in providing such cooperation (including reasonable legal fees and disbursements) by the Party (or Affiliate thereof, as the case may be) providing such cooperation and by its officers, directors, employees and agents, but not including reimbursing such Party (or Affiliate thereof, as the case may be) or its officers, directors, employees and agents for their time spent in such cooperation.
(b)    Direct Claims.  If any Indemnified Party has a claim against any Indemnifying Party under this Article X that does not involve a Third Party Claim being asserted or threatened against such Indemnified Party (a “Direct Claim”), such Indemnified Party shall promptly deliver to the Indemnifying Party a written notice (a “Direct Claim Notice”) setting forth a description in reasonable detail of the nature of the Direct Claim; provided, that the failure to so transmit a Direct Claim Notice shall not affect the Indemnifying Party’s obligations 

61

under this Article X, except to the extent that the Indemnifying Party is materially prejudiced as a result of such failure. 

SECTION 10.06.    Tax Treatment of Indemnity Payments. For all Tax purposes, the Parties and Abbott agree to treat all payments made under any indemnity provisions contained in this Agreement as adjustments to the Purchase Price, except to the extent applicable Law requires otherwise. 

SECTION 10.07.    Exclusivity.  Except in cases of Fraud, from and after the Closing, recovery pursuant to this Article X shall constitute Abbott’s and the Parties’ sole and exclusive remedy for any and all claims relating to or arising from this Agreement or the Transactions, and each Party and Abbott hereby expressly waives and releases, to the fullest extent permitted by applicable Law, any and all other rights, remedies, claims and causes of action (including rights of contributions, if any), whether in contract, tort or otherwise, known or unknown, foreseen or unforeseen, which exist or may arise in the future, arising under or based upon any federal, state or local Law, that any Party or Abbott may have against the other Persons party hereto relating to or arising from this Agreement or the Transactions; provided, however, that the foregoing shall not be deemed to deny (a) any Party equitable remedies (including injunctive relief or specific performance) when any such remedy is otherwise available under this Agreement or applicable Law or (b) any Party or any of their respective Affiliates any remedies under any Ancillary Agreement, and the foregoing shall not interfere with or impede the resolution of disputes relating to (i) the determination of the Final Allocation of the U.S. Tax Purchase Price and Local Tax Purchase Price by the Allocation Firm pursuant to Section 2.06 or (ii) the determination of Final Transferred Inventory by the Consultant pursuant to Section 2.11.  Notwithstanding anything herein to the contrary, the obligations of Seller and Abbott under this Agreement are several and not joint. 

ARTICLE XI     
 
GENERAL PROVISIONS

SECTION 11.01.    Amendment.  This Agreement may not be amended or supplemented except by an instrument in writing signed on behalf of each of the Parties and Abbott.

SECTION 11.02.    Extension of Time; Waiver, Etc.  Any agreement on the part of any of Purchaser, Seller or Abbott to extend the time for the performance of any of the obligations or other acts of the other Persons party to this Agreement or to waive any inaccuracies in the representations and warranties contained in this Agreement or in any 

62

document delivered pursuant to this Agreement shall be valid only if set forth in an instrument in writing signed on behalf of such Person; provided further, that any such agreement on the part of Purchaser or Seller shall only be valid if such instrument is also signed on behalf of Abbott. The failure or delay of any of Purchaser, Seller or Abbott to assert any of its rights under this Agreement or otherwise shall not constitute a waiver of such rights, nor shall any single or partial exercise by any of Purchaser, Seller or Abbott of any of its rights under this Agreement preclude any other or further exercise of such rights or any other rights under this Agreement.

SECTION 11.03.    Assignment.  Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned, in whole or in part, by operation of Law or otherwise, by any Party or Abbott without the prior written consent of each Party and Abbott except that, following the Closing, no consent shall be required in connection with a merger, consolidation or similar change-in-control transaction of Abbott, Purchaser Parent or any successor thereto. No assignment by any Party or Abbott shall relieve such Person of any of its obligations hereunder. Subject to the immediately preceding two (2) sentences, this Agreement shall be binding upon, inure to the benefit of, and be enforceable by, the Parties, Abbott and their respective successors and permitted assigns. Any purported assignment not permitted under this Section 11.03 shall be null and void.

SECTION 11.04.    Counterparts.  This Agreement may be executed in one or more counterparts (including by facsimile or electronic mail), each of which shall be deemed to be an original but all of which taken together shall constitute one and the same agreement, and shall become effective when one or more counterparts have been signed by each of the Parties and Abbott and delivered to each of the other Persons party hereto.

SECTION 11.05.    Entire Agreement; No Third Party Beneficiaries.  This Agreement, including the Seller Disclosure Letter, together with the Ancillary Agreements, the Triage Purchase Agreement, and the Confidentiality Agreement, constitutes the entire agreement, and supersedes all other prior agreements and understandings, both written and oral, among the Parties, Abbott and their Affiliates, or any of them, with respect to the subject matter hereof and thereof; provided, however, that (a) as between Seller and Abbott, nothing herein shall (or be deemed or in any way interpreted to) supersede, modify, waive, amend, interpret, or constitute an admission regarding, the terms and provisions of the Merger Agreement or of that certain Confidentiality Agreement, dated January 5, 2016, by and between Seller and Abbott and (b) nothing herein shall (or be deemed or in any way interpreted to) supersede, modify, waive, amend, interpret, or constitute an admission regarding, the terms of the Triage Purchase Agreement. This Agreement is not intended to and does not confer upon any Person other than the Parties and Abbott any rights or remedies hereunder, except for (a) Purchaser Parent to the extent expressly set forth herein, including Section 10.02 and (b) Article X, which are intended to be enforceable by the Persons specified therein.

SECTION 11.06.    Governing Law; Jurisdiction.  
(a)    This Agreement shall be governed and construed in accordance with the Laws of the State of New York without giving effect to the principles of conflicts of law thereof 

63

or of any other jurisdiction that would result in the application of the Laws of any other jurisdiction.
(b)    All Actions arising out of or relating to this Agreement shall be heard and determined in the United States District Court for the Southern District of New York located in the City of New York, New York (or, if the United States District Court for the Southern District of New York located in the City of New York, New York declines to accept jurisdiction over any Action, in the New York State Court located in the City of New York, Borough of Manhattan, New York) and the Parties and Abbott hereby irrevocably submit to the exclusive jurisdiction and venue of such courts in any such Action and irrevocably waive the defense of an inconvenient forum, improper venue or lack of jurisdiction to the maintenance of any such Action. The consents to jurisdiction and venue set forth in this Section 11.06(b) shall not constitute general consents to service of process in the State of New York and shall have no effect for any purpose except as provided in this paragraph and shall not be deemed to confer rights on any Person other than the Parties and Abbott. Each Party and Abbott agrees that service of process upon such Person, as applicable, in any Action arising out of or relating to this Agreement shall be effective if notice is given by overnight courier at the address set forth in Section 11.09. The Parties and Abbott agree that a final judgment in any such Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law; provided, however, that nothing in the foregoing shall restrict any Party’s or Abbott’s rights to seek any post-judgment relief regarding, or any appeal from, a trial court judgment.

SECTION 11.07.    Specific Enforcement.  The Parties and Abbott agree that irreparable damage for which monetary relief, even if available, would not be an adequate remedy, would occur in the event that any provision of this Agreement is not performed in accordance with its specific terms or is otherwise breached, including if the Parties and Abbott fail to take any action required of them hereunder to consummate this Agreement.  Subject to the following sentence, the Parties and Abbott acknowledge and agree that (a) each of the Parties and Abbott shall be entitled to an injunction or injunctions, specific performance or other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in the courts described in Section 11.06(b) without proof of damages or otherwise, this being in addition to any other remedy to which they are entitled under this Agreement and (b) the right of specific enforcement is an integral part of the Transactions and without that right none of Seller, Purchaser or Abbott would have entered into this Agreement. The Parties and Abbott acknowledge and agree that any Person party hereto seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this Section 11.07 shall not be required to provide any bond or other security in connection with any such order or injunction. 

SECTION 11.08.    WAIVER OF JURY TRIAL. EACH OF THE PARTIES AND ABBOTT HEREBY KNOWINGLY, INTENTIONALLY AND VOLUNTARILY IRREVOCABLY WAIVES ANY AND ALL RIGHTS TO TRIAL BY JURY IN ANY LEGAL ACTION ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS.

64

SECTION 11.09.    Notices.  All notices, requests and other communications to any Party or Abbott hereunder shall be in writing and shall be deemed given if delivered personally, by facsimile (which is confirmed), or sent by overnight courier (providing proof of delivery) to the Persons at the following addresses:
if to Purchaser, to: 
Quidel Corporation 
12544 High Bluff Drive, Suite 200 
San Diego, CA 92130 
Attn:  Chief Financial Officer
Facsimile:  (858) 646-8028
with a copy (which shall not constitute notice) to: 
Quidel Corporation 
12544 High Bluff Drive, Suite 200 
San Diego, CA 92130 
Attn:  General Counsel 
Facsimile:  (858) 646-8028
and
Gibson, Dunn & Crutcher LLP 
3161 Michelson Drive, Suite 1200 
Irvine, CA 92612 
Attn:  Michelle Hodges 
Facsimile:  (949) 475-4703
if to Abbott (and, following the Closing, Abbott or Seller), to: 
Abbott Laboratories
100 Abbott Park Road
Building AP6C, Dept. 5MDB
Abbott Park, Illinois 60064-6112
Attn: Vice President, Licensing and Acquisitions
Fax: 224-668-2800
with a copy (which shall not constitute notice) to Seller and to: 
Abbott Laboratories
100 Abbott Park Road
Building AP6D, Dept. D-364
Abbott Park, Illinois 60064-3500
Attn: Executive Vice President, General Counsel and Secretary 
Fax: 224-667-3966 

65

and

Baker & McKenzie LLP
300 East Randolph Street, Suite 5000
Chicago, Illinois 60601
Attention:     Olivia Tyrrell
Attention:     Andrew Warmus
		
	Facsimile:
	(312) 698-2429

if to Seller prior to the Closing, to: 
Alere Inc.
51 Sawyer Road, Suite 200
Waltham, Massachusetts 02453
Attention:     General Counsel
Facsimile: (781) 647-3939
with a copy (which shall not constitute notice) to Abbott and to: 
Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas
New York, NY 10019        
Attention:     Scott A. Barshay, Esq.
Attention:     Ross A. Fieldston, Esq.
Facsimile: (212) 757-3990

or such other address or facsimile number as such Person may hereafter specify by like notice to the other Persons party hereto. All such notices, requests and other communications shall be deemed received on the date of actual receipt by the recipient thereof if received prior to 5:00 p.m. local time in the place of receipt and such day is a Business Day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received until the next succeeding Business Day in the place of receipt.

SECTION 11.10.    Bulk Sales Laws. Each of the Parties and Abbott hereby waives and will cause its Affiliates to waive compliance by the other Party and Abbott and their respective Affiliates with any applicable bulk sale or bulk transfer Laws of any jurisdiction in connection with the sale of the Purchased Assets to the applicable Designated Purchaser.

SECTION 11.11.    Severability.  If any term, condition or other provision of this Agreement is determined by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other terms, conditions and provisions of this Agreement shall nevertheless remain in full force and effect, provided that the Parties and Abbott shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties and Abbott as closely as possible to the fullest extent 

66

permitted by applicable Law such that the economic and legal substance of the Transactions are not affected in any manner materially adverse to any party. 

SECTION 11.12.    Fees and Expenses.  Whether or not the Transactions are consummated, all fees and expenses incurred in connection with this Agreement and the Transactions shall be paid by the party incurring or required to incur such fees or expenses, except as otherwise expressly set forth in this Agreement.

SECTION 11.13.    No Recourse.  The obligations of Abbott under this Agreement may only be enforced against Abbott, any claims or causes of action for breach of this Agreement by Abbott may only be made against Abbott, and no other Person (including Seller or any of its Affiliates) shall have any Liability for any Liabilities of Abbott for or relating to any claim (whether in tort, contract or otherwise) for any breach or alleged breach of this Agreement by Abbott. The obligations of Seller under this Agreement may only be enforced against Seller, any claims or causes of action for breach of this Agreement by Seller may only be made against Seller, and no other Person (including Abbott or any of its Affiliates) shall have any Liability for any Liabilities of Seller for or relating to any claim (whether in tort, contract or otherwise) for any breach or alleged breach of this Agreement by Seller.

SECTION 11.14.    Rescission.  In the event the FTC shall not have approved on or prior to the Closing Date the final Decision and Order issued by it in disposition of its proceeding relating to the Merger Transaction, and following the Closing Date, the FTC shall have notified Abbott that, for purposes thereof, Purchaser would not be an acceptable purchaser of the Business and that the Transactions are required to be rescinded, then Abbott shall give prompt written notice thereof to the Parties, and the Parties and Abbott shall promptly take all actions as may be necessary or desirable to rescind the consummation of the Transactions and to restore to each Party and Abbott its rights, powers and obligations as in existence immediately prior to the Closing, including (a) Seller refunding to Purchaser all funds received by Seller from Purchaser as payment of the Purchase Price, (b) execution by Purchaser of such assignments, transfers and other documents and instruments as may be necessary or desirable to convey, assign and transfer back to the applicable Asset Seller Entities all of any Designated Purchaser’s right, title and interest in and to any Purchased Assets and to terminate and cancel the Ancillary Agreements and (c) execution by the applicable Asset Seller Entities of such assumptions and other documents and instruments as may be necessary or desirable to relieve each Designated Purchaser of Liability for any Assumed Liabilities existing on the Closing Date and to terminate and cancel the Ancillary Agreements.

SECTION 11.15.    Guarantee. Purchaser Parent (“Guarantor”) irrevocably guarantees each and every covenant and obligation of Purchaser and the full and timely performance of its obligations under the provisions of this Agreement (including the performance of any of Purchaser’s indemnity obligations under this Agreement), in each case, on the terms and subject to the conditions hereof. This is a guarantee of payment and performance, and not of collection, and Guarantor acknowledges and agrees that this guarantee is full and unconditional, and no release or extinguishments of Purchaser’s Liabilities (other than in accordance with the terms of this Agreement), whether by decree in any bankruptcy proceeding 

67

or otherwise, will affect the continuing validity and enforceability of this guarantee. Guarantor hereby waives, for the benefit of Abbott and Seller, (a) any right to require Abbott or Seller as a condition of payment or performance of Guarantor to proceed against Purchaser or pursue any other remedies whatsoever and (b) to the fullest extent permitted by Law, any defenses or benefits that may be derived from or afforded by Law that limit the liability of or exonerate guarantors or sureties, except to the extent that any such defense is available to Purchaser. Guarantor understands that Abbott and Seller are relying on this guarantee in entering into this Agreement.

SECTION 11.16.    Supremacy. To the extent that any term or provision of this Agreement conflicts with any directly corresponding term or provision of the European Commission Decision, dated January 25, 2017 (the “EC Decision”), the Parties and Abbott hereby agree that the terms or provisions of the EC Decision shall control the rights and obligations of the Parties and Abbott.
[Remainder of page intentionally left blank; signature page follows.]

68

IN WITNESS WHEREOF, the Parties, Abbott and Purchaser Parent have caused this Agreement to be executed as of the date first written above by their respective officers thereunto duly authorized.

ALERE INC.
By:/s/ Namal Nawana                 
Name:  Namal Nawana 
Title:  President and Chief Executive Officer

QUIDEL CARDVIOVASCULAR INC. 
 
By:/s/ Douglas C. Bryant                 
Name:  Douglas C. Bryant 
Title:  President 
 

for purposes of Section 11.15, 
 
QUIDEL CORPORATION 
 
By:/s/ Douglas C. Bryant                 
Name:  Douglas C. Bryant 
Title:  President and Chief Executive Officer 
 

for the limited purposes herein set forth, 
 
ABBOTT LABORATORIES 
 
By:/s/ Brian B. Yoor                     
Name:  Brian B. Yoor 
Title:  Executive Vice President, Finance and Chief Financial Officer

[Amended and Restated Purchase Agreement Signature Page]EX-4.1

 Exhibit 4.1 

EXECUTION VERSION 
  

 
  

CHENIERE ENERGY PARTNERS, L.P. 

as Partnership 
 and

 any Subsidiary Guarantors party hereto 

and 
 THE BANK OF NEW
YORK MELLON 
 as Trustee 

INDENTURE 
 Dated as of
September 18, 2017 
  
  

 

 CHENIERE ENERGY PARTNERS, L.P. 

RECONCILIATION AND TIE BETWEEN TRUST INDENTURE ACT OF 1939 

AND INDENTURE, DATED AS OF SEPTEMBER 18, 2017 
  

			
	 Section of Trust Indenture
 Act of
1939
	  	Section(s) of Indenture
		
	 Section 310 (a)(1)
	  	7.10
		
	 (a)(2)
	  	7.10
		
	 (a)(3)
	  	Not Applicable
		
	 (a)(4)
	  	Not Applicable
		
	 (a)(5)
	  	7.10
		
	 (b)
	  	7.08, 7.10
		
	 Section 311 (a)
	  	7.11
		
	 (b)
	  	7.11
		
	 (c)
	  	Not Applicable
		
	 Section 312 (a)
	  	2.07
		
	 (b)
	  	11.03
		
	 (c)
	  	11.03
		
	 Section 313 (a)
	  	7.06
		
	 (b)
	  	7.06
		
	 (c)
	  	7.06
		
	 (d)
	  	7.06
		
	 Section 314 (a)
	  	4.03, 4.04
		
	 (b)
	  	Not Applicable
		
	 (c)(1)
	  	12.04
		
	 (c)(2)
	  	12.04

  
 i 

			
	 (c)(3)
	  	Not Applicable
		
	 (d)
	  	Not Applicable
		
	 (e)
	  	12.05
		
	 Section 315 (a)
	  	7.01(b)
		
	 (b)
	  	7.05
		
	 (c)
	  	7.01(a)
		
	 (d)
	  	7.01(c)
		
	 (d)(1)
	  	7.01(c)(i)
		
	 (d)(2)
	  	7.01(c)(ii)
		
	 (d)(3)
	  	7.01(c)(iii)
		
	 (e)
	  	6.11
		
	 Section 316 (a)(1)(A)
	  	6.05
		
	 (a)(1)(B)
	  	6.04
		
	 (a)(2)
	  	Not Applicable
		
	 (a)(last sentence)
	  	2.11
		
	 (b)
	  	6.07
		
	 Section 317 (a)(1)
	  	6.08
		
	 (a)(2)
	  	6.09
		
	 (b)
	  	2.06
		
	 Section 318 (a)
	  	12.01

 Note: This reconciliation and tie shall not, for any purpose, be deemed to be a part of the Indenture. 

  
 ii 

 CONTENTS 
  

							
	Clause	  	 	  	Page	 
		
	 ARTICLE I. DEFINITIONS AND INCORPORATION BY REFERENCE
	  	 	1	 
			
	 Section 1.01
	  	Definitions	  	 	1	 
	 Section 1.02
	  	Other Definitions	  	 	22	 
	 Section 1.03
	  	Incorporation by Reference of Trust Indenture Act	  	 	23	 
	 Section 1.04
	  	Rules of Construction	  	 	23	 
		
	 ARTICLE II. THE NOTES
	  	 	24	 
			
	 Section 2.01
	  	Amount Unlimited; Issuable in Series	  	 	24	 
	 Section 2.02
	  	Denominations	  	 	26	 
	 Section 2.03
	  	Forms	  	 	26	 
	 Section 2.04
	  	Execution, Authentication, Delivery and Dating	  	 	28	 
	 Section 2.05
	  	Registrar and Paying Agent; Depositary	  	 	30	 
	 Section 2.06
	  	Paying Agent to Hold Money in Trust	  	 	30	 
	 Section 2.07
	  	Holder Lists	  	 	31	 
	 Section 2.08
	  	Transfer and Exchange	  	 	31	 
	 Section 2.09
	  	Replacement Notes	  	 	46	 
	 Section 2.10
	  	Outstanding Notes	  	 	46	 
	 Section 2.11
	  	Original Issue Discount, Foreign-Currency Denominated and Treasury Notes	  	 	46	 
	 Section 2.12
	  	Temporary Notes	  	 	46	 
	 Section 2.13
	  	Cancellation	  	 	47	 
	 Section 2.14
	  	Payments; Defaulted Interest	  	 	47	 
	 Section 2.15
	  	Persons Deemed Owners	  	 	47	 
	 Section 2.16
	  	Computation of Interest	  	 	48	 
		
	 ARTICLE III. REDEMPTION
	  	 	48	 
			
	 Section 3.01
	  	Redemption	  	 	48	 
	 Section 3.02
	  	Applicability of Article	  	 	48	 
	 Section 3.03
	  	Notice to the Trustee	  	 	48	 
	 Section 3.04
	  	Selection of Notes to be Redeemed	  	 	48	 
	 Section 3.05
	  	Notice of Redemption	  	 	49	 
	 Section 3.06
	  	Effect of Notice of Redemption	  	 	49	 
	 Section 3.07
	  	Deposit of Redemption Price	  	 	49	 
	 Section 3.08
	  	Notes Redeemed or Purchased in Part	  	 	50	 
	 Section 3.09
	  	Purchase of Notes	  	 	50	 
		
	 ARTICLE IV. COVENANTS
	  	 	50	 
			
	 Section 4.01
	  	Payment of Notes	  	 	50	 
	 Section 4.02
	  	Maintenance of Office or Agency	  	 	51	 
	 Section 4.03
	  	SEC Reports; Financial Statements	  	 	51	 

  
 iii 

							
	 Section 4.04
	  	Compliance Certificate	  	 	52	 
	 Section 4.05
	  	Existence	  	 	52	 
	 Section 4.06
	  	Waiver of Stay, Extension or Usury Laws	  	 	53	 
	 Section 4.07
	  	Additional Amounts	  	 	53	 
	 Section 4.08
	  	Change of Control	  	 	53	 
	 Section 4.09
	  	Asset Sales	  	 	56	 
	 Section 4.10
	  	Limitation on Liens	  	 	58	 
	 Section 4.11
	  	Restriction on Sale-Leasebacks	  	 	58	 
	 Section 4.12
	  	Limitation on Transactions with Affiliates	  	 	59	 
		
	 ARTICLE V. SUCCESSORS
	  	 	61	 
			
	 Section 5.01
	  	Merger, Consolidation or Sale of Assets	  	 	61	 
	 Section 5.02
	  	Successor Person Substituted	  	 	62	 
	 Section 5.03
	  	Subsidiary Guarantors	  	 	62	 
		
	 ARTICLE VI. DEFAULTS AND REMEDIES
	  	 	64	 
			
	 Section 6.01
	  	Events of Default	  	 	64	 
	 Section 6.02
	  	Acceleration	  	 	66	 
	 Section 6.03
	  	Other Remedies	  	 	66	 
	 Section 6.04
	  	Waiver of Defaults	  	 	67	 
	 Section 6.05
	  	Control by Majority	  	 	67	 
	 Section 6.06
	  	Limitations on Suits	  	 	67	 
	 Section 6.07
	  	Rights of Holders to Receive Payment	  	 	68	 
	 Section 6.08
	  	Collection Suit by Trustee	  	 	68	 
	 Section 6.09
	  	Trustee May File Proofs of Claim	  	 	68	 
	 Section 6.10
	  	Priorities	  	 	68	 
	 Section 6.11
	  	Undertaking for Costs	  	 	69	 
		
	 ARTICLE VII. TRUSTEE
	  	 	69	 
			
	 Section 7.01
	  	Duties of Trustee	  	 	69	 
	 Section 7.02
	  	Rights of Trustee	  	 	70	 
	 Section 7.03
	  	May Hold Notes	  	 	72	 
	 Section 7.04
	  	Trustee’s Disclaimer	  	 	72	 
	 Section 7.05
	  	Notice of Defaults	  	 	72	 
	 Section 7.06
	  	Reports by Trustee to Holders	  	 	73	 
	 Section 7.07
	  	Compensation and Indemnity	  	 	73	 
	 Section 7.08
	  	Replacement of Trustee	  	 	74	 
	 Section 7.09
	  	Successor Trustee by Merger, etc.	  	 	75	 
	 Section 7.10
	  	Eligibility; Disqualification	  	 	76	 
	 Section 7.11
	  	Preferential Collection of Claims Against the Partnership or a Subsidiary Guarantor	  	 	76	 
	 Section 7.12
	  	Tax Withholding	  	 	76	 
	 Section 7.13
	  	Appointment of Co-Trustee	  	 	77	 

  
 iv 

							
	 ARTICLE VIII. DISCHARGE OF INDENTURE
	  	 	78	 
			
	 Section 8.01
	 	Termination of the Partnership’s and the Subsidiary Guarantors’ Obligations	  	 	78	 
	 Section 8.02
	 	Application of Trust Money	  	 	82	 
	 Section 8.03
	 	Repayment to Partnership or Subsidiary Guarantor	  	 	82	 
	 Section 8.04
	 	Reinstatement	  	 	82	 
		
	 ARTICLE IX. SUPPLEMENTAL INDENTURES AND AMENDMENTS
	  	 	83	 
			
	 Section 9.01
	 	Without Consent of Holders	  	 	83	 
	 Section 9.02
	 	With Consent of Holders	  	 	85	 
	 Section 9.03
	 	Compliance with Trust Indenture Act	  	 	86	 
	 Section 9.04
	 	Revocation and Effect of Consents	  	 	86	 
	 Section 9.05
	 	Notation on or Exchange of Notes	  	 	87	 
	 Section 9.06
	 	Trustee to Sign Amendments, etc.	  	 	87	 
		
	 ARTICLE X. GUARANTEE
	  	 	87	 
			
	 Section 10.01
	 	Guarantee	  	 	87	 
	 Section 10.02
	 	Execution and Delivery of Guarantee	  	 	89	 
	 Section 10.03
	 	Limitation on Liability of the Subsidiary Guarantors	  	 	90	 
	 Section 10.04
	 	Release of Subsidiary Guarantors from Guarantee	  	 	90	 
	 Section 10.05
	 	Reinstatement of Guarantees	  	 	91	 
	 Section 10.06
	 	Contribution	  	 	91	 
	 Section 10.07
	 	Execution of Supplemental Indenture by Additional Guarantors	  	 	91	 
		
	 ARTICLE XI. COLLATERAL AND SECURITY
	  	 	92	 
			
	 Section 11.01
	 	General	  	 	92	 
	 Section 11.02
	 	Collateral Documents	  	 	92	 
	 Section 11.03
	 	Recording, Registration and Opinions; Trustee’s Disclaimer Regarding Collateral	  	 	93	 
	 Section 11.04
	 	Possession, Use and Release of Collateral	  	 	94	 
	 Section 11.05
	 	Certificates of the Partnership and the Subsidiary Guarantors	  	 	96	 
	 Section 11.06
	 	Purchaser Protected	  	 	96	 
		
	 ARTICLE XII. MISCELLANEOUS
	  	 	96	 
			
	 Section 12.01
	 	Trust Indenture Act Controls	  	 	96	 
	 Section 12.02
	 	Notices	  	 	96	 
	 Section 12.03
	 	Communication by Holders with Other Holders	  	 	98	 
	 Section 12.04
	 	Certificate and Opinion as to Conditions Precedent	  	 	98	 
	 Section 12.05
	 	Statements Required in Certificate or Opinion	  	 	98	 
	 Section 12.06
	 	Rules by Trustee and Agents	  	 	99	 
	 Section 12.07
	 	Legal Holidays	  	 	99	 
	 Section 12.08
	 	No Recourse Against Others	  	 	99	 
	 Section 12.09
	 	Governing Law, etc.	  	 	99	 

  
 v 

							
	 Section 12.10
	 	No Adverse Interpretation of Other Agreements	  	 	100	 
	 Section 12.11
	 	Successors	  	 	100	 
	 Section 12.12
	 	Severability	  	 	100	 
	 Section 12.13
	 	Counterpart Originals	  	 	100	 
	 Section 12.14
	 	Table of Contents, Headings, etc.	  	 	101	 
	 Section 12.15
	 	Separateness	  	 	101	 
		
	 EXHIBIT INDEX
	  			
		
	 EXHIBIT A – FORM OF SUPPLEMENTAL INDENTURE
	  			
		
	 EXHIBIT B – FORM OF CERTIFICATE OF TRANSFER
	  			
		
	 EXHIBIT C – FORM OF CERTIFICATE OF EXCHANGE
	  			
	
	 EXHIBIT D – FORM OF SUPPLEMENTAL INDENTURE FOR ADDITIONAL
GUARANTORS
	  

  
 vi 

 INDENTURE dated as of September 18, 2017 among Cheniere Energy Partners, L.P., a
Delaware limited partnership, as issuer (the “Partnership”), any Subsidiary Guarantors (as defined herein) party hereto or that may become party hereto from time to time, and The Bank of New York Mellon, as trustee (the
“Trustee”). 
 The Partnership, the Guarantors and the Trustee agree as follows for the benefit of each other and for the
equal and ratable benefit of the Holders (as defined herein) of Notes (as defined herein). 
 All things necessary to make this Indenture a
valid agreement of the Partnership and the Subsidiary Guarantors, in accordance with its terms, have been done. 
 ARTICLE I. 

DEFINITIONS AND INCORPORATION BY REFERENCE 

Section 1.01 Definitions. 

“Acceptable Rating Agency” means S&P, Fitch, Moody’s, or any other “nationally recognized statistical rating
organization” registered with the SEC, including any successor to S&P, Fitch or Moody’s. 
 “Additional
Agent” means the administrative agent and/or trustee (as applicable) or any other similar agent, representative or Person under any Secured Credit Document (other than the Credit Agreement), in each case, together with its successors and
permitted assigns in such capacity. 
 “Additional Amounts” means any additional amounts required by the express terms of a
Note or by or pursuant to a Board Resolution, under circumstances specified therein or pursuant thereto, to be paid by the Partnership or any Subsidiary Guarantor, as the case may be, with respect to certain taxes, assessments or other governmental
charges imposed on certain Holders and that are owing to such Holders. 
 “Additional First Lien Debt Facility” means one
or more debt facilities, commercial paper facilities or indentures whose Senior Class Debt Representative has become a party to the Intercreditor Agreement in accordance therewith, in each case with banks, other lenders or trustees, providing
for revolving credit loans, term loans, letters of credit, notes or other borrowings, in each case, as amended, amended and restated, supplemented or otherwise modified, refinanced or replaced from time to time; provided that the Credit Agreement
shall not constitute an Additional First Lien Debt Facility at any time. 
 “Additional First Lien Documents” means, with
respect to any Series of Additional First Lien Obligations, the Notes, credit agreements, indentures, security documents and other operative agreements evidencing or governing such Indebtedness, and each other agreement entered into for the purpose
of securing any Series of Additional First Lien Obligations, as the same may be amended, restated, supplemented or otherwise modified from time to time. 

  

 “Additional First Lien Obligations” means, with respect to any Additional First
Lien Debt Facility, (a) all principal of and interest (including, without limitation, any interest that accrues after the commencement of any case, proceeding or other action relating to the bankruptcy, insolvency or reorganization of any
Obligor, whether or not allowed or allowable as a claim in any such proceeding) payable with respect to such Additional First Lien Debt Facility, (b) all other amounts payable to the related Additional First Lien Secured Parties under the
related Additional First Lien Documents and (c) any renewals or extensions of the foregoing. 
 “Additional First Lien Secured
Parties” means, with respect to any Series of Additional First Lien Obligations, the holders of such Additional First Lien Obligations, the Additional Agent with respect thereto, any trustee or agent or any other similar agent or Person
therefor under any related Additional First Lien Documents and the beneficiaries of each indemnification obligation undertaken by the Partnership or any Subsidiary Guarantor under any related Additional First Lien Documents. 

“Additional Interest” means all liquidated damages then owing pursuant to the Registration Rights Agreement. 

“Additional Notes” means Notes (other than the Initial Notes and Exchange Notes) issued under this Indenture pursuant to a
Supplemental Indenture in accordance with Section 2.03(d). 
 “Affiliate” of any specified Person
means any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person. For purposes of this definition, “control,” as used with respect to any Person, means the
possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise. For purposes of this definition, the terms
“controlling,” “controlled by” and “under direct or indirect common control with” have correlative meanings. 

“Agent” means any Registrar or Paying Agent. 

“Applicable Procedures” means, with respect to any transfer or exchange of or for beneficial interests in any Global Note,
the rules and procedures of the Depositary, Euroclear and Clearstream that apply to such transfer or exchange. 
 “Asset
Sale” means: 
 (1) the sale, lease, conveyance or other disposition of any assets or properties of the Partnership or any
Subsidiary Guarantor (including the sale by the Partnership or any Subsidiary Guarantor of Equity Interests in any of the Partnership’s Subsidiaries, but excluding the sale of directors’ qualifying shares or shares required to be owned by
other persons pursuant to applicable law and excluding any sale by the Partnership of the Partnership’s equity securities or incentive distribution rights); provided, however, that the sale, lease, conveyance or other disposition of all
or substantially all of the properties or assets (including by merger or consolidation) of the Partnership or a Subsidiary Guarantor will be governed by Section 4.08 and/or Section 5.01 and not by
the provisions of Section 4.09; and 
 (2) the issuance of Equity Interests by any of the Partnership’s
Subsidiaries (but for greater certainty excluding any issuance of Equity Interests by the Partnership). 

  
 2 

 Notwithstanding the preceding, none of the following items will be deemed to be an Asset Sale:

 (1) any single transaction or series of related transactions that involves properties or assets having a Fair Market Value of less than
$100 million; 
 (2) (i) a transfer of properties or assets between or among the Partnership and the Subsidiary Guarantors or
(ii) a transfer of properties or assets among non-guarantor Subsidiaries; 
 (3) an issuance or
sale of Equity Interests by a Subsidiary of the Partnership to the Partnership or to a Subsidiary of the Partnership; provided that if the Subsidiary effecting such issuance or sale is a Subsidiary Guarantor, the issuance or sale is to the
Partnership or a Subsidiary Guarantor; 
 (4) the sale or lease of products, services or accounts receivable, or other properties or assets
in the ordinary course of business, including the sale or other disposition of cool-down gas, excess retainage gas and LNG or natural gas or other commercial products (and options to purchase any of the foregoing) in the ordinary course of business
and any sale or other disposition of damaged, worn-out or obsolete properties or assets in the ordinary course of business; 

(5) the sale or other disposition of cash or Cash Equivalents, Hedging Obligations or other financial instruments in the ordinary course of
business; 
 (6) the grant in the ordinary course of business of a non-exclusive license of patents,
trade secrets, trademarks, registrations therefor, know how or other similar intellectual property; 
 (7) any trade or exchange by the
Partnership or any Subsidiary of the Partnership of properties or assets of any type for properties or assets of any type owned or held by another Person, including any disposition of Equity Interests of a Subsidiary of the Partnership in exchange
for assets or properties and after which the Subsidiary whose Equity Interests have been so disposed of continues to be a Subsidiary, provided that the Fair Market Value of the properties or assets traded or exchanged by the Partnership or
such Subsidiary (together with any cash or Cash Equivalents and liabilities assumed) is reasonably equivalent to the Fair Market Value of the properties or assets (together with any cash or Cash Equivalents and liabilities assumed) to be received by
the Partnership or such Subsidiary; and provided further that any cash received must be applied in accordance with the provisions described in Section 4.09. 

(8) the creation or perfection of a Lien that is not prohibited by Section 4.10, and any disposition in connection
with a Permitted Lien; 
 (9) dispositions in compliance with any applicable court or governmental order; 

(10) the settlement, release, waiver or surrender of contract, tort or other claims in the ordinary course of business; 

 
 (11) the sale of liquefaction and other services in the ordinary course of
business; 

  
 3 

 (12) the sale of any LNG and related commercial products related to additional liquefaction
trains developed by the Partnership; and 
 (13) any single transaction or series of related transactions pursuant to the terms of an
agreement existing on the Issue Date. 
 “Asset Sale Triggering Event” means the occurrence of both an Asset Sale and a
Rating Decline with respect to the Notes. 
 “Attributable Indebtedness” when used with respect to any Sale-Leaseback
Transaction, means, as at the time of determination, the present value (discounted at the rate set forth or implicit in the terms of the lease included in such transaction) of the total obligations of the lessee for rental payments (other than
amounts required to be paid on account of property taxes, maintenance, repairs, insurance, assessments, utilities, operating and labor costs and other items that do not constitute payments for property rights) during the remaining term of the lease
included in such Sale-Leaseback Transaction (including any period for which such lease has been extended). In the case of any lease that is terminable by the lessee upon the payment of a penalty or other termination payment, such amount shall be the
lesser of the amount determined assuming termination upon the first date such lease may be terminated (in which case the amount shall also include the amount of the penalty or termination payment, but no rent shall be considered as required to be
paid under such lease subsequent to the first date upon which it may be so terminated) or the amount determined assuming no such termination. 

“Bankruptcy Code” means Title 11 of the United States Code, as amended. 

“Bankruptcy Custodian” means any receiver, trustee, assignee, liquidator or similar official under Bankruptcy Law. 

“Bankruptcy Law” means Title 11 of the United States Code or any similar federal, state or foreign law for the relief of
debtors. 
 “Board of Directors” means: 

(1) with respect to a corporation, the board of directors of the corporation or any committee thereof duly authorized to act on behalf of such
board; 
 (2) with respect to a partnership, the Board of Directors of the general partner of the partnership; 

(3) with respect to a limited liability company, the managing member or members or any controlling committee of managers or members thereof or
any board or committee serving a similar management function; and 
 (4) with respect to any other Person, the individual, board or committee
of such Person serving a management function similar to those described in clauses (1), (2) or (3) of this definition. 

  
 4 

 “Board Resolution” means a copy of a resolution certified by the Secretary or an
Assistant Secretary of the Partnership (or, in the case the Partnership is a limited partnership, the General Partner, acting on behalf of the Partnership) to have been duly adopted by the Board of Directors of the Partnership (or, in the case the
Partnership is a limited partnership, the General Partner, acting on behalf of the Partnership) and to be in full force and effect on the date of such certification, and delivered to the Trustee. 

“Broker-Dealer” has the meaning set forth in the applicable Registration Rights Agreement. 

“Business Day” means any day that is not a Legal Holiday. 

“Capital Stock” means: 

(1) in the case of a corporation, corporate stock; 

(2) in the case of an association or business entity, any and all shares, interests, participations, rights or other equivalents (however
designated) of corporate stock; 
 (3) in the case of a partnership or limited liability company, partnership interests (whether general or
limited) or membership interests; and 
 (4) any other interest or participation that confers on a Person the right to receive a share of the
profits and losses of, or distributions of assets of, the issuing Person, but excluding from all of the foregoing any debt securities convertible into Capital Stock, regardless of whether such debt securities include any right of participation with
Capital Stock. 
 “Cash Equivalents” means: 

(1) Dollars; 
 (2) securities
issued or directly and fully guaranteed or insured by the United States government or any agency or instrumentality of the United States government (provided that the full faith and credit of the United States is pledged in support of those
securities) having maturities of not more than one year from the date of acquisition; 
 (3) marketable general obligations issued by any
state of the United States of America or any political subdivision of any such state or any public instrumentality thereof maturing within one year from the date of acquisition thereof and, at the time of acquisition thereof, having a credit rating
of “A” or better from either S&P or Moody’s (or, if any of such entities cease to provide such ratings, the equivalent rating from any other Acceptable Rating Agency); 

(4) certificates of deposit, demand deposit accounts and eurodollar time deposits with maturities of one year or less from the date of
acquisition, bankers’ acceptances with maturities not exceeding one year and overnight bank deposits, in each case, with any domestic commercial bank having capital and surplus in excess of $500,000,000 and a Thomson Bank Watch Rating of
“B” or better; 

  
 5 

 (5) repurchase obligations with a term of not more than 30 days for underlying securities of the
types described in clauses (b), (c) and (d) above entered into with any financial institution meeting the qualifications specified in clause (d) above; 

(6) commercial paper or tax exempt obligations having one of the two highest ratings obtainable from Moody’s or S&P (or, if any of
such entities cease to provide such ratings, the equivalent rating categories from any other Acceptable Rating Agency) and, in each case, maturing within one year after the date of acquisition; and 

(7) money market funds at least 95% of the assets of which constitute Cash Equivalents of the kinds described in clauses (a) through
(f) of this definition or a money market fund or a qualified investment fund (including any such fund for which the Trustee or any Affiliate thereof acts as an advisor or a manager) given one of the two highest long-term ratings available from
S&P or Moody’s (or, if any of such entities cease to provide such ratings, the equivalent rating categories from any other Acceptable Rating Agency). 

“CEI” means Cheniere Energy, Inc. 

“Change of Control” means the occurrence of any of the following: 

(1) the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any
“person” or “group” of related persons (as such terms are used in Section 13(d) of the Exchange Act), other than an entity owned directly or indirectly by the partners of the Partnership in substantially the same proportion
as their ownership interests in the Partnership prior to such transaction, becomes the beneficial owner (as such term is used in Section 13(d) of the Exchange Act, except that such person or group shall be deemed to have “beneficial
ownership” of all shares that any such person or group has the right to acquire, whether such right is exercisable immediately or only after the passage of time), directly or indirectly, of more than 50% of the voting power of the Voting Stock
of the Partnership or the General Partner (or their respective successors by merger, consolidation or purchase of all or substantially all of their respective assets); 

(2) the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a
series of related transactions, of all or substantially all of the properties or assets of the Partnership and its Subsidiaries taken as a whole to any “person” (as such term is used in Sections 13(d) of the Exchange Act); or 

(3) the adoption of a plan relating to the liquidation or dissolution of the Partnership or the removal of the general partner by the limited
partners of the Partnership; 
 provided that a Change of Control shall be deemed to exclude transactions where (i) on a pro forma basis, CEI
retains greater than 50% control of the voting power of the Voting Stock of the General Partner, (ii) CEI is the surviving entity as a result of a corporate re-organization and combination of the
Partnership into CEI, (iii) the Partnership is the surviving entity as a result of a corporate reorganization and combination of CEI into the Partnership (including any such reorganization the result of which the Partnership ceases to be a
limited partnership) where on a pro forma basis, the equityholders of CEI and the Partnership (prior to such reorganization or combination) collectively retain greater than 50% control of the voting power of the Voting

  
 6 

 
Stock of (A) the General Partner if the Partnership is a limited partnership, (B) the managing member if the Partnership is a limited liability company or (C) the Partnership if
the Partnership is a corporation or a member managed limited liability company and (iv) following the conversion of the Partnership into a corporation, on a pro forma basis, CEI retains greater than 50% control of the voting power of the Voting
Stock of the Partnership. 
 “Change of Control Triggering Event” means the occurrence of both a Change of Control and a
Rating Decline with respect to the Notes. 
 “Clearstream” means Clearstream Banking, S.A. 

“Code” means the Internal Revenue Code of 1986, as amended, together with all rules and regulations promulgated with respect
thereto. 
 “Collateral” means all assets and properties subject to Liens created pursuant to any First Lien Security
Document to secure one or more Series of First Lien Obligations (other than (i) any cash or cash equivalents collateralizing letter of credit obligations under the Credit Facilities, (ii) proceeds of an event requiring a mandatory
prepayment under the Credit Agreement or (iii) any cash or cash equivalents (x) collateralizing letters of credit obligations under, or (y) deposited in a debt service reserve account relating to, in each case, other Series of First
Lien Obligations). 
 “Collateral Agency Agreement” means the Collateral Agency Appointment Agreement, dated as of
February 25, 2016, by and among the Partnership, the Collateral Agent and the other secured debt representatives party thereto, as it may be amended from time to time. 

“Collateral Agent” means MUFG Union Bank, N.A., as Collateral Agent under the Collateral Agency Agreement and its successors
and permitted assigns thereunder. 
 “Collateral Documents” means: 

(1) the Pledge and Security Agreement; 

(2) the Multiple Indebtedness Mortgage, Assignment of Leases and Rents and Security Agreement; 

(3) the Depositary Agreement; 

(4) the Collateral Agency Agreement; 

(5) the Intercreditor Agreement; and 

(6) each of the security agreements, uncertificated security control agreements, financing statements, deposit account control agreements and
other instruments executed and delivered by the Partnership or any Subsidiary Guarantor pursuant to the Credit Agreement, this Indenture or any other Additional First Lien Documents for purposes of providing collateral security or credit support for
any First Lien Obligation; 

  
 7 

 as the same may be amended, restated, supplemented or otherwise modified or replaced from time to time. 

“Control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management and
policies of a Person, whether through the ownership of voting securities, by contract or otherwise. 
 “Controlling Agent”
means the “Controlling Agent” as defined in the Intercreditor Agreement. 
 “Corporate Trust Office” means the
office of the Trustee at which at any particular time its corporate trust business shall be principally administered, which office at the date of the execution of this instrument is located at 500 Ross Street, 12th Floor, Pittsburgh PA 15262, Attention: Corporate Trust Administration – Corporate Finance Unit, or such other address as the Trustee may designate from time to time by notice to the Issuer, or
the principal corporate trust office of any successor Trustee (or such other address as such successor Trustee may designate from time to time by notice to the Issuer). 

“Credit Agreement” means that certain Credit and Guaranty Agreement, dated February 25, 2016, as amended by the Omnibus
Amendment and Waiver, dated October 14, 2016 and the Administrative Amendment dated August 7, 2017, by and among the Partnership, the subsidiary guarantors from time to time party thereto, the lenders party thereto from time to time, and
The Bank of Tokyo-Mitsubishi UFJ, Ltd. as administrative agent, as it may be further amended, amended and restated, supplemented or otherwise modified from time to time. 

“Credit Agreement Administrative Agent” means The Bank of Tokyo-Mitsubishi UFJ, Ltd., as administrative agent for the Credit
Agreement Secured Parties, in such capacity and together with its successors and permitted assigns. 
 “Credit Agreement
Obligations” means the “Obligations” as defined in the Credit Agreement. 
 “Credit Agreement Secured
Parties” means, with respect to the Credit Agreement, the holders of the Credit Agreement Obligations, the Credit Agreement Administrative Agent, any other agent or similar Person therefor under the Credit Agreement and the beneficiaries of
each indemnification obligation undertaken by the Partnership or any Subsidiary Guarantor under the Credit Agreement. 
 “Credit
Facilities” means one or more debt facilities of the Partnership or any Subsidiary Guarantor (which may be outstanding at the same time and including, without limitation, the Credit Agreement) with banks or other institutional lenders or
investors or indentures providing for revolving credit loans, term loans, letters of credit or other long-term indebtedness, including any guarantees, collateral documents, instruments and agreements executed in connection therewith, and, in each
case, as such agreements may be amended, refinanced or otherwise restructured, in whole or in part from time to time (including increasing the amount of available borrowings thereunder or adding Subsidiaries of the Partnership as additional
borrowers or guarantors thereunder) with respect to all or any portion of the Indebtedness under such agreement or agreements, any successor or replacement agreement or agreements or any indenture or successor or replacement indenture and whether by
the same or any other agent, lender, group of lenders or investors. 

  
 8 

 “Custodian” means the Trustee, as custodian with respect to the Notes in global
form, or any successor entity thereto. 
 “Default” means any event, act or condition that is, or after notice or the
passage of time or both would be, an Event of Default. 
 “Definitive Note” means a certificated Note (bearing the
Restricted Notes Legend if the transfer of such Note is restricted by applicable law) registered in the name of the Holder thereof, issued in accordance with Section 2.08, that does not include the Global Note Legend and
shall not have the “Schedule of Increases and Decreases in Global Note” attached thereto. 
 “Depositary” means
with respect to the Notes of any series issuable or issued in whole or in part in global form, the Person specified pursuant to Section 2.05 hereof as the initial Depositary with respect to the Notes of such series, until a
successor shall have been appointed and become such pursuant to the applicable provision of this Indenture, and thereafter “Depositary” shall mean or include such successor. 

“Depositary Agreement” means that certain Depositary Agreement, dated as of February 25, 2016, as amended by the Omnibus
Amendment and Waiver, dated October 14, 2016, by and among the Partnership, the Subsidiary Guarantors party thereto, the Collateral Agent and the Depositary Bank, as it may be further amended, amended and restated, supplemented or otherwise
modified from time to time. 
 “Depositary Bank” means MUFG Union Bank, N.A., as Depositary Bank under the Depositary
Agreement and its successors and permitted assigns thereunder. 
 “Disqualified Equity” means any Equity Interest that, by
its terms (or by the terms of any security into which it is convertible, or for which it is exchangeable, in each case, at the option of the holder of the Equity Interest), or upon the happening of any event, matures or is mandatorily redeemable,
pursuant to a sinking fund obligation or otherwise, or redeemable at the option of the holder of the Equity Interest, in whole or in part, on or prior to the date that is 91 days after the date on which the Notes mature (other than pursuant to a
change of control or asset sale prepayment offer provision). 
 “Dollars” and “$” means lawful money of
the United States. 
 “DTC” means The Depository Trust Company. 

“Equity Interests” means Capital Stock and all warrants, options or other rights to acquire Capital Stock (but excluding any
debt security that is convertible into, or exchangeable for, Capital Stock). 

  
 9 

 “Equity Offering” means any public or private issuance and sale of Equity
Interests (other than Disqualified Equity) made for cash on a primary basis by the Partnership after the date of this Indenture. Notwithstanding the foregoing, the term “Equity Offering” shall not include: 

(1) any issuance and sale with respect to common stock registered on Form S-4, Form F-4 or Form S-8; or 
 (2) any issuance and sale to any Subsidiary
of the Partnership. 
 “Euroclear” means Euroclear Bank S.A./N.V. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and any successor statute. 

“Exchange Notes” means the Notes issued in an Exchange Offer pursuant to Section 2.08(f). 

“Exchange Offer” means (i) the Registered Exchange Offer or (ii) the Private Exchange. 

“Exchange Offer Registration Statement” has the meaning set forth in the Registration Rights Agreement. 

“Fair Market Value” means, with respect to any asset, the price (after taking into account any liabilities relating to such
assets) that would be negotiated in an arm’s-length transaction for cash between a willing seller and a willing and able buyer, neither of which is under any compulsion to complete the transaction. 

“First Lien Obligations” means the Obligations under the Credit Agreement, the Note Obligations (during any Security
Requirement Period) and any Additional First Lien Obligations. 
 “First Lien Secured Parties” means (i) the
Collateral Agent, (ii) the Credit Agreement Secured Parties and (iii) the Additional First Lien Secured Parties with respect to each Series of Additional First Lien Obligations 

“Fitch” means Fitch Ratings Inc. or any successor to the rating agency business thereof. 

“GAAP” means generally accepted accounting principles in the United States, applied on a consistent basis and set forth in
the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants, the opinions and pronouncements of the Public Company Accounting Oversight Board and in the statements and pronouncements
of the Financial Accounting Standards Board or in such other statements by such other entity as have been approved by a significant segment of the accounting profession, which are in effect from time to time. 

“General Partner” means Cheniere Energy Partners GP, LLC, a Delaware limited liability company, and its successors and
permitted assigns as general partner of the Partnership or as the business entity with the ultimate authority to manage the business and operations of the Partnership. 

  
 10 

 “Global Notes” means, individually and collectively, each of the Restricted
Global Notes and the Unrestricted Global Notes issued as a Global Note, deposited with or on behalf of and registered in the name of the Depositary or its nominee, issued in accordance with Section 2.01 and
Section 2.08. 
 “Global Note Legend” means a legend required or permitted by
Section 2.08(g)(2). 
 “Government Obligations” means, with respect to a series of Notes, direct
obligations of the government that issues the currency in which the Notes of the series are payable for the payment of which the full faith and credit of such government is pledged, or obligations of a Person controlled or supervised by and acting
as an agency or instrumentality of such government, the payment of which is unconditionally guaranteed as a full faith and credit obligation by such government. 

“Guarantee” means the guarantee of the Partnership’s obligations under the Notes by a Subsidiary Guarantor as provided
in Article X. 
 “Hedging Contract” means (1) any agreement providing for options, swaps,
floors, caps, collars, forward sales or forward purchases involving interest rates, commodities or commodity prices, equities, currencies, bonds, or indexes based on any of the foregoing, (2) any option, futures or forward contract traded on an
exchange, and (3) any other derivative agreement or other similar agreement or arrangement. 
 “Hedging Obligations”
of any Person means the obligations of such Person under any Hedging Contract. 
 “Holder” means a Person in whose name a
Note is registered, as evidenced by the records of the Registrar. 
 “IAI Global Note” means a Global Note issued in
accordance with 2.03(c)(1)(B) hereof. 
 “Indebtedness” means, with respect to any Person, any obligation created or
assumed by such Person for the repayment of borrowed money or any guarantee thereof, if and to the extent such obligation would appear as a liability upon a balance sheet of the specified Person prepared in accordance with GAAP. 

“Indenture” means this Indenture as amended or supplemented from time to time pursuant to the provisions hereof, and includes
the terms of a particular series of Notes established as contemplated by Section 2.01. 
 “Indirect
Participant” means a Person who holds a beneficial interest in a Global Note through a Participant. 
 “Initial
Notes” means $1.5 billion aggregate principal amount of 5.250% Senior Notes due 2025 issued under this Indenture on the date hereof. 

“Intercreditor Agreement” means the Intercreditor Agreement dated as of February 25, 2016 among the Partnership, the
Collateral Agent and the other Senior Class Debt Representatives referred to therein, as it may be further amended, amended and restated, supplemented or otherwise modified from time to time. 

 

  
 11 

 “interest” means, (i) with respect to an Original Issue Discount Note that
by its terms bears interest only after Maturity, interest payable after Maturity and (ii) with respect to the Note means interest with respect thereto and Additional Interest, if any. 

“Interest Payment Date”, when used with respect to Notes of a series, shall have the meaning assigned to such series, as
contemplated by Section 2.01. 
 “Issue Date” means, with respect to Notes of a series, the date
on which the Notes of such series are originally issued under this Indenture. 
 “Joinder Documents” means (a) a
supplement to the Intercreditor Agreement required to be delivered by an Additional Agent to the Controlling Agent and Collateral Agent pursuant to the Intercreditor Agreement and (b) a supplement to the Collateral Agency Agreement required to
be delivered by an Additional Agent to the Controlling Agent and Collateral Agent pursuant to the Collateral Agency Agreement, in each case, in order to establish an additional Series of Additional First Lien Obligations and become Additional First
Lien Secured Parties under the Intercreditor Agreement. 
 “Legal Holiday” means a Saturday, a Sunday or a day on which
banking institutions in the City of New York or at a place of payment are authorized by law, regulation or executive order to remain closed. 

“Letter of Transmittal” means the letter of transmittal to be prepared by the Partnership and sent to all Holders for use by
such Holders in connection with an Exchange Offer. 
 “Lien” means, with respect to any asset, any mortgage, deed of trust,
lien, pledge, hypothecation, charge, security interest or similar encumbrance in, on, or of such asset, regardless of whether filed, recorded or otherwise perfected under applicable law, including any conditional sale or other title retention
agreement, any lease in the nature thereof, any option or other agreement to sell or give a security interest in and any filing of or agreement to give any financing statement under the Uniform Commercial Code (or equivalent statutes) of any
jurisdiction. 
 “LNG” means natural gas in a liquid state at or below its boiling point at a pressure of approximately one
atmosphere. 
 “Material Indebtedness” means Indebtedness of the Partnership for borrowed money in the outstanding
aggregate principal amount of $100 million or more. 
 “Maturity” means, with respect to Notes of a series, the date
on which the principal of such series or an installment of principal becomes due and payable as therein or herein provided, whether at the Stated Maturity thereof, or by declaration of acceleration, call for redemption or otherwise. 

  
 12 

 “Moody’s” means Moody’s Investors Service, Inc. or any successor to
the rating agency business thereof. 
 “Multiple Indebtedness Mortgage, Assignment of Leases and Rents and Security
Agreement” means the Multiple Indebtedness Mortgage, Assignment of Leases and Rents and Security Agreement, dated November 29, 2016, entered into between Sabine Pass LNG, L.P. and the Collateral Agent, as it may be amended, amended and
restated, supplemented or otherwise modified from time to time. 
 “Net Proceeds” means the aggregate cash proceeds and
Cash Equivalents received by the Partnership or any of its Subsidiary Guarantors in respect of any Asset Sale (including any cash and Cash Equivalents received upon the sale or other disposition of any
non-cash consideration received in any Asset Sale), net of: 
 (1) the direct costs relating to such
Asset Sale, including legal, accounting, investment banking and brokerage fees, and sales commissions, and any relocation expenses incurred as a result of the Asset Sale; 

(2) taxes paid or payable as a result of the Asset Sale, in each case, after taking into account any available tax credits or deductions and
any tax sharing arrangements; 
 (3) in the case of any Asset Sale by a Subsidiary, payments to holders of Equity Interests in such
Subsidiary in such capacity (other than such Equity Interests held by the Partnership or any Subsidiary) to the extent that such payment is required to permit the distribution of such proceeds to the Partnership or any Subsidiary; 

(4) amounts required to be applied to the repayment of Indebtedness, other than revolving credit Indebtedness except to the extent resulting in
a permanent reduction in availability of such Indebtedness under a Credit Facility, secured by a Lien on the properties or assets that were the subject of such Asset Sale and all distributions and payments required to be made to minority interest
holders in Subsidiaries as a result of such Asset Sale; and 
 (5) any amounts to be set aside in any reserve established in accordance with
GAAP or any amount placed in escrow, in either case for adjustment in respect of the sale price of such properties or assets or for liabilities associated with such Asset Sale and retained by the Partnership or any of its Subsidiaries until such
time as such reserve is reversed or such escrow arrangement is terminated, in which case Net Proceeds shall include only the amount of the reserve so reversed or the amount returned to the Partnership or its Subsidiaries from such escrow
arrangement, as the case may be; 
 provided that, for purposes of this definition, the following will be deemed to be cash or Cash Equivalents: 

(1) any liabilities, as shown on the Partnership’s or any Subsidiary Guarantor’s most recent consolidated balance sheet or in the
footnotes thereto (or as would be shown on the Partnership’s or such Subsidiary Guarantor’s consolidated balance sheet as of the date of such Asset Sale) of the Partnership or any Subsidiary Guarantor (other than contingent liabilities and
liabilities that are by their terms subordinated in right of payment to the Notes or any Subsidiary 

  
 13 

 
Guarantor’s guarantee of the Notes), that are (i) assumed by the transferee of any such assets pursuant to a written novation agreement or other similar agreement that releases the
Partnership or such Subsidiary Guarantor from further liability with respect thereto or (ii) otherwise cancelled or terminated in connection with the transaction with such transferee (other than intercompany debt owed to the Partnership or a
Subsidiary Guarantor); 
 (2) any securities, notes or other obligations or assets received by the Partnership or a Subsidiary Guarantor from
such transferee or in connection with such Asset Sale that are converted by the Partnership or such Subsidiary Guarantor into cash within 90 days of their receipt to the extent of the cash received in that conversion; and 

(3) Indebtedness of any Subsidiary Guarantor that ceases to be a Subsidiary Guarantor as a result of such Asset Sale (other than intercompany
debt owed to the Partnership or a Subsidiary), to the extent that the Partnership and each other Subsidiary Guarantor are released from any guarantee of payment of the principal amount of such Indebtedness in connection with such Asset Sale. 

“Net Tangible Assets” means, at any date of determination, the total amount of consolidated assets of the Partnership and its
Subsidiaries (including, without limitation, any assets consisting of equity securities or equity interests in any other entity) after deducting therefrom: 

(1) all current liabilities (excluding (A) any current liabilities that by their terms are extendable or renewable at the option of the
obligor thereon to a time more than twelve months after the time as of which the amount thereof is being computed, and (B) current maturities of long-term debt); and 

(2) the value (net of any applicable reserves) of all goodwill, trade names, trademarks, patents and other like intangible assets; 

all as prepared in accordance with GAAP and set forth, or on a pro forma basis would be set forth, on a consolidated balance sheet of the Partnership and its
Subsidiaries for the Partnership’s most recently completed fiscal quarter for which financial statements are available. 
 “Non-Recourse Indebtedness” means Indebtedness as to which neither the Partnership nor any of its Subsidiary Guarantors is directly or indirectly liable (as a guarantor or otherwise), other than pledges of
the equity of any Person that is not a Subsidiary Guarantor to secure such Non-Recourse Indebtedness of such Person. 

“Note Documents” means this Indenture, the Notes and the Collateral Documents. 

“Note Obligations” means all Obligations of the Partnership and the Subsidiary Guarantors under the Note Documents. 

“Notes” has the meaning given in the applicable Supplemental Indenture or, where the context requires, the Notes of each
applicable series. Unless the context otherwise requires, Notes includes the Initial Notes, the Exchange Notes and any Additional Notes. 

  
 14 

 “Obligations” means any principal, interest, premium, penalties, fees,
indemnifications, reimbursements, costs, expenses, damages and other liabilities, and guarantees of payment of such principal, interest, premium, penalties, fees, indemnifications, reimbursements, damages and other liabilities, payable under the
documentation governing any Indebtedness. 
 “Obligors” means the Partnership and each Subsidiary Guarantor, if any, and
any other Person who is liable for any of the First Lien Obligations. 
 “Officer” means the Chairman of the Board, the
President, any Vice Chairman of the Board, any Vice President, the Chief Financial Officer, the Treasurer, any Assistant Treasurer, the Controller, the Secretary or any Assistant Secretary of a Person. 

“Officer’s Certificate” means a certificate signed by an Officer of a Person and delivered to the Trustee. 

“Opinion of Counsel” means a written opinion from legal counsel who is acceptable to the Trustee. Such counsel may be an
employee of or counsel to the Partnership, a Subsidiary Guarantor or the Trustee. 
 “Original Issue Discount Note” means
any series of Notes that provides for an amount less than the principal amount thereof to be due and payable upon a declaration of acceleration of the Maturity thereof pursuant to Section 6.02. 

“Participant” means, with respect to the Depositary, Euroclear or Clearstream, a Person who has an account with the
Depositary, Euroclear or Clearstream, respectively (and, with respect to DTC, shall include Euroclear and Clearstream). 

“Partnership” means the Person named as the “Partnership” in the first paragraph of this instrument until a
successor Person shall have become such pursuant to the applicable provisions of this Indenture, and thereafter “Partnership” shall mean such successor Person; provided, however, that for purposes of any provision contained herein
which is required by the TIA, “Partnership” shall also mean each other obligor (if any), other than a Subsidiary Guarantor, on the Notes of a series. 

“Partnership Order” and “Partnership Request” mean, respectively, a written order or request signed in the
name of the Partnership or each Subsidiary Guarantor by two Officers of the Partnership (or, in the case the Partnership is a limited partnership, the General Partner, acting on behalf of the Partnership) and delivered to the Trustee. 

“Permitted Liens” means at any time: 

(1) any Lien existing on any property prior to the acquisition thereof by the Partnership or any Subsidiary Guarantor or existing on any
property of any Person that becomes a Subsidiary Guarantor after the Issue Date prior to the time such Person becomes a Subsidiary Guarantor; provided that (i) such Lien is not created in contemplation of or in connection with such
acquisition or such Person becoming a Subsidiary Guarantor, as the case may be, (ii) such Lien shall not apply to any other property of the Partnership or any Subsidiary Guarantor and (iii) such Lien shall secure only those obligations that it
secures on the date of such acquisition or the date such Person becomes a Subsidiary Guarantor, as the case may be; 

  
 15 

 (2) any Lien on any real or personal tangible property securing Purchase Money Indebtedness
incurred by the Partnership or any Subsidiary Guarantor; 
 (3) any Lien securing Indebtedness incurred in connection with extension,
renewal, refinancing, refunding or replacement (or successive extensions, renewals, refinancing, refunding or replacements), in whole or in part, of Indebtedness secured by Liens referred to in clauses (1) or (2) above or (5) below;
provided, however, that any such extension, renewal, refinancing, refunding or replacement Lien shall be limited to the property or assets (including replacements or proceeds thereof) covered by the Lien extended, renewed, refinanced,
refunded or replaced and that the Indebtedness secured by any such extension, renewal, refinancing, refunding or replacement Lien shall be in an amount not greater than the amount of the obligations secured by the Lien extended, renewed, refinanced,
refunded or replaced and any expenses of the Partnership or the Subsidiary Guarantors (including any premium) incurred in connection with such extension, renewal, refinancing, refunding or replacement; 

(4) any Lien resulting from the deposit of moneys or evidence of indebtedness in trust for the purpose of defeasing Indebtedness of the
Partnership or any Subsidiary Guarantor; 
 (5) Liens in favor of the Collateral Agent granted pursuant to the Collateral Documents securing
the First Lien Obligations; 
 (6) Liens securing Hedging Obligations not entered into for speculative purposes and letters of credit entered
into in the ordinary course of business; 
 (7) Banker’s liens, rights of setoff and other similar Liens that are customary in the
banking industry and existing solely with respect to cash and other amounts on deposit in one or more accounts (including securities and cash management arrangements) maintained by the Partnership or its Subsidiaries; 

(8) Liens for taxes not delinquent or being contested in good faith and by appropriate proceedings in relation to which appropriate reserves
are maintained and Liens for customs duties that have been deferred in accordance with the laws of any applicable jurisdiction; and 
 (9)
Liens imposed by law or order as a result of any proceeding before any court or regulatory body that is being contested in good faith, and Liens which secure a judgment or other court-ordered award or settlement as to which the Partnership or the
applicable Subsidiary has not exhausted its appellate rights. 
 “Person” means any individual, corporation, partnership,
limited liability company, joint venture, incorporated or unincorporated association, joint-stock company, trust, unincorporated organization or government or any agency or political subdivision thereof or any other entity. 

“Place of Payment” means, with respect to the Notes of any series, the place or places where the principal, interest on and
any Additional Amounts with respect to the Notes of that series are payable as specified in accordance with Section 2.14 subject to the provisions of Section 4.02. 

  
 16 

 “Pledge and Security Agreement” means the Pledge and Security Agreement, dated
as of February 25, 2016, among the Partnership, each other Grantor referred to therein and the Collateral Agent, as it may be amended, amended and restated, supplemented or otherwise modified from time to time. 

“principal” of a series of Notes means the principal of the series of Notes plus, when appropriate, the premium, if any, on
the series of Notes. 
 “Principal Property” any building, structure or other facility (together with the land on which it
is erected and fixtures comprising a part thereof) owned by the Partnership or any Subsidiary Guarantor and used primarily for manufacturing, processing, research, warehousing or distribution, in each case located within the United States, that has
a book value on the date of which the determination is being made, without deduction of any depreciation reserves, exceeding 2% of Net Tangible Assets, other than any such facility (or portion thereof) that the Partnership reasonably determines is
not material to the business of the Partnership and its Subsidiaries, taken as a whole. 
 “Private Exchange” has the
meaning set forth in the Registration Rights Agreement. 
 “Private Placement Legend” means the legend set forth in
Section 2.08(g)(1).  
 “Project Finance
Subsidiary” means any special purpose Subsidiary of the Partnership that (a) the Partnership designates as a “Project Finance Subsidiary” by written notice to the Trustee and is formed for the sole purpose of
(x) developing, financing and operating the infrastructure and capital projects of such Subsidiary or (y) owning or financing any such Subsidiary described in clause (x), (b) has no Indebtedness other than
Non-Recourse Indebtedness, (c) is a Person with respect to which neither the Partnership nor any of the Subsidiary Guarantors has any direct or indirect obligation to maintain or preserve such
Person’s financial condition or to cause such Person to achieve any specified levels of operating results and (d) has not guaranteed or otherwise directly provided credit support for any Indebtedness of the Partnership or any of the
Subsidiary Guarantors. SPL may not be designated as Project Finance Subsidiary. 
 “Purchase Money Indebtedness” of any
Person means any Indebtedness of such Person to any seller or other Person, that is incurred to finance the acquisition, construction, installation or improvement of any real or personal tangible property (including Capital Stock but only to the
extent of the tangible assets in such Subsidiary being acquired) used or useful in the business of such Person and its Subsidiaries and that is incurred concurrently with, or within one year following, such acquisition, construction, installation or
improvement. 
 “QIB” means a “qualified institutional buyer” as defined in Rule 144A. 

“Rating Decline” means, with respect to any Change of Control or Asset Sale, the occurrence of: 

  
 17 

 (1) during the occurrence and continuance of any period in which the Partnership has two or more
ratings equal to or greater than (x) Baa3 by Moody’s, (y) BBB- by S&P and (z) BBB- by Fitch (or, if any of such entities cease to provide such
ratings, the equivalent rating from any other “nationally recognized statistical rating organization” registered with the SEC) (such period, an “Investment Grade Period”), a ratings downgrade which results in the Partnership no
longer having two such ratings of at least BBB- or Baa3, as applicable, or 
 (2) during any period
which is not an Investment Grade Period, a ratings downgrade of the Partnership by any two of (x) Moody’s, (y) S&P and (z) Fitch (or, if any of such entities cease to provide such ratings, the equivalent rating from any other
“nationally recognized statistical rating organization” registered with the SEC); 
 provided, however, that in each case such decrease
occurs on, or within 90 days after the earlier of (a) such Change of Control or Asset Sale, as applicable, (b) the date of public notice of the occurrence of such Change of Control or Asset Sale, as applicable or (c) public notice of
the intention by the Partnership to effect such Change of Control or Asset Sale, as applicable (which period shall be extended so long as the rating of the Notes is under publicly announced consideration for downgrade by any two of Moody’s,
S&P or Fitch); and provided further that a Rating Decline otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control or Asset Sale, as applicable (and
thus will disregarded in determining whether a Rating Decline has occurred for purposes of the definition of Change of Control Triggering Event or Asset Sale Triggering Event), if the Rating Agencies making the reduction in rating do not announce or
publicly confirm or inform the Trustee in writing at the Partnership’s or the Trustee’s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of,
the applicable Change of Control or Asset Sale, as applicable (whether or not the applicable Change of Control or Asset Sale, as applicable, has occurred at the time of the Rating Decline). 

“Redemption Date” means, with respect to any series of Notes to be redeemed, the date fixed for such redemption by or
pursuant to the applicable Supplemental Indenture. 
 “Redemption Price” means, with respect to any series of Notes to be
redeemed, the price at which it is to be redeemed pursuant to the applicable Supplemental Indenture. 
 “Registered Exchange
Offer” has the meaning set forth in the Registration Rights Agreement. 
 “Registration Rights Agreement” means
that certain Registration Rights Agreement dated as of September 18, 2017 relating to the Initial Notes by and among the Partnership, the Subsidiary Guarantors and the initial purchasers set forth therein, as such agreement may be amended from
time to time and, with respect to any other series of Notes issued pursuant to Section 2.01 hereof, one or more Registration Rights Agreements among the Partnership and the other parties thereto, as such agreement(s) may be
amended, modified or supplemented from time to time, relating to rights given by the Partnership to the purchasers of Notes of such other series to register such Notes of other series under the Securities Act. 

  
 18 

 “Regulation S” means Regulation S promulgated under the Securities Act. 

“Regulation S Global Note” means a Regulation S Temporary Global Note or Regulation S Permanent Global Note, as appropriate.

 “Regulation S Permanent Global Note” means a permanent Global Note issued in accordance with the second paragraph of
Section 2.03(c). 
 “Regulation S Temporary Global Note” means a temporary Global Note issued in
accordance with the first paragraph of Section 2.03(c). 
 “Responsible Officer” means, with
respect to the Trustee, any officer assigned to the Corporate Trust Division – Corporate Finance Unit (or any successor division or unit) of the Trustee located at the Corporate Trust Office of the Trustee, who shall have direct responsibility
for the administration of this Indenture, and for the purposes of Section 7.01(c)(2) and the second sentence of Section 7.05 shall also include any other officer of the Trustee to whom any corporate trust matter is referred because of such
officer’s knowledge of and familiarity with the particular subject. 
 “Restricted Definitive Note” means a Definitive
Note bearing the Private Placement Legend. 
 “Restricted Global Note” means a Global Note bearing the Private Placement
Legend. 
 “Restricted Period” means, with respect to any series of Notes, the
40-day distribution compliance period as defined in Regulation S. 
 “Rule 144A”
means Rule 144A promulgated under the Securities Act. 
 “Rule 144A Global Notes” means a Global Note
issued in accordance with Section 2.03(c)(1)(A). 
 “Rule 903” means Rule 903 promulgated under
the Securities Act. 
 “Rule 904” means Rule 904 promulgated under the Securities Act. 

“S&P” means Standard & Poor’s Ratings Services, a division of The McGraw-Hill Companies, Inc. or any
successor to the rating agency business thereof. 
 “SEC” means the United States Securities and Exchange Commission and
any successor agency thereto. 
 “Secured Credit Document” means (i) the Credit Agreement and each other Financing
Document (as defined in the Credit Agreement) and (ii) each Additional First Lien Document. 
 “Senior
Class Debt Representative” means, with respect to the Credit Agreement Obligations, the Credit Agreement Administrative Agent, with respect to this Indenture, the Trustee, and with respect to any Additional First Lien
Debt Facility, the Additional Agent representing such Additional First Lien Debt Facility pursuant to the Additional First Lien Documents applicable to such Additional First Lien Debt Facility that becomes a party to the Intercreditor Agreement.

  
 19 

 “Senior Notes Parties” means, collectively, the Trustee, the Collateral Agent,
each other agent, and the Holders of the Notes, in each case, under this Indenture. 
 “Series” means (a) with respect
to the First Lien Secured Parties, each of (i) the Credit Agreement Secured Parties (in their capacities as such), (ii) during the Security Requirement Period, the Senior Notes Parties and (iii) the Additional First Lien Secured Parties
whose Additional Agent has become a Senior Class Debt Representative under the Intercreditor Agreement and (b) with respect to any First Lien Obligations, each of (i) the Credit Agreement Obligations, (ii) during the Security
Requirement Period, the Note Obligations and (iii) the Additional First Lien Obligations incurred pursuant to any Additional First Lien Debt Facility or any related Additional First Lien Documents, which pursuant to any Joinder Documents, are
to be represented under the Intercreditor Agreement by a Senior Class Debt Representative (in its capacity as such for such Additional First Lien Obligations). 

“Shelf Registration Statement” means the Shelf Registration Statement as defined in the Registration Rights Agreement. 

“Significant Subsidiary” means any Subsidiary that would be a “significant subsidiary” as defined in Article 1,
Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such Regulation is in effect on the Issue Date. 

“SPL Member” means Sabine Pass LNG-LP, LLC, an indirect Subsidiary of the
Partnership. 
 “Stated Maturity” means, when used with respect to any series of Notes or any installment of principal
thereof or interest thereon, the date specified as the fixed date on which the principal of such Note or such installment of principal or interest is due and payable. 

“Subordinated Indebtedness” means Indebtedness of the Partnership or a Subsidiary Guarantor that is contractually
subordinated in right of payment, in any respect (by its terms or the terms of any document or instrument relating thereto), to the Notes or the Guarantee of such Subsidiary Guarantor, as applicable. 

“Subsidiary” means, with respect to any Person: 

(1) any corporation, association or other business entity of which more than 50% of the total voting power of the Capital Stock entitled
(without regard to the occurrence of any contingency and after giving effect to any voting agreement that effectively transfers voting power) to vote in the election of directors, managers or Trustees of the corporation, association or other
business entity is at the time of determination owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person (or a combination thereof); and 

  
 20 

 (2) any partnership (a) the sole general partner or the managing general partner of which is
such Person or a Subsidiary of such Person or (b) the only general partners of which are that Person or one or more Subsidiaries of that Person (or any combination thereof). 

“Subsidiary Guarantor” means Cheniere Energy Investments, LLC, Sabine Pass LNG-GP,
LLC, Sabine Pass LNG-LP, LLC, Sabine Pass LNG, L.P., Sabine Pass Tug Services, LLC, Cheniere Creole Trail Pipeline, L.P. and Cheniere Pipeline GP Interests, LLC, and any future Subsidiary of the Partnership
(excluding, for the avoidance of doubt, Sabine Pass Liquefaction, LLC) that provides a Guarantee with respect to the Notes pursuant to the terms of this Indenture, but only so long as such entity is a guarantor with respect to the Notes on the terms
provided for in this Indenture. 
 “Supplemental Indenture” means any indenture supplemental to this Indenture, which, in
the case of a supplemental indenture creating a new series of Notes, shall be substantially in the form set forth in Exhibit A hereto. 

“Supplemental Indenture for Additional Guarantors” means any indenture supplemental to this Indenture substantially in the
form set forth in Exhibit D hereto. 
 “Term Loans” means, collectively, the $450,000,000 Cheniere Creole Trail
Pipeline, L.P. tranche term loan and the $2,110,000,000 Sabine Pass LNG, L.P. tranche term loan under the Credit Agreement. 

“TIA” means the Trust Indenture Act of 1939, as amended, as in effect on the date hereof. 

“Trustee” means the Person named as such above until a successor replaces it in accordance with the applicable provisions of
this Indenture, and thereafter “Trustee” means each Person who is then a trustee hereunder, and if at any time there is more than one such Person, “Trustee” as used with respect to the Notes of any series means the Trustee with
respect to Notes of that series. 
 “United States” means the United States of America (including the States and the
District of Columbia) and its territories and possessions, which include Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, Wake Island and the Northern Mariana Islands. 

“Unrestricted Definitive Note” means a Definitive Note that does not bear and is not required to bear the Private Placement
Legend. 
 “Unrestricted Global Note” means a Global Note that does not bear and is not required to bear the Private
Placement Legend. 
 “U.S. Government Obligations” means Government Obligations with respect to Notes payable in Dollars.

 “U.S. Person” means a U.S. Person as defined in Rule 902(k) promulgated under the Securities Act. 

  
 21 

 “Voting Stock” of any specified Person as of any date means the Capital Stock of
such Person that is at the time entitled to vote in the election of the Board of Directors of such Person. 
 Section 1.02 Other
Definitions. 
  

					
	 Term
	  	Defined in
Section	 
		
	 “Affiliate Transaction”
	  	 	4.12	 
		
	 “Asset Sale Payment”
	  	 	4.09	 
		
	 “Asset Sale Payment Date”
	  	 	4.09	 
		
	 “Authentication Order”
	  	 	2.04	 
		
	 “Bankruptcy Custodian”
	  	 	6.01	 
		
	 “Change of Control Offer”
	  	 	4.08	 
		
	 “Change of Control Payment”
	  	 	4.08	 
		
	 “Change of Control Payment Date”
	  	 	4.08	 
		
	 “covenant defeasance”
	  	 	8.01	 
		
	 “Event of Default”
	  	 	6.01	 
		
	 “Excess Proceeds”
	  	 	4.09	 
		
	 “Exchange Rate”
	  	 	2.11	 
		
	 “Funding Guarantor”
	  	 	10.05	 
		
	 “Judgment Currency”
	  	 	6.10	 
		
	 “legal defeasance”
	  	 	8.01	 
		
	 “Pari Passu Debt”
	  	 	4.09	 
		
	 “Paying Agent”
	  	 	2.05	 
		
	 “Payment Default”
	  	 	6.01	 
		
	 “Registrar”
	  	 	2.05	 
		
	 “Required Currency”
	  	 	6.10	 
		
	 “Sale-Leaseback Transaction”
	  	 	4.11	 
		
	 “Successor Company”
	  	 	5.01	 
		
	 “Successor Person”
	  	 	5.03	 

  
 22 

 Section 1.03 Incorporation by Reference of Trust Indenture Act. Whenever this
Indenture refers to a provision of the TIA, the provision is incorporated by reference in and made a part of this Indenture (and if this Indenture is not qualified under the TIA at that time, as if it were so qualified unless otherwise provided).
The following TIA terms used in this Indenture have the following meanings: 
 “Commission” means the SEC. 

“indenture trustee” or “institutional trustee” means the Trustee. 

“Institutional Accredited Investor” means an institution that is an “accredited investor” as defined in Rule
501(a)(1), (2), (3) or (7) under the Securities Act, who is not also a QIB. 
 “obligor” on the Notes means the
Partnership, any Subsidiary Guarantor or any other obligor on the Notes. 
 All terms used in this Indenture that are defined by the TIA,
defined by a TIA reference to another statute or defined by an SEC rule under the TIA have the meanings so assigned to them. 

Section 1.04 Rules of Construction. Unless the context otherwise requires: 

(a) a term has the meaning assigned to it; 

(b) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 

(c) “or” is not exclusive; 

(d) words in the singular include the plural, and in the plural include the singular; 

(e) provisions apply to successive events and transactions; 

(f) all references in this instrument to Articles, Sections and Exhibits are references to the corresponding Articles, Sections and Exhibits in
and of this instrument. 
 (g) the words “herein”, hereof” and “hereunder” and other words of similar import refer
to this Indenture as a whole and not to any particular Article, Section or other subdivision; and 
 (h) the words “including,”
“includes” and “include” shall be deemed to be followed by the words “without limitation”. 

  
 23 

 ARTICLE II. 

THE NOTES 

Section 2.01 Amount Unlimited; Issuable in Series. The aggregate principal amount of Notes that may be authenticated and delivered
under this Indenture is unlimited. The Notes may be issued in one or more series. There shall be established in or pursuant to a Board Resolution, and set forth, or determined in the manner provided, in an Officer’s Certificate of the
Partnership (or, in the case the Partnership is a limited partnership, the General Partner, acting on behalf of the Partnership) or in a Partnership Order, or established in one or more Supplemental Indentures, prior to the issuance of Notes of any
series: 
 (a) the title of the Notes of the series (which shall distinguish the Notes of the series from the Notes of all other series);

 (b) if there is to be a limit, the limit upon the aggregate principal amount of the Notes of the series that may be authenticated and
delivered under this Indenture (except for Notes authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Notes of the series pursuant to Section 2.08, 2.09, 2.12,
3.07 or 9.05 and except for any Notes which, pursuant to Section 2.04 or 2.08, are deemed never to have been authenticated and delivered hereunder); provided that unless otherwise provided in the
terms of the series, the authorized aggregate principal amount of such series may be increased before or after the issuance of any Notes of the series by a Board Resolution (or action pursuant to a Board Resolution) to such effect; 

(c) whether any Notes of the series are to be issuable initially in temporary global form and whether any Notes of the series are to be
issuable in permanent global form, as Global Notes or otherwise, and, if so, whether beneficial owners of interests in any such Global Note may exchange such interests for Notes of such series and of like tenor of any authorized form and
denomination and the circumstances under which any such exchanges may occur, if other than in the manner provided in Section 2.08, and the initial Depositary and Custodian, if any, for any Global Note or Notes of such
series; 
 (d) the manner in which any interest payable on a temporary Global Note on any Interest Payment Date will be paid if other than in
the manner provided in Section 2.14; 
 (e) the date or dates on which the principal of the Notes of the series is
payable or the method of determination thereof; 
 (f) the rate or rates, or the method of determination thereof, at which the Notes of the
series shall bear interest, if any, whether and under what circumstances Additional Amounts with respect to such Notes shall be payable, the date or dates from which such interest shall accrue, the Interest Payment Dates on which such interest shall
be payable and the record date for the interest payable on any Notes on any Interest Payment Date, or if other than provided herein, the Person to whom any interest on Notes of the series shall be payable; 

(g) the Place of Payment; 

  
 24 

 (h) the period or periods within which, the price or prices (whether denominated in cash,
securities or otherwise) at which and the terms and conditions upon which Notes of the series may be redeemed, in whole or in part, at the option of the Partnership, if the Partnership is to have that option, and the manner in which the Partnership
must exercise any such option, if different from those set forth herein; 
 (i) whether Notes of the series are entitled to the benefits of
any Guarantee of any Subsidiary Guarantor pursuant to this Indenture; 
 (j) the obligation, if any, of the Partnership to redeem, purchase
or repay Notes of the series pursuant to any sinking fund or analogous provisions or at the option of a Holder thereof and the period or periods within which, the price or prices (whether denominated in cash, securities or otherwise) at which and
the terms and conditions upon which Notes of the series shall be redeemed, purchased or repaid in whole or in part pursuant to such obligation; 

(k) if other than denominations of $1,000 and any integral multiple thereof, the denomination in which any Notes of that series shall be
issuable; 
 (l) if other than Dollars, the currency or currencies (including composite currencies) or the form, including equity securities,
other debt securities (including Notes), warrants or any other securities or property of the Partnership, any Subsidiary Guarantor or any other Person, in which payment of the principal of, interest on and any Additional Amounts with respect to the
Notes of the series shall be payable; 
 (m) if the principal of, or interest on or any Additional Amounts with respect to the Notes of the
series are to be payable, at the election of the Partnership or a Holder thereof, in a currency or currencies (including composite currencies) other than that in which the Notes are stated to be payable, the currency or currencies (including
composite currencies) in which payment of the principal of, interest on and any Additional Amounts with respect to Notes of such series as to which such election is made shall be payable, and the periods within which and the terms and conditions
upon which such election is to be made; 
 (n) if the amount of payments of principal of, interest on and any Additional Amounts with respect
to the Notes of the series may be determined with reference to any commodities, currencies or indices, values, rates or prices or any other index or formula, the manner in which such amounts shall be determined; 

(o) if other than the entire principal amount thereof, the portion of the principal amount of Notes of the series that shall be payable upon
declaration of acceleration of the Maturity thereof pursuant to Section 6.02; 
 (p) any additional means of
satisfaction and discharge of this Indenture and any additional conditions or limitations to discharge with respect to Notes of the series and the related Guarantees pursuant to Article VIII or any modifications of or
deletions from such conditions or limitations; 

  
 25 

 (q) any deletions or modifications of or additions to the Events of Default set forth in
Section 6.01 or covenants of the Partnership or any Subsidiary Guarantor set forth in Article IV pertaining to the Notes of the series; 

(r) any restrictions or other provisions with respect to the transfer or exchange of Notes of the series, which may amend, supplement, modify
or supersede those contained in this Article II; 
 (s) if the Notes of the series are to be convertible into or
exchangeable for capital stock, other debt securities (including Notes), warrants, other equity securities or any other securities or property of the Partnership, any Subsidiary Guarantor or any other Person, at the option of the Partnership or the
Holder or upon the occurrence of any condition or event, the terms and conditions for such conversion or exchange; 
 (t) whether the Notes
of the series are issued pursuant to Rule 144A; and 
 (u) any other terms of the series (which terms shall not be prohibited by the
provisions of this Indenture). 
 All Notes of any one series shall be substantially identical except as to denomination and except as may
otherwise be provided in or pursuant to the Board Resolution referred to above and (subject to Section 2.03) set forth, or determined in the manner provided, in the Officer’s Certificate or Partnership Order referred
to above or in any such indenture supplemental hereto. If any of the terms of the series are established by action taken pursuant to a Board Resolution, a copy of an appropriate record of such action, together with such Board Resolution, shall be
set forth in an Officer’s Certificate or certified by the Secretary or an Assistant Secretary of the Partnership (or, in the case the Partnership is a limited partnership, the General Partner, acting on behalf of the Partnership) and delivered
to the Trustee at or prior to the delivery of the Officer’s Certificate or Partnership Order setting forth the terms of the series. 

Section 2.02 Denominations. The Notes of each series shall be issuable in such denominations as shall be specified as contemplated
by Section 2.01. In the absence of any such provisions with respect to the Notes of any series, the Notes of such series denominated in Dollars shall be issuable in denominations of $1,000 and any integral multiples
thereof. 
 Section 2.03 Forms. 

(a) General. The terms and provisions contained in the Notes will constitute, and are hereby expressly made, a part of this Indenture
and the Partnership, the Guarantors and the Trustee, by their execution and delivery of this Indenture, expressly agree to such terms and provisions and to be bound thereby. However, to the extent any provision of any series of Notes conflicts with
the express provisions of this Indenture, the provisions of this Indenture shall govern and be controlling. 
 (b) Global Notes.
Except as otherwise provided in this Section 2.03, Notes issued in global form (and the Trustee’s certificate of authentication of such Notes) will be substantially in the form of Exhibit A-1 or Exhibit A-2 to each Supplemental Indenture (including the Global Note Legend thereon and the “Schedule of Increases and Decreases in

  
 26 

 
Global Note” attached thereto). Each such Note will be dated the date of its authentication. Except as otherwise provided in this Section 2.03, Notes issued in
definitive form will be substantially in the form of Exhibit A-1 to the Supplemental Indenture (but without the Global Note Legend thereon and without the “Schedule of Increases and Decreases in
Global Note” attached thereto) in an aggregate denomination equal to the aggregate initial principal amount of such Notes. Each Global Note will represent such of the outstanding Notes as will be specified therein and each shall provide that it
represents the aggregate principal amount of outstanding Notes from time to time endorsed thereon and that the aggregate principal amount of outstanding Notes represented thereby may from time to time be reduced or increased, as appropriate, to
reflect exchanges and redemptions. Any endorsement of a Global Note to reflect the amount of any increase or decrease in the aggregate principal amount of outstanding Notes represented thereby will be made by the Trustee or the Custodian, at the
direction of the Trustee, in accordance with instructions given by the Holder thereof as required by Section 2.08. 

(c) Temporary Global Notes. Notes offered and sold in reliance on Regulation S will be issued in a denomination equal to the outstanding
principal amount of such Notes initially in the form of Exhibit A-2 to the Supplemental Indenture. Such Notes will be deposited on behalf of the purchasers of the Notes represented thereby with or on
behalf of, and registered in the name of, the Depositary or the nominee of the Depositary for the accounts of designated agents holding on behalf of Euroclear or Clearstream, duly executed by the Partnership and authenticated by the Trustee as
hereinafter provided. The Restricted Period will be terminated upon the receipt by the Trustee of: 
 (1) a written certificate from the
Depositary, together with copies of certificates from Euroclear and Clearstream certifying that they have received certification of non-United States beneficial ownership of 100% of the aggregate principal
amount of the Regulation S Temporary Global Note (except to the extent of any beneficial owners thereof who acquired an interest therein during the Restricted Period pursuant to another exemption from registration under the Securities Act and who
will take delivery of a beneficial ownership interest in (A) a Global Note substantially in the form of Exhibit A-1 to the Supplemental Indenture, bearing the Global Note Legend and the Private
Placement Legend, deposited with or on behalf of, and registered in the name of, the Depositary or its nominee, and issued in a denomination equal to the outstanding principal amount of the Notes sold in reliance on Rule 144A or (B) a Global
Note bearing the Global Note Legend and the Private Placement Legend, deposited with or on behalf of, and registered in the name of, the Depositary or the nominee of the Depositary, and issued in a denomination equal to the outstanding principal
amount of Notes sold to Institutional Accredited Investors), all as contemplated by Section 2.08(b) hereof; and 

(2) an Officer’s Certificate from the Partnership. 

Following the termination of the Restricted Period with respect to any Notes, beneficial interests in the Regulation S Temporary Global Note
will be exchanged, pursuant to the Applicable Procedures, for beneficial interests in a permanent Global Note, which will be in the form of Exhibit A-1 to the Supplemental Indenture bearing the Global
Note Legend and the Private Placement Legend, deposited with or on behalf of, and registered in the name of, the Depositary or the nominee of the Depositary, and issued in a denomination equal to the outstanding principal amount of the Regulation S
Temporary Global Note upon expiration of the 

  
 27 

 
Restricted Period. Simultaneously with the authentication of the Regulation S Permanent Global Note, the Trustee will cancel the Regulation S Temporary Global Note. The aggregate principal amount
of the Regulation S Temporary Global Note and the Regulation S Permanent Global Note may from time to time be increased or decreased by adjustments made on the records of the Trustee and the Depositary or its nominee, as the case may be, in
connection with transfers of interest as hereinafter provided. 
 (3) Euroclear and Clearstream Procedures Applicable. The
provisions of the “Operating Procedures of the Euroclear System” and “Terms and Conditions Governing Use of Euroclear” and the “General Terms and Conditions of Clearstream Banking” and
“Customer Handbook” of Clearstream will be applicable to transfers of beneficial interests in the Regulation S Temporary Global Note and the Regulation S Permanent Global Note that are held by Participants through Euroclear or
Clearstream. 
 (d) Additional Notes. Subject to compliance with the provisions of this Indenture, the Partnership may from time to
time after the Issue Date issue Additional Notes. 
 (e) Exchange Notes. Any Exchange Notes shall be in the same form as the Notes of
the applicable series, except as otherwise provided in Section 2.08(f), and Exchange Notes issued in the Registered Exchange Offer shall be Unrestricted Global Notes or Unrestricted Definitive Notes. 

Section 2.04 Execution, Authentication, Delivery and Dating. At least one Officer of the Partnership (or, in the case the
Partnership is a limited partnership, the General Partner, acting on behalf of the Partnership) shall sign the Notes on behalf of the Partnership by manual or facsimile signature. 

If an Officer of the Partnership (or, in the case the Partnership is a limited partnership, the General Partner, acting on behalf of the
Partnership) whose signature is on a Note no longer holds that office at the time the Note is authenticated, the Note shall be valid nevertheless. 

A Note shall not be entitled to any benefit under this Indenture or the related Guarantees or be valid or obligatory for any purpose until
authenticated by the manual signature of an authorized signatory of the Trustee, which signature shall be conclusive evidence that the Note has been authenticated under this Indenture. Notwithstanding the foregoing, if any Note has been
authenticated and delivered hereunder but never issued and sold by the Partnership, and the Partnership delivers such Note to the Trustee for cancellation as provided in Section 2.13, together with a written statement
(which need not comply with Section 12.05 and need not be accompanied by an Opinion of Counsel) stating that such Note has never been issued and sold by the Partnership, for all purposes of this Indenture such Note shall be
deemed never to have been authenticated and delivered hereunder and shall never be entitled to the benefits of this Indenture or the related Guarantees. 

At any time and from time to time after the execution and delivery of this Indenture, the Partnership may deliver Notes of any series executed
by the Partnership and each Subsidiary Guarantor to the Trustee for authentication, and the Trustee shall authenticate and deliver such Notes for original issue upon a Partnership Order for the authentication (an “Authentication 

  
 28 

 
Order”) and delivery of such Notes or pursuant to such procedures acceptable to the Trustee as may be specified from time to time by Partnership Order. Such order shall specify the
amount of the Notes to be authenticated, the date on which the original issue of Notes is to be authenticated, the name or names of the initial Holder or Holders and any other terms of the Notes of such series not otherwise determined. If provided
for in such procedures, such Partnership Order may authorize (1) authentication and delivery of Notes of such series for original issue from time to time, with certain terms (including, without limitation, the Maturity date or dates, original
issue date or dates and interest rate or rates) that differ from Note to Note and (2) may authorize authentication and delivery pursuant to oral or electronic instructions from the Partnership or its duly authorized agent, which instructions
shall be promptly confirmed in writing. 
 If the form or terms of the Notes of the series have been established in or pursuant to one or
more Board Resolutions as permitted by Section 2.01, in authenticating such Notes, and accepting the additional responsibilities under this Indenture in relation to such Notes, the Trustee shall be entitled to receive (in
addition to the Partnership Order referred to above and the other documents required by Section 12.04), and (subject to Section 7.01) shall be fully protected in relying upon: 

(a) an Officer’s Certificate setting forth the Board Resolution and, if applicable, an appropriate record of any action taken pursuant
thereto, as contemplated by the last paragraph of Section 2.01; and 
 (b) an Opinion of Counsel to the effect
that: 
 (1) the form of such Notes has been established in conformity with the provisions of this Indenture; 

(2) the terms of such Notes have been established in conformity with the provisions of this Indenture; and 

(3) that, when authenticated and delivered by the Trustee and issued by the Partnership in the manner and subject to any conditions specified
in such Opinion of Counsel, such Notes and the related Guarantees will constitute valid and binding obligations of the Partnership and the Subsidiary Guarantors, respectively, enforceable against the Partnership and the Subsidiary Guarantors,
respectively, in accordance with their respective terms, except as the enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other similar laws in effect from time to time
affecting the rights of creditors generally, and the application of general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). 

If all the Notes of any series are not to be issued at one time, it shall not be necessary to deliver an Officer’s Certificate and
Opinion of Counsel at the time of issuance of each such Note, but such Officer’s Certificate and Opinion of Counsel shall be delivered at or before the time of issuance of the first Note of the series to be issued. 

The Trustee shall not be required to authenticate such Notes if the issuance of such Notes pursuant to this Indenture would affect the
Trustee’s own rights, duties or immunities under the Notes and this Indenture or otherwise in a manner not reasonably acceptable to the Trustee. 

  
 29 

 The Trustee may appoint an authenticating agent acceptable to the Partnership to authenticate
Notes. Unless limited by the terms of such appointment, an authenticating agent may authenticate Notes whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by such agent. An
authenticating agent has the same rights as an Agent to deal with the Partnership, any Subsidiary Guarantor or an Affiliate of the Partnership or any Subsidiary Guarantor. 

Each Note shall be dated the date of its authentication. 

Section 2.05 Registrar and Paying Agent; Depositary. The Partnership shall maintain an office or agency for each series of Notes
where Notes of such series may be presented for registration of transfer or exchange (“Registrar”) and an office or agency where Notes of such series may be presented for payment (“Paying Agent”). The Registrar
shall keep a register of the Notes of such series and of their transfer and exchange. The Partnership may appoint one or more co-registrars and one or more additional paying agents. The term
“Registrar” includes any co-registrar and the term “Paying Agent” includes any additional paying agent. 

The Partnership shall enter into an appropriate agency agreement with any Registrar or Paying Agent not a party to this Indenture. The
agreement shall implement the provisions of this Indenture that relate to such Agent. The Partnership shall notify the Trustee of the name and address of any Agent not a party to this Indenture. The Partnership may change any Paying Agent or
Registrar without notice to any Holder. If the Partnership fails to appoint or maintain another entity as Registrar or Paying Agent, the Trustee shall act as such. The Partnership, any Subsidiary Guarantor or any Subsidiary may act as Paying Agent
or Registrar. 
 The Partnership initially appoints the Trustee as Registrar and Paying Agent. 

The Partnership initially appoints DTC to act as Depositary with respect to the Global Notes. 

Section 2.06 Paying Agent to Hold Money in Trust. The Partnership shall require each Paying Agent other than the Trustee to agree
in writing that the Paying Agent will hold in trust for the benefit of Holders or the Trustee all money held by the Paying Agent for the payment of principal of, interest on or any Additional Amounts with respect to Notes and will notify the Trustee
of any default by the Partnership in making any such payment. While any such default continues, the Trustee may require a Paying Agent to pay all money held by it to the Trustee and to account for any funds disbursed. The Partnership at any time may
require a Paying Agent to pay all money held by it to the Trustee and to account for any funds disbursed. Upon payment over to the Trustee and upon accounting for any funds disbursed, the Paying Agent (if other than the Partnership, a Subsidiary
Guarantor or a Subsidiary) shall have no further liability for the money. If the Partnership, a Subsidiary Guarantor or a Subsidiary acts as Paying Agent, it shall segregate and hold in a separate trust fund for the benefit of the Holders all money
held by it as Paying Agent. Each Paying Agent shall otherwise comply with TIA Section 317(b). 

  
 30 

 Section 2.07 Holder Lists. The Trustee shall preserve in as current a form as is
reasonably practicable the most recent list available to it of the names and addresses of Holders and shall otherwise comply with TIA Section 312(a). If the Trustee is not the Registrar with respect to a series of Notes,
the Partnership shall furnish to the Trustee at least five Business Days before each Interest Payment Date with respect to such series of Notes, and at such other times as the Trustee may request in writing, a list in such form and as of such date
as the Trustee may reasonably require of the names and addresses of Holders of such series, and the Partnership shall otherwise comply with TIA Section 312(a). 

Section 2.08 Transfer and Exchange. 

(a) A Global Note may not be transferred except as a whole by the Depositary to a nominee of the Depositary, by a nominee of the Depositary to
the Depositary or to another nominee of the Depositary, or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary. All Global Notes will be exchanged by the Partnership for Definitive Notes if: 

(1) the Partnership delivers to the Trustee notice from the Depositary that it is unwilling or unable to continue to act as Depositary for the
Global Notes or that it has ceased to be a clearing agency registered under the Exchange Act and, in either case, a successor Depositary is not appointed by the Partnership within 120 days after the date of such notice from the Depositary; 

(2) the Partnership, at its option, determines that the Global Notes (in whole but not in part) should be exchanged for Definitive Notes and
delivers a written notice to the Trustee; provided that in no event shall the Regulation S Temporary Global Note be exchanged by the Partnership for Definitive Notes prior to (A) the expiration of the Restricted Period and (B) the
receipt by the Registrar of any certificates required pursuant to Rule 903(b)(3)(ii)(B) under the Securities Act; or 
 (3) there has
occurred and is Continuing an Event of Default with respect to the Notes. 
 Upon the occurrence of either of the preceding events in
(1) or (2) above, Definitive Notes shall be issued in such names as the Depositary shall instruct the Trustee. Global Notes also may be exchanged or replaced, in whole or in part, as provided in Sections 2.09 and 2.12. Every Note
authenticated and delivered in exchange for, or in lieu of, a Global Note or any portion thereof, pursuant to this Section 2.08 or Sections 2.09 or 2.12, shall be authenticated and delivered in the form of,
and shall be, a Global Note. A Global Note may not be exchanged for another Note other than as provided in this Section 2.08(a), however, beneficial interests in a Global Note may be transferred and exchanged as provided in
Section 2.08(b), (c) or (f). 
 (b) Transfer and Exchange of Beneficial Interests in the Global
Notes. The transfer and exchange of beneficial interests in the Global Notes will be effected through the Depositary, in accordance with the provisions of this Indenture and the Applicable Procedures. Beneficial interests in the Restricted
Global Notes will be subject to restrictions on transfer comparable to those set forth herein to the extent required by the Securities Act. Transfers of beneficial interests in the Global Notes also will require compliance with either subparagraph
(1) or (2) below, as applicable, as well as one or more of the other following subparagraphs, as applicable: 

  
 31 

 (1) Transfer of Beneficial Interests in the Same Global Note. Beneficial interests in any
Restricted Global Note may be transferred to Persons who take delivery thereof in the form of a beneficial interest in the same Restricted Global Note in accordance with the transfer restrictions set forth in the Private Placement Legend;
provided that prior to the expiration of the Restricted Period, transfers of beneficial interests in the Regulation S Temporary Global Note may not be made to a U.S. Person or for the account or benefit of a U.S. Person (other than the
Initial Purchasers). Beneficial interests in any Unrestricted Global Note may be transferred to Persons who take delivery thereof in the form of a beneficial interest in an Unrestricted Global Note. No written orders or instructions shall be
required to be delivered to the Registrar to effect the transfers described in this Section 2.08(b)(1). 
 (2)
All Other Transfers and Exchanges of Beneficial Interests in Global Notes. In connection with all transfers and exchanges of beneficial interests that are not subject to Section 2.08(b)(1), the transferor of such
beneficial interest must deliver to the Registrar either: 
 (i) both: 

(A) a written order from a Participant or an Indirect Participant given to the Depositary in accordance with the Applicable
Procedures directing the Depositary to credit or cause to be credited a beneficial interest in another Global Note in an amount equal to the beneficial interest to be transferred or exchanged; and 

(B) instructions given in accordance with the Applicable Procedures containing information regarding the Participant account
to be credited with such increase; or 
 (ii) both: 

(A) a written order from a Participant or an Indirect Participant given to the Depositary in accordance with the Applicable
Procedures directing the Depositary to cause to be issued a Definitive Note in an amount equal to the beneficial interest to be transferred or exchanged; and 

(B) instructions given by the Depositary to the Registrar containing information regarding the Person in whose name such
Definitive Note shall be registered to effect the transfer or exchange referred to in (1) above; 
 provided that in no event shall Definitive
Notes be issued upon the transfer or exchange of beneficial interests in the Regulation S Temporary Global Note prior to (A) the expiration of the Restricted Period and (B) the receipt by the Registrar of any certificates required pursuant
to Rule 903 under the Securities Act. 

  
 32 

 Upon consummation of an Exchange Offer by the Partnership in accordance with
Section 2.08(f), the requirements of this Section 2.08(b)(2) shall be deemed to have been satisfied upon receipt by the Registrar of the instructions contained in the Letter of Transmittal
delivered by the Holder of such beneficial interests in the Restricted Global Notes. Upon satisfaction of all of the requirements for transfer or exchange of beneficial interests in Global Notes contained in this Indenture and the Notes or otherwise
applicable under the Securities Act, the Trustee shall adjust the principal amount of the relevant Global Note(s) pursuant to Section 2.08(h). 

(3) Transfer of Beneficial Interests to Another Restricted Global Note. A beneficial interest in any Restricted Global Note may be
transferred to a Person who takes delivery thereof in the form of a beneficial interest in another Restricted Global Note if the transfer complies with the requirements of Section 2.08(b)(2) and the Registrar receives the
following: 
 (i) if the transferee will take delivery in the form of a beneficial interest in the Rule 144A Global Note,
then the transferor must deliver a certificate in the form of Exhibit B, including the certifications in item (1) thereof; 

(ii) if the transferee will take delivery in the form of a beneficial interest in the Regulation S Temporary Global Note or
the Regulation S Permanent Global Note, then the transferor must deliver a certificate in the form of Exhibit B, including the certifications in item (2) thereof; and 

(iii) if the transferee will take delivery in the form of a beneficial interest in the IAI Global Note, then the transferor
must deliver a certificate in the form of Exhibit B hereto, including the certifications, certificates and Opinion of Counsel required by item (3) thereof, if applicable. 

(4) Transfer and Exchange of Beneficial Interests in a Restricted Global Note for Beneficial Interests in an Unrestricted Global Note.
A beneficial interest in any Restricted Global Note may be exchanged by any Holder thereof for a beneficial interest in an Unrestricted Global Note or transferred to a Person who takes delivery thereof in the form of a beneficial interest in an
Unrestricted Global Note if the exchange or transfer complies with the requirements of Section 2.08(b)(2) and: 

(i) such exchange or transfer is effected pursuant to an Exchange Offer in accordance with the Registration Rights Agreement
and the Holder of the beneficial interest to be transferred, in the case of an exchange, or the transferee, in the case of a transfer, certifies in the applicable Letter of Transmittal that it is not (A) a Broker-Dealer, (B) a Person
participating in the distribution of the Exchange Notes or (C) a Person who is an affiliate (as defined in Rule 144) of the Partnership; 

(ii) such transfer is effected pursuant to the Shelf Registration Statement in accordance with the Registration Rights
Agreement; 
 (iii) such transfer is effected by a Broker-Dealer pursuant to an Exchange Offer Registration Statement in
accordance with the Registration Rights Agreement; or 

  
 33 

 (iv) the Registrar receives the following: 

(A) if the Holder of such beneficial interest in a Restricted Global Note proposes to exchange such beneficial interest for a
beneficial interest in an Unrestricted Global Note, a certificate from such Holder in the form of Exhibit C, including the certifications in item (1)(a) thereof; or 

(B) if the Holder of such beneficial interest in a Restricted Global Note proposes to transfer such beneficial interest to a
Person who shall take delivery thereof in the form of a beneficial interest in an Unrestricted Global Note, a certificate from such Holder in the form of Exhibit B, including the certifications in item (4) thereof; and, in each such case
set forth in this subparagraph (iv), if the Registrar so requests or if the Applicable Procedures so require, an Opinion of Counsel in form reasonably acceptable to the Registrar and the Partnership to the effect that such exchange or transfer is in
compliance with the Securities Act and that the restrictions on transfer contained herein and in the Private Placement Legend are no longer required in order to maintain compliance with the Securities Act. 

If any such transfer is effected pursuant to subparagraph (ii) or (iv) above at a time when an Unrestricted Global Note has not yet been
issued, the Partnership shall issue and, upon receipt of an Authentication Order in accordance with Section 2.04, the Trustee shall authenticate one or more Unrestricted Global Notes in an aggregate principal amount equal
to the aggregate principal amount of beneficial interests transferred pursuant to subparagraph (ii) or (iv) above. 
 Beneficial
interests in an Unrestricted Global Note cannot be exchanged for, or transferred to Persons who take delivery thereof in the form of, a beneficial interest in a Restricted Global Note. 

(c) Transfer or Exchange of Beneficial Interests for Definitive Notes. 

(1) Beneficial Interests in Restricted Global Notes to Restricted Definitive Notes. If any Holder of a beneficial interest in a
Restricted Global Note proposes to exchange such beneficial interest for a Restricted Definitive Note or to transfer such beneficial interest to a Person who takes delivery thereof in the form of a Restricted Definitive Note, then, upon receipt by
the Registrar of the following documentation: 
 (i) if the Holder of such beneficial interest in a Restricted Global Note
proposes to exchange such beneficial interest for a Restricted Definitive Note, a certificate from such Holder in the form of Exhibit C, including the certifications in item (2)(a) thereof; 

(ii) if such beneficial interest is being transferred to a QIB in accordance with Rule 144A, a certificate to the effect set
forth in Exhibit B, including the certifications in item (1) thereof; 
 (iii) if such beneficial interest is
being transferred to a Non-U.S. Person in an offshore transaction in accordance with Rule 903 or Rule 904, a certificate to the effect set forth in Exhibit B, including the certifications in item
(2) thereof; 

  
 34 

 (iv) if such beneficial interest is being transferred pursuant to an exemption
from the registration requirements of the Securities Act in accordance with Rule 144, a certificate to the effect set forth in Exhibit B, including the certifications in item (3)(a) thereof; 

(v) if such beneficial interest is being transferred to an Institutional Accredited Investor in reliance on an exemption from
the registration requirements of the Securities Act other than those listed in subparagraphs (ii) through (iv) above, a certificate to the effect set forth in Exhibit B hereto, including the certifications, certificates and Opinion of
Counsel required by item (3)(d) thereof, if applicable; 
 (vi) if such beneficial interest is being transferred to the
Partnership or any of its Subsidiaries, a certificate to the effect set forth in Exhibit B, including the certifications in item (3)(b) thereof; or 

(vii) if such beneficial interest is being transferred pursuant to an effective registration statement under the Securities
Act, a certificate to the effect set forth in Exhibit B, including the certifications in item (3)(c) thereof, 
 the Trustee shall cause the
aggregate principal amount of the applicable Global Note to be reduced accordingly pursuant to Section 2.08(h), and the Partnership shall execute and the Trustee shall authenticate and deliver to the Person designated in
the instructions a Definitive Note in the appropriate principal amount. Any Definitive Note issued in exchange for a beneficial interest in a Restricted Global Note pursuant to this Section 2.08(c) shall be registered in
such name or names and in such authorized denomination or denominations as the Holder of such beneficial interest shall instruct the Registrar through instructions from the Depositary and the Participant or Indirect Participant. The Trustee shall
deliver such Definitive Notes to the Persons in whose names such Notes are so registered. Any Definitive Note issued in exchange for a beneficial interest in a Restricted Global Note pursuant to this Section 2.08(c)(1)
shall bear the Private Placement Legend and shall be subject to all restrictions on transfer contained therein. 
 (2) Beneficial
Interests in Regulation S Temporary Global Note to Definitive Notes. Notwithstanding Sections 2.08(c)(1)(i) and (iii), a beneficial interest in the Regulation S Temporary Global Note may not be exchanged for a Definitive Note or
transferred to a Person who takes delivery thereof in the form of a Definitive Note prior to (A) the expiration of the Restricted Period and (B) the receipt by the Registrar of any certificates required pursuant to Rule 903(b)(3)(ii)(B)
under the Securities Act, except in the case of a transfer pursuant to an exemption from the registration requirements of the Securities Act other than Rule 903 or Rule 904. 

(3) Beneficial Interests in Restricted Global Notes to Unrestricted Definitive Notes. A Holder of a beneficial interest in a Restricted
Global Note may exchange such beneficial interest for an Unrestricted Definitive Note or may transfer such beneficial interest to a Person who takes delivery thereof in the form of an Unrestricted Definitive Note only if: 

  
 35 

 (i) such exchange or transfer is effected pursuant to an Exchange Offer in
accordance with the Registration Rights Agreement and the Holder of such beneficial interest, in the case of an exchange, or the transferee, in the case of a transfer, certifies in the applicable Letter of Transmittal that it is not (A) a
Broker-Dealer, (B) a Person participating in the distribution of the Exchange Notes or (C) a Person who is an affiliate (as defined in Rule 144) of the Partnership; 

(ii) such transfer is effected pursuant to the Shelf Registration Statement in accordance with the Registration Rights
Agreement; 
 (iii) such transfer is effected by a Broker-Dealer pursuant to an Exchange Offer Registration Statement in
accordance with the Registration Rights Agreement; or 
 (iv) the Registrar receives the following: 

(A) if the Holder of such beneficial interest in a Restricted Global Note proposes to exchange such beneficial interest for an
Unrestricted Definitive Note, a certificate from such Holder in the form of Exhibit C, including the certifications in item (1)(b) thereof; or 

(B) if the Holder of such beneficial interest in a Restricted Global Note proposes to transfer such beneficial interest to a
Person who shall take delivery thereof in the form of an Unrestricted Definitive Note, a certificate from such Holder in the form of Exhibit B, including the certifications in item (4) thereof; 

and, in each such case set forth in this subparagraph (iv), if the Registrar so requests or if the Applicable Procedures so require, an Opinion of Counsel in
form reasonably acceptable to the Registrar and the Partnership to the effect that such exchange or transfer is in compliance with the Securities Act and that the restrictions on transfer contained herein and in the Private Placement Legend are no
longer required in order to maintain compliance with the Securities Act. 
 (4) Beneficial Interests in Unrestricted Global Notes to
Unrestricted Definitive Notes. If any Holder of a beneficial interest in an Unrestricted Global Note proposes to exchange such beneficial interest for a Definitive Note or to transfer such beneficial interest to a Person who takes delivery
thereof in the form of a Definitive Note, then, upon satisfaction of the conditions set forth in Section 2.08(b)(2), the Trustee will cause the aggregate principal amount of the applicable Global Note to be reduced
accordingly pursuant to Section 2.08(h), and the Partnership will execute and the Trustee will authenticate and deliver to the Person designated in the instructions a Definitive Note in the appropriate principal amount. Any
Definitive Note issued in exchange for a beneficial interest pursuant to this Section 2.08(c)(4) will be registered in such name or names and in such authorized denomination or denominations as the Holder of such beneficial
interest requests through instructions to the Registrar from or through the Depositary and the Participant or Indirect Participant. The Trustee will deliver such Definitive Notes to the Persons in whose names such Notes are so registered. Any
Definitive Note issued in exchange for a beneficial interest pursuant to this Section 2.08(c)(4) will not bear the Private Placement Legend. 

  
 36 

 (d) Transfer and Exchange of Definitive Notes for Beneficial Interests. 

(1) Restricted Definitive Notes to Beneficial Interests in Restricted Global Notes. If any Holder of a Restricted Definitive Note
proposes to exchange such Note for a beneficial interest in a Restricted Global Note or to transfer such Restricted Definitive Notes to a Person who takes delivery thereof in the form of a beneficial interest in a Restricted Global Note, then, upon
receipt by the Registrar of the following documentation: 
 (i) if the Holder of such Restricted Definitive Note proposes to
exchange such Note for a beneficial interest in a Restricted Global Note, a certificate from such Holder in the form of Exhibit C, including the certifications in item (2)(b) thereof; 

(ii) if such Restricted Definitive Note is being transferred to a QIB in accordance with Rule 144A, a certificate to the
effect set forth in Exhibit B, including the certifications in item (1) thereof; 
 (iii) if such Restricted
Definitive Note is being transferred to a Non-U.S. Person in an offshore transaction in accordance with Rule 903 or Rule 904, a certificate to the effect set forth in Exhibit B, including the
certifications in item (2) thereof; 
 (iv) if such Restricted Definitive Note is being transferred pursuant to an
exemption from the registration requirements of the Securities Act in accordance with Rule 144, a certificate to the effect set forth in Exhibit B , including the certifications in item (3)(a) thereof; 

(v) if such Restricted Definitive Note is being transferred to an Institutional Accredited Investor in reliance on an
exemption from the registration requirements of the Securities Act other than those listed in subparagraphs (ii) through (iv) above, a certificate to the effect set forth in Exhibit B hereto, including the certifications, certificates
and Opinion of Counsel required by item (3) thereof, if applicable; 
 (vi) if such Restricted Definitive Note is being
transferred to the Partnership or any of its Subsidiaries, a certificate to the effect set forth in Exhibit B hereto, including the certifications in item (3)(b) thereof; or 

(vii) if such Restricted Definitive Note is being transferred pursuant to an effective registration statement under the
Securities Act, a certificate to the effect set forth in Exhibit B, including the certifications in item (3)(c) thereof, 
 the Trustee will cancel
the Restricted Definitive Note, increase or cause to be increased the aggregate principal amount of, in the case of clause (i) above, the appropriate Restricted Global Note, in the case of clause (ii) above, the Rule 144A Global Note, in
the case of clause (iii) above, the Regulation S Global Note, in the case of clause (iv) above, the IAI Global Note and in all other cases, the appropriate Unrestricted Global Note. 

  
 37 

 (2) Restricted Definitive Notes to Beneficial Interests in Unrestricted Global Notes. A
Holder of a Restricted Definitive Note may exchange such Note for a beneficial interest in an Unrestricted Global Note or transfer such Restricted Definitive Note to a Person who takes delivery thereof in the form of a beneficial interest in an
Unrestricted Global Note only if: 
 (i) such exchange or transfer is effected pursuant to an Exchange Offer in accordance
with the applicable Registration Rights Agreement and the Holder, in the case of an exchange, or the transferee, in the case of a transfer, certifies in the applicable Letter of Transmittal that it is not (A) a Broker-Dealer, (B) a Person
participating in the distribution of the Exchange Notes or (C a Person who is an affiliate (as defined in Rule 144) of the Partnership; 

(ii) such transfer is effected pursuant to the Shelf Registration Statement in accordance with the applicable Registration
Rights Agreement; 
 (iii) such transfer is effected by a Broker-Dealer pursuant to an Exchange Offer Registration Statement
in accordance with the applicable Registration Rights Agreement; or 
 (iv) the Registrar receives the following: 

(1) if the Holder of such Definitive Notes proposes to exchange such Notes for a beneficial interest in the Unrestricted
Global Note, a certificate from such Holder in the form of Exhibit C, including the certifications in item (1)(c) thereof; or 

(2) if the Holder of such Definitive Notes proposes to transfer such Notes to a Person who shall take delivery thereof in the
form of a beneficial interest in the Unrestricted Global Note, a certificate from such Holder in the form of Exhibit B, including the certifications in item (4) thereof; 

and, in each such case set forth in this subparagraph (iv), if the Registrar so requests or if the Applicable Procedures so require, an Opinion of Counsel in
form reasonably acceptable to the Registrar and the Partnership to the effect that such exchange or transfer is in compliance with the Securities Act and that the restrictions on transfer contained herein and in the Private Placement Legend are no
longer required in order to maintain compliance with the Securities Act. 
 Upon satisfaction of the conditions of any of the subparagraphs
in this Section 2.08(d)(2), the Trustee will cancel the Definitive Notes and increase or cause to be increased the aggregate principal amount of the Unrestricted Global Note. 

  
 38 

 (3) Unrestricted Definitive Notes to Beneficial Interests in Unrestricted Global Notes. A
Holder of an Unrestricted Definitive Note may exchange such Note for a beneficial interest in an Unrestricted Global Note or transfer such Definitive Notes to a Person who takes delivery thereof in the form of a beneficial interest in an
Unrestricted Global Note at any time. Upon receipt of a request for such an exchange or transfer, the Trustee will cancel the applicable Unrestricted Definitive Note and increase or cause to be increased the aggregate principal amount of one of the
Unrestricted Global Notes. 
 If any such exchange or transfer from a Definitive Note to a beneficial interest is effected pursuant to
subparagraphs (2)(ii), (2)(iv) or (3) above at a time when an Unrestricted Global Note has not yet been issued, the Partnership will issue and, upon receipt of an Authentication Order in accordance with Section 2.04,
the Trustee will authenticate one or more Unrestricted Global Notes in an aggregate principal amount equal to the principal amount of Definitive Notes so transferred. 

(e) Transfer and Exchange of Definitive Notes for Definitive Notes. Upon request by a Holder of Definitive Notes and such Holder’s
compliance with the provisions of this Section 2.08(e), the Registrar will register the transfer or exchange of Definitive Notes. Prior to such registration of transfer or exchange, the requesting Holder must present or
surrender to the Registrar the Definitive Notes duly endorsed or accompanied by a written instruction of transfer in form satisfactory to the Registrar duly executed by such Holder or by its attorney, duly authorized in writing. In addition, the
requesting Holder must provide any additional certifications, documents and information, as applicable, required pursuant to the following provisions of this Section 2.08(e). 

(1) Restricted Definitive Notes to Restricted Definitive Notes. Any Restricted Definitive Note may be transferred to and registered in
the name of Persons who take delivery thereof in the form of a Restricted Definitive Note if the Registrar receives the following: 

(i) if the transfer will be made pursuant to Rule 144A, then the transferor must deliver a certificate in the form of
Exhibit B, including the certifications in item (1) thereof; 
 (ii) if the transfer will be made pursuant to
Rule 903 or Rule 904, then the transferor must deliver a certificate in the form of Exhibit B, including the certifications in item (2) thereof; and 

(iii) if the transfer will be made pursuant to any other exemption from the registration requirements of the Securities Act,
then the transferor must deliver a certificate in the form of Exhibit B, including the certifications, certificates and Opinion of Counsel required by item (3) thereof, if applicable. 

(2) Restricted Definitive Notes to Unrestricted Definitive Notes. Any Restricted Definitive Note may be exchanged by the Holder thereof
for an Unrestricted Definitive Note or transferred to a Person or Persons who take delivery thereof in the form of an Unrestricted Definitive Note if: 

(i) such exchange or transfer is effected pursuant to an Exchange Offer in accordance with the Registration Rights Agreement
and the Holder, in the case of an exchange, or the transferee, in the case of a transfer, certifies in the applicable Letter of Transmittal that it is not (A) a Broker-Dealer, (B) a Person participating in the distribution of the Exchange
Notes or (C) a Person who is an affiliate (as defined in Rule 144) of the Partnership; 

  
 39 

 (ii) any such transfer is effected pursuant to the Shelf Registration Statement
in accordance with the applicable Registration Rights Agreement; 
 (iii) any such transfer is effected by a Broker-Dealer
pursuant to an Exchange Offer Registration Statement in accordance with the applicable Registration Rights Agreement; or 

(iv) the Registrar receives the following: 

(A) if the Holder of such Restricted Definitive Notes proposes to exchange such Notes for an Unrestricted Definitive Note, a
certificate from such Holder in the form of Exhibit C, including the certifications in item (1)(d) thereof; or 
 (B)
if the Holder of such Restricted Definitive Notes proposes to transfer such Notes to a Person who shall take delivery thereof in the form of an Unrestricted Definitive Note, a certificate from such Holder in the form of Exhibit B, including
the certifications in item (4) thereof; 
 and, in each such case set forth in this subparagraph (iv), if the Registrar so requests, an Opinion of
Counsel in form reasonably acceptable to the Registrar to the effect that such exchange or transfer is in compliance with the Securities Act and that the restrictions on transfer contained herein and in the Private Placement Legend are no longer
required in order to maintain compliance with the Securities Act. 
 (3) Unrestricted Definitive Notes to Unrestricted Definitive
Notes. A Holder of Unrestricted Definitive Notes may transfer such Notes to a Person who takes delivery thereof in the form of an Unrestricted Definitive Note. Upon receipt of a request to register such a transfer, the Registrar shall register
the Unrestricted Definitive Notes pursuant to the instructions from the Holder thereof. 
 (f) Exchange Offer. Upon the occurrence of
an Exchange Offer in accordance with the applicable Registration Rights Agreement, the Partnership will issue and, upon receipt of an Authentication Order in accordance with Section 2.04, the Trustee will authenticate: 

(1) one or more Unrestricted Global Notes in an aggregate principal amount equal to the principal amount of the beneficial interests in the
Restricted Global Notes accepted for exchange in an Exchange Offer by Persons that certify in the applicable Letters of Transmittal that (A) they are not Broker-Dealers, (B) they are not participating in a distribution of the Exchange
Notes and (C) they are not affiliates (as defined in Rule 144) of the Partnership; and 

  
 40 

 (2) Unrestricted Definitive Notes in an aggregate principal amount equal to the principal amount
of the Restricted Definitive Notes accepted for exchange in an Exchange Offer by Persons that certify in the applicable Letters of Transmittal that (A) they are not Broker-Dealers, (B) they are not participating in a distribution of the
Exchange Notes and (C) they are not affiliates (as defined in Rule 144) of the Partnership. 
 Concurrently with the issuance of such
Notes, the Trustee will cause the aggregate principal amount of the applicable Restricted Global Notes to be reduced accordingly, and the Partnership will execute and the Trustee will authenticate and deliver to the Persons designated by the Holders
of Definitive Notes so accepted Unrestricted Definitive Notes in the appropriate principal amount. 
 (g) Legends. The following legends will
appear on the face of all Global Notes and Definitive Notes issued under this Indenture unless specifically stated otherwise in the applicable provisions of this Indenture or any Supplemental Indenture. 

(1) Private Placement Legend. 

(i) Except as permitted by subparagraph (ii) below, each Global Note and each Definitive Note (and all Notes issued in
exchange therefor or substitution thereof) shall bear the legend in substantially the following form: 
 THIS NOTE HAS NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS. NEITHER THIS NOTE NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE
DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, REGISTRATION. THE HOLDER OF THIS NOTE, BY ITS ACCEPTANCE HEREOF (1) REPRESENTS THAT (A) IT IS A “QUALIFIED INSTITUTIONAL
BUYER” (AS DEFINED IN RULE 144A PROMULGATED UNDER THE SECURITIES ACT), (B) IT IS A NON-U.S. PERSON AND IS ACQUIRING THIS NOTE IN AN OFFSHORE TRANSACTION WITHIN THE MEANING OF REGULATION S PROMULGATED
UNDER THE SECURITIES ACT AND IN ACCORDANCE WITH THE LAWS APPLICABLE TO IT IN THE JURISDICTION IN WHICH SUCH PURCHASE IS MADE, OR (C) IT IS AN “ACCREDITED INVESTOR” WITHIN THE MEANING OF REGULATION D PROMULGATED UNDER THE SECURITIES
ACT AND (2) AGREES TO OFFER, SELL OR OTHERWISE TRANSFER SUCH NOTE, PRIOR TO THE DATE THAT IS [IN THE CASE OF RULE 144A NOTES: ONE YEAR AFTER THE LATER OF THE ORIGINAL ISSUE DATE HEREOF, THE ORIGINAL ISSUE DATE OF THE ISSUANCE OF ANY ADDITIONAL
NOTES AND THE LAST DATE ON WHICH THE PARTNERSHIP OR ANY AFFILIATE OF THE PARTNERSHIP WAS THE OWNER OF THIS NOTE (OR ANY PREDECESSOR OF SUCH NOTE),] [IN THE CASE OF REGULATION S NOTES: 40 DAYS AFTER THE LATER OF THE ORIGINAL ISSUE DATE HEREOF, THE
ORIGINAL ISSUE DATE OF THE ISSUANCE OF ANY ADDITIONAL NOTES AND THE DATE ON WHICH THIS 

  
 41 

 
NOTE (OR ANY PREDECESSOR OF SUCH NOTE) WAS FIRST OFFERED TO PERSONS OTHER THAN DISTRIBUTORS (AS DEFINED IN RULE 902 OF REGULATION S) IN RELIANCE ON REGULATION S] ONLY (A) TO THE ISSUER OR
ANY SUBSIDIARY THEREOF, (B) FOR SO LONG AS THE NOTES ARE ELIGIBLE FOR RESALE PURSUANT TO RULE 144A, TO A PERSON IT REASONABLY BELIEVES IS A “QUALIFIED INSTITUTIONAL BUYER” (AS DEFINED IN RULE 144A PROMULGATED UNDER THE SECURITIES ACT)
THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHICH NOTICE IS GIVEN THAT THE TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, (C) PURSUANT TO OFFERS AND SALES TO
NON-U.S. PERSONS THAT OCCUR OUTSIDE THE UNITED STATES WITHIN THE MEANING OF REGULATION S AND IN ACCORDANCE WITH THE LAWS APPLICABLE TO IT IN THE JURISDICTION IN WHICH SUCH PURCHASE IS MADE, (D) TO AN
“ACCREDITED INVESTOR” WITHIN THE MEANING OF REGULATION D THAT IS ACQUIRING THE NOTE FOR ITS OWN ACCOUNT, OR FOR THE ACCOUNT OF SUCH AN ACCREDITED INVESTOR, FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TO, OR FOR OFFER OR SALE IN CONNECTION
WITH, ANY DISTRIBUTION IN VIOLATION OF THE SECURITIES ACT, (E) PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BEEN DECLARED EFFECTIVE UNDER THE SECURITIES ACT OR (F) PURSUANT TO ANOTHER AVAILABLE EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT, SUBJECT TO THE ISSUER’S AND THE TRUSTEE’S, OR REGISTRAR’S, AS APPLICABLE, RIGHT PRIOR TO ANY SUCH OFFER, SALE OR TRANSFER PURSUANT TO CLAUSE (C), (D) OR (F) TO REQUIRE THE DELIVERY OF A
CERTIFICATE OF TRANSFER IN THE FORM APPEARING ON THE OTHER SIDE OF THIS NOTE IS COMPLETED AND DELIVERED BY THE TRANSFEROR TO THE TRUSTEE OR REGISTRAR. THIS LEGEND WILL BE REMOVED UPON THE REQUEST OF THE HOLDER AFTER THE EXPIRATION OF THE APPLICABLE
HOLDING PERIOD WITH RESPECT TO RESTRICTED SECURITIES SET FORTH IN RULE 144. 
 (ii) Notwithstanding the foregoing, any
Global Note or Definitive Note issued pursuant to subparagraphs (b)(4), (c)(3), (c)(4), (d)(2), (d)(3), (e)(2), (e)(3) or (f) of this Section 2.08 (and all Notes
issued in exchange therefor or substitution thereof) will not bear the Private Placement Legend. 
 (2) Global Note Legend. Each
Global Note will bear a legend in substantially the following form: 
 “THIS GLOBAL NOTE IS HELD BY THE DEPOSITARY (AS DEFINED IN THE
INDENTURE GOVERNING THIS NOTE) OR ITS NOMINEE IN CUSTODY FOR THE BENEFIT OF THE BENEFICIAL OWNERS HEREOF, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY CIRCUMSTANCES EXCEPT THAT (1) THE INDENTURE TRUSTEE MAY MAKE SUCH NOTATIONS HEREON AS MAY
BE REQUIRED PURSUANT TO SECTION 2.08 OF THE INDENTURE, (2) THIS GLOBAL NOTE MAY BE EXCHANGED IN WHOLE BUT NOT IN PART 

  
 42 

 
PURSUANT TO SECTION 2.08(a) OF THE INDENTURE, (3) THIS GLOBAL NOTE MAY BE DELIVERED TO THE INDENTURE TRUSTEE FOR CANCELLATION PURSUANT TO SECTION 2.13 OF THE INDENTURE AND
(4) THIS GLOBAL NOTE MAY BE TRANSFERRED TO A SUCCESSOR DEPOSITARY WITH THE PRIOR WRITTEN CONSENT OF THE PARTNERSHIP. 
 UNLESS AND UNTIL
IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE
DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (55 WATER STREET, NEW YORK,
NEW YORK) (“DTC”), TO THE PARTNERSHIP OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS MAY BE REQUESTED BY AN
AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR SUCH OTHER ENTITY AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.” 
 (3) Regulation S Temporary Global
Note Legend. The Regulation S Temporary Global Note will bear a legend in substantially the following form: 
 “THE RIGHTS ATTACHING
TO THIS REGULATION S TEMPORARY GLOBAL NOTE, AND THE CONDITIONS AND PROCEDURES GOVERNING ITS EXCHANGE FOR CERTIFICATED SECURITIES, ARE AS SPECIFIED IN THE INDENTURE (AS DEFINED HEREIN). NEITHER THE HOLDER NOR THE BENEFICIAL OWNERS OF THIS REGULATION
S TEMPORARY GLOBAL NOTE SHALL BE ENTITLED TO RECEIVE PAYMENT OF INTEREST HEREON.” 
 (h) Cancellation and/or Adjustment of Global
Notes. At such time as all beneficial interests in a particular Global Note have been exchanged for Definitive Notes or a particular Global Note has been redeemed, repurchased or canceled in whole and not in part, each such Global Note will be
returned to or retained and canceled by the Trustee in accordance with Section 2.13. At any time prior to such cancellation, if any beneficial interest in a Global Note is exchanged for or transferred to a Person who will
take delivery thereof in the form of a beneficial interest in another Global Note or for Definitive Notes, the principal amount of Notes represented by such Global Note will be reduced accordingly and an endorsement will be made on such Global Note
by the Trustee or by the Depositary at the direction of the Trustee to reflect such reduction; and if the beneficial interest is being exchanged for or transferred to a Person who will take delivery thereof in the form of a beneficial interest in
another Global Note, such other Global Note will be increased accordingly and an endorsement will be made on such Global Note by the Trustee or by the Depositary at the direction of the Trustee to reflect such increase. 

  
 43 

 (i) General Provisions Relating to Transfers and Exchanges. 

(1) To permit registrations of transfers and exchanges, the Partnership will execute and the Trustee will authenticate Global Notes and
Definitive Notes upon receipt of an Authentication Order in accordance with Section 2.04 or at the Registrar’s request. 

(2) No service charge will be made to a Holder of a beneficial interest in a Global Note or to a Holder of a Definitive Note for any
registration of transfer or exchange, but the Partnership may require payment of a sum sufficient to cover any transfer tax or similar governmental charge payable in connection therewith (other than any such transfer taxes or similar governmental
charge payable upon exchange or transfer pursuant to Section 2.12, Section 3.08, Section 4.08, Section 4.09 and
Section 9.05). 
 (3) The Registrar will not be required to register the transfer of or exchange of any Note
selected for redemption in whole or in part, except the unredeemed portion of any Note being redeemed in part. 
 (4) All Global Notes and
Definitive Notes issued upon any registration of transfer or exchange of Global Notes or Definitive Notes will be the valid obligations of the Partnership, evidencing the same debt, and entitled to the same benefits under this Indenture, as the
Global Notes or Definitive Notes surrendered upon such registration of transfer or exchange. 
 (5) Neither the Registrar nor the
Partnership will be required: 
 (i) to issue, to register the transfer of or to exchange any Note during a period beginning
at the opening of business 15 days before the day of any selection of Notes for redemption under Section 3.04 and ending at the close of business on the day of selection; 

(ii) to register the transfer of or to exchange any Note selected for redemption in whole or in part, except the unredeemed
portion of any Note being redeemed in part; or 
 (iii) to register the transfer of or to exchange a Note between a record
date and the next succeeding Interest Payment Date. 
 (6) Prior to due presentment for the registration of a transfer of any Note, the
Trustee, any Agent and the Partnership may deem and treat the Person in whose name any Note is registered as the absolute owner of such Note for the purpose of receiving payment of principal of and interest on such Notes and for all other purposes,
and none of the Trustee, any Agent or the Partnership shall be affected by notice to the contrary. 
 (7) The Trustee will authenticate
Global Notes and Definitive Notes in accordance with the provisions of Section 2.04. 

  
 44 

 (8) All certifications, certificates and Opinions of Counsel required to be submitted to the
Registrar pursuant to this Section 2.08 to effect a registration of transfer or exchange may be submitted by facsimile. 

(9) None of the Trustee or any Agent shall have any responsibility or obligation to any beneficial owner in a Global Note, any Participant or
agent member of the Depositary or other Person with respect to the accuracy of the records of the Depositary or its nominee or of any Participant or agent member of the Depositary, with respect to any ownership interest in the Note or with respect
to the delivery to any Participant or agent member of the Depositary, beneficial owner or other Person (other than the Depositary) of any notice (including any notice of redemption) or the payment of any amount, under or with respect to such Notes.
All notices and communications to be given to the Holders and all payments to be made to Holders under the Notes and this Indenture shall be given or made only to or upon the order of the registered holders (which shall be the Depositary or its
nominee in the case of the Global Note). The rights of beneficial owners in the Global Note shall be exercised only through the Depositary subject to the applicable procedures. The Trustee and each Agent shall be entitled to rely and shall be fully
protected in relying upon information furnished by the Depositary with respect to its members, participants and any beneficial owners. The Trustee and each Agent shall be entitled to deal with the Depositary, and any nominee thereof, that is the
registered holder of any Global Note for all purposes of this Indenture relating to such Global Note (including the payment of principal and interest and Additional Interest, if any, and the giving of instructions or directions by or to the owner or
holder of a beneficial ownership interest in such Global Note) as the sole holder of such Global Note and shall have no obligations to the beneficial owners thereof. None of the Trustee or any Agent shall have any responsibility or liability for any
acts or omissions of the Depositary with respect to such Global Note, for the records of any such depositary, including records in respect of beneficial ownership interests in respect of any such Global Note, for any transactions between the
Depositary and any Participant or agent member of the Depositary or between or among the Depositary, any such Participant or agent member of the Depositary and/or any holder or owner of a beneficial interest in such Global Note, or for any transfers
of beneficial interests in any such Global Note. 
 (10) Notwithstanding the foregoing, with respect to any Global Note, nothing herein
shall prevent the Partnership, the Trustee, any Agent, or any agent of the Partnership or the Trustee from giving effect to any written certification, proxy or other authorization furnished by any Depositary (or its nominee), as a Holder, with
respect to such Global Note or shall impair, as between such Depositary and owners of beneficial interests in such Global Note, the operation of customary practices governing the exercise of the rights of such Depositary (or its nominee) as Holder
of such Global Note. 
 (11) None of the Trustee or any Agent shall have any obligation or duty to monitor, determine or inquire as to
compliance with any restrictions on transfer imposed under this Indenture or under applicable law with respect to any transfer of any interest in any security (including any transfers between or among Depositary Participants, members or beneficial
owners in any Global Note) other than to require delivery of such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by, the terms of this Indenture, and to examine the same to
determine substantial compliance as to form with the express requirements hereof. 

  
 45 

 Section 2.09 Replacement Notes. If any mutilated Note is surrendered to the Trustee,
or if the Holder of a Note claims that the Note has been destroyed, lost or stolen and the Partnership and the Trustee receive evidence to their satisfaction of the destruction, loss or theft of such Note, the Partnership shall issue, and the
Subsidiary Guarantors shall execute and the Trustee shall authenticate a replacement Note of the same series if the Trustee’s requirements are met. If any such mutilated, destroyed, lost or stolen Note has become or is about to become due and
payable, the Partnership in its discretion may, instead of issuing a new Note, pay such Note. If required by the Trustee, any Subsidiary Guarantor or the Partnership, such Holder must furnish an indemnity bond that is sufficient in the judgment of
the Trustee and the Partnership to protect the Partnership, each Subsidiary Guarantor, the Trustee, any Agent or any authenticating agent from any loss that any of them may suffer if a Note is replaced. The Partnership and the Trustee may charge a
Holder for their expenses in replacing a Note. Every replacement Note is an additional obligation of the Partnership. 
 Section 2.10
Outstanding Notes. The Notes outstanding at any time are all the Notes authenticated by the Trustee except for those canceled by it, those delivered to it for cancellation, those reductions in the interest in a Global Note effected by the
Trustee hereunder and those described in this Section 2.10 as not outstanding. If a Note is replaced pursuant to Section 2.09, it ceases to be outstanding unless the Trustee receives proof
satisfactory to it that the replaced Note is held by a bona fide purchaser. If the principal amount of any Note is considered paid under Section 4.01, it ceases to be outstanding and interest on it ceases to accrue. A Note
does not cease to be outstanding because the Partnership, a Subsidiary Guarantor or an Affiliate of the Partnership or a Subsidiary Guarantor holds the Note. 

Section 2.11 Original Issue Discount, Foreign-Currency Denominated and Treasury Notes. In determining whether the Holders of the
required principal amount of Notes have concurred in any direction, amendment, supplement, waiver or consent, (a) the principal amount of an Original Issue Discount Note shall be the principal amount thereof that would be due and payable as of
the date of such determination upon acceleration of the Maturity thereof pursuant to Section 6.02, (b) the principal amount of a Note denominated in a foreign currency shall be the Dollar equivalent, as determined by
the Partnership by reference to the noon buying rate in The City of New York for cable transfers for such currency, as such rate is certified for customs purposes by the Federal Reserve Bank of New York (the “Exchange Rate”) on the
date of original issuance of such Note, of the principal amount (or, in the case of an Original Issue Discount Note, the Dollar equivalent, as determined by the Partnership by reference to the Exchange Rate on the date of original issuance of such
Note, of the amount determined as provided in (a) above), of such Note and (c) Notes owned by the Partnership, a Subsidiary Guarantor or any other obligor upon the Notes or any Affiliate of the Partnership, of a Subsidiary Guarantor or of
such other obligor shall be disregarded, except that, for the purpose of determining whether the Trustee shall be protected in relying upon any such direction, amendment, supplement, waiver or consent, only Notes that a Responsible Officer of the
Trustee actually knows are so owned shall be so disregarded. 
 Section 2.12 Temporary Notes. Until definitive Notes of any
series are ready for delivery, the Partnership may prepare, and the Subsidiary Guarantors shall execute and the Trustee shall authenticate temporary Notes. Temporary Notes shall be substantially in the form of definitive Notes, but may have
variations that the Partnership considers appropriate for 

  
 46 

 
temporary Notes. Without unreasonable delay, the Partnership shall prepare, and the Subsidiary Guarantors shall execute and the Trustee shall authenticate definitive Notes in exchange for
temporary Notes. Until so exchanged, the temporary Notes shall in all respects be entitled to the same benefits under this Indenture as definitive Notes. 

Section 2.13 Cancellation. The Partnership or any Subsidiary Guarantor at any time may deliver Notes to the Trustee for
cancellation. The Registrar and the Paying Agent shall forward to the Trustee any Notes surrendered to them for registration of transfer, exchange, payment or redemption or for credit against any sinking fund payment. The Trustee shall cancel all
Notes surrendered for registration of transfer, exchange, payment, redemption, replacement or cancellation or for credit against any sinking fund. Unless the Partnership shall direct in writing that canceled Notes be returned to it, after written
notice to the Partnership all canceled Notes held by the Trustee shall be disposed of in accordance with the usual disposal procedures of the Trustee, and the Trustee shall maintain a record of their disposal. The Partnership may not issue new Notes
to replace Notes that have been paid or that have been delivered to the Trustee for cancellation. 
 Section 2.14 Payments;
Defaulted Interest. Unless otherwise provided as contemplated by Section 2.01, interest (except defaulted interest) on any Note that is payable, and is punctually paid or duly provided for, on any Interest Payment Date
shall be paid to the Persons who are registered Holders of that Note at the close of business on the record date next preceding such Interest Payment Date, even if such Notes are canceled after such record date and on or before such Interest Payment
Date. The Holder must surrender a Note to a Paying Agent to collect principal payments. Unless otherwise provided with respect to the Notes of any series, the Partnership will pay the principal of, interest on and any Additional Amounts with respect
to the Notes in Dollars. Such amounts shall be payable at the offices of the Trustee or any Paying Agent, provided that at the option of the Partnership, the Partnership may pay such amounts (a) by wire transfer with respect to Global Notes or
(b) by check payable in such money mailed to a Holder’s registered address with respect to any Notes. 
 If the Partnership
defaults in a payment of interest on the Notes of any series, the Partnership shall pay the defaulted interest in any lawful manner plus, to the extent lawful, interest on the defaulted interest, in each case at the rate provided in the Notes of
such series and in Section 4.01. The Partnership may pay the defaulted interest to the Persons who are Holders on a subsequent special record date. At least 15 days before any special record date selected by the
Partnership, the Partnership (or the Trustee, in the name of and at the expense of the Partnership upon 20 days’ prior written notice from the Partnership setting forth such special record date and the interest amount to be paid) shall
mail to Holders a notice that states the special record date, the related payment date and the amount of such interest to be paid. 

Section 2.15 Persons Deemed Owners. The Partnership, the Subsidiary Guarantors, the Trustee, any Agent and any authenticating
agent may treat the Person in whose name any Note is registered as the owner of such Note for the purpose of receiving payments of principal of or interest on or any Additional Amounts with respect to such Note and for all other purposes. None of
the Partnership, any Subsidiary Guarantor, the Trustee, any Agent or any authenticating agent shall be affected by any notice to the contrary. 

  
 47 

 Section 2.16 Computation of Interest. Except as otherwise specified as contemplated
by Section 2.01 for Notes of any series, interest on the Notes of each series shall be computed on the basis of a year comprising twelve 30-day months. 

ARTICLE III. 
 REDEMPTION

 Section 3.01 Redemption. The Notes may be redeemed, in whole at any time or in part from time to time, subject to the
conditions and at the redemption prices set forth in Paragraph 5 of the forms of Notes set forth in Exhibit A-1 and Exhibit A-2 to the Supplemental
Indenture, which is hereby incorporated by reference and made a part of this Indenture, together with accrued and unpaid interest to the redemption date. 

Section 3.02 Applicability of Article. Notes of any series that are redeemable before their Stated Maturity shall be redeemable in
accordance with their terms and (except as otherwise specified as contemplated by Section 2.01 for Notes of any series) in accordance with this Article III. 

Section 3.03 Notice to the Trustee. If the Partnership elects to redeem Notes of any series pursuant to this Indenture, it shall
notify the Trustee of the Redemption Date and the principal amount of Notes of such series to be redeemed. The Partnership shall so notify the Trustee at least 45 days before the Redemption Date (unless a shorter notice shall be satisfactory to
the Trustee) by delivering to the Trustee an Officer’s Certificate stating that such redemption will comply with the provisions of this Indenture and of the Notes of such series. Any such notice may be canceled at any time prior to the mailing
of such notice of such redemption to any Holder and shall thereupon be void and of no effect. 
 Section 3.04 Selection of Notes to
be Redeemed. If less than all the Notes of any series are to be redeemed (unless all of the Notes of such series of a specified tenor are to be redeemed), the particular Notes to be redeemed shall be selected not more than 60 days nor less than
30 days prior to the Redemption Date by the Trustee from the outstanding Notes of such series (and tenor) not previously called for redemption, either pro rata, by lot or by such other method as the Trustee shall deem fair and appropriate unless
otherwise required by law or by applicable stock exchange requirements and that may provide for the selection for redemption of portions (equal to the minimum authorized denomination for Notes of that series or any integral multiple thereof) of the
principal amount of Notes of such series of a denomination larger than the minimum authorized denomination for Notes of that series or of the principal amount of Global Notes of such series. 

The Trustee shall promptly notify the Partnership and the Registrar in writing of the Notes selected for redemption and, in the case of any
Notes selected for partial redemption, the principal amount thereof to be redeemed. 
 For purposes of this Indenture, unless the context
otherwise requires, all provisions relating to redemption of Notes shall relate, in the case of any of the Notes redeemed or to be redeemed only in part, to the portion of the principal amount thereof which has been or is to be redeemed. 

  
 48 

 Section 3.05 Notice of Redemption. Notice of redemption shall be given by first-class
mail, postage prepaid, mailed not less than 30 nor more than 60 days prior to the Redemption Date, to each Holder of Notes to be redeemed, at the address of such Holder appearing in the register of Notes maintained by the Registrar. All notices
of redemption shall identify the Notes to be redeemed and shall state: 
 (a) the Redemption Date; 

(b) the Redemption Price; 
 (c)
that, unless the Partnership and the Subsidiary Guarantors default in making the redemption payment, interest on Notes called for redemption ceases to accrue on and after the Redemption Date, and the only remaining right of the Holders of such Notes
is to receive payment of the Redemption Price upon surrender to the Paying Agent of the Notes redeemed; 
 (d) if any Note is to be redeemed
in part, the portion of the principal amount thereof to be redeemed and that on and after the Redemption Date, upon surrender for cancellation of such Note to the Paying Agent, a new Note or Notes in the aggregate principal amount equal to the
unredeemed portion thereof will be issued without charge to the Holder; 
 (e) that Notes called for redemption must be surrendered to the
Paying Agent to collect the Redemption Price and the name and address of the Paying Agent; 
 (f) that the redemption is for a sinking or
analogous fund, if such is the case; and 
 (g) the CUSIP number, if any, relating to such Notes. 

Notice of redemption of Notes to be redeemed at the election of the Partnership shall be given by the Partnership or, at the
Partnership’s written request, by the Trustee in the name and at the expense of the Partnership. 
 Section 3.06 Effect of
Notice of Redemption. Once notice of redemption is mailed, Notes called for redemption become due and payable on the Redemption Date and at the Redemption Price. Upon surrender to the Paying Agent, such Notes called for redemption shall be paid
at the Redemption Price, but interest installments whose maturity is on or prior to such Redemption Date will be payable on the relevant Interest Payment Dates to the Holders of record at the close of business on the relevant record dates specified
pursuant to Section 2.01. 
 Section 3.07 Deposit of Redemption Price. On or prior to 11:00 a.m.,
New York City time, on any Redemption Date, the Partnership or a Subsidiary Guarantor shall deposit with the Trustee or the Paying Agent (or, if the Partnership or such Subsidiary Guarantor is acting as the Paying Agent, segregate and hold in trust
as provided in Section 2.06) an amount of money in same day funds sufficient to pay the Redemption Price of, and (except if the Redemption Date shall be an Interest Payment Date) accrued interest on and any Additional
Amounts with respect to, the Notes or portions thereof which are to be redeemed on that date, other than Notes or portions thereof called for redemption on that date which have been delivered by the Partnership or a Subsidiary Guarantor to the
Trustee for cancellation. 

  
 49 

 If the Partnership or a Subsidiary Guarantor complies with the preceding paragraph, then, unless
the Partnership and the Subsidiary Guarantors default in the payment of such Redemption Price, interest on the Notes to be redeemed will cease to accrue on and after the applicable Redemption Date, whether or not such Notes are presented for
payment, and the Holders of such Notes shall have no further rights with respect to such Notes except for the right to receive the Redemption Price upon surrender of such Notes. If any Note called for redemption shall not be so paid upon surrender
thereof for redemption, the principal, any Additional Amounts, and, to the extent lawful, accrued interest thereon shall, until paid, bear interest from the Redemption Date at the rate specified pursuant to Section 2.01 or
provided in the Notes or, in the case of Original Issue Discount Notes, such Notes’ yield to maturity. 
 Section 3.08 Notes
Redeemed or Purchased in Part. Upon surrender to the Paying Agent of a Note to be redeemed in part, the Partnership and the Subsidiary Guarantors shall execute and the Trustee shall authenticate and deliver to the Holder of such Note without
service charge a new Note or Notes, of the same series and of any authorized denomination as requested by such Holder in aggregate principal amount equal to, and in exchange for, the unredeemed portion of the principal of the Note so surrendered
that is not redeemed. 
 Section 3.09 Purchase of Notes. Unless otherwise specified as contemplated by
Section 2.01, the Partnership, any Subsidiary Guarantor and any Affiliate of the Partnership or any Subsidiary Guarantor may, subject to applicable law, at any time purchase or otherwise acquire Notes in the open market or
by private agreement. Any such acquisition shall not operate as or be deemed for any purpose to be a redemption of the indebtedness represented by such Notes. Any Notes purchased or acquired by the Partnership or a Subsidiary Guarantor may be
delivered to the Trustee and, upon such delivery, the indebtedness represented thereby shall be deemed to be satisfied. Section 2.13 shall apply to all Notes so delivered. 

ARTICLE IV. 
 COVENANTS

 Section 4.01 Payment of Notes. The Partnership shall pay the principal of, interest on and any Additional Amounts with
respect to the Notes of each series on the dates and in the manner provided in the Notes of such series and in this Indenture. Principal, interest and any Additional Amounts shall be considered paid on the date due if the Paying Agent (other than
the Partnership, a Subsidiary Guarantor or a Subsidiary) holds on that date money deposited by the Partnership or a Subsidiary Guarantor designated for and sufficient to pay all principal, interest and any Additional Amounts then due. 

The Partnership shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal at a
rate equal to the then applicable interest rate on the Notes to the extent lawful; and it shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest and any Additional Amount
(without regard to any applicable grace period) at the same rate to the extent lawful. 

  
 50 

 Section 4.02 Maintenance of Office or Agency. The Partnership will maintain in each
Place of Payment for any series of Notes an office or agency (which may be an office of the Trustee, the Registrar or the Paying Agent) where Notes of that series may be presented for registration of transfer or exchange, where Notes of that series
may be presented for payment and where notices and demands to or upon the Partnership or a Subsidiary Guarantor in respect of the Notes of that series and this Indenture may be served. Unless otherwise designated by the Partnership by written notice
to the Trustee and the Subsidiary Guarantors, such office or agency shall be the office of the Trustee in The City of New York, which on the date hereof is located at 100 Wall Street, Suite 1600, New York, NY 10005. The Partnership will give prompt
written notice to the Trustee and the Subsidiary Guarantors of the location, and any change in the location, of such office or agency. If at any time the Partnership shall fail to maintain any such required office or agency or shall fail to furnish
the Trustee and the Subsidiary Guarantors with the address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee. 

The Partnership may also from time to time designate one or more other offices or agencies where the Notes of one or more series may be
presented or surrendered for any or all such purposes and may from time to time rescind such designations; provided that no such designation or rescission shall in any manner relieve the Partnership of its obligation to maintain an office or
agency in each Place of Payment for Notes of any series for such purposes. The Partnership will give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any such other office or agency.

 Section 4.03 SEC Reports; Financial Statements. 

(a) Regardless of whether required by the rules and regulations of the SEC, so long as any Notes are outstanding, the Partnership will file
with the SEC for public availability, within 15 days of the time periods specified in the SEC’s rules and regulations: 
 (1) all
quarterly and annual reports that would be required to be filed with the SEC on Forms 10-Q and 10-K if the Partnership were required to file such reports; and 

(2) all current reports that would be required to be filed with the SEC on Form 8-K if the Partnership
were required to file such reports. 
 (b) All such reports will be prepared in all material respects in accordance with all of the rules and
regulations applicable to such reports. Each annual report on Form 10-K will include a report on the Partnership’s consolidated financial statements by the Partnership’s certified independent
accountants. 
 (c) If, at any time, the Partnership is no longer subject to the periodic reporting requirements of the Exchange Act for any
reason, the Partnership will nevertheless continue filing the reports specified in subparagraphs (a)(1) and (a)(2) of this Section 4.03 with the SEC within the time periods specified above unless the SEC will not accept
such a filing. The Partnership will not take any action for the purpose of causing the SEC not to accept any such filings. If, notwithstanding the foregoing, the SEC will not accept the Partnership’s filings for any reason, the Partnership will
post the reports referred to in the preceding paragraphs on its website on a password-protected basis for availability solely for Holders within the time periods that would apply if the Partnership were required to file those reports with the SEC.

  
 51 

 (d) Delivery of such reports, information and documents to the Trustee is for informational
purposes only and the Trustee’s receipt of such reports shall not constitute actual or constructive notice of any information contained therein or determinable from information contained therein, including the Partnership’s or any other
Person’s compliance with any of its covenants under this Indenture or the Notes (as to which the Trustee is entitled to rely exclusively on Officer’s Certificates). 

(e) The Trustee shall not be obligated to monitor or confirm, on a continuing basis or otherwise, the Partnership’s or any other
Person’s compliance with the covenants described above or with respect to any reports or other documents filed under this Indenture; provided, however, that nothing herein shall relieve the Trustee of any obligations to monitor the
Partnership’s timely delivery of all reports and certificates described in this Indenture. 
 Section 4.04 Compliance
Certificate. 
 (a) Each of the Partnership and the Subsidiary Guarantors shall deliver to the Trustee, within 120 days after the
end of each fiscal year, a statement signed by an Officer of the Partnership (or, in the case the Partnership is a limited partnership, the General Partner, acting on behalf of the Partnership), which need not constitute an Officer’s
Certificate, complying with TIA Section 314(a)(4) and stating that in the course of performance by the signing Officer of his duties as such Officer of the Partnership (or, in the case the Partnership is a limited partnership, the General
Partner, acting on behalf of the Partnership), he would normally obtain knowledge of the keeping, observing, performing and fulfilling by the Partnership or such Subsidiary Guarantor, as the case may be, of its obligations under this Indenture, and
further stating that to the best of his knowledge the Partnership or such Subsidiary Guarantor, as the case may be, has kept, observed, performed and fulfilled each and every covenant contained in this Indenture and is not in default in the
performance or observance of any of the terms, provisions and conditions hereof (or, if a Default or Event of Default shall have occurred, describing all such Defaults or Events of Default of which such Officer may have knowledge and what action the
Partnership or such Subsidiary Guarantor, as the case may be, is taking or proposes to take with respect thereto). 
 (b) The Partnership or
any Subsidiary Guarantor shall, so long as Notes of any series are outstanding, deliver to the Trustee, as soon as possible and in any event within 30 days upon any Officer of the Partnership (or, in the case the Partnership is a limited
partnership, the General Partner, acting on behalf of the Partnership) becoming aware of any Default or Event of Default under this Indenture, an Officer’s Certificate specifying such Default or Event of Default and what action the Partnership
or such Subsidiary Guarantor, as the case may be, is taking or proposes to take with respect thereto. 
 Section 4.05 Existence.
Subject to Article V, each of the Partnership and the Subsidiary Guarantors shall do or cause to be done all things necessary to preserve and keep in full force and effect its existence. 

  
 52 

 Section 4.06 Waiver of Stay, Extension or Usury Laws. Each of the Partnership and the
Subsidiary Guarantors covenants (to the extent that it may lawfully do so) that it will not at any time insist upon, or plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay or extension law or any usury law or other
law that would prohibit or forgive it from paying all or any portion of the principal of or interest on the Notes as contemplated herein, wherever enacted, now or at any time hereafter in force, or which may affect the covenants or the performance
of this Indenture; and (to the extent that it may lawfully do so) each of the Partnership and the Subsidiary Guarantors hereby expressly waives all benefit or advantage of any such law, and covenants that it will not hinder, delay or impede the
execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted. 

Section 4.07 Additional Amounts. If the Notes of a series expressly provide for the payment of Additional Amounts, the Partnership
will pay to the Holder of any Note of such series Additional Amounts as expressly provided therein. Whenever in this Indenture there is mentioned, in any context, the payment of the principal of or interest on, or in respect of, any Note of any
series or the net proceeds received from the sale or exchange of any Note of any series, such mention shall be deemed to include mention of the payment of Additional Amounts provided for in this Section 4.07 to the extent
that, in such context, Additional Amounts are, were or would be payable in respect thereof pursuant to the provisions of this Section 4.07 and express mention of the payment of Additional Amounts (if applicable) in any
provisions hereof shall not be construed as excluding Additional Amounts in those provisions hereof where such express mention is not made. 

The Supplemental Indenture governing the Notes of such series shall include whether and under what circumstances, and the terms and conditions
on which, the Partnership will pay Additional Amounts and whether the Partnership will have the option to redeem such series of Notes rather than pay such Additional Amounts or to redeem such Notes in the event of the imposition of any
certification, documentation, information or other reporting requirement and, if so, under what circumstances and the terms and conditions on which the Partnership may exercise such option. 

Section 4.08 Change of Control. 

(a) If a Change of Control Triggering Event occurs, each Holder of Notes shall have the right to require the Partnership to repurchase all or
any part (equal to $1,000 or an integral multiple of $1,000) of that Holder’s Notes pursuant to an offer (a “Change of Control Offer”) on the terms set forth in this Indenture. In the Change of Control Offer, the Partnership
will offer a payment in cash (a “Change of Control Payment”) equal to 101 % of the aggregate principal amount of Notes repurchased plus accrued and unpaid interest on the Notes repurchased to, but excluding, the date of
purchase (the “Change of Control Payment Date”), subject to the rights of Holders of Notes on the relevant record date to receive interest, if any, due on the relevant interest payment date. Within 30 days following any Change of
Control Triggering Event, the Partnership shall mail a notice to each Holder describing the transaction or transactions that constitute the Change of Control Triggering Event and offering to repurchase Notes on the Change of Control Payment Date
specified in such notice, which date shall be no earlier than 30 days and no later than 60 days from the date such notice is mailed, pursuant to the 

  
 53 

 
procedures described in this Section 4.08. The Partnership shall comply with the requirements of Rule 14e-1 under the Exchange
Act and any other securities laws and regulations thereunder to the extent such laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions
of any securities laws or regulations conflict with the Change of Control Triggering Event provisions of this Indenture, the Partnership shall comply with the applicable securities laws and regulations and will not be deemed to have breached its
obligations under the Change of Control Triggering Event provisions of this Indenture by virtue of such compliance. 
 (b) On the Change of
Control Payment Date, the Partnership shall, to the extent lawful: 
 (1) accept for payment all Notes or portions thereof properly tendered
pursuant to the Change of Control Offer; 
 (2) deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of
all Notes or portions thereof properly tendered; and 
 (3) deliver or cause to be delivered to the Trustee the Notes properly accepted
together with an Officer’s Certificate stating the aggregate principal amount of Notes or portions thereof being purchased by the Partnership. 

(c) The Paying Agent shall promptly mail to each Holder of Notes properly tendered the Change of Control Payment for such Notes (or, if all the
Notes are then in global form, make such payment through the facilities of the Depositary), and the Trustee shall promptly authenticate and mail (or cause to be transferred by book entry) to each Holder a new Note equal in principal amount to any
unpurchased portion of the Notes surrendered, if any; provided that each such new Note shall be in a principal amount of $1,000 or an integral multiple of $1,000 in excess thereof. Any note so accepted for payment will cease to accrue interest on
and after the Change of Control Payment Date unless the Partnership defaults in making the Change of Control Payment. 
 (d) The Partnership
shall publicly announce the results of the Change of Control Offer on or as soon as practicable after the Change of Control Payment Date. 

(e) If Holders of not less than 90% in aggregate principal amount of the outstanding notes tender and do not withdraw such notes in a Change of
Control Offer and the Partnership, or any third party making a Change of Control Offer in lieu of the Partnership, purchases all of the Notes validly tendered and not withdrawn by such Holders, the Partnership or such third party will have the
right, upon not less than 30 nor more than 60 days’ prior notice, given not more than 30 days following such purchase pursuant to the Change of Control Offer, to redeem all notes that remain outstanding following such purchase at a price in
cash equal to 101% of the principal amount thereof plus accrued and unpaid interest to, but not including, the date of redemption. 

  
 54 

 (f) Notwithstanding anything to the contrary in this Section 4.08, the
Partnership shall not be required to make a Change of Control Offer upon a Change of Control Triggering Event if (i) a third party makes the Change of Control Offer in the manner, at the times and otherwise in compliance with the requirements
set forth in this Section 4.08 and all other provisions of this Indenture applicable to a Change of Control Offer made by the Partnership and purchases all Notes properly tendered and not withdrawn under such Change of
Control Offer, or (ii) notice of redemption has been given pursuant to Section 3.05 of this Indenture and all provisions of any Supplemental Indenture applicable to a redemption of Notes pursuant to
Section 3.01 of this Indenture, unless and until there is a default in payment of the Change of Control Payment. 

(g) A Change of Control Offer may be made in advance of a Change of Control, and conditioned upon the occurrence of such Change of Control, if
a definitive agreement is in place for a Change of Control at the time of making the Change of Control Offer. Notes repurchased by the Partnership pursuant to a Change of Control Offer will have the status of Notes issued but not outstanding or will
be retired and canceled, at the Partnership’s option. Notes purchased by a third party pursuant to clause (f) of this Section 4.08 will have the status of Notes issued and outstanding. 

(h) Upon the commencement of the Change of Control Offer, the Partnership shall send, by first class mail, a notice to the Trustee and each of
the Holders. The notice shall contain all instructions and materials necessary to enable such Holders to tender Notes pursuant to the Change of Control Offer. The Change of Control Offer shall be made to all Holders. The notice, which shall govern
the terms of the Change of Control Offer, shall state: 
 (1) that the Change of Control Offer is being made pursuant to this
Section 4.08, and the length of time the Change of Control Offer shall remain open; 
 (2) the Change of Control
Payment and the Change of Control Payment Date; 
 (3) that any Note not tendered or accepted for payment shall continue to accrue interest;

 (4) that, unless there is a default in making such payment on the Change of Control Payment Date, any Holder whose Notes (or any portion
thereof) are tendered and accepted for payment pursuant to the Change of Control Offer shall not be entitled to receive any interest accruing on and after the Change of Control Payment Date on such Notes or any portion thereof so tendered and
accepted; 
 (5) that Holders electing to have a Note purchased pursuant to the Change of Control Offer may elect to have Notes purchased
equal to $1,000 or an integral multiple of $1,000 only; 
 (6) that Holders electing to have a Note purchased pursuant to the Change of
Control Offer shall be required to surrender the Note, with the form entitled “Option of Holder to Elect Purchase” or transfer by book entry transfer, to the Partnership, the Depositary, if appointed by the Partnership, or a Paying Agent
at the address specified in the notice at least three days before the Change of Control Payment Date; 

  
 55 

 (7) that Holders shall be entitled to withdraw their election if the Partnership, the Depositary
or the Paying Agent, as the case may be, receives, not later than the expiration of the offer period, a telegram, telex, facsimile transmission or letter setting forth the name of the Holder, the principal amount of the Note the Holder delivered for
purchase and a statement that such Holder is withdrawing his election to have such Note purchased; and 
 (8) that Holders whose Notes were
purchased only in part shall be issued new Notes equal in principal amount to the unpurchased portion of the Notes surrendered (or transferred by book entry transfer). 

On the Change of Control Payment Date, the Partnership shall, to the extent lawful, accept for payment all Notes tendered and shall deliver to
the Trustee an Officer’s Certificate stating that such Notes (or portions thereof) were accepted for payment by the Partnership in accordance with the terms of this Section 4.08. The Partnership, the Depositary or the
Paying Agent, as the case may be, shall promptly (but in any case not later than three days after the Change of Control Payment Date) mail or deliver to each tendering Holder an amount equal to the Change of Control Payment of Notes tendered by such
Holder, as the case may be, and accepted by the Partnership for purchase, and the Partnership shall promptly issue a new Note to such Holders whose Note was purchased only in part. The Trustee, upon written request from the Partnership shall
authenticate and mail or deliver such new Note to such Holder, in a principal amount equal to any unpurchased portion of the Note surrendered. Any Note not so accepted for payment pursuant to the Change of Control Offer shall be promptly mailed or
delivered by the Partnership to the respective Holder thereof. 
 Section 4.09 Asset Sales. 

(a) Within 365 days after the receipt of any Net Proceeds by the Partnership or any Subsidiary Guarantor from an Asset Sale Triggering Event
(or within 180 days after such 365 day period in the event the Partnership or any of its Subsidiaries enters into a binding commitment with respect to such application), the Partnership or any of its Subsidiaries, as the case may be, may apply an
amount equal to such Net Proceeds at its option to: 
 (1) reduce (i) First Lien Obligations under the Credit Agreement or
(ii) First Lien Obligations of the Partnership or of a Subsidiary Guarantor; 
 (2) permanently repay or reduce other Indebtedness that
ranks pari passu in right of payment with the Notes (“Pari Passu Debt”); provided, that if the Partnership shall so reduce any such Pari Passu Debt, the Partnership shall equally and ratably reduce Obligations under
the Notes as provided either, at the Partnership’s option, in Paragraph 5 of the forms of Notes set forth in Exhibit A-1 and Exhibit A-2 to the
Supplemental Indenture, through open-market purchases (to the extent such purchases are at or above 100% of the principal amount thereof) or by making an offer (in accordance with the procedures set forth below for an offer to purchase) to all
Holders of Notes to purchase some or all of their Notes at a purchase price equal to 100% of the principal amount thereof, plus the amount of accrued but unpaid interest, if any, on the amount of Notes that would otherwise be paid; 

  
 56 

 (3) acquire all or substantially all of the assets of, or acquire capital stock of, another
business that, in the case of an acquisition of capital stock, is or becomes a Subsidiary of the Partnership; 
 (4) make capital
expenditures; 
 (5) pay costs and expenses of designing, engineering, permitting and developing capital projects and improvements or other
related costs and expenses; 
 (6) acquire other assets that are not classified as current assets under GAAP; 

(7) repay Indebtedness of a Subsidiary that is not a Guarantor (and, if the Indebtedness repaid is revolving credit Indebtedness, to
correspondingly and permanently reduce commitments with respect thereto), other than Indebtedness owed to the Partnership or another Subsidiary; or 

(8) any combination of the foregoing. 

(b) Any Net Proceeds from an Asset Sale Triggering Event that are not applied or invested as provided in the
Section 4.09(a) and that are held by or distributed to the Partnership or a Subsidiary Guarantor will constitute “Excess Proceeds.” If, as of the first day of any calendar month after the period referred to
above, the aggregate amount of Excess Proceeds exceeds $150 million, the Partnership must commence, not later than the 30th day of such month, and consummate an offer to purchase, from the Holders, the maximum principal amount of Notes that may
be purchased out of the Excess Proceeds (pro rata with any other senior indebtedness of the Partnership or any Subsidiary Guarantors that shall have a similar offer to purchase or redemption requirement). The offer price in any such offer to
purchase will be equal to 100% of the principal amount (or accreted value, if applicable) of the Notes plus accrued and unpaid interest, if any (the “Asset Sale Payment”), to but excluding the date of purchase (the “Asset
Sale Payment Date”), subject to the rights of Holders on the relevant record date to receive interest on the relevant interest payment date, and will be payable in cash. To the extent that any Excess Proceeds remain after consummation of an
offer to purchase pursuant to this Section 4.09, the Partnership or any of its Subsidiaries may use those Excess Proceeds for any purpose not otherwise prohibited by this Indenture. If the aggregate principal amount of the
Notes (and other senior indebtedness) tendered into such offer to purchase exceeds the amount of Excess Proceeds, the Trustee will select the Notes to be purchased on a pro rata basis. Upon completion of each offer to purchase the amount of Excess
Proceeds will be reset at zero. 
 (c) The Partnership will comply with the requirements of Rule
14e-1 under the Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the purchase of the Notes pursuant to an offer
to purchase. To the extent that the provisions of any securities laws or regulations conflict with the Asset Sale provisions of this Indenture, the Partnership will comply with the applicable securities laws and regulations and will not be deemed to
have breached its obligations under the Asset Sale provisions of this Indenture by virtue of such compliance. 

  
 57 

 (d) On the Asset Sale Payment Date, the Partnership will, to the extent lawful: 

(1) accept for payment all Notes or portions of Notes properly tendered pursuant to the offer to purchase; 

(2) deposit with the paying agent an amount equal to the Asset Sale Payment in respect of all Notes or portions of Notes properly tendered;
and 
 (3) deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officer’s Certificate stating
the aggregate principal amount of Notes or portions of Notes being purchased by the Partnership. 
 Section 4.10 Limitation on
Liens. 
 (a) The Partnership shall not, nor shall it permit any Subsidiary Guarantor to, create, assume or incur any Lien (other than
any Permitted Lien) upon any Principal Property, whether owned on the date hereof or thereafter acquired, to secure any Indebtedness of the Partnership or a Subsidiary Guarantor if, (x) after giving pro forma effect to such creation, assumption
or incurrence and the application of the proceeds thereof, the outstanding principal amount of all such Indebtedness (other than the Notes and any other series of notes issued under this Indenture) secured by a Lien on any Principal Property,
together with all Attributable Indebtedness from Sale-Leaseback Transactions (excluding Sale-Leaseback Transactions permitted by Section 4.11(a)(1) through (3), inclusive, hereof), is at any time in excess of, the
greater of $1.5 billion and 10% of Net Tangible Assets, or (y) the outstanding principal amount of Indebtedness under the Term Loans exceeds $1.0 billion, unless, contemporaneously with the creation, assumption or incurrence of such
Lien, effective provisions are made whereby all of the outstanding Notes are secured equally and ratably with, or prior to, such Indebtedness so long as such Indebtedness is so secured (except that Liens securing Subordinated Indebtedness shall be
expressly subordinate to any Lien securing the Notes to at least the same extent such Subordinated Indebtedness is subordinate to the Notes or a Guarantee, as the case may be). 

Section 4.11 Restriction on Sale-Leasebacks. 

(a) The Partnership shall not, and shall not permit any Subsidiary Guarantor to, engage in the sale or transfer by the Partnership or any
Subsidiary Guarantor of any Principal Property to a Person (other than the Partnership or a Subsidiary Guarantor) and the taking back by the Partnership or such Subsidiary Guarantor, as the case may be, of a lease of such Principal Property (a
“Sale-Leaseback Transaction”), unless: 
 (1) such Sale-Leaseback Transaction occurs within one year from the date of
completion of the acquisition of the Principal Property subject thereto or the date of the completion of construction, development or substantial repair or improvement, or commencement of full operations on such Principal Property, whichever is
later; 
 (2) the Sale-Leaseback Transaction involves a lease for a period, including renewals, of not more than three years; or 

(3) the Partnership or such Subsidiary Guarantor, within a one-year period after such Sale-Leaseback
Transaction, applies or causes to be applied an amount not less than the Attributable Indebtedness from such Sale-Leaseback Transaction to (a) the prepayment, repayment, redemption, reduction or retirement of any Indebtedness of the Partnership
or any Subsidiary Guarantor that is not Subordinated Indebtedness, or (b) the purchase of Principal Property used or to be used in the ordinary course of business of Partnership or the Subsidiaries. 

  
 58 

 (b) Notwithstanding the foregoing, the Partnership may, and may permit any Subsidiary Guarantor
to, effect any Sale-Leaseback Transaction that is not permitted by Section 4.11(a)(1) through (3), inclusive, provided that the Attributable Indebtedness from such Sale-Leaseback Transaction, together with the
aggregate amount of outstanding Indebtedness secured by Liens upon Principal Properties (other than Permitted Liens), does not exceed the greater of (x) $1.5 billion and (y) 10.0% of Net Tangible Assets. 

Section 4.12 Limitation on Transactions with Affiliates. 

(a) The Partnership will not, and will not cause or permit any Subsidiary to, directly or indirectly, enter into any transaction that is
otherwise permitted hereunder with or for the benefit of an Affiliate (including guarantees and assumptions of obligation of an Affiliate) (each an “Affiliate Transaction”) involving aggregate payments or consideration with respect
to a single transaction or a series of related transactions, in excess of $50 million, unless: 
 (1) the Affiliate Transaction is on
terms that are no less favorable to the Partnership or the relevant Subsidiary than those that would have been obtained in a comparable arm’s-length transaction with independent parties, or, if there is
no comparable arm’s length transaction, then on terms that are reasonably determined by a majority of independent members of the Board of Directors of the Partnership (or, in the case the Partnership is a limited partnership, the General
Partner, acting on behalf of the Partnership) (or if the Partnership has no independent directors, by a majority of the directors or managers, as applicable) to be fair and reasonable; and 

(2) with respect to any Affiliate Transaction or series of related Affiliate Transactions involving aggregate consideration in excess of
$100.0 million, the Partnership delivers to the Trustee a resolution of the Board of Directors of the Partnership (or, in the case the Partnership is a limited partnership, the General Partner, acting on behalf of the Partnership) set forth in
an Officer’s Certificate certifying that such Affiliate Transaction or series of related Affiliate Transactions complies with clause (1) of this Section 4.12(a) and that such Affiliate Transaction has been
approved by a majority of independent members of the Board of Directors of the Partnership (or, in the case the Partnership is a limited partnership, the General Partner, acting on behalf of the Partnership). 

(b) The following items will not be deemed to be Affiliate Transactions and, therefore, will not be subject to the provisions of
Section 4.12(a): 
 (1) any employment agreement, equity award, equity option or equity appreciation agreement or
plan or any similar arrangement entered into by the Partnership or any of its Subsidiaries in the ordinary course of business and payments pursuant thereto; 

(2) transactions between or among the Partnership and/or its Subsidiary Guarantors; 

  
 59 

 (3) transactions between or among non-guarantor
Subsidiaries; 
 (4) transactions with a Person that is an Affiliate of the Partnership solely because the Partnership owns, directly or
through a Subsidiary, an Equity Interest in, or controls, such Person; 
 (5) any issuance of Equity Interests (other than Disqualified
Equity) of the Partnership to Affiliates of the Partnership; 
 (6) customary compensation, indemnification and other benefits made
available to officers, directors or employees of the Partnership, a Subsidiary of the Partnership or the General Partner, including reimbursement or advancement of
out-of-pocket expenses and provisions of officers’ and directors’ liability insurance; 

(7) in the case of contracts for purchase, gathering, processing, sale, transportation and marketing of crude oil, natural gas, LNG,
condensate and natural gas liquids, hedging agreements, and production handling, operating, construction, terminalling, storage, lease, facilities sharing, or other operational contracts, any such contracts are entered into in the ordinary course of
business on terms substantially similar to those contained in similar contracts entered into by the Partnership or any of its Subsidiaries and third parties, or if neither the Partnership nor any of its Subsidiaries has entered into a similar
contract with a third party, that the terms are no less favorable than those available from third parties on an arm’s length basis, as determined by the Board of Directors of the General Partner, or in the case of processing, facilities
sharing, use or similar agreements, that the terms of such agreement provide for the recovery of at least the incremental operation and maintenance expenses associated with operations pursuant to such agreement; 

(8) transactions pursuant to agreements or arrangements in effect on the Issue Date, or any amendment, modification, or supplement thereto or
replacement thereof, as long as such agreement or arrangement, as so amended, modified, supplemented or replaced, taken as a whole, is not materially more disadvantageous to the Partnership and its Subsidiaries than the agreement or arrangement in
existence on the Issue Date; 
 (9) subordinated Indebtedness between or among the Partnership, any of its Subsidiaries and/or any of their
Affiliates; 
 (10) transactions or agreements required by applicable law; 

(11) transactions between Subsidiaries and Affiliates in connection with sales or purchases of products or services; provided that such
transactions comply with any other restrictions on transactions with Affiliates that are applicable to such Subsidiaries and have been approved by a governing body or committee of such Subsidiary; 

(12) transactions with customers, clients, suppliers or purchasers or sellers of goods or services, or lessors or lessees of property, in each
case in the ordinary course of business and otherwise in compliance with the terms of this Indenture which are, in the aggregate (taking into account all the costs and benefits associated with such transactions), not materially less favorable to the
Partnership and its Subsidiaries than those that would have been 

  
 60 

 
obtained in a comparable transaction by the Partnership or such Subsidiary with an unrelated person, in the good faith determination of the Board of Directors of the General Partner or any
officer of the Partnership involved in or otherwise familiar with such transaction, or are on terms at least as favorable as might reasonably have been obtained at such time from an unaffiliated party; 

(13) transactions permitted by, and complying with, the provisions of Article V; 

(14) any transaction with a Person in its capacity as a holder of Indebtedness or Capital Stock of the Partnership or any Subsidiary if such
Person is treated no more favorably than the other holders of Indebtedness or Capital Stock of the Partnership or such Subsidiary; and 

(15) any investment by the Partnership or a Subsidiary Guarantor in Sabine Pass Liquefaction, LLC or any Project Finance Subsidiary. 

ARTICLE V. 
 SUCCESSORS

 Section 5.01 Merger, Consolidation or Sale of Assets. 

(a) The Partnership may not: (A) consolidate or merge with or into another Person (regardless of whether the Partnership is the surviving
Person); or (B) directly or indirectly sell, lease, assign, transfer, convey or otherwise dispose of all or substantially all of its properties or assets, in one or more related transactions, to another Person, unless: 

(1) the Person formed by or resulting from any such consolidation or merger or to which such assets have been sold, leased, assigned,
transferred, conveyed or otherwise disposed of (the “Successor Company”) is the Partnership or expressly assumes by Supplemental Indenture all of the Partnership’s obligations and liabilities under this Indenture, the Notes and
any other Note Documents; 
 (2) the Successor Company is organized under the laws of the United States, any state or commonwealth within
the United States, or the District of Columbia; 
 (3) immediately after giving effect to the transaction, no Default or Event of Default
has occurred and is continuing; 
 (4) the Partnership has delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel,
each stating that such consolidation, merger , sale, lease, assignment, transfer, conveyance or other disposition complies with this Indenture and all conditions precedent provided for in this Indenture relating to such transaction have been
complied with; and 

  
 61 

 (5) if the transaction takes place during a Security Requirement Period, Collateral owned by or
transferred to the Successor Company shall: 
 (i) continue to constitute Collateral under this Indenture and the Collateral Documents; 

(ii) be subject to the Lien in favor of the Collateral Agent for the benefit of the Collateral Agent, the Trustee and the Holders of the
Notes; and 
 (iii) not be subject to any Lien other than Permitted Liens. 

(b) If the Partnership sells, assigns, transfers or otherwise disposes of all or substantially all of its assets, it shall be released from all
liabilities and obligations under this Indenture and under the Notes except that no such release will occur in the case of a lease of all or substantially all of its assets. 

(c) This Section 5.01 shall not apply to 

(1) a merger or consolidation of the Partnership with an Affiliate solely for the purpose of organizing the Partnership in another
jurisdiction within, or converting the Partnership into a corporation governed by the laws of, the United States, any state or commonwealth within the United States, or the District of Columbia; or 

(2) any merger or consolidation, or any sale, lease, assignment, transfer, conveyance or other disposition of assets between or among the
Partnership and the Subsidiary Guarantors. 
 (d) An event described in clause (a)(B) above shall be subject to the provisions of this
Section 5.01 and shall not constitute an Event of Default if the Partnership fails to comply with its obligations under Section 4.08. 

Section 5.02 Successor Person Substituted. Upon any merger or consolidation, or any sale, lease, assignment, transfer, conveyance
or other disposition of all or substantially all of the properties or assets of the Partnership and its Subsidiaries in accordance with Section 5.01, the Successor Company shall be substituted for the Partnership in this
Indenture with the same effect as if it had been an original party to this Indenture. Thereafter the Successor Company may exercise the rights and powers of the Partnership under this Indenture. 

Section 5.03 Subsidiary Guarantors. Subject to the limitations described in Section 10.04 governing
release of a Guarantee, no Subsidiary Guarantor will, and the Partnership will not permit any Subsidiary Guarantor to (x) consolidate or merge with or into another Person (regardless of whether such Subsidiary Guarantor is the surviving
Person); or (y) directly or indirectly sell, lease, assign, transfer, convey or otherwise dispose of all or substantially all of its properties or assets, in one or more related transactions, to another Person; unless 

(A): 
 (1) the Person formed by
or resulting from any such consolidation or merger or to which such assets have been sold, leased, assigned, transferred, conveyed or otherwise disposed of (the “Successor Person”) is the Subsidiary Guarantor or expressly assumes by
Supplemental Indenture all of the Subsidiary Guarantor’s obligations and liabilities under this Indenture, the Guarantees and any other Note Documents; 

  
 62 

 (2) the Successor Person is organized under the laws of the United States, any state or
commonwealth within the United States, or the District of Columbia; 
 (3) immediately after giving effect to the transaction no Default or
Event of Default has occurred and is continuing; 
 (4) the Partnership has delivered to the Trustee an Officer’s Certificate and an
Opinion of Counsel, each stating that such consolidation, merger or transfer complies with this Indenture; and 
 (5) if the transaction
takes place during a Security Requirement Period, Collateral owned by or transferred to the Successor Person shall: 
 (i) continue to
constitute Collateral under this Indenture and the Collateral Documents; 
 (ii) be subject to the Lien in favor of the Collateral Agent for
the benefit of the Collateral Agent, the Trustee and the Holders of the Notes; and 
 (iii) not be subject to any Lien other than Permitted
Liens; or 
 (B) the transaction is effected in compliance with Section 4.09. 

(b) The Successor Person will be substituted for the Subsidiary Guarantor in this Indenture with the same effect as if it had been an original
party to this Indenture. Thereafter, the Successor Person may exercise the rights and powers of the Subsidiary Guarantor under this Indenture. 

(c) If the Subsidiary Guarantor sells, assigns, transfers, conveys or otherwise disposes all or substantially all of its assets, it will be
released from all liabilities and obligations under this Indenture and under the guarantees except that no such release will occur in the case of a lease of all or substantially all of its assets. Notwithstanding the foregoing, this
Section 5.03 will not apply to: 
 (1) a merger or consolidation of a Subsidiary Guarantor with an Affiliate
solely for the purpose of organizing such Subsidiary Guarantor in another jurisdiction within the United States of America; or 
 (2) any
merger or consolidation, or any sale, lease, assignment, transfer, conveyance or other disposition of assets between or among the Partnership and the Subsidiary Guarantors. 

  
 63 

 ARTICLE VI. 

DEFAULTS AND REMEDIES 

Section 6.01 Events of Default. Unless either inapplicable to a particular series of Notes or specifically deleted or modified in
or pursuant to the Supplemental Indenture or Board Resolution establishing such series of Notes or in the form of Note for such series, each of the following events will be events of default under this Indenture (each, an “Event of
Default”): 
 (a) default for 30 days in the payment when due of interest on the Notes; 

(b) default in the payment of principal on the Notes when due and payable at their stated maturity, upon redemption, by declaration upon
required repurchase or otherwise; 
 (c) failure by the Partnership to comply with any of its agreements or covenants under Article V or in
respect of its obligations to make or consummate a purchase of Notes when required pursuant to the provisions in Paragraph 5 of the forms of Notes set forth in Exhibit A-1 and Exhibit A-2 to the Supplemental Indenture when required; 
 (d) failure by the Partnership to comply with the
provisions of this Indenture applicable to the Notes for 60 days after written notice of default given by the Trustee or the Holders of at least 33 1/3% in aggregate principal amount of the outstanding Notes; 

(e) default under any mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any
Indebtedness for money borrowed by the Partnership or any Subsidiary other than a Project Finance Subsidiary (or the payment of which is guaranteed by the Partnership or any of its Subsidiaries other than a Project Finance Subsidiary) whether such
Indebtedness or guarantee now exists, or is created after the Issue Date, if that default both (A) is caused by a failure to pay principal of or interest on such Indebtedness prior to the expiration of the grace period provided in such
Indebtedness on the date of such default (a “Payment Default”) and (B) results in the acceleration of such Indebtedness prior to its express maturity, and, in each case, the principal amount of any such Indebtedness, together
with the principal amount of any other such Indebtedness under which there has been a Payment Default or the maturity of which has been so accelerated, aggregates $150 million or more; 

(f) failure by the Partnership or any of its Subsidiaries other than a Project Finance Subsidiary to pay final and nonappealable judgments
aggregating in excess of $150 million or its foreign currency equivalent (net of any amounts which are covered by enforceable insurance policies issued by solvent carriers), which judgments are not discharged, waived or stayed for a period of
60 days and, in the event such judgment is covered by insurance, an enforcement proceeding has been commenced by any creditor upon such judgment or decree which is not promptly stayed; 

(g) the Partnership or any Significant Subsidiary of the Partnership (or any group of Subsidiaries of the Partnership that, taken together,
would constitute a Significant Subsidiary of the Partnership) pursuant to or within the meaning of Bankruptcy Law: 
 (1) commences a
voluntary case; 

  
 64 

 (2) consents to the entry of an order for relief against it in an involuntary case; 

(3) consents to the appointment of a Bankruptcy Custodian of it or for all or substantially all of its property; 

(4) makes a general assignment for the benefit of its creditors; or 

(5) generally is not paying its debts as they become due; 

(h) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: 

(1) is for relief against the Partnership or any Significant Subsidiary of the Partnership (or any group of Subsidiaries of the Partnership
that, taken together, would constitute a Significant Subsidiary of the Partnership) in an involuntary case; 
 (2) appoints a Bankruptcy
Custodian of the Partnership or any Significant Subsidiary of the Partnership (or any group of Subsidiaries of the Partnership that, taken together, would constitute a Significant Subsidiary of the Partnership) or for all or substantially all of the
property of the Partnership or any Significant Subsidiary of the Partnership (or any group of Subsidiaries of the Partnership that, taken together, would constitute a Significant Subsidiary of the Partnership); or 

(3) orders the liquidation of the Partnership or any Significant Subsidiary of the Partnership (or any group of Subsidiaries of the
Partnership that, taken together, would constitute a Significant Subsidiary of the Partnership); 
 and the order or decree remains unstayed and in effect
for 60 consecutive days; 
 (i) except as permitted by this Indenture, any Guarantee is held in any judicial proceeding to be unenforceable
or invalid or ceases for any reason to be in full force and effect, or any Subsidiary Guarantor, or any Person acting on behalf of any Subsidiary Guarantor, denies or disaffirms the obligations of such Subsidiary Guarantor under its Guarantee; and

 (j) during any Security Requirement Period, any security interest and Lien purported to be created by any Collateral Document with respect
to any Collateral, individually or in the aggregate, having a Fair Market Value in excess of $100 million (A) shall fail to be in full force and effect, or to give the Collateral Agent, for the benefit of the Holders of the Notes, the
Liens, rights, powers and privileges purported to be created and granted thereby (including a perfected first-priority security interest in and Lien on, all of the Collateral thereunder (except as otherwise expressly provided in this Indenture and
the Collateral Documents)) in favor of the Collateral Agent, and such failure shall continue for a period of 30 days after notice by the Trustee or by the Holders of at least 33 1/3% of the aggregate principal amount of the Notes then outstanding,
or (B) shall be asserted by the Partnership or any Subsidiary Guarantor to not be a valid, perfected, first-priority (except as otherwise expressly provided in this Indenture and the Collateral Documents) security interest in or Lien on the
Collateral covered thereby; except to the extent that any such loss of perfection or priority results from the failure of the Collateral Agent or the Trustee (or an agent or trustee on its behalf) to maintain possession of certificates actually
delivered to it (or such agent or trustee) representing securities pledged under the Collateral Documents. 

  
 65 

 The Trustee shall not be deemed to have notice or be charged with knowledge of any Default or
Event of Default unless written notice of any Default or Event of Default is received by a Responsible Officer of the Trustee at the Corporate Trust Office of the Trustee from the Partnership or any Holder, and such notice references the Notes and
this Indenture. 
 Section 6.02 Acceleration. 

(a) An Event of Default for a series of Notes will not necessarily constitute an Event of Default for any other series of Notes issued under
this Indenture. Further, an event of default under other Indebtedness of the Partnership or its Subsidiaries will not necessarily constitute a Default or an Event of Default for the Notes. 

(b) If an Event of Default (other than an Event of Default described in Section 6.01(g) or
Section 6.01(h) with respect to the Partnership) occurs and is continuing, the Trustee by notice in writing to the Partnership, or the Holders of at least 33 1/3% in principal amount of the outstanding Notes by notice in
writing to the Partnership and the Trustee, may, and the Trustee at the request of such Holders shall, declare the principal of and accrued and unpaid interest on all the Notes to be due and payable. Upon such a declaration, such principal and
accrued and unpaid interest shall be due and payable immediately. 
 (c) If an Event of Default described in
Section 6.01(g) or Section 6.01(h) with respect to the Partnership occurs, the principal of and accrued and unpaid interest on the Notes shall become and be immediately due and payable without any
declaration of acceleration, notice or other act on the part of the Trustee or any Holders of the Notes. 
 (d) Holders of a majority in
principal amount of the outstanding Notes may, by written notice to the Trustee, rescind any acceleration with respect to the Notes and annul its consequences if rescission would not conflict with any judgment or decree of a court of competent
jurisdiction and all existing Events of Default with respect to the Notes, other than the nonpayment of principal of, and interest on the Notes, that have become due solely by such acceleration, have been cured or waived. 

Section 6.03 Other Remedies. If an Event of Default occurs and is continuing, the Trustee may pursue any available remedy to
collect the payment of principal of or interest on the Notes or to enforce the performance of any provision of the Notes or this Indenture. The Trustee may maintain a proceeding even if it does not possess any of the Notes or does not produce any of
them in the proceeding. A delay or omission by the Trustee or any Holder in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. All
remedies are cumulative to the extent permitted by law. 

  
 66 

 Section 6.04 Waiver of Defaults. The Holders of a majority in aggregate principal
amount of the Notes then outstanding shall have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or of exercising any trust or power conferred on the Trustee with respect to such
Notes. However, the Trustee may refuse to follow any direction that conflicts with law or this Indenture or that the Trustee determines is unduly prejudicial to the rights of any other Holder, or would involve the Trustee in personal liability (it
being understood and agreed that the Trustee shall have no affirmative obligation to make any such determination); provided, however, that the Trustee may take any other action deemed proper by the Trustee that is not inconsistent with such
direction. Prior to taking any action hereunder, the Trustee shall be entitled to security or indemnity satisfactory to it in its sole discretion from Holders directing the Trustee against any cost, liability or expense caused by taking or not
taking such action. 
 Section 6.05 Control by Majority. With respect to Notes of any series, the Holders of a majority in
principal amount of the then outstanding Notes of such series may direct in writing the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on it relating to or
arising under an Event of Default described in clause (a), (b) or (i) of Section 6.01, and with respect to all Notes, the Holders of a majority in principal amount of all the then outstanding Notes affected may direct
in writing the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on it not relating to or arising under such an Event of Default. However, the Trustee may refuse to
follow any direction that conflicts with applicable law, or this Indenture, that the Trustee determines may be unduly prejudicial to the rights of other Holders, or that may involve the Trustee in personal liability; provided, however, that
the Trustee may take any other action deemed proper by the Trustee that is not inconsistent with such direction. Prior to taking any action hereunder, the Trustee shall be entitled to indemnification satisfactory to it in its sole discretion from
Holders directing the Trustee against all losses and expenses caused by taking or not taking such action. 
 Section 6.06
Limitations on Suits. Subject to Section 6.07 hereof, no Holder may pursue any remedy with respect to this Indenture or the Notes unless: 

(a) such Holder has previously given the Trustee written notice that an Event of Default with respect to the Notes is continuing; 

(b) Holders of at least 33 1/3% in principal amount of the outstanding Notes have requested in writing that the Trustee pursue the remedy; 

(c) such Holders have offered the Trustee security or indemnity satisfactory to the Trustee in its sole discretion against any loss, liability
or expense; 
 (d) the Trustee has not complied with such request within 60 days after the receipt of the request and the offer of security
or indemnity; and 
 (e) the Holders of a majority in principal amount of the outstanding Notes have not given the Trustee a direction that
is inconsistent with such request within such 60-day period. 
 A Holder may not use this Indenture
to prejudice the rights of another Holder or to obtain a preference or priority over another Holder. 

  
 67 

 Section 6.07 Rights of Holders to Receive Payment. Notwithstanding any other
provision of this Indenture, the right of any Holder of a Note to receive payment of principal of, interest on and any Additional Amounts with respect to the Note, on or after the respective due dates expressed in the Note, or to bring suit for the
enforcement of any such payment on or after such respective dates, is absolute and unconditional and shall not be impaired or affected without the consent of the Holder. 

Section 6.08 Collection Suit by Trustee. If an Event of Default specified in clause (a) or (b) of
Section 6.01 hereof occurs and is continuing, the Trustee is authorized to recover judgment in its own name and as trustee of an express trust against the Partnership or a Subsidiary Guarantor for the amount of principal,
interest and any Additional Amounts remaining unpaid on the Notes of the series affected by the Event of Default, and interest on overdue principal and, to the extent lawful, interest on overdue interest, and such further amount as shall be
sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel. 

Section 6.09 Trustee May File Proofs of Claim. The Trustee is authorized to file such proofs of claim and other papers or
documents and to take such actions, including participating as a member, voting or otherwise, of any committee of creditors, as may be necessary or advisable to have the claims of the Trustee (including any claim for the reasonable compensation,
expenses, disbursements and advances of the Trustee, its agents and counsel) and the Holders allowed in any judicial proceedings relative to the Partnership or a Subsidiary Guarantor or their respective creditors or properties and shall be entitled
and empowered to collect, receive and distribute any money or other property payable or deliverable on any such claims and any Bankruptcy Custodian in any such judicial proceeding is hereby authorized by each Holder to make such payments to the
Trustee, and in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its
agents and counsel, and any other amounts due the Trustee under Section 7.07. To the extent that the payment of any such compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any
other amounts due the Trustee under Section 7.07 out of the estate in any such proceeding, shall be denied for any reason, payment of the same shall be secured by a lien on, and shall be paid out of, any and all
distributions, dividends, money, securities and other properties which the Holders of the Notes may be entitled to receive in such proceeding whether in liquidation or under any plan of reorganization or arrangement or otherwise. Nothing herein
contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Notes or the rights of any Holder thereof, or
to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding. 
 Section 6.10 Priorities. If
the Trustee collects any money pursuant to this Article VI, or, after an Event of Default and acceleration of the obligations hereunder, any money or other property distributable in respect of the Partnership’s obligations under this
Indenture shall be applied in the following order: 
 (a) First: to the Trustee (including any predecessor trustee) for amounts due
under Section 7.07; 

  
 68 

 (b) Second: to Holders for amounts due and unpaid on the Notes in respect of which or for
the benefit of which such money has been collected, for principal, interest and any Additional Amounts ratably, without preference or priority of any kind, according to the amounts due and payable on such Notes for principal, interest and any
Additional Amounts, respectively; and 
 (c) Third: to the Partnership. 

The Trustee, upon prior written notice to the Partnership, may fix record dates and payment dates for any payment to Holders pursuant to this
Article VI. 
 To the fullest extent allowed under applicable law, if for the purpose of obtaining a judgment
against the Partnership or a Subsidiary Guarantor in any court it is necessary to convert the sum due in respect of the principal of or interest on or Additional Amounts with respect to the Notes of any series (the “Required
Currency”) into a currency in which a judgment will be rendered (the “Judgment Currency”), the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Trustee could purchase in The
City of New York the Required Currency with the Judgment Currency on the Business Day in The City of New York next preceding that on which final judgment is given. Neither the Partnership, any Subsidiary Guarantor nor the Trustee shall be liable for
any shortfall nor shall it benefit from any windfall in payments to Holders of Notes under this Section 6.10 caused by a change in exchange rates between the time the amount of a judgment against it is calculated as above
and the time the Trustee converts the Judgment Currency into the Required Currency to make payments under this Section 6.10 to Holders of Notes, but payment of such judgment shall discharge all amounts owed by the
Partnership and the Subsidiary Guarantors on the claim or claims underlying such judgment. 
 Section 6.11 Undertaking for
Costs. In any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken or omitted by it as a trustee, a court in its discretion may require the filing by any party litigant in
the suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys’ fees, against any party litigant in the suit, having due regard to the merits and good faith
of the claims or defenses made by the party litigant. This Section 6.11 does not apply to a suit by the Trustee, a suit by a Holder pursuant to Section 6.07, or a suit by a Holder or Holders of
more than 10% in principal amount of the then outstanding Notes of any series. 
 ARTICLE VII. 

TRUSTEE 
 Section 7.01
Duties of Trustee. 
 (a) If an Event of Default has occurred and is continuing, the Trustee shall exercise such of the rights and
powers vested in it by this Indenture, and use the same degree of care and skill in their exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person’s own affairs. 

  
 69 

 (b) Except during the continuance of an Event of Default with respect to the Notes of any series:

 (1) the Trustee undertakes to perform such duties and only such duties that are specifically set forth in this Indenture and no others,
and no implied covenants or obligations shall be read into this Indenture against the Trustee; and 
 (2) in the absence of bad faith on its
part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture, but in the
case of any such certificates or opinions which by any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of
this Indenture (but need not confirm or investigate the accuracy of mathematical calculations or other facts, statements, opinions or conclusions stated therein). 

(c) The Trustee may not be relieved from liabilities for its own negligent action, its own negligent failure to act or its own willful
misconduct, except that: 
 (1) this paragraph does not limit the effect of Section 7.01(b) and (e); 

(2) the Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer, unless it is proved that the
Trustee was negligent in ascertaining the pertinent facts; and 
 (3) the Trustee shall not be liable with respect to any action it takes or
omits to take in good faith in accordance with a direction received by it pursuant to Section 6.05. 
 (d) Whether
or not therein expressly so provided, every provision of this Indenture that in any way relates to the Trustee is subject to the provisions of this Section 7.01. 

(e) No provision of this Indenture shall require the Trustee to expend or risk its own funds or incur any liability in the performance of any
of its duties hereunder, or in the exercise of any of its rights or powers, if it shall have reasonable grounds for believing that repayment of such funds or adequate indemnity against such risk or liability is not reasonably assured to it. 

(f) The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Partnership
and the Subsidiary Guarantors. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law. All money received by the Trustee shall, until applied as herein provided, be held in trust for the
payment of the principal of, interest on and Additional Amounts with respect to the Notes. 
 Section 7.02 Rights of Trustee.

 (a) The Trustee may conclusively rely and shall be fully protected in acting or refraining from acting upon any resolution, certificate,
statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document believed by it to be genuine and to have been signed or presented by the proper
party or parties. 

  
 70 

 (b) Before the Trustee acts or refrains from acting, it may require that instruction in the form
of an Officer’s Certificate or an Opinion of Counsel or both to be provided. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on such instruction, Officer’s Certificate or Opinion of
Counsel. The Trustee may consult at the Partnership’s expense with counsel of its selection and the advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken,
suffered or omitted by it hereunder in good faith and in reliance thereon. 
 (c) The Trustee may execute any of the trusts or powers
hereunder or perform any duties hereunder either directly or by or through agents or attorneys and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed with due care by it hereunder.

 (d) The Trustee shall not be liable for any action it takes or omits to take in good faith which it believes to be authorized or within
its rights or powers conferred upon it by this Indenture. 
 (e) Unless otherwise specifically provided in this Indenture, any demand,
request, direction or notice from the Partnership or any Subsidiary Guarantor shall be sufficient if signed by an Officer of the Partnership (or, in the case the Partnership is a limited partnership, the General Partner, acting on behalf of the
Partnership). 
 (f) The Trustee shall not be obligated to make any investigation into the facts or matters stated in any resolution,
certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document. 

(g) The rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be
indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed to act hereunder. 

(h) The Trustee may request that the Partnership deliver a certificate setting forth the names of individuals and/or titles of officers
authorized at such time to take specified actions pursuant to this Indenture, which certificate may be signed by any person authorized to sign an Officer’s Certificate, including any person specified as so authorized in any such certificate
previously delivered and not superseded. 
 (i) The Trustee shall be under no obligation to exercise any of the rights or powers vested in it
by this Indenture at the request or direction of any of the Holders pursuant to this Indenture, unless such Holders shall have offered to the Trustee security or indemnity satisfactory to the Trustee against the costs, expenses and liabilities which
might be incurred by it in compliance with such request or direction. 

  
 71 

 (j) The Trustee shall not be liable for any action taken, suffered, or omitted to be taken by it
in good faith and believed by it to be authorized or within the discretion or rights or powers conferred upon it by this Indenture. 
 (k)
Anything in this Indenture notwithstanding, in no event shall the Trustee be liable for special, indirect, punitive or consequential or other similar loss or damage of any kind whatsoever (including but not limited to loss of profit), even if the
Trustee has been advised as to the likelihood of such loss or damage and regardless of the form of action. 
 (l) The Trustee shall not be
responsible or liable for any failure or delay in the performance of its obligations under this Indenture arising out of or caused, directly or indirectly, by circumstances beyond its control, including, without limitation, any provision of any law
or regulation or any act of any governmental authority, acts of God; earthquakes; fire; flood; terrorism; wars and other military disturbances; sabotage; epidemics; riots; interruptions; loss or malfunctions of utilities, computer (hardware or
software) or communication services; accidents; labor disputes; acts of civil or military authority and governmental action. 

Section 7.03 May Hold Notes. The Trustee in its individual or any other capacity may become the owner or pledgee of Notes and may
otherwise deal with the Partnership, any Subsidiary Guarantor or any of their respective Affiliates with the same rights it would have if it were not Trustee. Any Agent may do the same with like rights and duties. However, the Trustee is subject to
Sections 7.10 and 7.11. 
 Section 7.04 Trustee’s Disclaimer. The Trustee
makes no representation as to the validity or adequacy of this Indenture or the Notes, it shall not be accountable for the Partnership’s use of the proceeds from the Notes or any money paid to the Partnership or any Subsidiary Guarantor or upon
the Partnership’s or such Subsidiary Guarantor’s direction under any provision hereof, it shall not be responsible for the use or application of any money received by any Paying Agent other than the Trustee and it shall not be responsible
for any statement or recital herein or any statement in the Notes other than its certificate of authentication. The Trustee shall not be responsible to make any calculation with respect to any matter under this Indenture. The Trustee shall have no
duty to monitor or investigate the Partnership’s compliance with or the breach of, or cause to be performed or observed, any representation, warranty, or covenant, or agreement of any Person, other than the Trustee, made in this Indenture. 

Section 7.05 Notice of Defaults. If a Default or Event of Default with respect to the Notes of any series occurs and is continuing
and it is known to the Trustee, the Trustee shall mail to Holders of Notes of such series a notice of the Default or Event of Default within 90 days after it has knowledge thereof. Except in the case of a Default or Event of Default in payment of
principal of, interest on and Additional Amounts or any sinking fund installment with respect to the Notes of such series, the Trustee may withhold the notice if and so long as a committee of its Responsible Officers in good faith determines that
withholding the notice is in the interests of Holders of Notes of such series. 

  
 72 

 Section 7.06 Reports by Trustee to Holders. Within 60 days after each
May 15 of each year after the execution of this Indenture, the Trustee shall mail to Holders of a series, the Subsidiary Guarantors and the Partnership a brief report dated as of such reporting date that complies with TIA Section 313(a);
provided that if no event described in TIA Section 313(a) has occurred within the twelve months preceding the reporting date with respect to a series, no report need be transmitted to Holders of such series. The Trustee also shall comply
with TIA Section 313(b). The Trustee shall also transmit by mail all reports if and as required by TIA Sections 313(c) and 313(d). A copy of each report at the time of its mailing to Holders of a series of Notes shall be filed by the
Partnership or a Subsidiary Guarantor with the SEC and each securities exchange, if any, on which the Notes of such series are listed. The Partnership shall notify the Trustee if and when any series of Notes is listed on any securities exchange.

 Section 7.07 Compensation and Indemnity. The Partnership agrees to pay to the Trustee for its acceptance of this Indenture
and services hereunder such compensation as the Partnership and the Trustee shall from time to time agree in writing. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust. The Partnership
agrees to reimburse the Trustee upon request for all reasonable disbursements, advances and expenses incurred by it. Such expenses shall include the reasonable compensation, disbursements and expenses of the Trustee’s agents and counsel. 

The Partnership and each Subsidiary Guarantor jointly and severally hereby indemnifies the Trustee and any predecessor Trustee against any and
all loss, liability, damage, claim or expense (including fees and expenses of counsel), including taxes (other than taxes based upon, measured by or determined by the income of the Trustee), incurred by it arising out of or in connection with the
acceptance or administration of its duties under this Indenture of the trust or trusts hereunder, including the costs and expenses of defending itself against any claim (whether asserted by the Partnership, any Subsidiary Guarantor or any Holder or
any other Person) or liability in connection with the exercise or performance of any of its powers or duties hereunder, or in connection with enforcing the provisions of this Section, except as set forth in the next following paragraph. The Trustee
shall notify the Partnership and the Subsidiary Guarantors promptly of any claim for which it may seek indemnity, but the failure to provide such notice shall not affect the Trustee’s rights under this Section 7.07
except to the extent that the Partnership is actually prejudiced thereby. The Partnership shall defend the claim and the Trustee shall cooperate in the defense. The Trustee may have separate counsel and the Partnership shall pay the reasonable fees
and expenses of such counsel. The Partnership need not pay for any settlement made without its consent, which shall not be unreasonably withheld or delayed. 

The Partnership shall not be obligated to reimburse any expense or indemnify against any loss or liability incurred by the Trustee through the
Trustee’s gross negligence or willful misconduct. 
 To secure the payment obligations of the Partnership in this
Section 7.07, the Trustee shall have a lien prior to the Notes on all property and money held or collected by the Trustee, except that held in trust to pay principal of, interest on and any Additional Amounts with respect
to Notes of any series. Such lien and the Partnership’s obligations under this Section 7.07 shall survive the termination for any reason of this Indenture, the satisfaction and discharge of this Indenture or the
resignation or removal of the Trustee. 

  
 73 

 When the Trustee incurs expenses or renders services after an Event of Default specified in
Section 6.01(g) or (h) occurs, the expenses and the compensation for the services are intended to constitute expenses of administration under any Bankruptcy Law. 

“Trustee” for purposes of this Section shall include any predecessor Trustee; provided, however, that the negligence, willful
misconduct or bad faith of any Trustee hereunder shall not affect the rights of any other Trustee hereunder. 
 Section 7.08
Replacement of Trustee. A resignation or removal of the Trustee and appointment of a successor Trustee shall become effective only upon the successor Trustee’s acceptance of appointment as provided in this
Section 7.08. The Trustee may resign and be discharged at any time with respect to the Notes of one or more series by so notifying the Partnership and the Subsidiary Guarantors. The Holders of a majority in principal amount
of the then outstanding Notes of any series may remove the Trustee with respect to the Notes of such series by so notifying the Trustee, the Partnership and the Subsidiary Guarantors. The Partnership may remove the Trustee if: 

(a) the Trustee fails to comply with Section 7.10; 

(b) the Trustee is adjudged a bankrupt or an insolvent or an order for relief is entered with respect to the Trustee under any Bankruptcy Law;

 (c) a Bankruptcy Custodian or public officer takes charge of the Trustee or its property; or 

(d) the Trustee otherwise becomes incapable of acting. 

If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any reason, with respect to the Notes of one or more
series, the Partnership shall promptly appoint a successor Trustee or Trustees with respect to the Notes of that or those series (it being understood that any such successor Trustee may be appointed with respect to the Notes of one or more or all of
such series and that at any time there shall be only one Trustee with respect to the Notes of any particular series). Within one year after the successor Trustee with respect to the Notes of any series takes office, the Holders of a majority in
principal amount of the Notes of such series then outstanding may appoint a successor Trustee to replace the successor Trustee appointed by the Partnership. 

If a successor Trustee with respect to the Notes of any series does not take office within 30 days after the retiring or removed Trustee
resigns or is removed, the retiring or removed Trustee, the Partnership, any Subsidiary Guarantor or the Holders of at least 10% in principal amount of the then outstanding Notes of such series may (at the expense of the Partnership) petition any
court of competent jurisdiction for the appointment of a successor Trustee with respect to the Notes of such series. 
 If the Trustee with
respect to the Notes of a series fails to comply with Section 7.10, any Holder of Notes of such series may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor
Trustee with respect to the Notes of such series. 

  
 74 

 In case of the appointment of a successor Trustee with respect to all Notes, each such successor
Trustee shall deliver a written acceptance of its appointment to the retiring Trustee, to the Partnership and to the Subsidiary Guarantors and on the request of the Partnership or the successor trustee, such retiring Trustee shall, upon payment of
its charges and all other amounts payable to it hereunder, execute and deliver an instrument transferring to such successor trustee all the rights, powers and duties of the retiring Trustee. Thereupon the resignation or removal of the retiring
Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the retiring Trustee under this Indenture. The successor Trustee shall mail a notice of its succession to Holders. The retiring Trustee shall
promptly transfer all property held by it as Trustee to the successor Trustee, subject to the lien provided for in Section 7.07. 

In case of the appointment of a successor Trustee with respect to the Notes of one or more (but not all) series, the Partnership, the
Subsidiary Guarantors, the retiring Trustee and each successor Trustee with respect to the Notes of one or more (but not all) series shall execute and deliver an indenture supplemental hereto in which each successor Trustee shall accept such
appointment and that (i) shall confer to each successor Trustee all the rights, powers and duties of the retiring Trustee with respect to the Notes of that or those series to which the appointment of such successor Trustee relates, (ii) if
the retiring Trustee is not retiring with respect to all Notes, shall confirm that all the rights, powers and duties of the retiring Trustee with respect to the Notes of that or those series as to which the retiring Trustee is not retiring shall
continue to be vested in the retiring Trustee and (iii) shall add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee.
Nothing herein or in such Supplemental Indenture shall constitute such Trustees co-trustees of the same trust, and each such Trustee shall be trustee of a trust or trusts hereunder separate and apart from any
trust or trusts hereunder administered by any other such Trustee. Upon the execution and delivery of such Supplemental Indenture and the upon payment of the retiring Trustee’s charges and all other amounts payable to it hereunder, the
resignation or removal of the retiring Trustee shall become effective to the extent provided therein and each such successor Trustee shall have all the rights, powers and duties of the retiring Trustee with respect to the Notes of that or those
series to which the appointment of such successor Trustee relates. On request of the Partnership or any successor Trustee, such retiring Trustee shall transfer to such successor Trustee all property held by such retiring Trustee as Trustee with
respect to the Notes of that or those series to which the appointment of such successor Trustee relates. Such retiring Trustee shall, however, have the right to deduct its unpaid fees and expenses, including attorneys’ fees. 

Notwithstanding replacement of the Trustee or Trustees pursuant to this Section 7.08, the obligations of the
Partnership under Section 7.07 shall continue for the benefit of the retiring Trustee or Trustees. 

Section 7.09 Successor Trustee by Merger, etc. Subject to Section 7.10, if the Trustee consolidates,
merges or converts into, or transfers all or substantially all of its corporate trust business to, another Person, the successor Person without any further act shall be the successor Trustee; provided that in the case of a transfer of all or
substantially all of its corporate trust business to another Person, the transferee corporation expressly assumes all of the Trustee’s liabilities hereunder. 

  
 75 

 In case any Notes shall have been authenticated, but not delivered, by the Trustee then in
office, any successor by merger, conversion or consolidation to such authenticating Trustee may adopt such authentication and deliver the Notes so authenticated; and in case at that time any of the Notes shall not have been authenticated, any
successor to the Trustee may authenticate such Notes either in the name of any predecessor hereunder or in the name of the successor to the Trustee; and in all such cases such certificates shall have the full force which it is anywhere in the Notes
or in this Indenture provided that the certificate of the Trustee shall have. 
 Section 7.10 Eligibility; Disqualification.
There shall at all times be a Trustee hereunder which shall be a corporation or banking association organized and doing business under the laws of the United States, any State thereof or the District of Columbia and authorized under such laws to
exercise corporate trust power, shall be subject to supervision or examination by federal or state (or the District of Columbia) authority and shall have, or be a subsidiary of a bank or bank holding company having, a combined capital and surplus of
at least $50 million as set forth in its most recent published annual report of condition. 
 This Indenture shall always have a
Trustee who satisfies the requirements of TIA Sections 310(a)(1), 310(a)(2) and 310(a)(5). The Trustee is subject to and shall comply with the provisions of TIA Section 310(b) during the period of time required by this Indenture. Nothing in
this Indenture shall prevent the Trustee from filing with the SEC the application referred to in the penultimate paragraph of TIA Section 310(b). 

Section 7.11 Preferential Collection of Claims Against the Partnership or a Subsidiary Guarantor. The Trustee is subject to and
shall comply with the provisions of TIA Section 311(a), excluding any creditor relationship listed in TIA Section 311(b). A Trustee who has resigned or been removed shall be subject to TIA Section 311(a) to the extent indicated
therein. 
 Section 7.12 Tax Withholding. Notwithstanding any other provision of this Indenture, the Trustee shall be entitled
to make a deduction or withholding from any payment which it makes under this Indenture for or on account of any present or future taxes, duties or charges if and to the extent so required by any applicable law and any current or future regulations
or agreements thereunder or official interpretations thereof or any law implementing an intergovernmental approach thereto or by virtue of the relevant holder failing to satisfy any certification or other requirements in respect of the Notes, in
which event the Trustee shall make such payment after such withholding or deduction has been made and shall account to the relevant authorities for the amount so withheld or deducted and shall have no obligation to gross up any payment hereunder or
pay any additional amount as a result of such withholding tax. 
 The Partnership hereby covenants with the Trustee that it will provide the
Trustee with sufficient information so as to enable the Trustee to determine whether or not the Trustee is obliged, in respect of any payments to be made by it pursuant to this Indenture, to make any withholding or deduction pursuant to an agreement
described in Section 1471(b) of the Code or otherwise imposed pursuant to Sections 1471 through 1474 of the Code and any regulations, or agreements thereunder or official interpretations thereof or any intergovernmental agreement between the
United States and another jurisdiction facilitating the implementation thereof (or any law implementing such an intergovernmental agreement)(collectively, “FATCA”). The obligations imposed on the Partnership under this paragraph are
limited to the extent that the 

  
 76 

 
Partnership has the relevant information in its possession or control, or it is reasonably obtainable by the Partnership, and that the provision of such information to the Trustee will not result
in any breach of this Indenture, the Notes or any applicable law. The parties hereby agree and acknowledge that the Notes issued under this Indenture are not “grandfathered obligations” within the meaning of Treasury Regulation
Section 1.1471- 2(b)(2)(i) or 1.1471-2T(b)(2)(i) and, therefore, payments under the Notes may be subject to FATCA withholding tax, as further described in the section titled “Certain United States
Federal Income Tax Considerations” in the offering memorandum, dated September 12, 2017. 
 Section 7.13 Appointment of Co-Trustee. 
 (a) Notwithstanding any other provisions of this Indenture, at any time for the purpose
of meeting any legal requirement of any jurisdiction, the Trustee shall have the power and may execute and deliver all instruments necessary for the appointment of one or more Persons to act as a co-trustee or
co-trustees, or separate trustee or separate trustees, and to vest in such Person or Persons, in such capacity and for the benefit of the Holders, subject to the other provisions of this Section, such powers,
duties, obligations, rights and trusts as the Trustee may consider necessary or desirable. No co-trustee or separate trustee hereunder shall be required to meet the terms of eligibility as a successor trustee
under Section 7.10 hereof and no notice to Holders of the appointment of any co-trustee is or separate trustee shall be required under Section 7.08 hereof. 

(b) Every separate trustee and co-trustee shall, to the extent permitted by law, be appointed and act
subject to the following provisions and conditions: 
 (1) all rights, powers, duties and obligations conferred or imposed upon the Trustee
shall be conferred or imposed upon and exercised or performed by the Trustee and such separate trustee or co-trustee jointly (it being understood that such separate trustee or
co-trustee is not authorized to act separately without the Trustee joining in such act), except to the extent that under any law of any jurisdiction in which any particular act or acts are to be performed the
Trustee shall be incompetent or unqualified to perform such act or acts, in which event such rights, powers, duties and obligations shall be exercised and performed singly by such separate trustee or
co-trustee, but solely at the direction of the Trustee; 
 (2) the Trustee shall not be personally
liable by reason of any act or omission of any co-trustee or separate trustee hereunder. No co-trustee hereunder shall be personally liable by reason of any act or
omission of the Trustee, any separate trustee or any other co-trustee hereunder. No separate trustee hereunder shall be personally liable by reason of any act or omission of the Trustee, any co-trustee or any other separate trustee hereunder; and 
 (3) the Trustee may at any time accept the
resignation of or remove any separate trustee or co-trustee. 
 (c) Any notice, request or other
writing given to the Trustee shall be deemed to have been given to each of the then separate trustees and co-trustees, as effectively as if given to each of them. Every instrument appointing any separate
trustee or co-trustee shall refer to this Indenture and the conditions of this Article VII. Each separate trustee and co-trustee, upon its

  
 77 

 
acceptance of the trusts conferred, shall be vested with the estates or property specified in its instrument of appointment, either jointly with the Trustee or separately, as may be provided
therein, subject to all the provisions of this Indenture, specifically including every provision of this Indenture relating to the conduct of, affecting the liability of, or affording protection or rights (including the rights to compensation,
reimbursement and indemnification hereunder) to, the Trustee. Every such instrument shall be filed with the Trustee. 
 (d) Any separate
trustee or co-trustee may at any time constitute the Trustee its agent or attorney-in-fact with full power and authority, to the
extent not prohibited by law, to do any lawful act under or in respect of this Indenture on its behalf and in its name. If any separate trustee or co-trustee shall die, become incapable of acting, resign or be
removed, all of his, her or its estates, properties, rights, remedies and trusts shall vest in and be exercised by the Trustee, to the extent permitted by law, without appointment of a new or successor trustee. 

ARTICLE VIII. 
 DISCHARGE
OF INDENTURE 
 Section 8.01 Termination of the Partnership’s and the Subsidiary
Guarantors’ Obligations. 
 (a) This Indenture shall cease to be of further effect with respect to the Notes of a
series (except that the Partnership’s obligations under Section 7.07, the Trustee’s and Paying Agent’s obligations under Section 8.03 and the rights, powers, protections and
privileges accorded the Trustee under Article VII shall survive), and the Trustee and the Subsidiary Guarantors, on demand of the Partnership, shall execute proper instruments acknowledging the satisfaction and discharge of
this Indenture with respect to the Notes of such series, when: 
 (1) either: 

(i) all outstanding Notes of such series theretofore authenticated and issued (other than destroyed, lost or stolen Notes that
have been replaced or paid) have been delivered to the Trustee for cancellation; or 
 (ii) all outstanding Notes of such series not
theretofore delivered to the Trustee for cancellation: 
 (1) have become due and payable; or 

(2) will become due and payable at their Stated Maturity within one year; or 

(3) are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of
redemption by the Trustee in the name, and at the expense, of the Partnership; 

  
 78 

 and, in the case of clause (1), (2) or (3) above, the Partnership or a Subsidiary
Guarantor has irrevocably deposited or caused to be deposited with the Trustee as funds (immediately available to the Holders in the case of clause (1)) in trust for such purpose (x) cash in an amount, or (y) Government Obligations,
maturing as to principal and interest at such times and in such amounts as will ensure the availability of cash in an amount or (z) a combination thereof, which will be sufficient, without reinvestment, in the opinion (in the case of clauses
(y) and (z)) of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge the entire indebtedness on the Notes of such series for principal and
interest to the date of such deposit (in the case of Notes which have become due and payable) or for principal and interest to the Stated Maturity or Redemption Date, as the case may be; or 

(iii) the Partnership and the Subsidiary Guarantors have properly fulfilled such other means of satisfaction and discharge as
is specified, as contemplated by Section 2.01, to be applicable to the Notes of such series; 
 (2) the
Partnership or a Subsidiary Guarantor has paid or caused to be paid all other sums payable by them hereunder with respect to the Notes of such series; and 

(3) the Partnership has delivered to the Trustee an Officer’s Certificate stating that all conditions precedent to satisfaction and
discharge of this Indenture with respect to the Notes of such series have been complied with, together with an Opinion of Counsel to the same effect. 

(b) Unless this Section 8.01(b) is specified as not being applicable to Notes of a series as contemplated by
Section 2.01, the Partnership may, at its option, terminate certain of its and the Subsidiary Guarantors’ respective obligations under this Indenture (“covenant defeasance”) with respect to the Notes
of a series if: 
 (1) the Partnership or a Subsidiary Guarantor has irrevocably deposited or caused to be irrevocably deposited with the
Trustee as trust funds in trust for the purpose of making the following payments, specifically pledged as security for and dedicated solely to the benefit of the Holders of Notes of such series, (A) money in the currency in which payment of the
Notes of such series is to be made in an amount, or (B) Government Obligations with respect to such series, maturing as to principal and interest at such times and in such amounts as will ensure the availability of money in the currency in
which payment of the Notes of such series is to be made in an amount or (C) a combination thereof, that is sufficient, without reinvestment, in the opinion (in the case of clauses (B) and (C)) of a nationally recognized firm of independent
public accountants expressed in a written certification thereof delivered to the Trustee, to pay the principal of and interest on all Notes of such series on each date that such principal or interest is due and payable and (at the Stated Maturity
thereof or upon redemption as provided in Section 8.01(e)) to pay all other sums payable by it hereunder; provided that the Trustee shall have been irrevocably instructed to apply such money and/or the proceeds of such
Government Obligations to the payment of said principal and interest with respect to the Notes of such series as the same shall become due; 

  
 79 

 (2) the Partnership has delivered to the Trustee an Officer’s Certificate stating that all
conditions precedent to satisfaction and discharge of this Indenture with respect to the Notes of such series have been complied with, and an Opinion of Counsel to the same effect; 

(3) no Default or Event of Default with respect to the Notes of such series shall have occurred and be continuing on the date of such deposit;

 (4) the Partnership shall have delivered to the Trustee an Opinion of Counsel from a nationally recognized counsel acceptable to the
Trustee or a tax ruling to the effect that the Holders will not recognize income, gain or loss for U.S. Federal income tax purposes as a result of the Partnership’s exercise of its option under this Section 8.01(b) and
will be subject to U.S. Federal income tax on the same amount and in the same manner and at the same times as would have been the case if such option had not been exercised; 

(5) the Partnership and the Subsidiary Guarantors have complied with any additional conditions specified pursuant to
Section 2.01 to be applicable to the discharge of Notes of such series pursuant to this Section 8.01; and 

(6) such deposit and discharge shall not cause the Trustee to have a conflicting interest as defined in TIA Section 310(b). 

Upon the Partnership’s exercise of the option applicable to this Section 8.01(b), the Partnership and each of
the Subsidiary Guarantors will, subject to the satisfaction of the conditions set forth in this Section 8.01(b), be released from each of their obligations under the covenants contained in Sections 4.03, 4.05,
4.08, 4.09, 4.10, 4.11 and 4.12 hereof, and the Notes will thereafter be deemed not “outstanding” for the purposes of any direction, waiver, consent or declaration or act of Holders (and the consequences
of any thereof) in connection with such covenants, but will continue to be deemed “outstanding” for all other purposes hereunder (it being understood that such Notes will not be deemed outstanding for accounting purposes). For this
purpose, covenant defeasance means that, with respect to the outstanding Notes and Guarantees, the Partnership and the Subsidiary Guarantors may fail to comply with and will have no liability in respect of any term, condition or limitation set forth
in any such covenant, whether directly or indirectly, by reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other document and such failure to
comply will not constitute a Default or an Event of Default under Section 6.01 hereof, but, except as specified above, the remainder of this Indenture and such Notes and Guarantees will be unaffected thereby. In addition,
upon the Partnership’s exercise of the option applicable to this Section 8.01(b), subject to the satisfaction of the conditions set forth in this Section 8.01(b), any Event of Default pursuant
to Sections 6.01(c), 6.01(d), 6.01(e), 6.01(f), 6.01(i), or 6.01(j) will no longer constitute an Event of Default and any Event of Default pursuant to Sections 6.01(g) and 6.01(h), with respect to
Subsidiaries of the Partnership, will no longer constitute an Event of Default. 
 After such irrevocable deposit made pursuant to this
Section 8.01(b) and satisfaction of the other conditions set forth herein, the Trustee upon request shall acknowledge in writing the discharge of the Partnership’s and the Subsidiary Guarantors’ obligations under
this Indenture with respect to the Notes of such series except for those surviving obligations specified above. 

  
 80 

 In order to have money available on a payment date to pay principal of or interest on the Notes,
the Government Obligations shall be payable as to principal or interest on or before such payment date in such amounts as will provide the necessary money. Government Obligations shall not be callable at the issuer’s option. 

(c) If the Partnership and the Subsidiary Guarantors have previously complied or are concurrently complying with
Section 8.01(b) (other than any additional conditions specified pursuant to Section 2.01 that are expressly applicable only to covenant defeasance) with respect to Notes of a series, then, unless
this Section 8.01(c) is specified as not being applicable to Notes of such series as contemplated by Section 2.01, the Partnership may elect that its and the Subsidiary Guarantors’ respective
obligations to make payments with respect to Notes of such series be discharged (“legal defeasance”), if: 
 (1) no Default
or Event of Default under clauses (g) and (h) of Section 6.01 hereof, with respect to the Partnership or any Subsidiary Guarantor that is a Significant Subsidiary, shall have occurred at any time during the period
ending on the 91st day after the date of deposit contemplated by Section 8.01(b) (it being understood that this condition shall not be deemed satisfied until the expiration of such period); 

(2) unless otherwise specified with respect to Notes of such series as contemplated by Section 2.01, the Partnership
has delivered to the Trustee an Opinion of Counsel from a nationally recognized counsel acceptable to the Trustee to the effect referred to in Section 8.01(b)(iv) with respect to such legal defeasance, which opinion is
based on (A) a private ruling of the Internal Revenue Service addressed to the Partnership, (B) a published ruling of the Internal Revenue Service pertaining to a comparable form of transaction or (C) a change in the applicable
federal income tax law (including regulations) after the date of this Indenture; 
 (3) the Partnership and the Subsidiary Guarantors have
complied with any other conditions specified pursuant to Section 2.01 to be applicable to the legal defeasance of Notes of such series pursuant to this Section 8.01(c); and 

(4) the Partnership has delivered to the Trustee a Partnership Request requesting such legal defeasance of the Notes of such series and an
Officer’s Certificate stating that all conditions precedent with respect to such legal defeasance of the Notes of such series have been complied with, together with an Opinion of Counsel to the same effect. 

In such event, the Partnership and the Subsidiary Guarantors will be discharged from their respective obligations under this Indenture and the
Notes of such series to pay principal of and interest on, and any Additional Amounts with respect to, Notes of such series, the Partnership’s and the Subsidiary Guarantors’ respective obligations under
Sections 4.01, 4.02, 4.04, 4.06 and 4.07 and Article X shall terminate with respect to such Notes, and the entire indebtedness of the Partnership evidenced by such Notes and of the Subsidiary
Guarantors evidenced by the related Guarantees shall be deemed paid and discharged. 

  
 81 

 (d) If and to the extent additional or alternative means of satisfaction, discharge or defeasance
of Notes of a series are specified to be applicable to such series as contemplated by Section 2.01, each of the Partnership and the Subsidiary Guarantors may terminate any or all of its obligations under this Indenture with
respect to Notes of a series and any or all of its obligations under the Notes of such series if it fulfills such other means of satisfaction and discharge as may be so specified, as contemplated by Section 2.01, to be
applicable to the Notes of such series. 
 (e) If Notes of any series subject to subsections (a), (b), (c) or (d) of this
Section 8.01 are to be redeemed prior to their Stated Maturity, whether pursuant to any optional redemption provisions or in accordance with any mandatory or optional sinking fund provisions, the terms of the applicable
trust arrangement shall provide for such redemption, and the Partnership shall make such arrangements as are reasonably satisfactory to the Trustee for the giving of notice of redemption by the Trustee in the name, and at the expense, of the
Partnership. 
 Section 8.02 Application of Trust Money. The Trustee or a trustee satisfactory to the Trustee and the
Partnership shall hold in trust money or Government Obligations deposited with it pursuant to Section 8.01 hereof. It shall apply the deposited money and the money from Government Obligations through the Paying Agent and in
accordance with this Indenture to the payment of principal of, interest on and any Additional Amounts with respect to the Notes of the series with respect to which the deposit was made. 

Section 8.03 Repayment to Partnership or Subsidiary Guarantor. The Trustee and the Paying Agent shall promptly pay to the
Partnership or any Subsidiary Guarantor any excess money or Government Obligations (or proceeds therefrom) held by them at any time upon the written request of the Partnership. 

Subject to the requirements of any applicable abandoned property laws, the Trustee and the Paying Agent shall pay to the Partnership upon
written request any money held by them for the payment of principal, interest or any Additional Amounts that remain unclaimed for two years after the date upon which such payment shall have become due. After payment to the Partnership, Holders
entitled to the money must look to the Partnership for payment as general creditors unless an applicable abandoned property law designates another Person, and all liability of the Trustee and the Paying Agent with respect to such money shall cease.

 Section 8.04 Reinstatement. If the Trustee or the Paying Agent is unable to apply any money or Government Obligations
deposited with respect to Notes of any series in accordance with Section 8.01 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or
otherwise prohibiting such application, the obligations of the Partnership and the Subsidiary Guarantors under this Indenture with respect to the Notes of such series and under the Notes of such series shall be revived and reinstated as though no
deposit had occurred pursuant to Section 8.01 until such time as the Trustee or the Paying Agent is permitted to apply all such money or Government Obligations in accordance with Section 8.01;
provided that if the Partnership or any Subsidiary Guarantor has made any payment of principal of or interest on or any Additional Amounts with respect to any Notes because of the reinstatement of its obligations, the Partnership or such
Subsidiary Guarantor, as the case may be, shall be subrogated to the rights of the Holders of such Notes to receive such payment from the money or Government Obligations held by the Trustee or the Paying Agent. 

  
 82 

 ARTICLE IX. 

SUPPLEMENTAL INDENTURES AND AMENDMENTS 

Section 9.01 Without Consent of Holders. The Partnership and the Trustee may amend or supplement this Indenture or the Notes or
waive any provision hereof or thereof without the consent of any Holder: 
 (a) to cure any ambiguity, omission, defect or inconsistency;

 (b) to provide for the assumption by a successor of the Obligations of the Partnership under this Indenture and the Notes; 

(c) to provide for uncertificated Notes in addition to or in place of certificated Notes; 

(d) to establish any Guarantee or to reflect the release of any Subsidiary Guarantor from obligations in respect of its Guarantee, in either
case, as provided in this Indenture; 
 (e) to secure the Notes or any Guarantee; 

(f) to comply with the requirements of the SEC in order to effect or maintain the qualification of this Indenture under the TIA; 

(g) to add to the covenants of the Partnership or any Subsidiary Guarantor for the benefit of the Holders of all or any series of Notes (and if
such covenants are to be for the benefit of less than all series of Notes, stating that such covenants are expressly being included solely for the benefit of such series), or to surrender any right or power herein conferred upon the Partnership or
any Subsidiary Guarantor; 
 (h) to add any additional Events of Default with respect to all or any series of the Notes (and, if any Event of
Default is applicable to less than all series of Notes, specifying the series to which such Event of Default is applicable); 
 (i) to make
any change that does not adversely affect the rights under this Indenture of any Holder of Notes in any material respect (as determined in good faith by any Officer of the Partnership involved in or otherwise familiar with such change); 

(j) to conform the text of this Indenture or the Notes to any provision of the Description of Notes to the extent that such provision of the
Description of Notes was intended to be a verbatim recitation of a provision of this Indenture, the Guarantees or the Notes, as certified by an Officer’s Certificate delivered to the Trustee; 

(k) to provide for the issuance of Additional Notes under this Indenture; 

(l) to add a Subsidiary Guarantor or co-obligor under this Indenture or to release a Subsidiary
Guarantor in accordance with the terms of this Indenture; 

  
 83 

 (m) to provide for a successor Trustee in accordance with the provisions of this Indenture; or

 (n) to supplement any of the provisions of this Indenture to such extent as shall be necessary to permit or facilitate the defeasance and
discharge of any series of Notes; provided, however, that any such action does not adversely affect the interest of the Holders of Notes of such series or any other series of Notes in any respect; or 

(o) to establish the form or terms of Notes of any series as permitted by Section 2.01. 

For the avoidance of doubt, during any time where a Security Requirement Period is not in effect or the Trustee is not party to the Collateral
Documents, the Partnership may amend the Collateral Documents without the consent of any Holder of Notes or the Trustee. 
 During any time
when the Trustee is party to the Collateral Documents, without the consent of any Holder of Notes, the Partnership or the Trustee may amend the Collateral Documents to: 

(1) in the case of the Intercreditor Agreement or Collateral Agency Agreement, in order to subject the security interests in the Collateral in
respect of any Additional First Lien Debt Obligations and First Lien Obligations to the terms of the Intercreditor Agreement and/or Collateral Agency Agreement, in each case to the extent the Incurrence of such Indebtedness, and the grant of all
Liens on the Collateral held for the benefit of such Indebtedness are permitted hereunder; 
 (2) confirm and evidence the release,
termination or discharge of any Lien securing any of the Notes when such release, termination or discharge is permitted hereby or by the Collateral Documents; 

(3) with respect to any Collateral Document, to the extent such amendment is reasonably necessary to comply with the terms of the
Intercreditor Agreement or Collateral Agency Agreement; or 
 (4) make such amendments, supplements, modifications and waivers to the
Collateral Documents as reasonably required or that the Partnership deems reasonably necessary for the issuance of the Initial Notes, Notes of any other series (if applicable), any Additional Notes or any Additional First Lien Debt Facility,
including any amendments, necessary for the release of Collateral during any period that is not a Security Requirement Period or the grant of Collateral during a Security Requirement Period, or for any amendments, supplements or modifications to the
Depositary Agreement in respect of the provisions permitting distributions to the Partnership, in each case, at any time requested by the Partnership (and the Trustee shall be required to execute any such amendment, modification, supplement or
waiver upon delivery of an Officer’s Certificate of the Partnership that references this Section 9.01(iv)). 

  
 84 

 Upon the request of the Partnership, accompanied by a Board Resolution, and upon receipt by the
Trustee of the documents described in Section 9.06, the Trustee shall, subject to Section 9.06, join with the Partnership and the Subsidiary Guarantors in the execution of any Supplemental
Indenture authorized or permitted by the terms of this Indenture and make any further appropriate agreements and stipulations that may be therein contained. 

Section 9.02 With Consent of Holders. Except as provided below in this Section 9.02, the Partnership,
the Subsidiary Guarantors and the Trustee may amend or supplement this Indenture with the written consent (including consents obtained in connection with a tender offer or exchange offer for Notes of any one or more series or all series or a
solicitation of consents in respect of Notes of any one or more series or all series, provided that in each case such offer or solicitation is made to all Holders of then outstanding Notes of each such series (but the terms of such offer or
solicitation may vary from series to series)) of the Holders of at least a majority in principal amount of the then outstanding Notes of all series affected by such amendment or supplement (acting as one class). 

Upon the request of the Partnership, accompanied by a Board Resolution, and upon the filing with the Trustee of evidence of the consent of the
Holders as aforesaid, and upon receipt by the Trustee of the documents described in Section 9.06, the Trustee shall, subject to Section 9.06, join with the Partnership and the Subsidiary Guarantors
in the execution of such amendment or Supplemental Indenture. 
 It shall not be necessary for the consent of the Holders under this
Section 9.02 to approve the particular form of any proposed amendment, supplement or waiver, but it shall be sufficient if such consent approves the substance thereof. 

The Holders of a majority in principal amount of the then outstanding Notes of one or more series or of all series may waive compliance in a
particular instance by the Partnership or any Subsidiary Guarantor with any provision of this Indenture with respect to Notes of such series (including waivers obtained in connection with a tender offer or exchange offer for Notes of such series or
a solicitation of consents in respect of Notes of such series, provided that in each case such offer or solicitation is made to all Holders of then outstanding Notes of such series (but the terms of such offer or solicitation may vary from series to
series)). 
 However, without the consent of each Holder affected, an amendment, supplement or waiver under this
Section 9.02 may not: 
 (a) reduce the percentage in principal amount of Notes whose Holders must consent to an
amendment; 
 (b) reduce the rate of or change the time for payment of interest on any Note; 

(c) reduce the principal of or extend the stated maturity of any Note; 

(d) reduce the premium payable upon the redemption of any Note; provided, however, that any purchase or repurchase of any Notes,
including pursuant to Section 4.08 shall not be deemed a redemption of any Notes; 
 (e) make any Notes payable in
money other than U.S. dollars; 

  
 85 

 (f) impair the right of any Holder to receive payment of the principal of and interest on such
Holder’s Note or to institute suit for the enforcement of any payment on or with respect to such Holder’s Note; or 
 (g) make any
change in the provisions of this Article IX which require each Holder’s consent. 
 A Supplemental Indenture that changes or eliminates
any covenant or other provision of this Indenture which has expressly been included solely for the benefit of one or more particular series of Notes, or which modifies the rights of the Holders of Notes of such series with respect to such covenant
or other provision, shall be deemed not to affect the rights under this Indenture of the Holders of Notes of any other series. 
 The right
of any Holder to participate in any consent required or sought pursuant to any provision of this Indenture (and the obligation of the Partnership or any Subsidiary Guarantor to obtain any such consent otherwise required from such Holder) may be
subject to the requirement that such Holder shall have been the Holder of record of any Notes with respect to which such consent is required or sought as of a date identified by the Partnership or such Subsidiary Guarantor in a notice furnished to
Holders in accordance with the terms of this Indenture. 
 During the Security Requirement Period, without the consent of the Holders of at
least two-thirds in principal amount of the Notes then outstanding, an amendment or waiver may not make any change in any of the Note Documents in any way that would release all or substantially all of the
Collateral from the Liens of the Collateral Documents (except as permitted by the terms of the Note Documents) or change or alter the priority of the security interests in the Collateral. 

After an amendment, supplement or waiver under this Section 9.02 becomes effective, the Partnership shall mail to
the Holders of each Note affected thereby a notice briefly describing the amendment, supplement or waiver. Any failure of the Partnership to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any
such amendment, supplement or waiver. 
 Section 9.03 Compliance with Trust Indenture Act. Every amendment or supplement to this
Indenture or the Notes shall comply in form and substance with the TIA as then in effect. 
 Section 9.04 Revocation and Effect of
Consents. Until an amendment, supplement or waiver becomes effective, a consent to it by a Holder is a continuing consent by the Holder and every subsequent Holder of a Note or portion of a Note that evidences the same debt as the consenting
Holder’s Note, even if notation of the consent is not made on any Note. However, any such Holder or subsequent Holder may revoke the consent as to his or her Note or portion of a Note if the Trustee receives written notice of revocation before
a date and time therefor identified by the Partnership or any Subsidiary Guarantor in a notice furnished to such Holder in accordance with the terms of this Indenture or, if no such date and time shall be identified, the date the amendment,
supplement or waiver becomes effective. An amendment, supplement or waiver becomes effective in accordance with its terms and thereafter binds every Holder. 

  
 86 

 The Partnership or any Subsidiary Guarantor may, but shall not be obligated to, fix a record date
(which need not comply with TIA Section 316(c)) for the purpose of determining the Holders entitled to consent to any amendment, supplement or waiver or to take any other action under this Indenture. If a record date is fixed, then
notwithstanding the provisions of the immediately preceding paragraph, those Persons who were Holders at such record date (or their duly designated proxies), and only those Persons, shall be entitled to consent to such amendment, supplement or
waiver or to revoke any consent previously given, whether or not such Persons continue to be Holders after such record date. No consent shall be valid or effective for more than 90 days after such record date unless consents from Holders of the
principal amount of Notes required hereunder for such amendment or waiver to be effective shall have also been given and not revoked within such 90-day period. 

After an amendment, supplement or waiver becomes effective, it shall bind every Holder, unless it is of the type described in any of clauses
(a) through (i) of Section 9.02 hereof. In such case, the amendment, supplement or waiver shall bind each Holder who has consented to it and every subsequent Holder that evidences the same debt as the consenting
Holder’s Note. 
 Section 9.05 Notation on or Exchange of Notes. If an amendment or supplement changes the terms of an
outstanding Note, the Partnership may require the Holder of the Note to deliver it to the Trustee. The Trustee may place an appropriate notation on the Note at the request of the Partnership regarding the changed terms and return it to the Holder.
Alternatively, if the Partnership so determines, the Partnership in exchange for the Note shall issue, and the Subsidiary Guarantors shall execute and the Trustee shall authenticate a new Note that reflects the changed terms. Failure to make the
appropriate notation or to issue a new Note shall not affect the validity of such amendment or supplement. 
 Notes of any series
authenticated and delivered after the execution of any amendment or supplement may, and shall if required by the Trustee, bear a notation in form approved by the Trustee as to any matter provided for in such amendment or supplement. 

Section 9.06 Trustee to Sign Amendments, etc. The Trustee shall sign any amendment or supplement authorized pursuant to this
Article if the amendment or supplement does not adversely affect the rights, duties, liabilities or immunities of the Trustee. If it does, the Trustee may, but need not, sign it. In signing or refusing to sign such amendment or supplement, the
Trustee shall be entitled to receive, and, subject to Section 7.01 hereof, shall be fully protected in relying upon, an Officer’s Certificate and an Opinion of Counsel provided at the expense of the Partnership or a
Subsidiary Guarantor as conclusive evidence that such amendment or supplement is authorized or permitted by this Indenture. 
 ARTICLE X.

 GUARANTEE 

Section 10.01 Guarantee. 

(a) Notwithstanding any provision of this Article X to the contrary, the provisions of this
Article X relating to the Subsidiary Guarantors shall be applicable only to, and inure solely to the benefit of, the Notes of any series designated, pursuant to Section 2.01, as entitled to the
benefits of the Guarantee of each of the Subsidiary Guarantors. 

  
 87 

 (b) For value received, each of the Subsidiary Guarantors hereby fully, unconditionally and
absolutely guarantees (the “Guarantee”) to the Holders and to the Trustee the due and punctual payment of the principal of and interest on the Notes and all other amounts due and payable under this Indenture and the Notes by the
Partnership, when and as such principal and interest shall become due and payable, whether at the stated maturity or by declaration of acceleration, call for redemption or otherwise, according to the terms of the Notes and this Indenture, subject to
the limitations set forth in Section 10.03. 
 (c) Failing payment when due of any amount guaranteed pursuant to
the Guarantee, for whatever reason, each of the Subsidiary Guarantors will be jointly and severally obligated to pay the same immediately. The Guarantee hereunder is intended to be a general, secured during a Security Requirement Period, senior
obligation of each of the Subsidiary Guarantors and will rank pari passu in right of payment with all Indebtedness of such Subsidiary Guarantor that is not, by its terms, expressly subordinated in right of payment to the Guarantee. Each of the
Subsidiary Guarantors hereby agrees that its obligations hereunder shall be full, unconditional and absolute, irrespective of the validity, regularity or enforceability of the Notes, the Guarantee (including the Guarantee of any Subsidiary
Guarantor) or this Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder of the Notes with respect to any provisions hereof or thereof, the recovery of any judgment against the Partnership or any Subsidiary
Guarantor, or any action to enforce the same or any other circumstances which might otherwise constitute a legal or equitable discharge or defense of the Subsidiary Guarantors. Each of the Subsidiary Guarantors hereby agrees that in the event of a
default in payment of the principal of or interest on the Notes, whether at the Stated Maturity or by declaration of acceleration, call for redemption or otherwise, legal proceedings may be instituted by the Trustee on behalf of the Holders or,
subject to Section 6.06, by the Holders, on the terms and conditions set forth in this Indenture, directly against such Subsidiary Guarantor to enforce the Guarantee without first proceeding against the Partnership or any
other Subsidiary Guarantor. 
 (d) The obligations of each of the Subsidiary Guarantors under this Article X shall
be as aforesaid full, unconditional and absolute and shall not be impaired, modified, released or limited by any occurrence or condition whatsoever, including, without limitation, (i) any compromise, settlement, release, waiver, renewal,
extension, indulgence or modification of, or any change in, any of the obligations and liabilities of the Partnership or any of the Subsidiary Guarantors contained in the Notes or this Indenture, (ii) any impairment, modification, release or
limitation of the liability of the Partnership, any of the Subsidiary Guarantors or any of their estates in bankruptcy, or any remedy for the enforcement thereof, resulting from the operation of any present or future provision of any applicable
Bankruptcy Law, as amended, or other statute or from the decision of any court, (iii) the assertion or exercise by the Partnership, any of the Subsidiary Guarantors or the Trustee of any rights or remedies under the Notes or this Indenture or
their delay in or failure to assert or exercise any such rights or remedies, (iv) the assignment or the purported assignment of any property as security for the Notes, including all or any part of the rights of the Partnership or any of the
Subsidiary Guarantors under this Indenture, (v) the extension of the time for payment by the Partnership or 

  
 88 

 
any of the Subsidiary Guarantors of any payments or other sums or any part thereof owing or payable under any of the terms and provisions of the Notes or this Indenture or of the time for
performance by the Partnership or any of the Subsidiary Guarantors of any other obligations under or arising out of any such terms and provisions or the extension or the renewal of any thereof, (vi) the modification or amendment (whether
material or otherwise) of any duty, agreement or obligation of the Partnership or any of the Subsidiary Guarantors set forth in this Indenture, (vii) the voluntary or involuntary liquidation, dissolution, sale or other disposition of all or
substantially all of the assets, marshaling of assets and liabilities, receivership, insolvency, bankruptcy, assignment for the benefit of creditors, reorganization, arrangement, composition or readjustment of, or other similar proceeding affecting,
the Partnership or any of the Subsidiary Guarantors or any of their respective assets, or the disaffirmance of the Notes, the Guarantee or this Indenture in any such proceeding, (viii) the release or discharge of the Partnership or any of the
Subsidiary Guarantors from the performance or observance of any agreement, covenant, term or condition contained in any of such instruments by operation of law, (ix) the unenforceability of the Notes, the Guarantee or this Indenture or
(x) any other circumstances (other than payment in full or discharge of all amounts guaranteed pursuant to the Guarantee) which might otherwise constitute a legal or equitable discharge of a surety or guarantor. 

(e) Each of the Subsidiary Guarantors hereby (i) waives diligence, presentment, demand of payment, filing of claims with a court in the
event of the merger, insolvency or bankruptcy of the Partnership or any of the Subsidiary Guarantors, and all demands whatsoever, (ii) acknowledges that any agreement, instrument or document evidencing the Guarantee may be transferred and that
the benefit of its obligations hereunder shall extend to each holder of any agreement, instrument or document evidencing the Guarantee without notice to it and (iii) covenants that the Guarantee will not be discharged except by complete
performance of the Guarantee. Each of the Subsidiary Guarantors further agrees that if at any time all or any part of any payment theretofore applied by any Person to the Guarantee is, or must be, rescinded or returned for any reason whatsoever,
including without limitation, insolvency, bankruptcy or reorganization of the Partnership or any of the Subsidiary Guarantors, the Guarantee shall, to the extent that such payment is or must be rescinded or returned, be deemed to have continued in
existence notwithstanding such application, and the Guarantee shall continue to be effective or be reinstated, as the case may be, as though such application had not been made. 

(f) Each of the Subsidiary Guarantors shall be subrogated to all rights of the Holders and the Trustee against the Partnership in respect of
any amounts paid by such Subsidiary Guarantor pursuant to the provisions of this Indenture; provided that such Subsidiary Guarantor, shall not be entitled to enforce or to receive any payments arising out of, or based upon, such right of
subrogation until all of the Notes and the Guarantee shall have been paid in full or discharged. 
 Section 10.02 Execution and
Delivery of Guarantee. As evidence of the Guarantee set forth in Section 10.01, each of the Subsidiary Guarantors shall hereby execute this Indenture, a Supplemental Indenture in the form of Exhibit A creating a
new series of Notes or a Supplemental Indenture in the form of Exhibit C adding a new Subsidiary Guarantor, by either manual or facsimile signature of an Officer of the Partnership (or, in the case the Partnership is a limited partnership,
the General Partner, acting on behalf of the Partnership) or the Subsidiary 

  
 89 

 
Guarantor. If any Officer of the Partnership (or, in the case the Partnership is a limited partnership, the General Partner, acting on behalf of the Partnership) or the Subsidiary Guarantor,
whose signature is on this Indenture or a Supplemental Indenture no longer holds that office at the time the Trustee authenticates the applicable Note or at any time thereafter, the Guarantee of such Note shall be valid nevertheless. The delivery of
any Note by the Trustee, after the authentication thereof hereunder, shall constitute due delivery of the Guarantee set forth in this Indenture on behalf of the Subsidiary Guarantors. The Trustee hereby accepts the trusts in this Indenture upon the
terms and conditions herein set forth. 
 Section 10.03 Limitation on Liability of the Subsidiary Guarantors. Each Subsidiary
Guarantor and by its acceptance hereof each Holder of a Note entitled to the benefits of the Guarantee hereby confirm that it is the intention of all such parties that the guarantee by such Subsidiary Guarantor pursuant to its Guarantee not
constitute a fraudulent transfer or conveyance for purposes of any federal or state law. To effectuate the foregoing intention, the Holders of a Note entitled to the benefits of the Guarantee and the Subsidiary Guarantors hereby irrevocably agree
that the obligations of each Subsidiary Guarantor under its Guarantee shall be limited to the maximum amount as will, after giving effect to all other contingent and fixed liabilities of such Subsidiary Guarantor and to any collections from or
payments made by or on behalf of any other Subsidiary Guarantor in respect of the obligations of such other Subsidiary Guarantor under its Guarantee, result in the obligations of such Subsidiary Guarantor under the Guarantee not constituting a
fraudulent conveyance or fraudulent transfer under federal or state law. 
 Section 10.04 Release of Subsidiary Guarantors from
Guarantee. 
 (a) If no Default with respect to the Notes has occurred and is continuing under this Indenture, and to the extent not
otherwise prohibited by this Indenture, a Subsidiary Guarantor will be unconditionally released and discharged from its Guarantee: 
 (1)
automatically upon any direct or indirect sale, transfer or other disposition, whether by way of merger or otherwise, to any Person that is not a Subsidiary of the Partnership, of (a) all of the Capital Stock representing ownership of such
Subsidiary Guarantor or (b) all or substantially all the assets of such Subsidiary Guarantor, in each case, if such sale, transfer or other disposition, is made in compliance with the applicable provisions of this Indenture; 

(2) upon the liquidation or dissolution of such Subsidiary Guarantor; 

(3) following delivery by the Partnership to the Trustee of an Officer’s Certificate to the effect that such Subsidiary Guarantor has
been released from another guarantee that resulted in the creation of such Guarantee, except in the case of a release by or as a result of payment under such other guarantee; or 

(4) upon legal defeasance or satisfaction and discharge of this Indenture as provided in Article VIII. 

(b) In addition, the Guarantee of SPL Member will be unconditionally released during any period that is not a Security Requirement Period. 

  
 90 

 (c) The Trustee shall deliver an appropriate instrument evidencing any release of a Subsidiary
Guarantor from the Guarantee upon receipt of a written request of the Partnership accompanied by an Officer’s Certificate and an Opinion of Counsel that the Subsidiary Guarantor is entitled to such release in accordance with the provisions of
this Indenture. Any Subsidiary Guarantor not so released remains liable for the full amount of principal of and interest on the Notes entitled to the benefits of such Guarantee as provided in this Indenture, subject to the limitations of
Section 10.03. 
 Section 10.05 Reinstatement of Guarantees. 

(a) If at any time following any release of a Subsidiary from its Guarantee pursuant to Section 10.04(a)(3) above,
such Subsidiary again guarantees or becomes a co-obligor with respect to any obligations of the Partnership in respect of any Material Indebtedness, then the Partnership will cause such Subsidiary to again
become a Subsidiary Guarantor by executing and delivering a Supplemental Indenture to this Indenture in a form satisfactory to the Trustee and thus guarantee the Notes and all other Obligations of the Partnership under this Indenture, in accordance
with the terms of this Indenture. 
 (b) Upon the occurrence of a Security Requirement Period and provided that SPL Member is a
Subsidiary Guarantor or co-obligor with respect to any Obligations of the Partnership in respect of any Material Indebtedness, the Partnership will cause SPL Member to again become a Subsidiary Guarantor by
executing and delivering a Supplemental Indenture to this Indenture in a form satisfactory to the Trustee and thus guarantee the Notes and all other obligations of the Partnership under this Indenture, in accordance with the terms of this Indenture.

 Section 10.06 Contribution. In order to provide for just and equitable contribution among the Subsidiary Guarantors, the
Subsidiary Guarantors hereby agree, inter se, that in the event any payment or distribution is made by any Subsidiary Guarantor (a “Funding Guarantor”) under its Guarantee, such Funding Guarantor shall be entitled to a contribution
from each other Subsidiary Guarantor (as applicable) in a pro rata amount based on the net assets of each Subsidiary Guarantor (including the Funding Guarantor) for all payments, damages and expenses incurred by that Funding Guarantor in discharging
the Partnership’s obligations with respect to the Notes or any other Subsidiary Guarantor’s obligations with respect to its Guarantee. 

Section 10.07 Execution of Supplemental Indenture by Additional Guarantors  

If at any time following the Issue Date, any other Subsidiary of the Partnership (with the exception of Sabine Pass Liquefaction, LLC)
guarantees or becomes a co-obligor with respect to any obligations of the Partnership in respect of any Material Indebtedness, then the Partnership will cause such Subsidiary to promptly execute and deliver to
the Trustee a Supplemental Indenture in the form of Supplemental Indenture for Additional Guarantors pursuant to which such Subsidiary shall become a Subsidiary Guarantor under this Article 10 and shall guarantee all Obligations of the
Partnership with respect to the Notes on the terms provided for in this Indenture. 

  
 91 

 ARTICLE XI. 

COLLATERAL AND SECURITY 

Section 11.01 General.  

The Credit Agreement Obligations are secured on a first-priority basis with Liens on the Collateral. The Notes will be secured to the same
extent as such obligations are so secured so long as (x) the aggregate principal amount of all Indebtedness then outstanding under the Term Loans secured by such Liens exceeds $1.0 billion or (y) the aggregate amount of secured
Indebtedness of the Partnership and the Subsidiary Guarantors (other than the Initial Notes or any other series of Notes issued under this Indenture) outstanding at any one time, together with all Attributable Indebtedness from Sale-Leaseback
Transactions (excluding Sale-Leaseback Transactions permitted by Section 4.11(a)(1) through (3), inclusive), exceeds the greater of (i) $1.5 billion and (ii) 10% of Net Tangible Assets (such period, the
“Security Requirement Period”). Upon the release of the Liens securing the Notes pursuant to Section 11.04(d)(1), Section 4.10 will continue to govern the incurrence of Liens by
the Partnership and its Subsidiary Guarantors. 
 Section 11.02 Collateral Documents. 

(a) In order to secure the due and punctual payment of the Note Obligations, when the same shall be due and payable, whether on an Interest
Payment Date, at Maturity, by acceleration, repurchase, redemption or otherwise, and interest on the overdue principal of and interest (to the extent permitted by law) on the Notes and performance of all other Note Obligations, (i) the
Partnership and the Subsidiary Guarantors have, prior to the Issue Date, and substantially simultaneously with the incurrence of the Credit Agreement Obligations, entered into Collateral Documents granting the Collateral Agent a Lien on all property
and assets of the Partnership and the Subsidiary Guarantors (subject to the exclusions set forth in the Collateral Documents) securing the First Lien Obligations and (ii) the Partnership and the Subsidiary Guarantors agree that they will take
all such action as shall be required to ensure that the Note Obligations will, during any Security Requirement Period, be secured by a Lien, subject only to Permitted Liens, on the Collateral. 

(b) The Note Documents (other than the Intercreditor Agreement) are subject to the terms, limitations and conditions set forth in the
Intercreditor Agreement. Each Holder of Notes, by its acceptance of a Note, is deemed to (i) have consented and agreed to the terms of each Collateral Document, as originally in effect and as amended, supplemented or replaced from time to time
in accordance with its terms or the terms of this Indenture or the Intercreditor Agreement, (ii) have consented to the appointment of the Collateral Agent pursuant to the Collateral Agency Agreement, (iii) have authorized and directed the
Collateral Agent to enter into the Collateral Documents to which it is a party, and (iv) have authorized and empowered the Collateral Agent (through the Intercreditor Agreement and the Collateral Agency Agreement) to bind the Holders of Notes
and other holders of First Lien Obligations as set forth in the Collateral Documents to which they are a party and to perform its obligations and exercise its rights and powers thereunder, including entering into amendments permitted by the terms of
the Notes Documents. To the extent that any provision of the Note Documents is not consistent with or contradicts the Intercreditor Agreement or the Collateral Agency Agreement, the Intercreditor Agreement and/or the Collateral Agency Agreement will
govern. 

  
 92 

 (c) Each Holder of Notes, by its acceptance of a Note, is deemed to have: 

(1) authorized, consented to and directed the Trustee to enter into the Joinder Documents; 

(2) during any Security Requirement Period, agreed that it is subject to and bound by the provisions of the Intercreditor Agreement in its
capacity as a Holder of Notes; 
 (3) authorized the Collateral Agent’s execution and delivery of the Collateral Documents prior to the
date hereof (in accordance with the Intercreditor Agreement and Collateral Agency Agreement); 
 (4) consented and agreed that the
Collateral Agent may execute and deliver any additional Collateral Documents not in effect as of the date hereof and act in accordance with the terms thereof; 

(5) consented and agreed that the Collateral Agent may, in its sole discretion and without the consent of the Trustee or the Holders, take all
actions it deems necessary or appropriate in order to: 
 (i) enforce any of the terms of the Collateral Documents; and 

(ii) collect and receive any and all amounts payable in respect of the Note Obligations of the Partnership and the Subsidiary
Guarantors to the Holders, the Collateral Agent or the Trustee under the Note Documents. 
 (d) Any Person which, after the Issue Date,
becomes a Subsidiary Guarantor under this Indenture, shall, upon becoming a Subsidiary Guarantor under this Indenture, become a party to each applicable Collateral Document (on terms and conditions substantially the same as the then current
Collateral Documents) with respect to the assets or property of such Person that are Collateral. 
 Section 11.03 Recording,
Registration and Opinions; Trustee’s Disclaimer Regarding Collateral.  
 (a) Unless the Collateral has been
released, the Partnership and, if applicable, the Subsidiary Guarantors shall take or cause to be taken all action required to perfect, maintain, preserve and protect the Lien on the Collateral granted by the Collateral Documents (subject only to
Permitted Liens and to the terms of the Collateral Documents), or that are otherwise required by Section 314(b) of the TIA, including without limitation arranging for the filing of financing statements, continuation statements, mortgages and
any instruments of further assurance, in such manner and in such places as may be required by law fully to preserve and protect the rights of the Holders, the Trustee and the Collateral Agent under the Note Documents to all property now or hereafter
at any time comprising the Collateral. The Partnership shall from time to time promptly pay all financing, continuation statements and mortgage recording, registration and/or 

  
 93 

 
filing fees, charges and taxes relating to the Note Documents, any amendments thereto and any other instruments of further assurance required hereunder or pursuant to the Collateral Documents.
Neither the Trustee nor the Collateral Agent shall have any obligation to, and neither of them shall be responsible for any failure to, so register, file or record. Promptly after the execution and delivery of this Indenture, the Partnership shall
furnish to the Trustee and Collateral Agent an Opinion of Counsel that complies with TIA Section 314(b)(1). 
 (b) The Partnership will
otherwise comply with the provisions of TIA Section 314(b). 
 (c) Notwithstanding anything to the contrary set forth in the Note
Documents, neither the Trustee nor the Collateral Agent shall be responsible for the existence, genuineness or value of any of the Collateral, or for the creation, validity, perfection, priority or enforceability of the Liens in any of the
Collateral, whether impaired by operation of law or by reason of any action or omission to act on its part hereunder, for the validity or sufficiency of the Collateral or any agreement or assignment contained therein, for the validity of the title
of the Partnership to the Collateral, for insuring the Collateral or for the payment of taxes, charges, assessments or Liens upon the Collateral or otherwise as to the maintenance of the Collateral. 

(d) The Trustee shall have no duty to ascertain or inquire as to the performance or observance of any of the terms of this Indenture or any
other Collateral Document by the Partnership or any other Person that is a party thereto or bound thereby. The Trustee shall not be responsible or liable for seeing to or monitoring the attachment, perfection, or priority of any lien or security
interest created or intended to be created in the Collateral hereby or by any of the Collateral Documents. The Trustee shall not be responsible for the preparation, correctness, filing, re-filing, recording or
re-recording of any security documents or instruments, including UCC financing statements or continuation statements in any public office at any time or times or otherwise perfecting or maintaining the
perfection of any lien or security interest in any of the Collateral. 
 Section 11.04 Possession, Use and Release of
Collateral. 
 (a) Each Holder, by accepting a Note, consents and agrees to the provisions of the Note Documents governing the
possession, use and release of Collateral. Each Holder, by accepting a Note, consents and agrees that Collateral may, and, as applicable, shall, be released or substituted in accordance with the terms of the Collateral Documents. 

(b) The Liens upon the Collateral shall automatically be released in whole, upon (1) with respect to any Collateral sold, transferred or
disposed of (other than to the Partnership or a Subsidiary Guarantor) in accordance with the terms of this Indenture, upon the sale, transfer or other disposition of that Collateral; and (2) with respect to any Collateral owned by a Subsidiary
Guarantor whose Capital Stock is sold or otherwise disposed of in accordance with the terms of this Indenture to a Person that is not (either before or after giving effect to such transaction) the Partnership or a Subsidiary Guarantor, upon the sale
or other disposition of that Capital Stock. 

  
 94 

 (c) The Collateral Agent’s Liens upon the Collateral shall automatically no longer inure to
the benefit of the Note Obligations at any time this Indenture no longer requires the Note Obligations to be secured by the Collateral and the Trustee has delivered to the Collateral Agent a written notice withdrawing Note Obligations as being
secured under the Collateral Documents. 
 (d) In addition to the foregoing, so long as no Default or Event of Default in either case
relating to a failure to pay principal or interest on the Notes when due has occurred and is continuing, the obligations of the Partnership and the Subsidiary Guarantors to maintain the Note Obligations as First Lien Obligations or otherwise provide
Liens on Collateral in accordance with this Article XI may be terminated by the Partnership subject to satisfaction of any of the following circumstances: 

(1) the Security Requirement Period is not in effect; 

(2) upon payment in full of all outstanding Notes and all other amounts due under this Indenture and the Notes; 

(3) upon satisfaction and discharge of this Indenture as set forth under Article VIII; 

(4) upon a Legal Defeasance or Covenant Defeasance as set forth under Article VIII; or 

(5) as to any Collateral that constitutes all or substantially all of the Collateral, with the consent of the Holders of at least two-thirds in principal amount of the Notes then outstanding. 
 Under this Indenture, the Trustee, at the
request of the Partnership, as the Senior Class Debt Representative in respect of the Note Obligations, will be required to provide any such consent on behalf of Holders to the extent any such modification or release is otherwise permitted
under this Indenture, including as set forth under this Section 11.04(d). 
 Upon delivery of an Officer’s
Certificate and Opinion of Counsel delivered to the Trustee in accordance with in the requirements specified in this Indenture, the Trustee shall provide a notice to the Collateral Agent that the Note Obligations no longer constitute First Lien
Obligations; provided that in the case of clause (1) above, the Trustee shall include in any such notice that if a new Security Requirement Period comes into effect after the delivery of such notice, the Trustee shall deliver a
subsequent notice to the Collateral Agent indicating that the Note Obligations constitute First Lien Obligations during such new Security Requirement Period. 

(e) The Collateral Agent shall execute and deliver all such authorizations, instructions and other instruments and take such actions (and the
Holders will be deemed to have consented to and authorized the Collateral Agent to execute and deliver any such authorization, instruction or instrument and take any such action) under the Collateral Documents or otherwise as may be requested by the
Partnership to evidence, confirm and effectuate any release of Collateral provided for in Section 11.04(b), (c), and (d). 

  
 95 

 (f) At the request of the Partnership and upon delivery of the Opinion of Counsel and
Officer’s Certificate provided for in this Section 11.04(f), at the Partnership’s cost and expense, the Trustee will execute and deliver any documents, instructions or instruments evidencing any permitted release
by the Collateral Agent of the Liens on any Collateral in favor of the Collateral Agent and the Holders will be deemed to have consented to and authorized the Trustee to execute and deliver any such documentation, instruction or instrument. The
Trustee shall be entitled to receive an Opinion of Counsel and Officer’s Certificate in connection with any release of Liens evidencing compliance with the terms of this Indenture and the Collateral Documents. 

Section 11.05 Certificates of the Partnership and the Subsidiary Guarantors. 

The Partnership and the Subsidiary Guarantors will furnish to the Trustee, prior to each proposed release of Collateral pursuant to the
Security Documents: 
 (1) all documents required by TIA Section 314(d); and 

(2) an Opinion of Counsel, which may be rendered by internal counsel to the Partnership and the Subsidiary Guarantors, to the effect that such
accompanying documents constitute all documents required by TIA Section 314(d). 
 The Trustee may, to the extent permitted by
Sections 7.01 and 7.02, accept as conclusive evidence of compliance with the foregoing provisions the appropriate statements contained in such documents and such Opinion of Counsel. 

Section 11.06 Purchaser Protected. 

No purchaser or grantee of any property or rights purporting to be released herefrom shall be bound to ascertain the authority of the Trustee
or Collateral Agent to execute the release or to inquire as to the existence of any conditions herein prescribed for the exercise of such authority; nor shall any purchaser or grantee of any property or rights permitted by this Indenture to be sold
or otherwise disposed of by the Partnership or any Subsidiary Guarantor be under any obligation to ascertain or inquire into the authority of the Partnership or such Subsidiary Guarantor to make such sale or other disposition. 

ARTICLE XII. 

MISCELLANEOUS 

Section 12.01 Trust Indenture Act Controls. If any provision of this Indenture limits, qualifies or conflicts with the duties
imposed by operation of TIA Section 318(c), the imposed duties shall control. 
 Section 12.02 Notices. Any notice or
communication by the Partnership, any Subsidiary Guarantor or the Trustee to the others is duly given if in writing and delivered in person or mailed by first-class mail (registered or certified, return receipt requested), telex, facsimile or
overnight air courier guaranteeing next day delivery, to the other’s address: 

  
 96 

 If to the Partnership or the Subsidiary Guarantors: 

Cheniere Energy Partners, L.P. 

700 Milam Street, Suite 1900 

Houston, Texas 77002 
 Attn: Chief
Financial Officer 
 With a copy to (which copy shall be delivered as an accommodation and shall not be required to be delivered in
satisfaction of any requirement hereof): 
 Latham & Watkins LLP 

885 Third Avenue 
 New York, NY
10022-4834 
 Attn: Jonathan Rod 

If to the Trustee: 
 The Bank of
New York Mellon 
 500 Ross Street, 12th Floor 

Pittsburgh, PA 15262 
 Facsimile
No.: 412-234-8377 
 Attn: Corporate Trust Administration
– Corporation Finance Unit 
 The Partnership, any Subsidiary Guarantor or the Trustee by notice to the others may designate additional
or different addresses for subsequent notices or communications. 
 All notices and communications shall be deemed to have been duly given:
at the time delivered by hand, if personally delivered; five Business Days after being deposited in the mail, postage prepaid, if mailed; when answered back, if telexed; when receipt acknowledged, if by facsimile; and the next Business Day after
timely delivery to the courier, if sent by overnight air courier guaranteeing next day delivery. 
 Any notice or communication to a Holder
shall be mailed by first-class mail, postage prepaid, to the Holder’s address shown on the register kept by the Registrar. Failure to mail a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect
to other Holders. 
 If a notice or communication is mailed in the manner provided above within the time prescribed, it is duly given,
whether or not the addressee receives it, except in the case of notice to the Trustee, it is duly given only when received by the Trustee at its Corporate Trust Office. 

If the Partnership or a Subsidiary Guarantor mails a notice or communication to Holders, it shall mail a copy to the others and to the Trustee
and each Agent at the same time. 
 All notices or communications, including without limitation notices to the Trustee, the Partnership or a
Subsidiary Guarantor by Holders, shall be in writing, except as otherwise set forth herein. 

  
 97 

 In case by reason of the suspension of regular mail service, or by reason of any other cause, it
shall be impossible to mail any notice required by this Indenture, then such method of notification as shall be made with the approval of the Trustee shall constitute a sufficient mailing of such notice. 

The Trustee shall have the right, but shall not be required, to rely upon and comply with notices, instructions, directions or other
communications sent by e-mail, facsimile and other similar unsecured electronic methods by persons believed by the Trustee to be authorized to give instructions and directions on behalf of the Partnership. The
Trustee shall have no duty or obligation to verify or confirm that the person who sent such instructions or directions is, in fact, a person authorized to give instructions or directions on behalf of the Partnership; and the Trustee shall have no
liability for any losses, liabilities, costs or expenses incurred or sustained by the Partnership a result of such reliance upon or compliance with such notices, instructions, directions or other communications. The Partnership agrees to assume all
risks arising out of the use of such electronic methods to submit notices, instructions, directions or other communications to the Trustee, including without limitation the risk of the Trustee acting on unauthorized instructions, and the risk of
interception and misuse by third parties. The Partnership shall use all reasonable endeavors to ensure that any such notices, instructions, directions or other communications transmitted to the Trustee pursuant to this Indenture are complete and
correct. Any such notices, instructions, directions or other communications shall be conclusively deemed to be valid instructions from the Partnership to the Trustee for the purposes of this Indenture. 

Section 12.03 Communication by Holders with Other Holders. Holders may communicate pursuant to TIA Section 312(b) with other
Holders with respect to their rights under this Indenture or the Notes. The Partnership, the Subsidiary Guarantors, the Trustee, the Registrar and anyone else shall have the protection of TIA Section 312(c). 

Section 12.04 Certificate and Opinion as to Conditions Precedent. Upon any request or application by the Partnership or a
Subsidiary Guarantor to the Trustee to take any action under this Indenture, the Partnership or such Subsidiary Guarantor, as the case may be, shall, if requested by the Trustee, furnish to the Trustee at the expense of the Partnership or such
Subsidiary Guarantor, as the case may be: 
 (a) an Officer’s Certificate (which shall include the statements set forth in
Section 12.05) stating that, in the opinion of the signers, all conditions precedent and covenants, if any, provided for in this Indenture relating to the proposed action have been complied with; and 

(b) an Opinion of Counsel (which shall include the statements set forth in Section 12.05 hereof) stating that, in the
opinion of such counsel, all such conditions precedent and covenants have been complied with. 
 Section 12.05 Statements Required
in Certificate or Opinion. Each certificate or opinion with respect to compliance with a condition or covenant provided for in this Indenture (other than a certificate provided pursuant to TIA Section 314(a)(4)) shall comply with the
provisions of TIA Section 314(e) and shall include: 

  
 98 

 (a) a statement that the Person making such certificate or opinion has read such covenant or
condition; 
 (b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions
contained in such certificate or opinion are based; 
 (c) a statement that, in the opinion of such Person, he or she has made such
examination or investigation as is necessary to enable him or her to express an informed opinion as to whether or not such covenant or condition has been complied with; and 

(d) a statement as to whether or not, in the opinion of such Person, such condition or covenant has been complied with. 

Section 12.06 Rules by Trustee and Agents. The Trustee may make reasonable rules for action by or at a meeting of Holders. The
Registrar or the Paying Agent may make reasonable rules and set reasonable requirements for its functions. 
 Section 12.07 Legal
Holidays. If a payment date is a Legal Holiday at a Place of Payment, payment may be made at that place on the next succeeding day that is not a Legal Holiday, and no interest shall accrue for the intervening period. 

Section 12.08 No Recourse Against Others. A director, officer, employee, stockholder, partner or other owner of the Partnership, a
Subsidiary Guarantor or the Trustee, as such, shall not have any liability for any obligations of the Partnership under the Notes, for any obligations of any Subsidiary Guarantor under the Guarantee, or for any obligations of the Partnership, any
Subsidiary Guarantor or the Trustee under this Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. U.S. Bank National Association is acting under this Indenture solely as Trustee and not
individually and recourse against it as trustee for the obligations of the Partnership hereunder shall be limited solely to the assets held by it in its capacity as Trustee. Each Holder by accepting a Note waives and releases all such liability. The
waiver and release shall be part of the consideration for the issue of Notes. 
 Section 12.09 Governing Law, etc.. 

THIS INDENTURE, THE NOTES AND THE GUARANTEES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT
GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAWS TO THE EXTENT THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY. 

EACH OF THE PARTNERSHIP, THE SUBSIDIARY GUARANTORS AND THE TRUSTEE, AND EACH HOLDER OF A NOTE BY ITS ACCEPTANCE THEREOF, HEREBY IRREVOCABLY
WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT IT MAY HAVE TO TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY
OR THEREBY. 

  
 99 

 Each of the Partnership and the Subsidiary Guarantors irrevocably consents and submits, for
itself and in respect of any of its assets or property, to the nonexclusive jurisdiction of any court of the State of New York or any United States Federal court sitting, in each case, in the Borough of Manhattan, The City of New York, New York,
United States of America, and any appellate court from any thereof in any suit, action or proceeding that may be brought in connection with this Indenture or the Notes, and waives any immunity from the jurisdiction of such courts. Each of the
Partnership and the Subsidiary Guarantors irrevocably waives, to the fullest extent permitted by law, any objection to any such suit, action or proceeding that may be brought in such courts whether on the grounds of venue, residence or domicile or
on the ground that any such suit, action or proceeding has been brought in an inconvenient forum. Each of the Partnership and the Subsidiary Guarantors agrees, to the fullest extent that it lawfully may do so, that final judgment in any such suit,
action or proceeding brought in such a court shall be conclusive and binding upon the Partnership and the Subsidiary Guarantors, and waives, to the fullest extent permitted by law, any objection to the enforcement by any competent court in the
Partnership’s or Subsidiary Guarantor’s jurisdiction of organization of judgments validly obtained in any such court in New York on the basis of such suit, action or proceeding provided that neither the Partnership nor any
Subsidiary Guarantor waive, and the foregoing provisions of this sentence shall not constitute or be deemed to constitute a waiver of, (i) any right to appeal any such judgment, to seek any stay or otherwise to seek reconsideration or review of
any such judgment or (ii) any stay of execution or levy pending an appeal from, or a suit, action or proceeding for reconsideration of, any such judgment. 

Section 12.10 No Adverse Interpretation of Other Agreements. This Indenture may not be used to interpret another indenture, loan
or debt agreement of the Partnership, any Subsidiary Guarantor or any Subsidiary. Any such indenture, loan or debt agreement may not be used to interpret this Indenture. 

Section 12.11 Successors. All agreements of the Partnership and the Subsidiary Guarantors in this Indenture and the Notes shall
bind its successors. All agreements of the Trustee in this Indenture shall bind its successors. 
 Section 12.12 Severability.
In case any provision in this Indenture or in the Notes shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall, to the fullest extent permitted by applicable law, not in any way be
affected or impaired thereby. 
 Section 12.13 Counterpart Originals. The parties may sign any number of copies of this
Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of this Indenture and of signature pages by facsimile or electronic (i.e., “pdf” or “tif”)
transmission shall constitute effective execution and delivery of this Indenture as to the parties hereto and may be used in lieu of the original Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or electronic
(i.e., “pdf” or “tif”) transmission shall be deemed to be their original signatures for all purposes. 

  
 100 

 Section 12.14 Table of Contents, Headings, etc. The table of contents,
cross-reference table and headings of the Articles and Sections of this Indenture have been inserted for convenience of reference only, are not to be considered a part hereof and shall in no way modify or restrict any of the terms or provisions
hereof. 
 Section 12.15 Separateness. Each Holder of Notes, by accepting a Note, will be deemed to have acknowledged and
affirmed (i) the separateness of any non-guarantor Subsidiary from the Partnership, (ii) that it has purchased the Notes from the Partnership in reliance upon the separateness of such non-guarantor Subsidiary from the Partnership, (iii) that such non-guarantor Subsidiary may have assets and liabilities that are separate from those of the Partnership,
(iv) that the Note Obligations have not been guaranteed by any non-guarantor Subsidiaries or any of their respective Subsidiaries, and (v) that, except as other Persons may expressly assume or
guarantee any of the Note Documents or Note Obligations, the Holders of Notes shall look solely to the property and assets of the Partnership and the Subsidiary Guarantors, and any property pledged as Collateral with respect to the Note Documents,
for the repayment of any amounts payable under any Note Document or the Notes and for satisfaction of the Note Obligations and that none of the non-guarantor Subsidiaries or any of their respective
Subsidiaries shall be personally liable to the Holders of Notes for any amounts payable, or any other Note Obligation, under the Note Documents. 

  
 101 

 IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed as
of the day and year first above written. 
  

			
	CHENIERE ENERGY PARTNERS, L.P.
	
	By its general partner, CHENIERE ENERGY PARTNERS GP, LLC
		
		 	 /s/ Lisa C. Cohen

Name: Lisa C. Cohen

		 	Title: Vice President and Treasurer
	
	CHENIERE ENERGY INVESTMENTS, LLC
		
		 	 /s/ Lisa C. Cohen

Name: Lisa C. Cohen

		 	Title: Treasurer
	
	SABINE PASS LNG-GP, LLC
		
		 	 /s/ Lisa C. Cohen

Name: Lisa C. Cohen

		 	Title: Treasurer
	
	SABINE PASS LNG, L.P.
	 By its general partner, SABINE PASS LNG-GP, LLC

		
		 	 /s/ Lisa C. Cohen

Name: Lisa C. Cohen

		 	Title: Treasurer

 [Signature Page to Indenture] 

 
			
	SABINE PASS TUG SERVICES, LLC
		
		 	 /s/ Lisa C. Cohen

Name: Lisa C. Cohen

		 	Title: Treasurer
	
	SABINE PASS LNG-LP, LLC
		
		 	 /s/ Lisa C. Cohen

Name: Lisa C. Cohen

		 	Title: Treasurer
	
	CHENIERE PIPELINE GP INTERESTS, LLC
		
		 	 /s/ Lisa C. Cohen

Name: Lisa C. Cohen

		 	Title: Treasurer
	
	CHENIERE CREOLE TRAIL PIPELINE, L.P.
	By its general partner, CHENIERE PIPELINE GP INTERESTS, LLC
		
		 	 /s/ Lisa C. Cohen

Name: Lisa C. Cohen

		 	Title: Treasurer

 [Signature Page to Indenture] 

 
			
	 THE BANK OF NEW YORK MELLON,
 as
Trustee

		 	 /s/ Laurence J. O’Brien

Name:  Laurence J. O’Brien

Title:    Vice President

 [Signature Page to Indenture] 

 

 EXHIBIT A 

CHENIERE ENERGY PARTNERS, L.P. 
 as
Partnership, 
 and 
 any
Subsidiary Guarantors party hereto 
 and 

THE BANK OF NEW YORK MELLON, 
 as
Trustee 
 [ 🌑 ] SUPPLEMENTAL INDENTURE 

Dated as of [ 🌑 ] 

to 
 Indenture dated as of
September 18, 2017 
 [ 🌑 ]% Senior Notes due
20[ 🌑 ] 

  
 A-1 

			
	 ARTICLE I RELATION TO BASE INDENTURE; DEFINITIONS
	  	4
		
	 Section 1.1 Relation to Base Indenture
	  	4
	 Section 1.2 Generally
	  	4
	 Section 1.3 Definition of Certain Terms
	  	4
		
	 ARTICLE II GENERAL TERMS OF THE NOTES
	  	4
		
	 Section 2.1 Form
	  	4
	 Section 2.2 Title, Amount and Payment of Principal and Interest
	  	4
	 Section 2.3 Transfer and Exchange
	  	5
		
	 ARTICLE III MISCELLANEOUS PROVISIONS
	  	5
		
	 Section 3.1 Ratification of Base Indenture
	  	5
	 Section 3.2 Trustee Not Responsible for Recitals
	  	5
	 Section 3.3 Table of Contents, Headings, etc.
	  	6
	 Section 3.4 Counterpart Originals
	  	6
	 Section 3.5 Governing Law
	  	6

  
 A-2 

 THIS [ 🌑 ] SUPPLEMENTAL INDENTURE dated as
of [ 🌑 ] (this “[ 🌑 ] Supplemental Indenture”), is among Cheniere Energy Partners, L.P., a Delaware limited partnership, as issuer
(the “Partnership”), the Subsidiary Guarantors (as defined in the Base Indenture) and The Bank of New York Mellon, a national banking association, as trustee (the “Trustee”). 

RECITALS: 
 WHEREAS, the
Partnership and the Subsidiary Guarantors have executed and delivered to the Trustee an Indenture, dated as of September 18, 2017 (the “Base Indenture” and as supplemented by this
[ 🌑 ] Supplemental Indenture, the “Indenture”), providing for the issuance by the Partnership from time to time of its notes to be issued in one or more series unlimited as to principal
amount, including the issuance of the Initial Notes; 
 WHEREAS, the Partnership has duly authorized and desires to cause to be established
pursuant to the Base Indenture and this [ 🌑 ] Supplemental Indenture a new series of notes; 

WHEREAS, Sections 2.01 and 2.04 of the Base Indenture permit the execution of indentures supplemental thereto to establish the form and terms
of notes of any series; 
 WHEREAS, pursuant to Section 9.01 of the Base Indenture, the Partnership has requested and hereby requests
that the Trustee join in the execution of this [ 🌑 ] Supplemental Indenture to establish the form and terms of the Notes (as defined below) and the Trustee is authorized to execute and deliver
this [ 🌑 ] Supplemental Indenture; 
 WHEREAS, all things necessary have been done to
make the Notes, when executed by the Partnership and authenticated and delivered hereunder and under the Base Indenture and duly issued by the Partnership, the valid obligations of the Partnership and the Subsidiary Guarantors, and to make this
[ 🌑 ] Supplemental Indenture a valid agreement of the Partnership and the Subsidiary Guarantors enforceable in accordance with its terms. 

NOW, THEREFORE, in consideration of the premises, agreements and obligations set forth herein and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree, for the equal and proportionate benefit of all Holders of the Notes, as follows: 

  
 A-3 

 ARTICLE I. 

RELATION TO BASE INDENTURE; DEFINITIONS 

Section 1.01 Relation to Base Indenture. 

With respect to the Notes (as defined below), this [ 🌑 ] Supplemental Indenture
constitutes an integral part of the Base Indenture. 
 Section 1.02 Generally. 

The rules of interpretation set forth in the Base Indenture shall be applied hereto as if set forth in full herein. 

Section 1.03 Definition of Certain Terms 

Capitalized terms used herein and not otherwise defined herein shall have the respective meanings ascribed to them in the Base Indenture. 

ARTICLE II. 
 GENERAL
TERMS OF THE NOTES 
 Section 2.01 Form. 

The Notes and the Trustee’s certificates of authentication included therein shall be substantially in the form set forth on Exhibit
A-1 or Exhibit A-2 to this [ 🌑 ] Supplemental Indenture, which is hereby incorporated into this [ 🌑 ] Supplemental Indenture. The terms and provisions contained in the Notes shall constitute, and are hereby expressly made, a part of this [ 🌑 ]
Supplemental Indenture and to the extent applicable, the Partnership, the Subsidiary Guarantors and the Trustee, by their execution and delivery of this [ 🌑 ] Supplemental Indenture, expressly
agree to such terms and provisions and to be bound thereby. 
 The Notes shall be issued upon original issuance in whole in the form of one
or more Global Notes. Each Global Note shall represent such of the outstanding Notes as shall be specified therein and shall provide that it shall represent the aggregate amount of outstanding Notes from time to time endorsed thereon and that the
aggregate amount of outstanding Notes represented thereby may from time to time be reduced or increased, as appropriate, to reflect exchanges and redemptions. 

The Partnership initially appoints The Depository Trust Company to act as Depositary with respect to the Global Notes. 

Section 2.02 Title, Amount and Payment of Principal and Interest. 

(a) The Notes shall be entitled the “[ 🌑 ]% Senior Notes due 20[ 🌑 ]”. The Trustee shall authenticate and deliver (i) the Notes for original issue on the date hereof (the “Initial Notes”) in the aggregate principal amount of $[ 🌑 ], and (ii) additional Notes (the “Additional Notes”) for original issue from time to time after the date hereof in such principal amounts as may be specified in a Partnership Order
described in this paragraph, which will be 

  
 A-4 

 
part of the same series as the Initial Notes and which will have the same terms (except for the issue date, issue price and, in some cases, the initial interest accrual date and the first
Interest Payment Date), in each case upon a Partnership Order for the authentication and delivery thereof and satisfaction of the other provisions of Section 2.04 of the Base Indenture. Such order shall specify the amount of the Notes to be
authenticated, the date on which the original issue of Notes is to be authenticated, and the name or names of the initial Holder or Holders. The aggregate principal amount of Notes that may be outstanding at any time may not exceed $[ 🌑 ] plus such additional principal amounts as may be issued and authenticated pursuant to clause (ii) of this paragraph (except as provided in Section 2.09 of the Indenture). The Original Notes and
any additional Notes issued and authenticated pursuant to clause (ii) of this paragraph shall constitute a single series of notes for all purposes under the Indenture (collectively, the “Notes”). 

(b) The principal amount of each Note shall be payable on [ 🌑 ]. Each Note shall bear
interest from the date of original issuance, or the most recent date to which interest has been paid, at the fixed rate of [ 🌑 ]% per annum. The dates on which interest on the Notes shall be
payable shall be [ 🌑 ] and [ 🌑 ] of each year, commencing [ 🌑 ] (the “Interest
Payment Dates”). The regular record date for interest payable on the Notes on any Interest Payment Date shall be [ 🌑 ] and [ 🌑 ], as the
case may be, next preceding such Interest Payment Date. 
 (c) Payments of principal of, premium, if any, and interest due on the Notes
representing Global Notes on any Interest Payment Date or at maturity will be made available to the Trustee by 10:00 a.m., New York City time, on such date, unless such date falls on a day which is not a Business Day, in which case such payments
will be made available to the Trustee by 10:00 a.m., New York City time, on the next Business Day. As soon as possible thereafter, the Trustee will make such payments to the Depositary. 

Section 2.03 Transfer and Exchange. 

The transfer and exchange of Global Notes or beneficial interests therein shall be effected through the Depositary, in accordance with
Section 2.08 of the Base Indenture and the rules and procedures of the Depositary therefor, which shall include restrictions on transfer comparable to those set forth therein and herein to the extent required by the Securities Act of 1933, as
amended. 
 ARTICLE III. 

MISCELLANEOUS PROVISIONS 

Section 3.01 Ratification of Base Indenture. 

The Base Indenture, as supplemented by this [ 🌑 ] Supplemental Indenture, is in all
respects ratified and confirmed, and this [ 🌑 ] Supplemental Indenture shall be deemed part of the Base Indenture in the manner and to the extent herein and therein provided. 

Section 3.02 Trustee Not Responsible for Recitals. 

The recitals contained herein and in the Notes, except with respect to the Trustee’s certificates of authentication, shall be taken as the
statements of the Partnership, and the Trustee assumes no responsibility for the correctness of the same. The Trustee makes no representations as to the validity, adequacy or sufficiency of this
[ 🌑 ] Supplemental Indenture or of the Notes. The Trustee shall not be accountable for the use or application by the Partnership of the Notes or of the proceeds thereof. 

  
 A-5 

 Section 3.03 Table of Contents, Headings, etc. 

The table of contents and headings of the Articles and Sections of this [ 🌑 ] Supplemental
Indenture have been inserted for convenience of reference only, are not to be considered a part hereof and shall in no way modify or restrict any of the terms or provisions hereof. 

Section 3.04 Counterpart Originals. 

The parties may sign any number of copies of this [ 🌑 ] Supplemental Indenture. Each
signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of this [ 🌑 ] Supplemental Indenture and of signature pages by facsimile or
electronic (i.e., “pdf” or “tif”) transmission shall constitute effective execution and delivery of this [ 🌑 ] Supplemental Indenture as to the parties hereto and may be used
in lieu of the original Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or electronic (i.e., “pdf” or “tif”) transmission shall be deemed to be their original signatures for all purposes 

Section 3.05 Governing Law. 

THIS [ 🌑 ] SUPPLEMENTAL INDENTURE AND THE NOTES SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. 
 Section 3.06 Trust Indenture Act Controls. 

Upon registration of the Notes in accordance with the Registration Rights Agreement, if any provision of the Supplemental Indenture limits,
qualifies, or conflicts with another provision that is required to be included in the Indenture by the TIA, the required provision shall control. 

(Signature Pages Follow) 

  
 A-6 

 IN WITNESS WHEREOF, the parties hereto have caused this
[ 🌑 ] Supplemental Indenture to be duly executed as of the day and year first above written. 
  

			
	 CHENIERE ENERGY PARTNERS, L.P.

	By its general partner, CHENIERE ENERGY PARTNERS GP, LLC
		
		 	  
 Name:

		 	Title:
	
	 [SUBSIDIARY GUARANTORS]

		
		 	  
 Name:

		 	Title:

 [Signature Page to
[ 🌑 ] Supplemental Indenture] 

 
			
	 THE BANK OF NEW YORK MELLON,
 as
Trustee

		
		 	  
 Name:

Title:

 [Signature Page to
[ 🌑 ] Supplemental Indenture] 
  

 EXHIBIT A-1 

FORM OF NOTE 
 [FACE OF
NOTE] 
 [Insert the Global Note Legend, if applicable pursuant to the provisions of the Indenture] [Insert the Private Placement Legend, if
applicable pursuant to the provisions of the Indenture] 
  

			
	No.	  	$

 CUSIP: [ 🌑 ] 

ISIN: [ 🌑 ] 

CHENIERE ENERGY PARTNERS, L.P. 

[ 🌑 ]% SENIOR NOTES DUE 20[ 🌑 ] 
 CHENIERE ENERGY PARTNERS, L.P., a Delaware limited partnership (the
“Partnership,” which term includes any successor under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede & Co.* or its registered assigns, the principal sum of [ ] U.S. dollars ($[
]), [or such greater or lesser principal sum as is shown on the attached Schedule of Increases and Decreases in Global Note]*, on [ 🌑 ] in such coin and currency of the United States of America as
at the time of payment shall be legal tender for the payment of public and private debts, and to pay interest thereon at an annual rate of [ 🌑 ]% payable on
[ 🌑 ] and [ 🌑 ] of each year, to the person in whose name the Note is registered at the close of business on the record date for such interest,
which shall be the preceding [ 🌑 ] and [ 🌑 ], respectively, payable commencing on [ 🌑 ],
with interest accruing from [ 🌑 ], or the most recent date to which interest shall have been paid. 
  

 

	*	To be included in a Global Note. 

 Reference is made to the further provisions of this Note set
forth on the reverse hereof. Such further provisions shall for all purposes have the same effect as though fully set forth at this place. 

The statements in the legends set forth in this Note are an integral part of the terms of this Note and by acceptance hereof the Holder of
this Note agrees to be subject to, and bound by, the terms and provisions set forth in each such legend. 
 This Note is issued in respect
of a series of Notes of an initial aggregate principal amount of $[ 🌑 ] designated as the [ 🌑 ]% Senior Notes due 20[ 🌑 ] of the Partnership (the “[ 🌑 ]% Series Notes”) and is governed by the Indenture dated as of September 18, 2017 (the
“Base Indenture”), duly executed and delivered by the Partnership, as issuer, the Subsidiary Guarantors (as defined in the Base Indenture) party thereto and The Bank of New York Mellon, as trustee (the “Trustee”) as
supplemented by the [ 🌑 ]Supplemental Indenture dated as of [ 🌑 ], duly 

  
 A-1-1 

 
executed by the Partnership, the Subsidiary Guarantors party thereto and the Trustee (the “[ 🌑 ]Supplemental Indenture”, and
together with the Base Indenture, the “Indenture”). The terms of the Indenture are incorporated herein by reference. This Note shall in all respects be entitled to the same benefits as Definitive Notes under the Indenture. 

Upon registration of the Notes in accordance with the applicable registration rights agreement, if and to the extent any provision of the
Indenture limits, qualifies or conflicts with any other provision of the Indenture that is required to be included in the Indenture or is deemed applicable to the Indenture by virtue of the provisions of the Trust Indenture Act of 1939, as amended
(the “TIA”), such required provision shall control. 
 This Note shall not be valid or become obligatory for any purpose
until the Trustee’s Certificate of Authentication hereon shall have been manually signed by the Trustee under the Indenture. 

  
 A-1-2 

 IN WITNESS WHEREOF, the parties hereto have caused this instrument to be duly executed by its
sole General Partner. 
 Dated: [ 🌑 ] 

 

			
	CHENIERE ENERGY PARTNERS, L.P.
	
	By its general partner, CHENIERE ENERGY PARTNERS GP, LLC

 
			
		
	By:	 	  

	Name:	 	
	Title:	 	

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION: 

This is one of the Debt Securities of the series designated therein referred to in the within-mentioned Indenture. 

 

			
	 THE BANK OF NEW YORK MELLON,

 
 as Trustee

		
	By:	 	  

		 	 Authorized Signatory

  
 A-1-3 

 [REVERSE OF NOTE] 

CHENIERE ENERGY PARTNERS, L.P. 

[ 🌑 ]% SENIOR NOTES DUE
20[ 🌑 ] 
 This Note is one of a duly authorized series of the
[ 🌑 ]% Series Notes hereinafter specified, all issued or to be issued under and pursuant to the Indenture, to which Indenture reference is hereby made for a description of the rights, limitations
of rights, obligations, duties and immunities thereunder of the Trustee, the Partnership and the Holders of the [ 🌑 ]% Series Notes. 

 

	 	1.	Interest. 

 The Partnership promises to pay interest in cash on the principal amount of
this Note at the rate of [ 🌑 ]% per annum until maturity and shall pay the Additional Interest, if any, payable pursuant to Section 6 of the Registration Rights Agreement referred to below.

 The Partnership will pay interest and Additional Interest, if any, semi-annually in arrears on
[ 🌑 ] and [ 🌑 ] of each year, or if such day is not a Business Day, on the next succeeding Business Day (each an “Interest Payment
Date”), commencing [ 🌑 ]. Interest on the [ 🌑 ]% Series Notes will accrue from the most recent date to which interest has been paid
or, if no interest has been paid on the Notes, from [ 🌑 ]. Interest will be computed on the basis of a 360-day year consisting of twelve 30-day months. The Partnership shall pay interest (including post-petition interest in any proceeding under any applicable bankruptcy laws) on overdue installments of interest (without regard to any applicable grace
period) and on overdue principal and premium, if any, from time to time on demand at the same rate per annum, in each case to the extent lawful. 
  

	 	2.	Method of Payment. 

 The Partnership shall pay interest on the [ 🌑 ]% Series Notes (except Defaulted Interest) and Additional Interest, if any, to the persons who are the registered Holders at the close of business on
[ 🌑 ] and [ 🌑 ] immediately preceding the Interest Payment Date. Any such interest not so punctually paid or duly provided for
(“Defaulted Interest”) may be paid to the persons who are registered Holders at the close of business on a special record date for the payment of such Defaulted Interest, or in any other lawful manner not inconsistent with the
requirements of any securities exchange on which such [ 🌑 ]% Series Notes may then be listed if such manner of payment shall be deemed practicable by the Trustee, as more fully provided in the
Indenture. The Partnership shall pay principal, premium, if any, and interest and Additional Interest, if any, in such coin or currency of the United States of America as at the time of payment shall be legal tender for payment of public and private
debts. Payments in respect of a Global Note (including principal, premium, if any, interest and Additional Interest) will be made by wire transfer of immediately available funds to the accounts specified by the Depositary. Payments in respect of
[ 🌑 ]% Series Notes in definitive form (including principal, premium, if any, and interest) will be made at the office or agency of the Partnership maintained for such purpose within the City of
Philadelphia, which initially will be at the corporate trust office of the Trustee located at 500 

  
 A-1-1 

 
Ross Street, 12th Floor, Pittsburgh, Pennsylvania 15262, or, at the option of the Partnership, payment of interest or Additional Interest may
be made by check mailed to the Holders on the relevant record date at their addresses set forth in the register of Holders maintained by the Registrar or at the option of the Holder, payment of interest on
[ 🌑 ]% Series Notes in definitive form will be made by wire transfer of immediately available funds to any account maintained in the United States, provided such Holder has requested such method
of payment and provided timely wire transfer instructions to the Paying Agent. The Holder must surrender this Note to a Paying Agent to collect payment of principal. 
  

	 	3.	Paying Agent and Registrar. 

 Initially, The Bank of New York Mellon will act as Paying
Agent and Registrar. The Partnership may change any Paying Agent or Registrar at any time upon notice to the Trustee and the Holders. The Partnership may act as Paying Agent. 
  

	 	4.	Indenture. 

 This Note is one of a duly authorized issue of Notes of the Partnership
issued and to be issued in one or more series under the Indenture. 
 Capitalized terms herein are used as defined in the Indenture unless
otherwise defined herein. The terms of the [ 🌑 ]% Series Notes include those stated in the Base Indenture, those made part of the Indenture by reference to the TIA, as in effect on the date of the
Base Indenture, and those terms stated in the [ 🌑 ] Supplemental Indenture. The [ 🌑 ]% Series Notes are subject to all such terms (including
the Guarantees set forth in Article X of the Base Indenture), and Holders of [ 🌑 ]% Series Notes are referred to the Base Indenture, the [ 🌑 ]
Supplemental Indenture and the TIA for a statement of them. The [ 🌑 ]% Series Notes will initially be secured on a first-priority basis with the First Lien Obligations pursuant to Collateral
Documents referred to in the Indenture and are limited to an initial aggregate principal amount of $[ 🌑 ]; provided, however, that the authorized aggregate principal amount of such series
may be increased from time to time as provided in the [ 🌑 ] Supplemental Indenture. 
  

	 	5.	Redemption. 

 At any time prior to
[ 🌑 ], the Partnership may on any one or more occasions redeem up to [ 🌑 ]% of the aggregate principal amount of the [ 🌑 ]% Series Notes, upon not less than 30 nor more than 60 days’ notice, at a redemption price of [ 🌑 ]% of the principal amount of the [ 🌑 ]% Series Notes redeemed, plus accrued and unpaid interest, if any, to but excluding the redemption date (subject to the rights of Holders on the relevant record date to receive interest due on the
relevant Interest Payment Date), with the proceeds of one or more Equity Offerings; provided that: 
  

	 	(1)	at least [ 🌑]% of the aggregate principal amount of the [ 🌑 ]% Series Notes issued on the Issue Date (excluding
[ 🌑 ]% Series Notes held by the Partnership and its Subsidiaries) remains outstanding immediately after the occurrence of such redemption; and 

  
 A-1-2 

	 	(2)	the redemption occurs within 120 days of the date of the closing of such Equity Offering. 

At any time prior to [ 🌑 ], the Partnership may on any one or more
occasions redeem all or a part of the [ 🌑 ]% Series Notes, upon not less than 30 nor more than 60 days’ prior notice, at a redemption price equal to 100% of the principal amount of [ 🌑 ]% Series Notes redeemed, plus the Applicable Premium as of, and accrued and unpaid interest, if any, to but excluding, the redemption date, subject to the rights of Holders on the relevant record date to
receive interest due on the relevant Interest Payment Date. 
 Except pursuant to the preceding two paragraphs, the [ 🌑 ]% Series Notes will not be redeemable at the Partnership’s option prior to [ 🌑 ]. The Partnership is not prohibited, however, from acquiring the
[ 🌑 ]% Series Notes in market transactions by means other than a redemption, whether pursuant to a tender offer or otherwise. 

On or after [ 🌑 ], the Partnership may on any one or more occasions redeem
all or a part of the [ 🌑 ]% Series Notes upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as percentages of principal amount) set forth below, plus
accrued and unpaid interest, if any, on the [ 🌑 ]% Series Notes redeemed, to but excluding the applicable redemption date, if redeemed during the 12-month
period beginning on [ 🌑 ] of the years indicated below (subject to the rights of Holders on the relevant record date to receive interest on the relevant Interest Payment Date): 

 

					
	 Year
	  	 	Percentage	 
	 [ 🌑 ]
	  	 	[ 🌑 ]	% 
	 [ 🌑 ]
	  	 	[ 🌑 ]	% 
	 [ 🌑 ] and thereafter
	  	 	[ 🌑 ]	% 

 [ 🌑 ]% Series Notes called for redemption
become due on the redemption date. Notices of redemption will be mailed at least 30 but not more than 60 days before the redemption date to each Holder of the [ 🌑 ]% Series Notes to be redeemed at
its registered address. The notice of redemption for the [ 🌑 ]% Series Notes will state, among other things, the amount of [ 🌑 ]% Series Notes
to be redeemed, the redemption date, the method of calculating the redemption price and each place that payment will be made upon presentation and surrender of [ 🌑 ]% Series Notes to be redeemed.
Unless we default in payment of the redemption price, interest will cease to accrue on any [ 🌑 ]% Series Notes that have been called for redemption on the redemption date. For purposes of
determining the redemption price, the following definitions are applicable: 
 “Applicable Premium” means, with respect to
any note on any redemption date, the greater of: 
  

	 	(1)	1.0% of the principal amount of such note; or 

  
 A-1-3 

	 	(2)	the excess of: 

  

	 	(a)	the present value at such redemption date of (i) the redemption price of such [ 🌑 ]% Series Notes at [ 🌑 ]
(such redemption prices being set forth in the tables appearing above) plus (ii) all required remaining scheduled interest payments due on such note through [ 🌑 ] (in each case
excluding accrued but unpaid interest to but excluding the redemption date), computed using a discount rate equal to the Treasury Yield as of such redemption date plus [ 🌑 ] basis points; over

  

	 	(b)	the principal amount of the note. 

 “Comparable Treasury Issue”
means the United States Treasury security selected by the Independent Investment Banker as having a maturity comparable to the remaining term of the [ 🌑 ]% Series Notes to be redeemed that would
be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the
[ 🌑 ]% Series Notes to be redeemed; provided, however, that if no maturity is within three months before or after the maturity date for such
[ 🌑 ]% Series Notes, yields for the two published maturities most closely corresponding to such United States Treasury security will be determined and the treasury rate will be interpolated or
extrapolated from those yields on a straight line basis rounding to the nearest month. 
 “Comparable Treasury
Price” means, with respect to any redemption date, (a) the average of the Reference Treasury Dealer Quotations for the redemption date, after excluding the highest and lowest Reference Treasury Dealer Quotations, or (b) if the
Independent Investment Banker obtains fewer than four Reference Treasury Dealer Quotations, the average of all such quotations. 

“Independent Investment Banker” means [ 🌑 ] and its
successors or, if such firm is not willing and able to select the applicable Comparable Treasury Issue, an independent investment banking institution of national standing appointed by the Partnership. 

“Reference Treasury Dealer” means [ 🌑 ] and four
additional primary U.S. government securities dealers (each, a “Primary Treasury Dealer”) selected by the Partnership; provided, however, that if such firm or any such successor, as the case may be, shall cease to be a
primary U.S. government securities dealer, the Partnership will substitute therefor another Primary Treasury Dealer. 

“Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any
redemption date for the [ 🌑 ]% Series Notes, an average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue for the [ 🌑 ]% Series Notes to be redeemed (expressed in each case as a percentage of its principal amount) quoted in writing to the Independent Investment Banker by such Reference Treasury Dealer at 5:00 p.m., New
York City time, on the third business day preceding such redemption date. 

  
 A-1-4 

 “Treasury Yield” means, with respect to any redemption date,
(a) the yield, under the heading which represents the average for the immediately preceding week, appearing in the most recently published statistical release designated “H.15(519)” or any successor publication which is published
weekly by the Board of Governors of the Federal Reserve System and which establishes yields on actively traded United States Treasury securities adjusted to constant maturity under the caption “Treasury Constant Maturities,” for the
maturity corresponding to the Comparable Treasury Issue; or (b) if the release (or any successor release) is not published during the week preceding the calculation date or does not contain these yields, the rate per annum equal to the
semi-annual equivalent yield to maturity (computed as of the third business day immediately preceding such redemption date) of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its
principal amount) equal to the applicable Comparable Treasury Price for such redemption date. 
  

	 	6.	Repurchase of Notes at the Option of the Holders upon Change of Control Triggering Event and Asset Sale Triggering Event 

Upon the occurrence of a Change of Control Triggering Event, each Holder shall have the right, subject to certain conditions specified in the
Indenture, to require the Partnership to repurchase all or any part of such Holder’s Notes at a purchase price in cash equal to 101% of the principal amount thereof, plus accrued and unpaid interest, on the Notes repurchased to, but excluding,
the date of purchase (subject to the right of the Holders of record on the relevant record date to receive interest, if any, due on the relevant Interest Payment Date), as provided in, and subject to the terms of, the Indenture. In accordance with
Section 4.09 of the Indenture, the Partnership will be required to offer to purchase Notes upon the occurrence of certain Asset Sale Triggering Events. 
  

	 	7.	Denominations; Transfer; Exchange. 

 The
[ 🌑 ]% Series Notes are to be issued in registered form, without coupons, in denominations of $2,000 and integral multiples of $1,000 in excess of $2,000. A Holder may register the transfer of, or
exchange, [ 🌑 ]% Series Notes in accordance with the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay any
taxes and fees required by law or permitted by the Indenture. 
  

	 	8.	Person Deemed Owners. 

 The registered Holder of a Note may be treated as the owner of it
for all purposes. 
  

	 	9.	Amendment; Supplement; Waiver. 

 Subject to certain exceptions, the Indenture may be
amended or supplemented, and any existing Event of Default or compliance with any provision may be waived, with the consent of the Holders of a majority in principal amount of the outstanding Debt Securities of each series affected. Without consent
of any Holder of a Note, the parties thereto may amend or supplement the Indenture to, among other things, cure any ambiguity or omission, to correct any defect or inconsistency, or to make any other change that does not adversely affect the rights
of any 

  
 A-1-5 

 
Holder of a Note. Any such consent or waiver by the Holder of this Note (unless revoked as provided in the Indenture) shall be conclusive and binding upon such Holder and upon all future Holders
and owners of this Note and any [ 🌑 ]% Series Notes which may be issued in exchange or substitution herefor, irrespective of whether or not any notation thereof is made upon this Note or such
other [ 🌑 ]% Series Notes. 
  

	 	10.	Additional Rights of Holders of Restricted Global Notes and Restricted Definitive Notes.  

In addition to the rights provided to Holders of Notes under the Indenture, Holders of Restricted Global Notes and Restricted Definitive Notes
will have all the rights set forth in the Registration Rights Agreement dated as of [ 🌑 ], between the Partnership and the other parties named on the signature pages thereof or, in the case of
Additional Notes, Holders of Restricted Global Notes and Restricted Definitive Notes will have the rights set forth in one or more registration rights agreements, if any, among the Partnership, the Subsidiary Guarantors, if any, and the other
parties thereto, relating to rights given by the Partnership and the Subsidiary Guarantors, if any, to the purchasers of any Additional Notes (collectively, the “Registration Rights Agreement”). By such Holders’ acceptance of
Restricted Global Notes or Restricted Definitive Notes, such Holder acknowledges and agrees to the provisions of the Registration Rights Agreement, including without limitation the obligations of the Holders with respect to indemnification of the
Partnership and the Subsidiary Guarantors to the extent provided therein. 
  

	 	11.	Defaults and Remedies. 

 Certain events of bankruptcy or insolvency are Events of Default
that will result in the principal amount of the [ 🌑 ]% Series Notes, together with premium, if any, and accrued and unpaid interest thereon, becoming due and payable immediately upon the
occurrence of such Events of Default. If any other Event of Default with respect to the [ 🌑 ]% Series Notes occurs and is continuing, then in every such case the Trustee or the Holders of not less
than 33 1/3% in aggregate principal amount of the [ 🌑 ]% Series Notes then outstanding may declare the principal amount of all the [ 🌑 ]%
Series Notes, together with premium, if any, and accrued and unpaid interest thereon, to be due and payable immediately in the manner and with the effect provided in the Indenture. Notwithstanding the preceding sentence, however, if at any time
after such a declaration of acceleration has been made, the Holders of a majority in principal amount of the outstanding [ 🌑 ]% Series Notes, by written notice to the Trustee, may rescind such
declaration and annul its consequences if the rescission would not conflict with any judgment or decree of a court already rendered and if all Events of Default with respect to the [ 🌑 ]% Series
Notes, other than the nonpayment of the principal, premium, if any, or interest which has become due solely by such declaration acceleration, shall have been cured or shall have been waived. No such rescission shall affect any subsequent default or
shall impair any right consequent thereon. Holders of [ 🌑 ]% Series Notes may not enforce the Indenture or the [ 🌑 ]% Series Notes except as
provided in the Indenture. The Trustee may require indemnity or security satisfactory to it before it enforces the Indenture or the [ 🌑 ]% Series Notes. Subject to certain limitations, Holders of
a majority in aggregate principal amount of the [ 🌑 ]% Series Notes then outstanding may direct the Trustee in its exercise of any trust or power. 

  
 A-1-6 

	 	12.	Trustee Dealings with Partnership. 

 The Trustee under the Indenture, in its individual
or any other capacity, may make loans to, accept deposits from, and perform services for the Partnership or its Affiliates, and may otherwise deal with the Partnership or its Affiliates as if it were not the Trustee. 

13. Authentication. 
 This
Note shall not be valid until the Trustee signs the certificate of authentication on the other side of this Note. 
 14. Abbreviations
and Defined Terms. 
 Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as: TEN COM (tenant in
common), TEN ENT (tenants by the entireties), JT TEN (joint tenants with right of survivorship and not as tenants in common), CUST (Custodian), and U/G/M/A (Uniform Gifts to Minors Act). 

15. CUSIP Numbers. 

Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Partnership has caused CUSIP
numbers to be printed on the [ 🌑 ]% Series Notes as a convenience to the Holders of the [ 🌑 ]% Series Notes. No representation is made as to
the accuracy of such number as printed on the [ 🌑 ]% Series Notes and reliance may be placed only on the other identification numbers printed hereon. 

16. Absolute Obligation. 

No reference herein to the Indenture and no provision of this Note or the Indenture shall alter or impair the obligation of the Partnership,
which is absolute and unconditional, to pay the principal of, premium, if any, and interest on this Note in the manner, at the respective times, at the rate and in the coin or currency herein prescribed. 

17. No Recourse. 
 No
director, officer, employee, limited partner or shareholder, as such, of the Partnership or the General Partner shall have any personal liability in respect of the obligations of the Partnership under the
[ 🌑 ]% Series Notes, the Indenture or any Guarantee by reason of his, her or its status. Each Holder by accepting the [ 🌑 ]% Series Notes
waives and releases all such liability. The waiver and release are part of the consideration for issuance of the [ 🌑 ]% Series Notes. 

 

	 	18.	Governing Law. 

 This Note shall be construed in accordance with and governed by the laws
of the State of New York. 

  
 A-1-7 

 ABBREVIATIONS 

The following abbreviations, when used in the inscription on the face of this instrument, shall be construed as though they were written out
in full according to applicable laws or regulations: 
  

			
	 TEN COM—as tenants in common
	  	 UNIF GIFT MIN ACT -

		  	(Cust.)
	TEN ENT—as tenants by entireties	  	Custodian for:
		  	(Minor)
	 JT TEN—as joint tenants with right of survivorship and not as tenants in common
	  	Under Uniform Gifts to Minors Act of
		  	(State)

 ADDITIONAL ABBREVIATIONS MAY ALSO
BE USED THOUGH NOT IN THE ABOVE LIST. 

  
 A-1-8 

 ASSIGNMENT 

FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and transfer(s) unto 

PLEASE INSERT SOCIAL SECURITY OR OTHER 
 IDENTIFYING NUMBER OF
ASSIGNEE 
 Please print or type name and address including postal zip code of assignee: 

the within Note and all rights thereunder, hereby irrevocably constituting and appointing to transfer said Note on the books of the Partnership, with full
power of substitution in the premises. 
  

			
	Dated	  	Registered Holder

  
 A-1-9 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Note purchased by the Partnership pursuant to Section 4.08 or
Section 4.09 of the Indenture, check the appropriate box below: 
  

			
	 ☐Section 4.08
	  	☐Section 4.09
	 [Change of Control]
	  	[Asset Sale]

 If you want to elect to have only part of the Note purchased by the Partnership pursuant to
Section 4.08 or 4.09 of the Indenture, state the amount you elect to have purchased: 
 $ 

Date: 
  

	
	 Your
Signature:                                       
             
 (Sign exactly as your name
appears on the face of this Note)

	
	 Tax Identification No:

 Signature Guarantee*: 
  

 

	*	Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). 

  
 A-1-10 

 SCHEDULE OF INCREASES OR DECREASES 

IN GLOBAL NOTE* 
 The
following increases or decreases in this Global Note have been made: 
  

									
	 Date of Exchange
	 	 Amount of Decrease

in Principal Amount
 of this
Global
 Note
	 	 Amount of Increase

in Principal Amount
 of this
Global
 Note
	  	 Principal Amount of

this Global Note
 following
such
 decrease (or increase)
	  	 Signature of

authorized officer of

Trustee or Depositary

  

	*	To be included in a Global Note. 

  
 A-1-11 

 EXHIBIT A-2 

FORM OF NOTE 
 [FACE OF
NOTE] 
 [Insert the Global Note Legend, if applicable pursuant to the provisions of the Indenture] [Insert the Private Placement Legend, if
applicable pursuant to the provisions of the Indenture] [Insert the Regulation S Temporary Global Note Legend, if applicable pursuant to the provisions of the Indenture] 

 

			
	No.	  	$

 CUSIP: [ 🌑 ] 

ISIN: [ 🌑 ] 

CHENIERE ENERGY PARTNERS, L.P. 

[ 🌑 ]% SENIOR NOTES DUE 20[ 🌑 ] 
 CHENIERE ENERGY PARTNERS, L.P., a Delaware limited partnership (the
“Partnership,” which term includes any successor under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede & Co.* or its registered assigns, the principal sum of
[         ] U.S. dollars ($[         ]), [or such greater or lesser principal sum as is shown on the attached Schedule of Increases and Decreases in Regulation S
Temporary Global Note]*, on [ 🌑 ] in such coin and currency of the United States of America as at the time of payment shall be legal tender for the payment of public and private debts, and to pay
interest thereon at an annual rate of [ 🌑 ]% payable on [ 🌑 ] and [ 🌑 ] of each year, to
the person in whose name the Note is registered at the close of business on the record date for such interest, which shall be the preceding [ 🌑 ] and
[ 🌑 ], respectively, payable commencing on [ 🌑 ], with interest accruing from [ 🌑 ], or
the most recent date to which interest shall have been paid. 
  
  

	*	To be included in a Global Note. 

 Reference is made to the further provisions of this Note set
forth on the reverse hereof. Such further provisions shall for all purposes have the same effect as though fully set forth at this place. 

The statements in the legends set forth in this Note are an integral part of the terms of this Note and by acceptance hereof the Holder of
this Note agrees to be subject to, and bound by, the terms and provisions set forth in each such legend. 
 This Note is issued in respect
of a series of Notes of an initial aggregate principal amount of $[ 🌑 ] designated as the [ 🌑 ]% Senior Notes due 20[ 🌑 ] of the Partnership (the “[ 🌑 ]% Series Notes”) and is governed by the Indenture dated as of September 18, 2017 (the
“Base  

  
 A-2-1 

 
Indenture”), duly executed and delivered by the Partnership, as issuer, the Subsidiary Guarantors (as defined in the Base Indenture) party thereto and The Bank of New York Mellon, as
trustee (the “Trustee”) as supplemented by the [ 🌑 ] Supplemental Indenture dated as of [ 🌑 ], duly executed by the
Partnership, the Subsidiary Guarantors party thereto and the Trustee (the “[ 🌑 ] Supplemental Indenture”, and together with the Base
Indenture, the “Indenture”). The terms of the Indenture are incorporated herein by reference. This Note shall in all respects be entitled to the same benefits as Definitive Notes under the Indenture. 

Upon registration of the Notes in accordance with the applicable registration rights agreement, if and to the extent any provision of the
Indenture limits, qualifies or conflicts with any other provision of the Indenture that is required to be included in the Indenture or is deemed applicable to the Indenture by virtue of the provisions of the Trust Indenture Act of 1939, as amended
(the “TIA”), such required provision shall control. 
 This Note shall not be valid or become obligatory for any purpose
until the Trustee’s Certificate of Authentication hereon shall have been manually signed by the Trustee under the Indenture. 

  
 A-2-2 

 IN WITNESS WHEREOF, the parties hereto have caused this instrument to be duly executed by its
sole General Partner. 
 Dated: [ 🌑 ] 

 

			
	 CHENIERE ENERGY PARTNERS, L.P.

	By its general partner, CHENIERE ENERGY PARTNERS GP, LLC

 
			
		
	By:	 	  

	Name:	 	
	Title:	 	

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION: 

This is one of the Debt Securities of the series designated therein referred to in the within-mentioned Indenture. 

 

			
	 THE BANK OF NEW YORK MELLON,

 
 as Trustee

		
	By:	 	  

		 	Authorized Signatory

  
 A-2-3 

 [REVERSE OF NOTE] 

CHENIERE ENERGY PARTNERS, L.P. 

[ 🌑 ]% SENIOR NOTES DUE
20[ 🌑 ] 
 This Note is one of a duly authorized series of the
[ 🌑 ]% Series Notes hereinafter specified, all issued or to be issued under and pursuant to the Indenture, to which Indenture reference is hereby made for a description of the rights, limitations
of rights, obligations, duties and immunities thereunder of the Trustee, the Partnership and the Holders of the [ 🌑 ]% Series Notes. 

 

	 	1.	Interest. 

 The Partnership promises to pay interest in cash on the principal amount of
this Note at the rate of [ 🌑 ]% per annum until maturity and shall pay the Additional Interest, if any, payable pursuant to Section 6 of the Registration Rights Agreement referred to below.

 The Partnership will pay interest and Additional Interest, if any, semi-annually in arrears on
[ 🌑 ] and [ 🌑 ] of each year or if such day is not a Business Day, on the next succeeding Business Day (each an “Interest Payment
Date”), commencing [ 🌑 ]. Interest on the [ 🌑 ]% Series Notes will accrue from the most recent date to which interest has been paid
or, if no interest has been paid on the Notes, from [ 🌑 ]. Interest will be computed on the basis of a 360-day year consisting of twelve 30-day months. The Partnership shall pay interest (including post-petition interest in any proceeding under any applicable bankruptcy laws) on overdue installments of interest (without regard to any applicable grace
period) and on overdue principal and premium, if any, from time to time on demand at the same rate per annum, in each case to the extent lawful. 

Until this Regulation S Temporary Global Note is exchanged for one or more Regulation S Permanent Global Note, the Holder hereof shall not be
entitled to receive payments of interest hereon; until so exchanged in full, this Regulation S Temporary Global Note shall in all other respects be entitled to the same benefits as other Notes under the Indenture. 

 

	 	2.	Method of Payment. 

 The Partnership shall pay interest on the [ 🌑 ]% Series Notes (except Defaulted Interest) and Additional Interest, if any, to the persons who are the registered Holders at the close of business on
[ 🌑 ] and [ 🌑 ] immediately preceding the Interest Payment Date. Any such interest not so punctually paid or duly provided for
(“Defaulted Interest”) may be paid to the persons who are registered Holders at the close of business on a special record date for the payment of such Defaulted Interest, or in any other lawful manner not inconsistent with the
requirements of any securities exchange on which such [ 🌑 ]% Series Notes may then be listed if such manner of payment shall be deemed practicable by the Trustee, as more fully provided in the
Indenture. The Partnership shall pay principal, premium, if any, and interest and Additional Interest, if any, in such coin or currency of the United States of America as at the time of payment shall be legal tender for payment of public and private
debts. Payments in respect of a Regulation S 

  
 Exhibit A-2-1 

 
Temporary Global Note (including principal, premium, if any, interest and Additional Interest) will be made by wire transfer of immediately available funds to the accounts specified by the
Depositary. Payments in respect of [ 🌑 ]% Series Notes in definitive form (including principal, premium, if any, and interest) will be made at the office or agency of the Partnership maintained
for such purpose within the City of Philadelphia, which initially will be at the corporate trust office of the Trustee located at 500 Ross Street, 12th Floor, Pittsburgh, Pennsylvania 15262, or,
at the option of the Partnership, payment of interest or Additional Interest may be made by check mailed to the Holders on the relevant record date at their addresses set forth in the register of Holders maintained by the Registrar or at the option
of the Holder, payment of interest on [ 🌑 ]% Series Notes in definitive form will be made by wire transfer of immediately available funds to any account maintained in the United States, provided
such Holder has requested such method of payment and provided timely wire transfer instructions to the Paying Agent. The Holder must surrender this Note to a Paying Agent to collect payment of principal. 

 

	 	3.	Paying Agent and Registrar. 

 Initially, The Bank of New York Mellon will act as Paying
Agent and Registrar. The Partnership may change any Paying Agent or Registrar at any time upon notice to the Trustee and the Holders. The Partnership may act as Paying Agent. 
  

	 	4.	Indenture. 

 This Note is one of a duly authorized issue of Notes of the Partnership
issued and to be issued in one or more series under the Indenture. 
 Capitalized terms herein are used as defined in the Indenture unless
otherwise defined herein. The terms of the [ 🌑 ]% Series Notes include those stated in the Base Indenture, those made part of the Indenture by reference to the TIA, as in effect on the date of the
Base Indenture, and those terms stated in the [ 🌑 ] Supplemental Indenture. The [ 🌑 ]% Series Notes are subject to all such terms (including
the Guarantees set forth in Article X of the Base Indenture), and Holders of [ 🌑 ]% Series Notes are referred to the Base Indenture, the [ 🌑 ]
Supplemental Indenture and the TIA for a statement of them. The [ 🌑 ]% Series Notes will initially be secured on a first-priority basis with the First Lien Obligations pursuant to Collateral
Documents referred to in the Indenture and are limited to an initial aggregate principal amount of $[ 🌑 ]; provided, however, that the authorized aggregate principal amount of such series
may be increased from time to time as provided in the [ 🌑 ] Supplemental Indenture. 
  

	 	5.	Redemption. 

 At any time prior to
[ 🌑 ] the Partnership may on any one or more occasions redeem up to [ 🌑 ]% of the aggregate principal amount of the [ 🌑 ]% Series Notes, upon not less than 30 nor more than 60 days’ notice, at a redemption price of [ 🌑 ]% of the principal amount of the [ 🌑 ]% Series Notes redeemed, plus accrued and unpaid interest, if any, to but excluding the redemption date (subject to the rights of Holders on the relevant record date to receive interest due on the
relevant Interest Payment Date), with the proceeds of one or more Equity Offerings; provided that: 

  
 Exhibit A-2-2 

	 	(3)	at least [ 🌑 ]% of the aggregate principal amount of the [ 🌑 ]% Series Notes issued on the Issue Date (excluding
[ 🌑 ]% Series Notes held by the Partnership and its Subsidiaries) remains outstanding immediately after the occurrence of such redemption; and 

 

	 	(4)	the redemption occurs within 120 days of the date of the closing of such Equity Offering. 

 At
any time prior to [ 🌑 ], the Partnership may on any one or more occasions redeem all or a part of the [ 🌑 ]% Series Notes, upon not less than
30 nor more than 60 days’ prior notice, at a redemption price equal to 100% of the principal amount of [ 🌑 ]% Series Notes redeemed, plus the Applicable Premium as of, and accrued and unpaid
interest, if any, to but excluding, the redemption date, subject to the rights of Holders on the relevant record date to receive interest due on the relevant Interest Payment Date. 

Except pursuant to the preceding two paragraphs, the [ 🌑 ]% Series Notes will not be
redeemable at the Partnership’s option prior to [ 🌑 ]. The Partnership is not prohibited, however, from acquiring the [ 🌑 ]% Series Notes
in market transactions by means other than a redemption, whether pursuant to a tender offer or otherwise. 
 On or after [ 🌑 ], the Partnership may on any one or more occasions redeem all or a part of the [ 🌑 ]% Series Notes upon not less than 30 nor more than 60 days’
notice, at the redemption prices (expressed as percentages of principal amount) set forth below, plus accrued and unpaid interest, if any, on the [ 🌑 ]% Series Notes redeemed, to but excluding the
applicable redemption date, if redeemed during the 12-month period beginning on [ 🌑 ] of the years indicated below (subject to the rights of Holders on the
relevant record date to receive interest on the relevant Interest Payment Date): 
  

					
	 Year
	  	Percentage	 
	 [ 🌑 ]
	  	 	[ 	🌑 ]% 
	 [ 🌑 ]
	  	 	[ 	🌑 ]% 
	 [ 🌑 ] and thereafter
	  	 	[ 	🌑 ]% 

 [ 🌑 ]% Series Notes called for redemption become due on
the redemption date. Notices of redemption will be mailed at least 30 but not more than 60 days before the redemption date to each Holder of the [ 🌑 ]% Series Notes to be redeemed at its
registered address. The notice of redemption for the [ 🌑 ]% Series Notes will state, among other things, the amount of [ 🌑 ]% Series Notes to
be redeemed, the redemption date, the method of calculating the redemption price and each place that payment will be made upon presentation and surrender of [ 🌑 ]% Series Notes to be redeemed.
Unless we default in payment of the redemption price, interest will cease to accrue on any [ 🌑 ]% Series Notes that have been called for redemption on the redemption date. For purposes of
determining the redemption price, the following definitions are applicable: 

  
 Exhibit A-2-3 

 “Applicable Premium” means, with respect to any note on any redemption date, the
greater of: 
  

	 	(3)	1.0% of the principal amount of such note; or 

  

	 	(4)	the excess of: 

  

	 	(a)	the present value at such redemption date of (i) the redemption price of such [ 🌑 ]% Series Notes at [ 🌑 ]
(such redemption prices being set forth in the tables appearing above) plus (ii) all required remaining scheduled interest payments due on such note through [ 🌑 ] (in each case
excluding accrued but unpaid interest to but excluding the redemption date), computed using a discount rate equal to the Treasury Yield as of such redemption date plus [ 🌑 ] basis points; over

  

	 	(b)	the principal amount of the note. 

 “Comparable Treasury Issue” means the
United States Treasury security selected by the Independent Investment Banker as having a maturity comparable to the remaining term of the [ 🌑 ]% Series Notes to be redeemed that would be
utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the
[ 🌑 ]% Series Notes to be redeemed; provided, however, that if no maturity is within three months before or after the maturity date for such
[ 🌑 ]% Series Notes, yields for the two published maturities most closely corresponding to such United States Treasury security will be determined and the treasury rate will be interpolated or
extrapolated from those yields on a straight line basis rounding to the nearest month. 
 “Comparable Treasury Price”
means, with respect to any redemption date, (a) the average of the Reference Treasury Dealer Quotations for the redemption date, after excluding the highest and lowest Reference Treasury Dealer Quotations, or (b) if the Independent
Investment Banker obtains fewer than four Reference Treasury Dealer Quotations, the average of all such quotations. 
 “Independent
Investment Banker” means [ 🌑 ] and its successors or, if such firm is not willing and able to select the applicable Comparable Treasury Issue, an independent investment banking
institution of national standing appointed by the Partnership. 
 “Reference Treasury Dealer” means [ 🌑 ] and four additional primary U.S. government securities dealers (each, a “Primary Treasury Dealer”) selected by the Partnership; provided, however, that if such firm or any such
successor, as the case may be, shall cease to be a primary U.S. government securities dealer, the Partnership will substitute therefor another Primary Treasury Dealer. 

“Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any redemption date for the
[ 🌑 ]% Series Notes, an average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue for the
[ 🌑 ]% Series Notes to be redeemed (expressed in each case as a percentage of its principal amount) quoted in writing to the Independent Investment Banker by such Reference Treasury Dealer at 5:00
p.m., New York City time, on the third business day preceding such redemption date. 

  
 Exhibit A-2-4 

 “Treasury Yield” means, with respect to any redemption date, (a) the yield,
under the heading which represents the average for the immediately preceding week, appearing in the most recently published statistical release designated “H.15(519)” or any successor publication which is published weekly by the Board of
Governors of the Federal Reserve System and which establishes yields on actively traded United States Treasury securities adjusted to constant maturity under the caption “Treasury Constant Maturities,” for the maturity corresponding to the
Comparable Treasury Issue; or (b) if the release (or any successor release) is not published during the week preceding the calculation date or does not contain these yields, the rate per annum equal to the semi-annual equivalent yield to
maturity (computed as of the third business day immediately preceding such redemption date) of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the
applicable Comparable Treasury Price for such redemption date. 
  

	 	6.	Repurchase of Notes at the Option of the Holders upon Change of Control Triggering Event and Asset Sale Triggering Event 

Upon the occurrence of a Change of Control Triggering Event, each Holder shall have the right, subject to certain conditions specified in the
Indenture, to require the Partnership to repurchase all or any part of such Holder’s Notes at a purchase price in cash equal to 101% of the principal amount thereof, plus accrued and unpaid interest, on the Notes repurchased to, but excluding,
the date of purchase (subject to the right of the Holders of record on the relevant record date to receive interest, if any, due on the relevant Interest Payment Date), as provided in, and subject to the terms of, the Indenture. In accordance with
Section 4.09 of the Indenture, the Partnership will be required to offer to purchase Notes upon the occurrence of certain Asset Sale Triggering Events. 
  

	 	7.	Denominations; Transfer; Exchange. 

 The
[ 🌑 ]% Series Notes are to be issued in registered form, without coupons, in denominations of $2,000 and integral multiples of $1,000 in excess of $2,000. A Holder may register the transfer of, or
exchange, [ 🌑 ]% Series Notes in accordance with the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay any
taxes and fees required by law or permitted by the Indenture. 
  

	 	8.	Person Deemed Owners. 

 The registered Holder of a Note may be treated as the owner of it
for all purposes. 

  
 Exhibit A-2-5 

	 	9.	Amendment; Supplement; Waiver. 

 Subject to certain exceptions, the Indenture may be
amended or supplemented, and any existing Event of Default or compliance with any provision may be waived, with the consent of the Holders of a majority in principal amount of the outstanding Debt Securities of each series affected. Without consent
of any Holder of a Note, the parties thereto may amend or supplement the Indenture to, among other things, cure any ambiguity or omission, to correct any defect or inconsistency, or to make any other change that does not adversely affect the rights
of any Holder of a Note. Any such consent or waiver by the Holder of this Note (unless revoked as provided in the Indenture) shall be conclusive and binding upon such Holder and upon all future Holders and owners of this Note and any [ 🌑 ]% Series Notes which may be issued in exchange or substitution herefor, irrespective of whether or not any notation thereof is made upon this Note or such other
[ 🌑 ]% Series Notes. 
  

	 	10.	Additional Rights of Holders of Restricted Global Notes and Restricted Definitive Notes. 

 In addition to
the rights provided to Holders of Notes under the Indenture, Holders of Restricted Global Notes and Restricted Definitive Notes will have all the rights set forth in the Registration Rights Agreement dated as of
[ 🌑 ], between the Partnership and the other parties named on the signature pages thereof or, in the case of Additional Notes, Holders of Restricted Global Notes and Restricted Definitive Notes
will have the rights set forth in one or more registration rights agreements, if any, among the Partnership, the Subsidiary Guarantors, if any, and the other parties thereto, relating to rights given by the Partnership and the Subsidiary Guarantors,
if any, to the purchasers of any Additional Notes (collectively, the “Registration Rights Agreement”). By such Holders’ acceptance of Restricted Global Notes or Restricted Definitive Notes, such Holder acknowledges and agrees
to the provisions of the Registration Rights Agreement, including without limitation the obligations of the Holders with respect to indemnification of the Partnership and the Subsidiary Guarantors to the extent provided therein. 

 

	 	11.	Defaults and Remedies. 

 Certain events of bankruptcy or insolvency are Events of Default
that will result in the principal amount of the [ 🌑 ]% Series Notes, together with premium, if any, and accrued and unpaid interest thereon, becoming due and payable immediately upon the
occurrence of such Events of Default. If any other Event of Default with respect to the [ 🌑 ]% Series Notes occurs and is continuing, then in every such case the Trustee or the Holders of not less
than 33 1/3% in aggregate principal amount of the [ 🌑 ]% Series Notes then outstanding may declare the principal amount of all the [ 🌑 ]%
Series Notes, together with premium, if any, and accrued and unpaid interest thereon, to be due and payable immediately in the manner and with the effect provided in the Indenture. Notwithstanding the preceding sentence, however, if at any time
after such a declaration of acceleration has been made, the Holders of a majority in principal amount of the outstanding [ 🌑 ]% Series Notes, by written notice to the Trustee, may rescind such
declaration and annul its consequences if the rescission would not conflict with any judgment or decree of a court already rendered and if all Events of Default with respect to the [ 🌑 ]% Series
Notes, other than the nonpayment of the principal, premium, if any, or interest which has become due solely by such declaration acceleration, shall have been cured or shall have been waived. No such rescission shall affect any subsequent default or
shall impair any right consequent thereon. Holders of [ 🌑 ]% Series Notes may not enforce the Indenture or the [ 🌑 ]% Series Notes except as
provided in the Indenture. The Trustee may require indemnity or security satisfactory to it before it enforces the Indenture or the [ 🌑 ]% Series Notes. Subject to certain limitations, Holders of
a majority in aggregate principal amount of the [ 🌑 ]% Series Notes then outstanding may direct the Trustee in its exercise of any trust or power. 

  
 Exhibit A-2-6 

 This Regulation S Temporary Global Note is exchangeable in whole or in part for one or more
Global Notes only (i) on or after the termination of the 40-day distribution compliance period (as defined in Regulation S) and (ii) upon presentation of certificates (accompanied by an Opinion of
Counsel, if applicable) required by Article 2 of the Indenture. Upon exchange of this Regulation S Temporary Global Note for one or more Global Notes, the Trustee shall cancel this Regulation S Temporary Global Note. 

 

	 	12.	Trustee Dealings with Partnership. 

 The Trustee under the Indenture, in its individual
or any other capacity, may make loans to, accept deposits from, and perform services for the Partnership or its Affiliates, and may otherwise deal with the Partnership or its Affiliates as if it were not the Trustee. 

 

	 	13.	Authentication. 

 This Note shall not be valid until the Trustee signs the certificate of
authentication on the other side of this Note. 
  

	 	14.	Abbreviations and Defined Terms. 

 Customary abbreviations may be used in the name of a
Holder of a Note or an assignee, such as: TEN COM (tenant in common), TEN ENT (tenants by the entireties), JT TEN (joint tenants with right of survivorship and not as tenants in common), CUST (Custodian), and U/G/M/A (Uniform Gifts to Minors Act).

  

	 	15.	CUSIP Numbers. 

 Pursuant to a recommendation promulgated by the Committee on Uniform
Security Identification Procedures, the Partnership has caused CUSIP numbers to be printed on the [ 🌑 ]% Series Notes as a convenience to the Holders of the
[ 🌑 ]% Series Notes. No representation is made as to the accuracy of such number as printed on the [ 🌑 ]% Series Notes and reliance may be
placed only on the other identification numbers printed hereon. 
  

	 	16.	Absolute Obligation. 

 No reference herein to the Indenture and no provision of this Note
or the Indenture shall alter or impair the obligation of the Partnership, which is absolute and unconditional, to pay the principal of, premium, if any, and interest on this Note in the manner, at the respective times, at the rate and in the coin or
currency herein prescribed. 
  

	 	17.	No Recourse. 

 No director, officer, employee, limited partner or shareholder, as such,
of the Partnership or the General Partner shall have any personal liability in respect of the obligations of the Partnership under the [ 🌑 ]% Series Notes, the Indenture or any Guarantee by reason
of his, her or its status. Each Holder by accepting the [ 🌑 ]% Series Notes waives and releases all such liability. The waiver and release are part of the consideration for issuance of the [ 🌑 ]% Series Notes. 

  
 Exhibit A-2-7 

	 	18.	Governing Law. 

 This Note shall be construed in accordance with and governed by the laws
of the State of New York. 
 ABBREVIATIONS 

The following abbreviations, when used in the inscription on the face of this instrument, shall be construed as though they were written out
in full according to applicable laws or regulations: 
  

			
	TEN COM—as tenants in common	  	UNIF GIFT MIN ACT -
		  	                                      
                                  (Cust.)
	TEN ENT—as tenants by entireties	  	Custodian for:
		  	                                      
                                  (Minor)
	JT TEN—as joint tenants with right of survivorship and not as tenants in common	  	Under Uniform Gifts to Minors Act of
		  	                                      
                                  (State)

 ADDITIONAL ABBREVIATIONS MAY ALSO
BE USED THOUGH NOT IN THE ABOVE LIST. 

  
 Exhibit A-2-8 

 ASSIGNMENT 

FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and transfer(s) unto 

PLEASE INSERT SOCIAL SECURITY OR OTHER 
 IDENTIFYING NUMBER OF
ASSIGNEE 
 Please print or type name and address including postal zip code of assignee: 

the within Note and all rights thereunder, hereby irrevocably constituting and appointing to transfer said Note on the books of the Partnership, with full
power of substitution in the premises. 
 Dated
                                         
                                         
                                         
                             Registered Holder 

  
 Exhibit A-2-9 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Note purchased by the Partnership pursuant to Section 4.08 or
Section 4.09 of the Indenture, check the appropriate box below: 
  

			
	☐ Section 4.08	  	☐ Section 4.09
	    [Change of Control]	  	    [Asset Sale]

 If you want to elect to have only part of the Note purchased by the Partnership pursuant to
Section 4.08 or 4.09 of the Indenture, state the amount you elect to have purchased: 
 $ 

Date: 
  

			
	 Your Signature:
	 	  

		 	 (Sign exactly as your name appears on the face of this Note)

	
	Tax Identification No:

 Signature Guarantee*: 

 

	*	Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). 

  
 Exhibit A-2-10 

 SCHEDULE OF INCREASES OR DECREASES 

IN THE REGULATION S TEMPORARY GLOBAL NOTE* 

The following increases or decreases in this Regulation S Temporary Global Note have been made: 

 

									
	 Date of Exchange
	 	 Amount of Decrease

in Principal Amount
 of this
Global
 Note
	 	 Amount of Increase

in Principal Amount
 of this
Global
 Note
	  	 Principal Amount of

this Global Note
 following
such
 decrease (or increase)
	  	 Signature of

authorized officer of

Trustee or Depositary

		 		 		  		  	
		 		 		  		  	
		 		 		  		  	

  

	*	To be included in a Global Note. 

  
 Exhibit A-2-11 

 EXHIBIT B 

FORM OF CERTIFICATE OF TRANSFER 
 The Bank of New
York Mellon, as Trustee 
 101 Barclay Street, 7 W 
 New York,
New York 10286 
  

	cc:	Cheniere Energy Partners, L.P. 

 c/o Cheniere Energy, Inc. 

700 Milam Street, Suite 1900 

Houston, TX 77002 
 Re: [ 🌑 ]% Senior Notes due [ 🌑 ] issued by Cheniere Energy Partners, L.P. 

Reference is hereby made to the Indenture, dated as of September 18, 2017, as supplemented by the
[ 🌑 ] supplemental indenture dated as of [ 🌑 ], (the “Indenture”), among Cheniere Energy Partners, L.P., as issuer (the
“Partnership”), the Guarantors party thereto and The Bank of New York Mellon, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. 

                       
         , (the “Transferor”) owns and proposes to transfer the Note[s] or interest in such Note[s] specified in Annex A hereto, in the principal amount of
$             in such Note[s] or interests (the “Transfer”),
to                                 (the “Transferee”), as further
specified in Annex A hereto. In connection with the Transfer, the Transferor hereby certifies that: 
 [CHECK ALL THAT APPLY] 

 

	1.	☐ Check if Transferee will take delivery of a beneficial interest in the Rule 144A Global Note or a Restricted Definitive Note pursuant to Rule 144A. The Transfer is being effected pursuant to and in
accordance with Rule 144A (“Rule 144A”) under the Securities Act of 1933, as amended (the “Securities Act”), and, accordingly, the Transferor hereby further certifies that the beneficial interest or Definitive Note
is being transferred to a Person that the Transferor reasonably believes is purchasing the beneficial interest or Definitive Note for its own account, or for one or more accounts with respect to which such Person exercises sole investment
discretion, and such Person and each such account is a “qualified institutional buyer” within the meaning of Rule 144A in a transaction meeting the requirements of Rule 144A, and such Transfer is in compliance with any applicable blue sky
securities laws of any state of the United States. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will be subject to the restrictions on transfer
enumerated in the Private Placement Legend printed on the Rule 144A Global Note and/or the Restricted Definitive Note and in the Indenture and the Securities Act. 

  
 Exhibit B-1 

	2.	☐ Check if Transferee will take delivery of a beneficial interest in the Regulation S Temporary Global Note, the Regulation S Permanent Global Note or a Restricted Definitive Note
pursuant to Regulation S. The Transfer is being effected pursuant to and in accordance with Rule 903 or Rule 904 under the Securities Act and, accordingly, the Transferor hereby further certifies that (i) the Transfer is not being made
to a Person in the United States and (x) at the time the buy order was originated, the Transferee was outside the United States or such Transferor and any Person acting on its behalf reasonably believed and believes that the Transferee was
outside the United States or (y) the transaction was executed in, on or through the facilities of a designated offshore securities market and neither such Transferor nor any Person acting on its behalf knows that the transaction was prearranged
with a buyer in the United States, (ii) no directed selling efforts have been made in contravention of the requirements of Rule 903(b) or Rule 904(b) of Regulation S under the Securities Act, (iii) the transaction is not part of a plan or
scheme to evade the registration requirements of the Securities Act and (iv) if the proposed transfer is being made prior to the expiration of the Restricted Period, (x) the transfer is not being made to a U.S. Person or for the account or
benefit of a U.S. Person (other than the Initial Purchasers) and (y) the interest transferred will be held immediately thereafter through Euroclear or Clearstream. Upon consummation of the proposed transfer in accordance with the terms of the
Indenture, the transferred beneficial interest or Definitive Note will be subject to the restrictions on Transfer enumerated in the Private Placement Legend printed on the Regulation S Permanent Global Note, the Regulation S Temporary Global Note
and/or the Restricted Definitive Note and in the Indenture and the Securities Act. 

  

	3.	☐ Check and complete if Transferee will take delivery of a beneficial interest in a Restricted Definitive Note pursuant to any provision of the Securities Act other than Rule 144A or Regulation S.
The Transfer is being effected in compliance with the transfer restrictions applicable to beneficial interests in Restricted Global Notes and Restricted Definitive Notes and pursuant to and in accordance with the Securities Act and any applicable
blue sky securities laws of any state of the United States, and accordingly the Transferor hereby further certifies that (check one): 

  

	 	a.	☐ such Transfer is being effected pursuant to and in accordance with Rule 144 under the Securities Act; 

or 
  

	 	b.	☐ such Transfer is being effected to the Partnership or a subsidiary thereof; 

 or 

 

	 	c.	☐ such Transfer is being effected pursuant to an effective registration statement under the Securities Act and in compliance with the prospectus delivery requirements of the Securities Act; 

or 
  

	 	d.	 ☐ such Transfer is being effected to an Institutional Accredited Investor and pursuant to an exemption from
the registration requirements of the Securities Act other than Rule 144A, Rule 144, Rule 903 or Rule 904, and the Transferor hereby further certifies that it has not engaged in any general solicitation within the meaning of Regulation D under the
Securities 

  
 Exhibit B-2 

	 	
Act and the Transfer complies with the transfer restrictions applicable to beneficial interests in a Restricted Global Note or Restricted Definitive Notes and the requirements of the exemption
claimed, which certification is supported by (1) a certificate executed by the Transferee in the form of Exhibit G to the Indenture and (2) if such Transfer is in respect of a principal amount of Notes at the time of transfer of less than
$250,000, an Opinion of Counsel provided by the Transferor or the Transferee (a copy of which the Transferor has attached to this certification), to the effect that such Transfer is in compliance with the Securities Act. Upon consummation of the
proposed transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the IAI Global Note and/or
the Restricted Definitive Notes and in the Indenture and the Securities Act. 

  

	4.	☐ Check IF TRANSFEREE WILL TAKE DELIVERY OF A BENEFICIAL INTEREST IN AN UNRESTRICTED GLOBAL NOTE OR OF AN UNRESTRICTED DEFINITIVE NOTE. 

 

	 	a.	☐ Check if Transfer is pursuant to Rule 144. (i) The Transfer is being effected pursuant to and in accordance with Rule 144 under the Securities Act and in compliance with the transfer restrictions contained in
the Indenture and any applicable blue sky securities laws of any state of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with
the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will no longer be subject to the restrictions on transfer enumerated in the Private
Placement Legend printed on the Restricted Global Notes, on Restricted Definitive Notes and in the Indenture. 

  

	 	b.	☐ Check if Transfer is Pursuant to Regulation S. (i) The Transfer is being effected pursuant to and in accordance with Rule 903 or Rule 904 under the Securities Act and in compliance with the transfer
restrictions contained in the Indenture and any applicable blue sky securities laws of any state of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to
maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will no longer be subject to the restrictions on transfer
enumerated in the Private Placement Legend printed on the Restricted Global Notes, on Restricted Definitive Notes and in the Indenture. 

  

	 	c.	☐ Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule
144, Rule 903 or Rule 904 and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture
and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive
Note will not be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. 

  
 Exhibit B-3 

 This certificate and the statements contained herein are made for your benefit and the benefit of
the Partnership. 
  

			
	  

[Insert Name of Transferor]

		
	 By:
	 	  

	 Name:
	 	
	 Title:
	 	

 Dated: 

  
 Exhibit B-4 

 ANNEX A TO CERTIFICATE OF TRANSFER 

 

	 	(a)	The Transferor owns and proposes to transfer the following: 

 [CHECK ONE OF (a) OR (b)]

  

	 	(1)	☐ a beneficial interest in the: 

  

	 	(i)	☐ Rule 144A Global Note (CUSIP                      ),
or                     

  

	 	(ii)	☐ Regulation S Global Note (CUSIP                      ); or 

 

	 	(iii)	☐ IAI Global Note (CUSIP                      ); or 

 

	 	(2)	☐ a Restricted Definitive Note. 

  

	 	(b)	After the Transfer the Transferee will hold: 

 [CHECK ONE] 

 

	 	(1)	☐ a beneficial interest in the: 

  

	 	(i)	☐ Rule 144A Global Note (CUSIP                      ), or 

 

	 	(ii)	☐ Regulation S Global Note (CUSIP                      ); or 

 

	 	(iii)	☐ IAI Global Note (CUSIP                      ); or 

 

	 	(iv)	☐ Unrestricted Global Note (CUSIP                      ). 

 

	 	(2)	☐ Restricted Definitive Note; or 

  

	 	(3)	☐ an Unrestricted Definitive Note, 

 in accordance with the terms of the Indenture. 

  
 Exhibit B-5 

 EXHIBIT C 

FORM OF CERTIFICATE OF EXCHANGE 
 The Bank
of New York Mellon, as Trustee 
 101 Barclay Street, 7 W 
 New
York, New York 10286 
  

	cc:	Cheniere Energy Partners, L.P. 

 c/o Cheniere Energy, Inc. 

700 Milam Street, Suite 1900 

Houston, TX 77002 
 Re: [ 🌑 ]% Senior Notes due [ 🌑 ] issued by Cheniere Energy Partners, L.P. 

(CUSIP                     ) 

Reference is hereby made to the Indenture, dated as of September 18, 2017, as supplemented by the
[ 🌑 ] supplemental indenture dated as of [ 🌑 ] (the “Indenture”), among Cheniere Energy Partners, L.P., as issuer (the
“Partnership”), the Guarantors party thereto and The Bank of New York Mellon, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. 

                       
     , (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified herein, in the principal amount of
$                         in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the
Owner hereby certifies that: 
 1. Exchange of Restricted Definitive Notes or Beneficial Interests in a Restricted Global Note for Unrestricted
Definitive Notes or Beneficial Interests in an Unrestricted Global Note 
 a. ☐ Check if Exchange is from beneficial
interest in a Restricted Global Note to beneficial interest in an Unrestricted Global Note. In connection with the Exchange of the Owner’s beneficial interest in a Restricted Global Note for a beneficial interest in an Unrestricted
Global Note in an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer, (ii) such Exchange has been effected in compliance with the transfer
restrictions applicable to the Global Notes and pursuant to and in accordance with the Securities Act of 1933, as amended (the “Securities Act”), (iii) the restrictions on transfer contained in the Indenture and the Private
Placement Legend are not required in order to maintain compliance with the Securities Act and (iv) the beneficial interest in an Unrestricted Global Note is being acquired in compliance with any applicable blue sky securities laws of any state
of the United States. 
 b. ☐ Check if Exchange is from beneficial interest in a Restricted Global Note to Unrestricted
Definitive Note. In connection with the Exchange of the Owner’s beneficial interest in a Restricted Global Note for an Unrestricted Definitive Note, the Owner hereby certifies (i) the Definitive Note is being acquired for the
Owner’s own 

  
 Exhibit C-1 

	 	
account without transfer, (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with
the Securities Act, (iii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act and (iv) the Definitive Note is being acquired in
compliance with any applicable blue sky securities laws of any state of the United States. 

 c. ☐ Check if
Exchange is from Restricted Definitive Note to beneficial interest in an Unrestricted Global Note. In connection with the Owner’s Exchange of a Restricted Definitive Note for a beneficial interest in an Unrestricted Global Note, the
Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer, (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to Restricted Definitive
Notes and pursuant to and in accordance with the Securities Act, (iii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act and
(iv) the beneficial interest is being acquired in compliance with any applicable blue sky securities laws of any state of the United States. 

d. ☐ Check if Exchange is from Restricted Definitive Note to Unrestricted Definitive Note. In connection with the
Owner’s Exchange of a Restricted Definitive Note for an Unrestricted Definitive Note, the Owner hereby certifies (i) the Unrestricted Definitive Note is being acquired for the Owner’s own account without transfer, (ii) such
Exchange has been effected in compliance with the transfer restrictions applicable to Restricted Definitive Notes and pursuant to and in accordance with the Securities Act, (iii) the restrictions on transfer contained in the Indenture and the
Private Placement Legend are not required in order to maintain compliance with the Securities Act and (iv) the Unrestricted Definitive Note is being acquired in compliance with any applicable blue sky securities laws of any state of the United
States. 
 2. Exchange of Restricted Definitive Notes or Beneficial Interests in Restricted Global Notes for Restricted Definitive Notes or Beneficial
Interests in Restricted Global Notes 
 a. ☐ Check if Exchange is from beneficial interest in a Restricted Global Note to
Restricted Definitive Note. In connection with the Exchange of the Owner’s beneficial interest in a Restricted Global Note for a Restricted Definitive Note with an equal principal amount, the Owner hereby certifies that the Restricted
Definitive Note is being acquired for the Owner’s own account without transfer. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the Restricted Definitive Note issued will continue to be subject to the
restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Definitive Note and in the Indenture and the Securities Act. 

b. ☐ Check if Exchange is from Restricted Definitive Note to beneficial interest in a Restricted Global Note. In connection with the
Exchange of the Owner’s Restricted Definitive Note for a beneficial interest in the [CHECK ONE] ☐ Rule 144A Global Note or ☐ Regulation S Global Note or ☐ IAI Global Note with an equal principal amount, the Owner hereby
certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer and (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and
pursuant to and in accordance with the Securities Act, and in compliance with any applicable blue sky 

  
 Exhibit C-2 

	 	
securities laws of any state of the United States. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the beneficial interest issued will be subject to the
restrictions on transfer enumerated in the Private Placement Legend printed on the relevant Restricted Global Note and in the Indenture and the Securities Act. 

  
 Exhibit C-3 

 This certificate and the statements contained herein are made for your benefit and the benefit of
the Partnership. 
  

			
	  

[Insert Name of Transferor]

		
	 By:
	 	  

	 Name:
	 	
	 Title:
	 	

  
 Exhibit C-4 

 EXHIBIT D 

FORM OF SUPPLEMENTAL INDENTURE 

FOR ADDITIONAL GUARANTORS 

SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of
                    , 20    , among
[                    ] (the “Additional Guarantor”), a subsidiary of Cheniere Energy Partners, L.P. (or its permitted successor), a
Delaware limited partnership (the “Partnership”), the Partnership, the other Subsidiary Guarantors (as defined in the Indenture referred to herein) and The Bank of New York Mellon, as trustee under the Indenture referred to below
(the “Trustee”). 
 W I T N E S S E T H 

WHEREAS, the Partnership and the Subsidiary Guarantors have heretofore executed and delivered to the Trustee an indenture (the
“Indenture”), dated as of September 18, 2017 providing for the issuance of the Notes (as defined in the Indenture); 

WHEREAS, the Indenture provides that under certain circumstances the Additional Guarantor shall execute and deliver to the Trustee a
supplemental indenture pursuant to which the Additional Guarantor shall unconditionally guarantee all of the Partnership’s obligations under the Notes and the Indenture on the terms and conditions set forth herein (the “Note
Guarantee”); and 
 WHEREAS, pursuant to Section 9.01 of the Indenture, the Partnership has requested and hereby requests that
the Trustee join in the execution of this Supplemental Indenture and the Trustee is authorized to execute and deliver this Supplemental Indenture. 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged,
the Additional Guarantor and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders as follows: 
 1.
Capitalized Terms. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture. 
 2.
Guarantee. The Additional Guarantor hereby provides an unconditional Guarantee on the terms and subject to the conditions set forth in the Note Guarantee and in the Indenture including but not limited to Article X thereof. 

3. No Recourse Against Others. No past, present or future director, officer, employee, incorporator, stockholder or agent of the
Additional Guarantor, as such, shall have any liability for any obligations of the Partnership or any Additional Guarantor under the Notes, any Note Guarantees, the Indenture or this Supplemental Indenture or for any claim based on, in respect of,
or by reason of, such obligations or their creation. Each Holder of the Notes by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Notes. 

4. NEW YORK LAW TO GOVERN. THE LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE. 

  
 D-1 

 5. Counterpart Originals. The parties may sign any number of copies of this Supplemental
Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or electronic (i.e., “pdf” or
“tif”) transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Indenture for all purposes. Signatures of the parties hereto transmitted
by facsimile or electronic (i.e., “pdf” or “tif”) transmission shall be deemed to be their original signatures for all purposes. 

6. Table of Contents, Headings, etc.. The table of contents and headings of the Articles and Sections of this Supplemental
Indenture have been inserted for convenience of reference only, are not to be considered a part hereof and shall in no way modify or restrict any of the terms or provisions hereof. 

7. Trust Indenture Act Controls. Upon registration of the Notes in accordance with the Registration Rights Agreement, if any provision
of the Supplemental Indenture limits, qualifies, or conflicts with another provision that is required to be included in the Indenture by the TIA, the required provision shall control. 

8. Ratification of Base Indenture. The Indenture, as supplemented by this Supplemental Indenture, is in all respects except as modified
by the Supplemental Indenture ratified and confirmed, and this Supplemental Indenture shall be deemed part of the Indenture in the manner and to the extent herein and therein provided. 

9. Trustee Not Responsible for Recitals. The recitals contained herein shall be taken as the statements of the Partnership and the
Additional Guarantors, and the Trustee assumes no responsibility for the correctness of the same. The Trustee makes no representations as to the validity, adequacy or sufficiency of this Supplemental Indenture 

  
 D-2 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested,
all as of the date first above written. 
 Dated
                    , 20     
  

	
	[ADDITIONAL GUARANTOR]
	
	  
 Name:

	Title:
	
	CHENIERE ENERGY PARTNERS, L.P.
	
	  
 Name:

	Title:
	
	[EXISTING GUARANTORS]
	
	  
 Name:

	Title:
	
	 THE BANK OF NEW YORK MELLON

    as Trustee

	
	  
 Name:

	Title:

  
 Exhibit D-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}]]